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Abstract 
Phosphorus (P) is one of the essential nutrients for living organisms; however, excess P in 
aquatic systems often causes environmental and ecological problems including eutrophication. 
Removal of P from domestic wastewater, industrial wastewater, and agricultural organic-waste 
systems is required to minimize loading of P to receiving water bodies.  A variety of sorbents or 
filter materials have previously been evaluated for P removal, including natural materials, 
industrial byproducts, and synthetic products. Among these materials industrial byproducts were 
reported as most effective. However, only a few of these studies were based on field 
experiments. Pharmaceutically active compounds (PhACs) and acesulfame-K (an artificial 
sweetener) are emerging contaminants observed in wastewater. The removal of PhACs in 
conventional wastewater treatment systems has been studied; however, few studies on 
alternative treatment systems are available. Studies related to the removal of acesulfame-K are 
even more limited. This thesis was focused on evaluation of basic oxygen furnace slag (BOFS), 
a byproduct from the steel manufacturing industry, as a potential reactive media for P removal 
from surface water and wastewater. The removal of PhACs and acesulfame-K in wastewater 
treatment systems containing BOFS as a treatment component was also evaluated.      
The effectiveness of BOFS for removing P from lake water was evaluated in a three year pilot-
scale hypolimnetic withdrawal P treatment system at Lake Wilcox, Richmond Hill, Ontario. 
Phosphate concentrations of the hypolimnion water ranged from 0.3 to 0.5 mg L
-1
. About 83-
100% P was removed during the experiment.  The reactive mixtures were changed each year to 
improve the performance of the treatment system. Elevated pH (9-12) at the effluent of the 
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treatment system was adjusted by sparging CO2(g) to near neutral pH. Elevated Al was removed 
through this pH adjustment.  Elevated concentrations of V were removed in a column containing 
5 wt% zero valent iron (ZVI) mixed with sand (0.5 m
3
) at the end of the BOFS based column. 
Removal of P in the BOFS based media is attributed to adsorption and co-precipitation at the 
outer layer of BOFS. Geochemical modeling results showed supersaturation with respect to 
hydroxyapatite, -tricalciumphosphate, aragonite, and calcite. Solid phase analyzes of the BOFS 
based reactive media collected after completion of the year 2 experiment (spent media) through 
combination of scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy 
(EDX), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy 
(FTIR), and X-ray absorption near edge structure spectroscopy (XANES) support the presence 
of calcium phosphate minerals on the outer layer of the spent media.  
A multistep wastewater treatment experiment was carried out in an indoor facility at the 
Center for Alternative Wastewater Treatment, Fleming College, Lindsay, Ontario, Canada. This 
experiment evaluated the removal of P, ammonia, cBOD5, COD, E. coli, total coliform, and 
trace metals in a series of treatment cells including a mixing cell, a vertical subsurface flow 
aerobic cell, a vertical subsurface flow P treatment cell containing BOFS, and a horizontal 
subsurface flow anaerobic cell. About 97-99% removal of P, NH3, cBOD5, E. coli, and total 
coliform; and ~72% removal of COD were achieved in the treatment system. The mixing cell 
and the aerated cell reduced the concentrations of P, ammonia, cBOD5, E. coli, and total 
coliform significantly and the P treatment cell provided additional treatment. However, the 
primary objective of the P treatment cell was to reduce P concentrations to the acceptable range 
according to the water quality guidelines. The P treatment cell had successfully fulfilled this 
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objective. Elevated concentration of Al and V were also observed in the P treatment cell 
effluent. The concentration of Al decreased to below the guideline value of 0.075 mg L
-1
 after 
introducing a pH adjustment unit between the P treatment cell and the anaerobic cell. The 
concentration of V was decreased in the anaerobic cell effluent. However, the effluent 
concentration of V was much higher than the guideline value. Geochemical speciation modeling 
results showed supersaturation with respect to hydroxyapatite, -tricalciumphosphate, aragonite 
and calcite along the flow path. Accumulation of P on the outer layer of the spent BOFS media 
was identified by energy dispersive X-ray spectroscopy (EDX). Although X-ray photoelectron 
spectroscopy (XPS) can provide information to a depth of 5-7 nm from the outer layer of the 
spent media, both Ca and P were positively identified in some of the samples. Accumulation of 
P at the edge of the grains of the spent media was clearly identified on the element map of 
polished cross-sections and corresponding FTIR spectra. The phosphate and carbonate 
functional groups were identified by the distribution of different vibrational frequencies through 
FTIR spectroscopy. The presence of calcite and hydroxyapatite were inferred based on the wave 
numbers assigned for these minerals in the literature. Finally, X-ray absorption near edge 
structure spectroscopy (XANES) on the outer layer samples from the spent BOFS media and 
corresponding linear combination fitting analysis indicated the presence of -
tricalciumphosphate, hydroxyapatite, and calcium phosphate dibasic.             
Based on the observations from the indoor wastewater treatment experiment, a multistep 
demonstration-scale outdoor wastewater treatment experiment was conducted to investigate the 
applicability of the integration of the P treatment technology and engineered wetland technology 
at a relatively large scale prior to a full-scale field installation. The anaerobic treatment cell was 
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not included in this outdoor system because this unit did not efficiently remove ammonia and 
metals (e.g. V) from the Cell 4 effluent in the indoor system. A 10 cm layer of zero valent iron 
was placed at the bottom part of the down flowing P treatment cell to address the elevated V in 
the P treatment cell effluent observed in the indoor system and also to treat PhACs in the 
effluent. More than 99% removal of P, E. coli, and total coliform; >82, >98, and >76% removal 
of ammonia, cBOD5, and COD were achieved in this treatment system. The effluent pH 
(10.88±1.47) was neutralized and the concentration of V remained < 0.006 mg L
-1
. The Al 
concentration was adjusted to <0.075 mg L
-1
 with the neutralization of pH. Geochemical 
speciation modeling results showed the supersaturation of hydroxyapatite, -
tricalciumphosphate, octatricalciumphosphate, aragonite, and calcite.  The FTIR and XANES 
spectra showed the presence of calcium phosphate minerals on the outer layer of the spent 
media.     
Removal of the PhACs, including caffeine, ibuprofen, carbamazepine, naproxen, and 
sulfamethoxazole, and acesulfame-K was monitored in the demonstration-scale outdoor 
wastewater treatment system, which consisted of five different treatment cells including a 
horizontal subsurface flow constructed wetland, a vertical subsurface flow aerated cell, a vertical 
subsurface flow BOFS cell, and a pH neutralization unit. Significant removal of caffeine (>75%) 
and ibuprofen (50-75%), and moderate removal of sulfamethoxazole and naproxen (25-50%) 
were observed.  The removal of carbamazepine was less effective with <25% removal observed. 
Acesulfame-K was also persistent along the flow path with <25% removal.   
This study demonstrated that removal of P from lake water and wastewater in excess of 95% 
could be achieved using BOFS as a reactive media. Integration of this media into an engineered 
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wetland system enhances its performance in removing nutrients and other wastewater 
contaminants.   
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Chapter 1 
Introduction 
1.1 Background  
1.1.1 Geochemistry of the contaminants  
The release of phosphorus (P) to any surface water body has environmental significance because 
P is an essential component of cells in living organisms, and the limiting nutrient in many 
aquatic ecosystems (Schindler 1974, 1977). Excess P in surface water can cause eutrophication, 
which is a process that leads to excessive growth of aquatic plant life and depletion of dissolved 
oxygen (Parry 1998). Phosphorus concentrations in wastewater are typically 5 to 15 mg L
-1
 PO4-
P (Snoeyink and Jenkins, 1980). The P attenuation capacity of natural sediments is limited, thus, 
excess inputs of P can result in the unattenuated movement of this contaminant in groundwater 
flow systems. The discharge of domestic wastewater or agricultural organic-waste systems in 
close proximity to surface waters is a particular concern due to P mobility, and potential impacts 
on surface water bodies. Groundwater discharge or surface runoff can contribute P loading to the 
receiving surface water bodies. The internal cycling of P in lake sediments is an important cause 
of eutrophication (Nürnberg, 1988; Bostrom et al., 1988; Søndergaard et al., 2003). The 
concentration ranges of total phosphorus for ultra-oligotrophic, oligotrophic, mesotrophic, meso-
eutrophic, eutrophic, and hyper-eutrophic lakes described in CWQG (2005) are <0.004, 0.004-
0.01, 0.01-0.02, 0.02-0.035, 0.035-0.1, and >0.1 mg L
-1
. To prevent eutrophication, phosphate 
concentrations should be below 0.025 mg L
-1 
within a lake and below 0.05 mg L
-1
 when streams 
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discharge into lakes (U. S. EPA 1986). Thus, loading of very small concentrations of P (0.001 to 
0.01 mg L
-1
) in lakes can boost algal growth (Tomson and Vignona, 1984).  
Factors that control the P exchange between sediments of lakes and the overlying water 
column are primarily biological, chemical, and physical. The biological factors include bacterial 
activities, biomineralization processes, and bioturbation; chemical factors include redox 
conditions, pH, Fe:P ratio, nitrate availability; and physical factors  include resuspension and 
sediment mixing (Boström and Petterson, 1982; Søndergaard et al., 2003). Phosphorus release 
from lake sediments is related to thermal stratiﬁcation and anoxia in the hypolimnion, which is 
the dense, bottom layer of water in a thermally-statified lake (Nürnberg, 1984). 
Anoxic conditions in the sediment-water interface favour P release from the lake sediment to 
the overlying water column (Bostrom et al., 1988). Under anoxic conditions, P and Fe are 
released from the lake sediment through reductive dissolution of iron oxy-hydroxide -phosphate 
complexes. Sulfate in the sediment (if present) can be reduced to sulfide under anoxic conditions 
and combines with Fe released from sediment to form FeS and ultimately increases the 
concentrations of P in the water column (Caraco et al., 1993; Figure 1.1).  Søndergaard et al. 
(2003) also described the redox-dependent release of FeOOH-bound P and microbial processes 
as major P release mechanisms from lake sediments. In addition to release of P under anaerobic 
conditions, P also can be released from sediments under aerobic conditions through desorption, 
mineral dissolution and organic matter oxidation reactions (Reed et al., 2011). 
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About 90% of the anaerobically released P is derived from the sediment Fe-P fraction and both 
the amount of aerobically released P and the maximum growth yield of algae is proportional to 
the sediment Fe-P fraction (Hosomi et al., 1982). 
Phosphorus removal from wastewater is an important challenge in the development of 
wastewater treatment technologies. Existing technologies for control of P can be classified into 
several broad categories, such as chemical precipitation, biological P removal, crystallization 
technologies, advanced chemical precipitation and nutrient removal, and sludge-based processes 
Morse et al. (1998).  
Chemical precipitation is one of the most important mechanisms for inorganic P removal.  
Precipitation of calcium-, aluminum-, and iron-phosphates are three commonly applied methods 
of chemical precipitation (Yeoman et al., 1988). Calcium ion (Ca
2+
) derived from lime or any 
other sources can be combined with aqueous phase phosphate ion (PO4
3-
) to produce 
hydroxyapatite, or other calcium-phosphate minerals, under the pH range 8.0 to 11.0, through 
reactions of the following form (Yeoman et al., 1988): 
(1.1)                
                         
 Precipitation of aluminum phosphate using aluminum sulfate (Shannon, 1980): 
(1.2)                      
              
         
Precipitation of aluminum phosphate from trivalent aluminum salts (Metcalf and Eddy, 2003; 
Arvin, 1983): 
(1.3)            
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Precipitation of ferric phosphate from trivalent iron salts (Stumm & Morgan, 1981; Metcalf and 
Eddy, 2003):  
(1.4)            
            
  
Thus, the basic reaction associated with phosphate removal by trivalent metals (Aguilar et al., 
2002):  
(1.5)            
            
  
A number of low-cost reactive materials to remove phosphate from wastewater have been 
identified. Of these, the low-cost reactive materials that showed significant capacity in removing 
phosphate can be classified as natural materials (natural soils, limestone, opoka, clay minerals, 
zeolite, sand, manganese nodules), modified natural materials (granular activated carbon and 
bone char), and waste materials (water treatment plant residuals, blast furnace slag, red mud, 
steel furnace slag, fly ash, and activated red mud) (Mortula et al., 2007). Phosphate removal 
capacities (performance) of the commonly used filter media to remove phosphate from 
wastewater have been reviewed by Vohla et al. (2011).  In this review, 39 articles on natural 
materials, 25 articles on industrial byproducts, and 10 articles on man-made products were 
summarized. The industrial byproducts, including some furnace slags, showed the highest 
phosphate removal capacities of about 420 g P kg
-1
.The natural materials and the man-made 
filter media demonstrated maximum removal capacities of about 40 g P kg
-1
 and12 g P kg
-1
 
respectively.   
Baker et al. (1998) observed >90% P removal over four years in a laboratory column 
containing basic oxygen furnace (BOF) oxide combined with crushed limestone and silica sand 
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and >99% P removal over two years in another laboratory column containing activated alumina 
combined with crushed limestone and silica sand.  Baker et al. (1998) suggested two potential 
phosphate removal mechanisms based on mineralogical investigations, which include phosphate 
adsorption on the surfaces of metal oxides, and precipitation of insoluble calcium phosphate. 
Thus, the governing reactions would be related to one of the following calcium phosphate 
mineral forming reactions:  
(1.6)                           
                        
   
(1.7)                                      
                        
(1.8)                                   
               
(1.9)                  
         
               
Basic oxygen furnace slag contains a high percentage of lime (CaO) and portlandite Ca(OH)2.  
Dissolution of these components significantly increases the pH (to pH~12) and the concentration 
of Ca in solution (Baker et al. 1998).  
(1.10)               
         
At these high pH values, hydroxyapatite may precipitate and retain phosphate on the solid phase 
in the BOFS based reactive media. 
There are challenges in the identification of an effective media and a suitable methodology for 
sustained phosphate removal from a large volume of wastewater and phosphate contaminated 
surface water. The phosphate retention capacity, low cost, and availability of BOF slag and BOF 
oxide suggest that these materials may be appropriate media to restrict phosphate release to 
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surface-water flow systems. Several of the previous studies, however, have identified concerns 
that may limit the widespread application of this approach. These concerns include the release of 
high pH effluent, which may have a negative impact on aquatic receptors; the release of elevated 
concentrations of Al and V; and the formation of secondary minerals, notably calcium carbonate, 
which may limit water flow through the reactive material.  
Pharmaceutically active compounds (PhACs) have been identified as potential surface water 
and groundwater contaminants over the last two decades. PhACs can be introduced to surface 
water and groundwater through sewage-treatment plant effluent, surface runoff from agricultural 
applications of manure and sewage sludge, waste-disposal sites, septic systems, and 
pharmaceutical production plants (Figure 1.2; Heberer, 2002a;  Daughton, 2003; Khetan and 
Collins, 2007; Sabourin et al., 2009).  The individual concentrations of these contaminants are 
usually very low (ng L
-1
 to µg L
-1
) in surface water and groundwater (Ternes, 1998, Halling-
Sørensen et al., 1998; Daughton and Ternes, 1999; Sacher et al., 2001; Kolpin et al., 2002; 
Ternes et al., 2007; Carrara et al., 2008; Fram and Belitz 2011; Sanderson, 2011). However, the 
combined effect of multiple PhACs has potential to develop significant environmental concern. 
Immense attention has focused on these compounds, due to their wide distribution in the 
aquatic ecosystem, and due to their unknown individual or collective impact on living organisms 
including humans and fish. Efforts are underway to explore effective remediation options to 
prevent the release of PhACs to groundwater and surface water flow systems.  
Environmental exposures of PhACs are well documented in literature. Most articles published 
in last two decades focused on the occurrence of PhACs at various points of entry to the 
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environment and transport pathways (Halling-Sørensen et al., 1998; Ternes, 1998; Dughton and 
Ternes, 1999; Kolpin et al., 2002; Heberer, 2002a; Nikolaou et al., 2007; Khetan and Collins, 
2007), and some articles discussed the potential for their removal (Heberer, 2002a; Ternes, 1998; 
Matamoros et al., 2005; Castiglioni et al., 2006; Carballa et al., 2007; Suarez et al., 2008; Benotti 
et al., 2009; Matamoros et al., 2009).    
Caffeine is one of the most studied compounds detected in the aquatic environment and often 
is considered as a potential wastewater tracer (Heberer et al., 2002). Conventional wastewater 
treatment plants usually remove caffeine with high efficiency (up to >99%) through aeration and 
clarification processes (Ternes et al., 2001; Heberer et al., 2002; Bendz et al., 2005; Conkle et al., 
2008). In the US surface streams, the frequency of detection for caffeine is reported as 62% with 
a maximum concentration of 6.0 µg L
-1
 (Kolpin et al., 2002). This compound is also detected in 
groundwater at concentrations between 0.02 and 0.29 µg L
-1
 (Rabiet et al., 2006; Barnes et al., 
2008; Fram and Belitz, 2011), and in drinking water sources (Focazio et al., 2008).  
Ibuprofen is another frequently detected PhAC in STPs effluent and surface water. Although 
some municipal STPs remove up to 95% ibuprofen (Lishman et al., 2006; Suarez et al., 2010), 
STPs  are not always effective (<25% removal) in removing this compound (Metcalfe et al., 
2003). Ibuprofen can be removed both in aerobic and anaerobic conditions as this compound is 
recognized as one of the most biodegradable PhACs in the aquatic environment (Dordio et al., 
2010). However, aerobic conditions (91-99% removal) are more efficient than anaerobic 
conditions (11-63% removal) (Suarez et al., 2010). Ibuprofen is also detected in surface water 
(Kolpin et al., 2002; Rabiet et al., 2006), groundwater (Carrara et al., 2008; Barnes et al., 2008), 
and drinking water sources (Webb et al., 2003; Focazio et al., 2008). 
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Carbamazepine is frequently detected in STP effluents and surface water (Ternes, 1998; 
Heberer, 2002a; Miao and Metcalfe, 2003) and often detected in groundwater (Sacher et al., 
2001). Carbamazepine is not significantly removed in many STPs due to its low biodegradability 
and its neutral form (pKa=13.9) under the pH conditions prevalent in most wastewaters (Ternes 
et al., 2007). In many STPs, the effluent concentrations of carbamazepine are higher than the 
influent concentrations (Metcalfe et al., 2003; Vieno et al., 2006, Spongberg and Witter, 2008). 
In surface water bodies, concentrations of carbamazepine range from 0.06 to 1.10 µg L
-1
 (Kolpin 
et al., 2002; Rabiet et al., 2006; Vieno et al., 2006). Carbamazepine is also detected in 
groundwater at concentrations from 0.03 to 0.42 µg L
-1
 (Webb et al., 2003; Fram and Belitz, 
2011), and untreated drinking water at concentrations from <0.05 to 0.19 µg L
-1
 (Webb et al., 
2003; Focazio et al., 2008). The recalcitrant nature of carbamazepine in the aquatic environment 
has been reported in previous studies (Andreozzi et al., 2002; Heberer, 2002a; Matamoros et al., 
2005). Although conventional STPs show low to negative removal of carbamazepine, significant 
removal (20 to 48%) of this compound in different types of constructed wetlands has been 
reported (Hijosa-Valsero et al., 2010; Matamoros et al., 2007; Matamoros et al., 2008; Zhang et 
al., 2011 ). Dordio et al. (2010) reported extremely high (86-99%) removal of carbamazepine in 
microcosm constructed wetland systems filled with light expanded clay aggregates and planted 
with Typha spp. 
Naproxen is a widely used PhAC and frequently detected in STP effluents and surface water. 
Over 90% removal of this PhAC in STPs is reported in previous studies (Ternes, 1998; Metcalfe 
et al., 2003; Bendz et al., 2005; Lishman et al., 2006, Carrara et al., 2008). Occurrence of 
naproxen in surface water is also reported in some studies (Ternes, 1998; Stumpf et al., 1999; 
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Verenitch et al., 2006; Khetan and Collins, 2007). Photodegradation is an important process 
involving transformation of naproxen to its photoproducts (Khetan and Collins, 2007).  
Sulfamethoxazole has been detected in aquatic environments including STP effluent, surface 
water and groundwater. Although some STPs remove sulfamethoxazole with more than 34-78% 
efficiency (Stumpf et al, 1999; Hendricks and Pool, 2012), some other STPs show negative 
removal of this compound (Spongberg and Witter, 2008, Bendz et al., 2005). Sulfamethoxazole 
also is detected in surface water (Kolpin, 2002) and groundwater (Sacher et al., 2001; Barnes et 
al., 2008). Poor attenuation while passing through aquifer materials and resistance to 
biodegradation makes this compound persistent in groundwater and surface water (Sacher et al., 
2001; Snyder et al., 2004; Suarez et al., 2010; Benotti and Brownawell, 2009).      
Acesulfame-K is one of the widely used artificial sweeteners that is detected in the aquatic 
environment. Acesulfame-K is detected in wastewater treatment plant effluents and often the 
effluent concentrations exceed the influent concentrations (Buerge et al., 2009). Acesulfame-K 
also is detected in groundwater samples (Buerge et al., 2009, van Stempvoort et al., 2011a,b; 
Robertson et al., 2013), and surface water (Buerge et al., 2009; Scheurer et al., 2009; van 
Stempvoort et al., 2011a,b). Acesulfame-K is identified as one of the potential tracers for 
anthropogenic contamination due to its wide spread distribution in the aquatic environment 
including wastewater treatment effluents, surface water, groundwater, and even in drinking water 
(Scheurer et al., 2009; Buerge et al., 2009; Robertson et al., 2013; van Stempvoort et al., 2011a).      
The current study focuses on the use of BOF slag for P removal, attempts to address potential 
concerns associated with this material, and investigates the P removal mechanism(s).  This study 
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also investigates the attenuation and persistence of a number of frequently detected PhACs and 
an artificial sweetener in a wastewater treatment system incorporating a BOF slag component.    
1.2 Research Objectives  
1.2.1 Main objective 
The goals of the proposed research project are to evaluate the P retention capacity of BOF slag, 
to determine the mechanisms of P removal, to assess the applicability of the use of BOF slag as a 
reactive media at various levels and scales of P contamination, and to assess the removal 
efficiencies in multistep wastewater treatment systems for nutrients (P and N), pathogens, and 
PhACs. 
1.2.2 Specific objectives 
The specific objectives of this research are to: 
 Evaluate the effectiveness of BOF slag for removal of P in field settings. 
 Investigate field scale columns to better understand P removal mechanisms through 
evaluating aqueous geochemistry and solid-phase analyzes of the precipitates on spent 
reactive media.     
 Evaluate CO2 addition as a method to neutralize the high pH of the effluent from a BOF 
slag filter. 
 Assess the mechanisms of V removal from the effluent of reactive media (mixture of 
BOF slag, gravel, and sand) filter. 
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 Evaluate mechanisms and the effectiveness of pH adjustment and sand filtration to 
remove Al from the effluent of a reactive media (mixture of BOF slag, gravel, and sand) 
filter. 
 Evaluate the effectiveness of the integration of a P treatment cell (BOFS cell with a layer 
of ZVI) into an engineered wetland wastewater treatment system for the removal of 
nutrients, pathogens, PhACs, and an artificial sweetener.   
 Evaluate the removal of PhACs within aerated cells and a BOFS cell with a layer of ZVI 
in an integrated wastewater treatment system.  
1.3 Thesis Organization  
This thesis consists of six chapters including an introduction, four research chapters and a 
conclusion.  Chapter 2, the first research chapter, describes a three year field-scale column 
experiment conducted to evaluate the potential for BOF slag to remove P from lake water, and to 
investigate the P-removal mechanisms. This chapter also addresses the potential issues related to 
elevated pH and metal release from BOFS reactive media.  Chapters 3 and 4 describe the pilot-
scale indoor and demonstration-scale outdoor experiments where the integration of a P treatment 
cell into an engineered wetland wastewater treatment system for removing nutrients and 
pathogens was evaluated. Detailed solid-phase analyzes of the precipitates from the outer layer 
of the spent reactive media were performed at the end of the experiments are described in 
Chapters 2, 3, and 4. Chapter 5 describes the effectiveness of the demonstration-scale outdoor 
system in removing five PhACs and an artificial sweetener.   
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Figure 1.1 Phosphorus release mechanisms at the sediment-water interface modified from 
Hupfer and Lewandowski (2008). a) Oxidized sediment surface with high P retention capacity; 
b) Reduced sediment surface, where redox cycle controls P availability in the hypolimnion; c) 
Reduced sediment surface, where high sulfate concentration consume Fe and enhance the P 
release. 
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Figure 1.2 Potential point and non-point sources of PhACs to surface water, groundwater, and 
drinking water (After Ternes, 1998 and Heberer, 2002a). 
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Chapter 2 
Evaluation of Basic Oxygen Furnace Slag for Removal 
of Phosphorus from Lake Water 
2.1 Executive Summary 
The effectiveness of basic oxygen furnace slag (BOFS) for removing dissolved phosphorus (P) 
was evaluated in a hypolimnetic withdrawal experiment. Lake water gravity fed through a small 
scale (pore volume, ~0.87 m
3
) field treatment system consisting of three BOFS columns 
arranged in series and operated over three successive summers. Phosphate (PO4-P) influent 
concentrations ranged from 0.3 to 0.5 mg L
-1
, of which 82.9-94.8%, 96.1-98.1%, and 97.4-99.9% 
was removed in years 1, 2, and 3, respectively. The PO4 removal rate was positively dependent 
on pH and hydraulic retention time. The hydraulic retention times in years 1, 2, and 3 were 0.73 
to 0.98 days, 0.26 to 0.58 days, and 0.33 to 0.42 days. Column effluent pH was 8.69±0.43, 
11.37±0.17, and 11.96±0.17 in years 1, 2, and 3, respectively, with the increase attributed to 
dissolution of calcium oxide and calcium hydroxide from the BOFS. The effluent was 
neutralized by addition of CO2(g) before discharging to the environment. Vanadium and Al 
derived from the BOFS were likely removed within a 5 wt. % granular zero valent iron mixure 
with sand and by neutralizing pH. Diminished hydraulic performance in year 2 was attributed to 
calcium carbonate accumulating on the spent media. The solid phase analyzes of the outer layer 
materials of the spent media through FESEM-EDX, XPS, FTIR, and XANES spectroscopy 
confirmed the presence of calcium carbonate and calcium phosphate minerals. Restricting 
ingress of atmospheric CO2 into the system minimized calcium carbonate accumulation on the 
 15 
treatment media and ultimately led to improved hydraulic characteristics in year 3.  The results 
show potential for effective removal of P.  
2.2 Introduction 
Release of phosphorus (P) to surface water bodies is of environmental significance. Phosphorus 
is an essential, often limiting nutrient for plants and microorganisms, especially in aquatic 
ecosystems impacted by anthropogenic activities (Schindler, 1977). Phosphorus can be 
introduced to aquatic ecosystems through both groundwater and surface waters impacted by 
urban and agricultural activities (Sharpley, 1994). Excess P in surface waters may cause 
eutrophication (Parry, 1998),
 
which can lead to toxic algal blooms; loss of oxygen; fish kills; loss 
of biodiversity, including loss of species important for commerce and recreation; loss of aquatic 
plants and coral reefs; and other problems (Carpenter et al., 1998). Eutrophication can result in 
the development of anoxic, P-rich lake bottom sediments, which, in turn, release P that 
accumulates in anoxic hypolimnia (Nürnberg and Peters, 1984).
  
Hypolimnetic withdrawal is a 
restoration method whereby water is withdrawn from an anoxic hypolimnion to enhance the 
removal of limiting nutrients and to reduce anoxic conditions at the sediment surface interface 
(Kortmann et al., 1983). In many systems, the withdrawn water is discharged to water bodies 
downstream (Nürnberg et al., 1987). In this study, however, the objective was to remove P and 
return the treated water to the lake. Specifically, this study was conducted to evaluate P removal 
from the hypolimnion of Lake Wilcox, Richmond Hill, Ontario, Canada, a mesotrophic, hard 
water lake that strongly stratifies in the summer and quickly develops anoxia within the entire 
hypolimnion (Nürnberg et al., 2003). 
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Phosphorus can be removed from water in several ways, including chemical removal, 
advanced biological treatment, or a combination of both. Typically, chemical treatment is 
specifically aimed at the removal of P from wastewaters. Several studies have evaluated P 
removal through surface adsorption and combined adsorption and precipitation (Morse et al., 
1998; Vohla et al., 2011). Natural materials including limestone (Drizo et al. 1999),
 
opoka 
(Johansson and Gustafsson, 2000), and zeolite (Sakadevan and Bravor, 1998), modified natural 
materials including granular activated carbon and bone char (Mortula et al., 2007), and industrial 
by-products including basic oxygen furnace slag (BOFS) (Baker et al., 1998; Smyth et al., 
2002a; Kim et al., 2006), basic oxygen furnace oxide (BOF Oxide) (Baker et al., 1998), blast 
furnace slag (BFS) (Mann and Bavor, 1993; Yamada et al., 1996; Baker et al., 1998; Johansson 
and Gustafsson, 2000), and electric arc furnace slag (EAFS) (Drizo et al., 2006)
 
are capable of 
removing P from water. Steel slag removes dissolved inorganic PO4 through adsorption, with 
higher rates of adsorption observed for materials with greater porosity (Yamada et al., 1996). 
Basic oxygen furnace slag (BOFS) is one of the major waste by-products of the steel-making 
process (Mikhail et al., 1994; Bowden et al., 2009). The major phases (>10 wt. %) of BOFS are 
di-calcium silicate (Ca2SiO4), tri-calcium silicate (Ca3SiO5), ferrous oxide (FeO), and Ca-Mg-
Mn-Zn-ferrite ((Ca,Mg,Mn,Zn)Fe2O4) (Mikhail et al., 1994). The mean percentage of the major 
constituents of 17 BOFS samples are Ca (28.01%), Fe (18.43%), Si (5.97%), Mg (5.53%), Mn 
(3.29%), and Al (2.38%); significant minor constituents are P (0.32%), C (0.26%), Cr-total 
(0.13%), S (0.11%), and V (0.10%) (Proctor et al., 2000). Major oxides that comprise 70-80% of 
BOFS include CaO, Fe2O3, and SiO2, with lesser contributions from MgO, MnO, Al2O3, P2O5, 
TiO2, K2O, Na2O, and Cr2O3 (Kim et al., 2006; Bowden et al., 2009).  
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Due to the dissolution of lime (CaO) and portlandite (Ca(OH)2), the concentration of dissolved 
Ca and the pH of water in contact with BOFS can significantly increase (Baker et al., 1998). At 
these high pH values (e.g., ~12), hydroxyapatite (Ca5(PO4)3(OH)) may precipitate and retain PO4 
on the solid phase in the reactive media (Yeoman et al., 1988; Baker et al., 1998). Removal of 
phosphorus by BOF Oxide has been observed over a prolonged period of flow, with the removal 
attributed to adsorption and precipitation (Baker et al., 1998). Due to microbial inactivation at 
high pH, BOFS media also effectively removes coliforms, such as E. coli, from wastewater 
(Smyth et al., 2002b). Potentially toxic trace elements V and Cr may leach from BOFS (Proctor 
et al., 2000), but can be removed from water using granular zero valent iron (ZVI) filings 
(Blowes et al., 2000; Morrison et al., 2002). 
This chapter describes experiments focused on P removal in a hypolimnetic withdrawal system 
using BOFS from two different sources as the reactive media. The study evaluated the extent of 
P removal under recirculating conditions and determined the mechanisms of P removal. An 
additional ZVI layer, incorporated at the effluent end of the system and intended to remove V 
from the BOFS effluent, was evaluated in year 3. The outer layer of the spent reactive media of 
year 2 were investigated in this study in order to characterize the phases contributing to P 
removal.   
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2.3 Materials and Methods 
2.3.1 Reactive material  
Basic oxygen furnace slag (BOFS) was obtained from the Levy Corporation (Detroit, MI, USA) 
for the initial trial (BOFS-A) and from the US Steel Stelco Hilton Works facility (Hamilton, ON, 
Canada) for the two subsequent years (BOFS-B and BOFS-C). The particle density of the BOFS 
was determined using a pycnometer (Air Comparison Beckman, Model 930). Surface area was 
determined with a surface area analyzer (Micromeritics Gemini
®
, VII 2390 Series). The 
composition of the BOFS was determined by X-ray fluorescence (XRF; MiniPal4, 
PANanalytical). The constituent phases of the BOFS were determined using X-ray 
diffractometry (XRD) (Rigaku D/MAX 2500 rotating anode powder diffractometer) with 
monochromatic CuKα radiation at 50 kV and 260 mA.  
2.3.2 System configuration 
The hypolimnetic withdrawal treatment system was constructed adjacent to Lake Wilcox. The 
system consisted of three fiberglass columns with a total volume of 2.09 m
3
 (Figure 2.1). The 
columns were filled with a mixture of BOFS-A (screened coarser than 149 µm; 100 mesh) and 
aggregate (19 mm, ¾ in) during year 1. In year 2, the BOFS-A mixture was replaced with an 
aggregate mixture containing BOFS-B, and in year 3 an aggregate mixture containing BOFS-C.  
In Column 1, the reactive material filled the entire column, extending from the base to the top 
(Table 2.1). The influent water samples temperature were between 8.7 and 24.2
0
C in year 1, 
between 7.0 and 24.5
0
C in year 2, and between 8.0 and 24.8
0
C in year 3. Columns 2 and 3, which 
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were longer than Column 1, had 30 cm of head space above the material. In year 3, 5 wt. % ZVI, 
mixed with sand, was added to the upper half of Column 3. Total pore volume of the BOFS 
reactive materials was 0.87 m
3
, 0.87 m
3
, and 0.78 m
3
 in years 1, 2, and 3, respectively. The three 
columns were placed in series and connected with a piping network (Figure 2.1). Each column 
included lateral ports (designated as Px in Figure 2.1) to collect samples at various distances 
along the flow path. An influent tank was placed above the maximum height of the treatment 
columns to maintain flow due to gravity. The influent tank was filled with water from the 
hypolimnion withdrawal system (to maintained constant head) and was introduced to the series 
of columns by gravity flow. The flow was adjusted manually using a metering valve. A CO2(g) 
tank was installed following the treatment columns to lower the pH of the column effluent via 
sparging. Carbon dioxide was added occasionally in year 1, and more consistently in years 2 and 
3.  A sand filter, graded from coarse gravel to coarse sand, was installed after the CO2 addition 
tank to remove CaCO3 precipitates and excess aluminum hydroxide precipitates. Finally, an 
effluent tank was installed after the filtration tank before discharging to a municipal sanitary 
sewer system. 
2.3.3 Sample collection and analysis 
The pilot treatment system was monitored weekly. Samples were collected from 13 different 
locations along the treatment system, including the influent and effluent tanks. The pH was 
measured in the field on unfiltered samples. Samples for determination of PO4, anion, cation, and 
trace metal concentrations were passed through 0.45 μm syringe filters into polyethylene bottles, 
chilled to less than 4°C during transport to the laboratory, and refrigerated until analysis. Cation 
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samples were acidified in the field with HNO3 to a pH of less than 2, and PO4 samples were 
acidified in the field with H2SO4 to a pH of less than 2. Alkalinity was measured in the field on 
filtered (0.45 μm) samples with standardized H2SO4 using a Hach™ digital titrator, where 
phenolpthalein and bromocresol green-methyl red pH indicators were used to distinguish 
hydroxide alkalinity from total alkalinity. The concentration of S
2-
 was measured in the field 
using the methylene-blue method (APHA, 2005), and ortho-phosphate was analyzed using the 
ascorbic acid method (APHA, 2005) within 7 days of collection. Major cations were analyzed by 
inductively coupled plasma optical emission spectroscopy (ICP-OES) and trace elements were 
analyzed by ICP-mass spectrometry (ICP-MS).  
2.3.4 Characterization of reactive material  
In year 2, the hydraulic performance of the treatment system declined after 144 days of operation 
and Column 2 and Column 3 were bypassed at this time. The reactive media were sampled at the 
end of year 2. Solid-phase samples were collected at 15-20 cm intervals from all three columns 
and examined using a Leo 1530 field emission scanning electron microscope (FE-SEM) with 
energy dispersive X-ray (EDX) analysis. The materials of the spent BOFS outer layer were 
analyzed by Fourier transform infrared spectroscopy (FTIR). Transparent 1 cm diameter KBr 
disks/pellets were prepared using a 13 mm pellet die by pressing (with 5 to 6 tonnes pressure for 
1 min) a  mixture of the ground samples and KBr (sample to KBr ratio were approximately 
1:100). A Bruker Tensor 27 infrared spectrometer was used to examine the KBr pellets. The data 
acquisition parameters for these analyzes included 4 cm
-1
 resolution, sixteen scans, and wave 
numbers between 4000 and 400 cm
-1
. Spectra for blank KBr samples were subtracted from each 
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sample spectrum to minimize the influence of the KBr.  Reference materials were purchased 
from Sigma Aldrich, Canada. These included iron (III) phosphate (FeP), -tricalcium phosphate 
(-TCP), -tricalcium phosphate (-TCP), hydroxyapatite (HAP-S), calcium phosphate dibasic 
(CPD), and calcium phosphate dibasic dihydrate (CPDD). In addition, hydroxyapatite was 
synthesized in the laboratory following a liquid mix technique described in Pena and Vallet-Regi 
(2003) and included as an additional reference material (labeled hydroxyapatite-wet method; 
HAP-WM). Phosphate sorbed on calcite (PSC) was synthesized by adding 5 g calcite powder to 
1 L of a 250 mg L
-1
 PO4-P solution and shaking for 48 hours. The white precipitates were 
collected on a Whatman grade no.4 filter paper and freeze dried before charecterization by FTIR 
and SEM-EDX. The percent of phosphate in the PSC was estimated from the initial and the final 
concentrations of P in the solution.          
X-ray photoelectron spectroscopic (XPS) analyzes were performed using a Kratos Axis Ultra 
spectrometer. This instrument used a monochromatic Al K(α) source (15mA, 14kV). XPS can 
provide information from the uppermost 5-7 ηm of the surface and can detect all elements but 
hydrogen and helium with detection limits varying from 0.1 to 0.5 atomic percent depending on 
the element. The work function of the instrument was calibrated to a binding energy (BE) of 
83.96 eV based on Au 4f7/2 line for metallic gold and the dispersion of the spectrometer was 
adjusted to a BE of 932.62 eV based on Cu 2p3/2 line of metallic copper. The Kratos charge 
neutralizer system was used for all samples. The acquired spectra were corrected for charge to 
the main line of the carbon 1s spectrum and set to 284.8 eV. The XPS data processing software 
CasaXPS (version 2.3.14) was used to analyze the spectra. 
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XANES analysis was conducted at the Canadian Light Source, Saskatoon, Canada. The energy 
of the storage ring in this facility is 2.9 GeV. Soft X-ray Micro-characterization Beam line 
(SXRMB; 06B1-1) covering the energy region of 1700-10000 eV with photon resolution of 
0.2eV and a beam spot size of 300 μm x 300 μm was used to record XANES data for 
phosphorus. XANES data were collected in Total Electron Yield (TEY) and Fluorescent Yield 
(FY) mode. A monochromator with Si (111) crystals and a flux of >1X10
11
 photons s
-1 
was used 
to collect experimental and standard data. To improve signal-to-noise ratios the spectral data 
were averaged over 2–3 scans. The reference materials used for the FTIR analysis, also were 
used for the XANES experiments. The XANES spectra of the unknown samples were compared 
with reference materials through linear combination fitting using Athena software package, 
version 0.8.56 (Ravel and Newville, 2005). 
2.3.5 Geochemical modeling 
The geochemical modeling code PHREEQC Interactive (Parkhurst and Appelo, 1999) was used 
to calculate the saturation indices (SI) for calcium phosphate and other mineral phases relevant to 
the treatment system. The WATEQ4F database was used for these calculations. Solubility 
product values for brushite, monetite, octacalciumphosphate, β-tricalciumphosphate, and 
variscite were added to the WATEQ4F database using previously published thermodynamic data 
(Baker et al., 1998; Stumm and Morgan, 1981). Calculations were conducted with data from five 
sampling events at all 13 sampling locations during the final year of the experiment. 
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2.4 Results and Discussion 
2.4.1 Characteristics of the reactive materials 
The surface area of all three BOFS samples was dominated by the finest fraction (Table 2.2). The 
particle densities of BOFS-A, BOFS-B, and BOFS-C were 3.30, 3.67, and 3.53 g cm
-3
, 
respectively, demonstrating the consistency of the BOFS materials. All BOFS samples contained 
between 33 and 40 wt. % CaO. BOFS-C contained a lower percentage of Fe2O3 and a higher 
proportion of SiO2 than BOFS-A and BOFS-B (Table 2.2). The main mineral phases obtained 
from the XRPD analysis were srebrodolskite (Ca2Fe2O5), larnite (Ca2SiO4), periclase (MgO), 
wuestite (Fe0.942O), magnetite-ulvöspinel (Fe3O4-Fe2TiO4), lime (CaO), hatrurite (Ca3(SiO4)O), 
and anhydrite (CaSO4) in BOFS-A; wuestite (Fe0.925O), larnite (Ca2SiO4), brownmillerite 
(Ca2((Fe1.885Al0.115)O5), lime (CaO), anhydrite (CaSO4) and quartz (SiO2) in BOFS-B;  larnite 
(Ca2SiO4), wuestite (Fe0.9O), hatrurite (Ca3(SiO4)O), lime (CaO), anhydrite (CaSO4) in BOFS-C. 
Beside these minerals phases portlandite (Ca(OH)2; peak at 4.92A, 18.00 2-theta) was a probable 
mineral phase in all of these BOFS samples.  
2.4.2 pH, Eh, alkalinity, and temperature 
The pH of the influent water, collected from the hypolimnion of Lake Wilcox, was consistently 
near neutral (7.28±0.08 in year 1, 7.32±0.07 in year 2, and 7.26 ±0.11 in year 3; Figure 2.2). In 
year 1, a gradual increase in pH was observed as the water flowed through the reactive columns. 
A maximum pH of 9.6 was observed during year 1 of the study; during year 2 and year 3, the pH 
increased rapidly in Column 1 and then remained relatively constant through the rest of the 
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columns, reaching a maximum of 11.53 in year 2 and 12.13 in year 3 (Figure 2.2). The alkalinity 
of the effluent in years 1, 2, and 3 was 129±51, 183±75, and 698±448 mg L
-1
 as CaCO3, 
respectively (Figure 2.2). The total alkalinity did not change abruptly along the column profile 
during years 1 and 2. However, the total alkalinity increased rapidly in the initial stage 
(maximum 1214 mg L
-1
 as CaCO3) of year 3 and gradually decreased with time as the system 
was continuously flushed and as free lime (CaO) and portlandite (Ca(OH)2) were leached from 
the outer layer of the BOFS. A decrease in the caustic alkalinity, compared to the total alkalinity, 
was observed in year 3.  The release of high pH effluent from the treatment system was 
addressed through the addition of a neutralization component in year 1, 2 and 3. The pH 
adjustment involved addition of CO2 following the treatment columns. The amount of CO2 
required to neutralize the high effluent pH was determined on the basis of the difference between 
the OH
-
 concentration measured in the effluent from Column 3 and the desired OH
-
 
concentration (typically 10
-2
 moles of CO2 per litre of effluent were required to reduce the pH 
from 12 to 7.5). The pH of the treatment column effluent typically varied between 6.5 and 8.5; 
however, there were a few exceptions when an insufficient amount of CO2 was delivered to the 
system (Figure 2.2).  
The Eh of the influent varied between -24 and 154 mV in year 1, between -25 and 186 mV in 
year 2, and between -8 and 73 mV in year 3 (Figure 2.3). The Eh of the treatment system effluent 
varied between 283 and 341 mV in year 1,and between 286 and 403 mV in year 2 and between 
226 and 428 in year 3 (Figure 2.3).  The temperature of the treatment systm effluents varied 
between 5.9 and 26
0 
C. 
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2.4.3 Major ion chemistry 
During year 1, Ca concentrations gradually increased along Columns 1 and 2 and then decreased 
along Column 3 (Figure 2.4). In year 2, Ca concentrations initially increased along Columns 1 
and 2, and then decreased later in the year. However, clogging was observed during year 2, and 
Ca concentrations did not follow a discernable pattern later in the year (Figure 2.4). In the early 
stages of year 3, sharp increases in Ca concentrations accompanied increases in pH and caustic 
(OH
- 
based) alkalinity observed in Column 1 (Figure 2.4, Figure 2.5). The dissolution of calcium 
hydroxide, calcium oxides and calcium hydroxosilicates probably were the principal sources of 
Ca to the water.    
In year 1, Mg concentrations progressively increased along the flow path through the treatment 
materials. In contrast, Mg concentrations declined sharply along the flowpath during both year 2 
and year 3. In year 3, for example, Mg concentrations decreased sharply in Column 1 and 
remained low in the remainder of the columns (Figure 2.5).  
Influent SO4 concentrations were 10.9±1.4, 11.7±0.9, and 11.9±1.8 mg L
-1
 in years 1, 2, and 3 
and remained relatively uniform throughout the study (Figure 2.5). Each year a decline in SO4 
concentrations along the length of the treatment system was observed. In year 3, this removal 
resulted in an 80% decline in the SO4 concentration at the beginning of the year and a 40% 
decline at the end of the year (Figure 2.5). 
2.4.4 Phosphorus removal 
Mean influent PO4-P concentrations were 0.362, 0.345 and 0.339 mg L
-1
 in years 1, 2 and 3, 
respectively; the corresponding mean effluent concentrations were 0.034, 0.011, and 0.005 mg L
-
 26 
1 
(Figure 2.2, Table 2.3). These mean effluent concentrations were in the range observed for 
meso-eutrophic, mesotrophic, and oligotrophic conditions for years 1, 2, and 3, respectively 
(CCME, 2004). In year 1, between 82.9 and 94.8% removal of PO4 was observed when the flow 
rate was adjusted between 1.2 and 0.89 m
3
 day
-1
 (hydraulic retention time 0.73 to 0.98 days) by a 
valve at the system inlet tank. In year 2, the flow rate was adjusted several times, between 3.31 
and 1.51 m
3
 day
-1
 (hydraulic retention time 0.26 to 0.58 days),
 
corresponding to 96.1 to 98.1% 
removal of PO4. Finally, in year 3, the flow rate was adjusted to between 2.35 and 1.86 m
3
 day
-1
 
(hydraulic retention time 0.33 to 0.42 days),
 
corresponding to a PO4 removal of 97.4 to 99.9%.  
At the end of year 1, the extent of PO4 removal decreased. There was no significant decrease in 
the extent of PO4 removal during years 2 and 3.  The total P-masses that entered in the treatment 
system were 36, 50, and 55 g in years 1, 2, and 3; while the total P-masses that exited from the 
system were 6, 1, and 1 g in years 1, 2, and 3 (Figure 2.6, Table 2.4). Thus the total masses 
retained by the system were 86, 98, and 98% in years 1, 2, and 3.  
At pH values over 9, adsorption of the dominant phosphate species (HPO4
2-
 and PO4
3-
) onto 
iron oxyhydroxides is not expected (Stumm and Morgan, 1981).
 
However, certain oxides (MgO 
and Al2O3) may favour limited adsorption due to the high pH of the zero point of charge (pHZPC) 
of these phases. The presence of 8-9% MgO (pHZPC = 12.4; Parks, 1965) and 4-6% Al2O3 (pHZPC 
= 9.1; Parks, 1965) in the BOFS materials used in this study suggests that adsorption was one of 
the potential PO4 removal mechanisms. Precipitation of calcium phosphate phases (dependent on 
the Ca concentration) including hydroxyapatite (HAP) is another potentially important PO4 
removal mechanism in BOFS-based treatment systems (Baker et al., 1998; Bowden et al., 2009). 
However, Mg in the pore water may replace the Ca in hydroxyapatite and inhibit the formation 
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of crystalline hydroxyapatite (Kim et al., 2006). Thus, both adsorption and precipitation were 
probable mechanisms involved in removing PO4 in this treatment system. At the end of year 1, 
the rate of PO4 removal decreased (Figure 2.2). However, there was no significant decrease in 
the rate of PO4 removal during years 2 and 3. 
The FE-SEM images and EDX data were collected from samples of the fresh BOFS material 
and from the spent media along the flow path from the year 2 material, to investigate changes in 
composition on the outer layers of these materials (Figure 2.7, Table 2.5). The phosphorus 
content of the fresh BOFS was ~0.08 wt% and the mass of P on the spent media increased with 
increasing distance along the flow path (Figure 2.7, 2.8). The phosphorus content was negatively 
correlated (r=-0.96) with the dissolved PO4 concentration and positively correlated (r=0.88) with 
the aqueous pH in Columns 1 and 2 (Figure 2.8). The P mass in the upper part of Column 2 was 
slightly less than in the middle zone of Column 2 (Figure 2.7, Sample 8-9), which suggests 
extensive removal of aqueous PO4 in the middle zone of Column 2. In Column 3, which was 
beyond the P-removal front, the solid mass of P remained low (Table 2.5).  
In year 1, BOFS-A was used in the reactive mixture. The PO4 removal efficiency of this slag 
was not as high as observed in previous laboratory experiments (Figure 2.2; Baker et al., 1998). 
Low effluent pH (as low as 8.75 after two months of operation) and less efficient PO4 removal 
(83%) were observed. BOF slag is an industrial byproduct, which is stored in stockpiles out of 
doors. The low PO4-removal efficiency observed for BOFS-A suggests that this material likely 
underwent prolonged exposure to atmospheric CO2 before it was acquired for this experiment. 
BOFS-B was used during year 2. Moderately high effluent pH and low PO4 concentrations were 
observed (Figure 2.2). The reactive material was replaced in year 3 with BOFS-C. High effluent 
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pH, very low effluent PO4 concentrations immediately after Column 1 and high alkalinity values 
suggest that this BOFS-C was less weathered than the BOFS-A or BOFS-B (Figure 2.2).  
2.4.4.1 FTIR 
The FTIR spectra of the outer layer materials of the spent media from different parts of Columns 
1, 2, and 3 from year 2 were analyzed. Carbonate vibrational bands including v4  at 712-713 cm
-
1
, v3 at 1424-1428  cm
-1
, v2 at 874-875 cm
-1
, and carbonate overtones or combination bands v1+ 
v4  at 1796-1799 cm
-1
, v1+ v3 or 2v2+ v4; at 2513-2517 cm
-1
, and  2v3  at 2871-2876 cm
-1
 and 
2979-2986 cm
-1
 (Gillet et al., 1996; Vongsavat et al., 2006; Tatzber et al., 2007; Gunasekaran 
and Anbalagan, 2008) were observed in the FTIR spectra in the samples. Presence of these 
carbonate bands, particularly the range obtained for v4 and v2 were comparable to the ranges 
reported for calcite (Vagenas et al., 2003; Vongsavat et al., 2006; Ni and Ratner, 2008; Kurap et 
al., 2010), which suggested that calcite is the principal carbonate mineral in the precipitates 
collected from the outer layer of the spent BOFS (Table 2.6). However, the presence of a 
shoulder of carbonate v2 band at 858 cm
-1
 (an unique feature of aragonite; Vongsavat et al., 
2006), in sample C2-S10 in addition to the sharp v2 band at 875 cm
-1
 and v4 band at 712 cm
-1
 
suggested that the sample may contain a small percentage of aragonite as well.  
The phosphate vibrational bands for the reference materials were determined. Vibrational 
bands for the hydroxyapatite (Sigma) were at 475 cm
-1 
(v2), 568 cm
-1 
(v4), 603 cm
-1 
(v4),  and 633 
cm
-1 
(v4), 962 cm
-1
 (v1), 1045 cm
-1 
(v3), and 1092 cm
-1 
(v3). For the laboratory-synthesized 
hydroxyapatite, vibrational bands were at 474 cm
-1 
(v2), 571 cm
-1 
(v4), 602 cm
-1 
(v4), and 633 cm
-1 
(v4), 962 cm
-1 
(v1),
 
1042 cm
-1 
(v3) and  1090 cm
-1 
(v3); and for β-TCP,  vibrational bands were at 
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474 cm
-1  
(v2), 564 cm
-1 
(v4), 603 cm
-1 
(v4), and 634 cm
-1 
(v4), 962 cm
-1 
(v1),
 
1033 cm
-1 
(v3) and  
1098 cm
-1 
(v3) (Table 2.7). These values were consistent with the vibrational bands observed in 
other studies (Table 2.8; Rehman and Bonfield, 1997; Pena and Vallet-Regi, 2003).  
Phosphate v3 bands were observed in all of the samples at 1009-1041 cm
-1
 and 1078-1082 cm
-
1
. Weak peaks from phosphate v4 bands were mainly observed at 581-586 cm
-1
. However, in 
some samples it was possible to identify very weak phosphate v4 bands at 600-608 cm
-1
, 588-595 
cm
-1
, and 562-578 cm
-1
. Weak phosphate v2 bands were observed in most of the samples at 444-
473 cm
-1
. Phosphate v1 bands were observed in samples C2-S10 (at 979 cm
-1
) and C2-S3 (at 977 
cm
-1
) as very weak shoulders. Among the samples analyzed, C2-S10 and C2-S3 showed more 
distinct and complete vibrational bands for carbonate and phosphate (Figure 2.9). Due to the 
weak phosphate vibrational bands (corresponding to low phosphorus concentrations 0.65 -1.29 
wt. %) it was very difficult to confirm the occurrence of hydroxyapatite or β-TCP. However, the 
location of the peaks indicated the possibility of formation of similar Ca-PO4 phases. The unused 
BOFS showed similer carbonate vibrational bands observed in the samples, however, the 
phosphate vibrational bands were not as distinct compared to the samples.    
2.4.4.2 XPS      
The XPS survey spectra of samples C1-S2, C1-S3, C1-S4, C2-S4, C2-S9, S2-S10, and C2-S1 
were obtained.  Most of the samples showed peaks for O, Ca, Mg, C, P, Si and Al in the survey 
XPS spectra. High resolution spectra of samples with the highest P concentrations, C1-S2 (0.4% 
P) and C1-S3 (0.3% P), were collected. A calcium carbonate reference material showed a peak of 
Ca 2p3/2 at binding energies of 346.7 to 347.0 eV, and a calcium phosphate reference material 
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showed peak of Ca 2p3/2 at a binding energy of 347.3 eV and P 2p3/2 peak at 133.0 eV. The 
binding energies of Ca 2p3/2, Ca p1/2, and carbonate peaks of samples C1-S2 and C1-S3 were at 
346.88, 350.43, and 289.38 eV and 347.07, 350.62, and 289.54 eV (Table 2.9), which are 
consistent with the values for calcite and vaterite reported in Ni and Ratner (2008). The surface 
atomic ratios of Ca/C in samples C1-S2 (0.32) and C1-S3 (0.29) were much lower than the ratio 
reported for calcite or vaterite reported in Ni and Ratner (2008). Whereas the surface atomic ratio 
of O/Ca in sample C1-S2 was ~88% higher than that of calcite and in sample C1-S3 the O/Ca 
ratio was ~25% higher expected for vaterite reported in Ni and Ratner (2008). The binding 
energies of P 2p3/2 and P 2p1/2 were at 132.57 and 133.41eV for C1-S2 and 132.77 and 133.61 
eV for C1-S3 (Table 2.9). The binding energies of Ca 2p3/2 and P 2p3/2 in the samples and the 
reference materials were within the same range. However, due to low concentrations of P in the 
samples the intensity of the P 2p3/2 peaks was not high enough to interpret the type of calcium 
phosphate in the samples.  
2.4.4.3 XANES 
Phosphorus K-edges or white lines (energy required to eject electrons from the K shell of P 
atoms; Güngör et al., 2007) for phosphate reference materials were observed at 2151.6  0.1 eV. 
Similar peak positions for phosphate species are reported in previous studies (Shober et al., 2006; 
Brandes et al., 2007). Depending on the charge, electronegativity, and interatomic distance of the 
coordinating cation, the position of white lines for phosphate phases may vary between ± 0.5 eV 
(Franke and Hormes, 1995). XANES spectra of the reference materials showed pre- and post-
edge features between -3 and ~18 eV (Figure 2.10), which were within the range (from -50 to 
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+200 eV with respect to the edge energy) described by Kelly et al. (2008).  The FeP reference 
material showed white line at 2152 eV and a pre-edge feature at ~2148.5 eV (-2.5 eV with 
respect the white line), which is consistent (between -2 and -5 eV) with previous studies 
(Hesterberg et al., 1999; Khare et al., 2007; Ajiboye et. al., 2008; Shober et al., 2006, Sato et al., 
2005, Eveborn et al., 2009; and Beauchemin et al., 2003). Despite the fact that the primary peak 
positions of the phosphate-bearing (oxidation state +5) phases are similar, the characteristics of 
the secondary spectral features, including size, shape, and position, are diagnostic for different 
compounds and minerals (Brandes et al., 2007).  Phosphorus K-edge XANES spectra with all 
spectral features for Ca-, Al-, and Fe-phosphates were characterized in previous studies to adapt 
the finger printing approach in interpreting unknown samples (Hesterberg et al., 1999; Ajiboye 
et. al., 2008; Shober et al., 2006; Sato et al., 2005; Eveborn et al., 2009; Beauchemin et al., 
2003).   
The presence of a shoulder at ~2154.7 eV (Figure 2.10 c), peaks at ~2162.5 eV and ~2169 eV 
(Figure 2.10 d, e) were  important spectral features observed in all calcium phosphate reference 
materials. The post-edge features have been attributed to the presence of Ca-PO4 species and the 
oxygen oscillation. The relative positions of these features with respect to P K-edge were 
consistent features observed in other studies (Peak et al., 2002; Sato et al., 2005).  
Comparison of the XANES spectra of reference materials and the samples (Figure 2.10) 
indicates the presence of spectral features similar to the reference materials particularly CaP 
within the samples. The white lines of the samples and the CaP reference materials fell within 
the same range of 2151.60.1 eV. The post-edge features in the samples spectra were located in 
the same energy range as observed in the reference materials. However, none of the samples 
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showed post-edge features as distinct as observed for the crystalline CaP reference materials 
including HAP and -TCP. Linear combination (LC) fitting analysis of a series of binary and 
ternary combinations of spectra from the reference materials showed that mixtures of -TCP, -
TCP, and CPDD provided the best-fitting spectra for samples C3-S1 and C2-S10 with lower 2 
values of 2.13 and 2.30 (Figure 2.11, Table 2.10). The LC fitting results indicated that FeP does 
not constitute a significant component of the samples, due to the absence of the distinct pre-edge 
feature, which was not present in any of the samples. LC fitting for the other samples including 
C2-S9, C1-S2, C2-S11, and C2-S4 showed comparatively higher 2 values of 3.21, 3.29, 4.42, 
and 5.48 (Table 2.10) lesser goodness of fit to these spectra. The combination of -TCP, -TCP, 
and CPDD provided the best combination for all of these samples.  
 
2.4.5 Geochemical modeling 
The influent water during year 3 was undersaturated with respect to brushite, monetite, 
octacalcium phosphate, β-tricalcium phosphate, vivianite, and, variscite (Figure 2.12). This water 
also was undersaturated with respect to calcite and aragonite and supersaturated with respect to 
hydroxyapatite, MnHPO4, strengite, gibbsite, goethite, and ferrihydrite. The influent water was 
supersaturated with respect to hydroxyapatite according to the WATEQ4F database, but 
undersaturated with respect to hydroxyapatite using log Ksp value derived from a laboratory 
experiment using BOF oxide at pH values similar to those in this study (Baker et al., 1998). 
Using both Ksp values, the water passing through the columns became supersaturated with 
respect to hydroxyapatite, β-tricalcium phosphate, brucite, calcite, and aragonite. Although the 
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water remained supersaturated with respect to gibbsite, ferrihydrite, MnHPO4, and strengite in 
the first 1m of the flow path, it was undersaturated with respect to these mineral phases for the 
remainder of the flow path. The water remained undersaturated with respect to brushite, 
monetite, and octacalcium phosphate along the flow path. Hydroxyapatite is considered one of 
the major P-bearing phases in Ca- and P-rich environments (Stumm and Morgan, 1981; Baker et 
al., 1998; Bowden et al., 2009), and the supersaturation with respect to hydroxyapatite observed 
in the pore water of all three columns. The very low concentrations of phosphate in the column 
effluent and indications of the presence of Ca-PO4 phases in FTIR and XANES spectra, suggest 
that precipitation of Ca-PO4 phases is a mechanism through which P is retained by the reactive 
media. The PHREEQCI model results showed that the pore water was supersaturated with 
respect to calcite and aragonite along the flow path, which is consistent with the high carbonate 
alkalinity measurements and the identification of calcite in the column materials during the 
mineralogical study. These observations suggest that the dissolved Ca concentrations are 
probably limited by the precipitation of CaCO3 and Ca-PO4 phases. 
A zone of Mg removal progressively migrated along the length of the system over the course 
of year 3 (Figure 2.5). The migration of the Mg reaction front coincides with the migration of the 
decline in pH and the PO4-P removal zone, suggesting that both reaction fronts may be 
associated with the depletion of Ca oxides and hydroxides. The geochemical modeling results 
suggest that at high (>9.2) pH values, the formation of MgCO3(s) is favoured; however, no 
MgCO3 precipitates were observed during the mineralogical examination of the treatment 
materials. The decrease in Mg concentrations may also be due to co-precipitation of Mg with 
CaCO3 or Ca-PO4 precipitates. The substitution of Mg for Ca in hydroxyapatite (Kim et al., 
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2006) is a possible mechanism contributing to Mg removal. An elevated abundance of Mg 
(~13%), associated with Ca in precipitates, was observed in some of the EDX data. In addition, 
the pore water was supersaturated with respect to brucite when the hydroxide alkalinity 
contributed to the total alkalinity.  
PHREEQCI speciation calculations indicated that the pore water throughout the columns was 
undersaturated with respect to gypsum and other SO4 minerals, indicating that the decrease in 
SO4 concentrations observed along the columns was probably not due to precipitation of SO4-
bearing phases. Sulfate also may be removed from the water by SO4 reduction and metal sulfide 
precipitation. Measurements made in year 3 indicate that dissolved S
2-
 concentrations in the 
influent were above detection (0.005 to 0.8 mg L
-1
). Later, in year 3, dissolved S
2-
 concentrations 
gradually decreased to very low concentrations, and were often below the detection limit. 
PHREEQCI results indicated saturation with respect to amorphous FeS was attained 
occasionally.  
 
2.4.6 Trace metals 
Dissolved trace metals, including Cd, Co, Cr, Cu, Fe, Mo, Ni, Pb, Ti, and Zn, were present in the 
treatment system effluent at very low concentrations that remained low, below water quality  
guidelines for Ontario (MOEE, 1994). However, Al and V concentrations were up to 0.85 mg L
-1
 
and 0.13 mg L
-1
 respectively, exceeding guideline values of 0.075 mg L
-1 
and 0.006 mg L
-1
.  
Vanadium concentrations in the influent during all three years of the trial were close to or below 
the detection limit (0.000025 mg L
-1
). In the BOFS column effluent, mean V concentrations 
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increased to 0.008, 0.098, and 0.039 mg L
-1
 in years 1, 2, and 3, respectively (Figure 2.13). The 
configuration of the treatment system was modified in year 3 when 5 wt. % ZVI, mixed with 
sand, was added to the upper half of Column 3. Following this modification, the mean effluent V 
concentrations derived from the ZVI layer was 0.027 mg L
-1
. Vanadium was removed from the 
system to below the water quality guidelines (0.006 mg L
-1
) for 50 days after introducing the 
ZVI layer. The removal decreased after this period, suggesting that 5 wt. % ZVI (2.05 vol. %) is 
insufficient to sustain prolonged V removal and an increase in the ZVI content would be required 
for full-scale implementation.  
Mean Al concentrations in the influent water were 0.002, 0.002, and 0.010 mg L
-1
 in years 1, 
2, and 3, respectively; the corresponding mean effluent Al concentrations were 0.022, 0.294, and 
0.426 mg L
-1
 (Figure 2.13). The influent water and pore water in Column 1 were supersaturated 
with respect to gibbsite but, as the pH increased, the water became undersaturated with respect to 
gibbsite and Al concentrations increased. The solubility of Al reaches a minimum at near neutral 
pH values (Stumm and Morgan, 1981). Therefore, the pH was adjusted through CO2 addition to 
decrease the dissolved Al concentration in the final effluent and a sand filter was added to 
remove the particulate Al that formed. After these system modifications, Al concentrations 
decreased to below 0.075 mg L
-1
, the water quality guidelines for Ontario (MOEE, 1994). 
Geochemical calculations indicate that the column effluent became supersaturated with respect 
to gibbsite following the pH adjustment and suggest that the Al concentrations declined due to 
precipitation of an Al hydroxide phase, with subsequent removal of this phase in the sand filter.  
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2.4.7 Accumulation of precipitates in columns 
No noticeable impedance in flow of lake water through the treatment system was observed 
during year 1. However, during year 2 there was a noticable decline in flow. Extensive 
precipitation was observed near the top of Column 1 at the end of year 2 and was presumed 
responsible for the observed decline in flow. Samples of the precipitate reacted with HCl 
vigorously, indicating the presence of carbonate minerals. Binocular microscopic examination of 
the precipitate from the top of the Column 1 showed the presence of abundant acicular crystals 
(Figure 2.14). Crystals with well-developed faces and elevated concentrations of Ca (9%), C 
(45%), and O (25%) were observed in the FE-SEM images and EDX data (Figure 2.5, Sample 
5a). All of these observations suggest that the precipitates were CaCO3, which formed due to the 
ingress of atmospheric CO2(g) into the BOFS columns, and reaction with Ca derived from the 
BOFS. Hydraulic performance was greatly improved in year 3 by sealing the reactive columns to 
restrict the ingress of atmospheric CO2(g) and prevent the formation of excessive CaCO3.     
2.5 Conclusions 
Basic oxygen furnace slag (BOFS), a waste by-product of the steel-making process, was used in 
a hypolimnetic withdrawal phosphorus treatment system. The BOFS removed phosphorus (P) 
(up to >99% removal) to concentrations of < 0.005 mg L
-1
. Precipitation of P- bearing solids was 
the principal P removal mechanism. The BOFS treatment material generated a high pH effluent 
(ranging from pH 8 to 12), attributed to dissolution of CaO and Ca(OH)2. This effluent was 
neutralized by sparging with CO2(g) prior to discharge to the environment. Elevated V and Al 
concentrations also were derived from the BOFS. Vanadium in the effluent was removed likely 
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by reduction with 5 wt. % granular zero valent iron mixed with sand. Aluminum was removed by 
a sand filter following pH neutralization. Utilization of less weathered BOFS in years 2 and 3 led 
to improved P removal. In year 3, further isolating the BOFS from atmospheric CO2  by tightly 
sealing the treatment columns lessened the extent of CaCO3 accumulation on the treatment 
media, which in turn improved the hydraulic performance of the system. A trend of increasing P 
content along the flow path in first two columns indicates that the location of maximum P 
accumulation coincided with the location of a sharp increase the pH and a sharp decrease in the 
PO4 aqueous concentration.  Surface techniques including BSE imaging with EDX spectra, XPS, 
FTIR, and XANES spectra and corresponding LC fitting suggest that phosphorus accumulated 
on the outer layer of the spent BOFS media as -tricalciumphosphate and -tricalciumphosphate.  
The results of this study suggest that the BOFS based reactive material can be used for extended 
periods with little maintenance, potentially providing a sustainable option for the removal of P 
from small lakes.   
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Figure 2.1 Schematic diagram of the field columns at Lake Wilcox, Richmond Hill, Ontario. 
Influent waters were collected from the hypolimnion of the lake and made available periodically 
for continuous flow by gravity feed into the treatment system. 
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Figure 2.2 pH values, alkalinity and PO4-P concentrations versus vertical distance along the 
treatment flow path in years 1, 2, and 3 of the hypolimnetic withdrawal P treatment experiment, 
respectively. C1, C2, C3, and CO2 at the top represent Columns 1 to 3 and the neutralization 
tank, respectively. The dashed lines represent the relevant Ontario Provincial Water Quality 
Objectives (PWQO).  
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Figure 2.3  Eh values measures along the flow path in years 1, 2, and 3 
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Figure 2.4 Ca, Na, Mg, Mn, and SO4 concentrations versus distance along the treatment flow 
path in three successive years of the hypolimnetic withdrawal P treatment experiment. C1, C2, 
C3, and CO2 at the top represent Columns 1 to 3 and the neutralization tank, respectively. 
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Figure 2.5  pH values and PO4-P, Ca, Na, Mg, and SO4 concentrations versus distance along the 
treatment flow path in year 3 of the hypolimnetic withdrawal P treatment experiment. C1, C2, 
C3, and CO2 at the top represent Columns 1 to 3 and the neutralization tank, respectively. The 
dashed lines represent the relevant water quality guidelines for Ontario. 
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Figure 2.6  Flow rate, PO4-P concentrations in the influent and effluent, and P load in the 
treatment system during years 1, 2, and 3.    
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Figure 2.7  SEM images of fresh BOFS (sample 1) and precipitates that formed on the spent 
reactive media along the flow path (sample 2-9) in year 2. The direction of flow is indicated by 
the arrows. Unless indicated with small circles, the EDX data were obtained from the entire 
image area. The phosphorus contents obtained from the EDX data are shown on the images. 
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Figure 2.8  a) Dissolved P and solid phase P versus distance, and b) pH and solid phase P versus 
distance along the treatment flow path in year 2 of the hypolimnetic withdrawal P treatment 
experiment. C1, C2, and C3 at the top represent Columns 1, 2, and 3.  
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Figure 2.9  FTIR spectrum of sample C2-S10 and major phosphate vibrational bands of a) HAP-
S, and b) -TCP; and major carbonate bands of c) calcite, and d) aragonite are compared. 
Vertical dotted lines in “a” and “b” represent phosphate vibrational bands, while vertical dotted 
lines in “c” and “d” represent carbonate vibrational bands. 
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Figure 2.10 XANES spectra for reference materials, PO4 sorbed on CaCO3 (PSC), and samples 
C2-S10 and C3-S1. Vertical lines represent various spectral features: a) pre edge feature for FeP; 
b) absorption edge (white line) for CaP species; c) shoulder (sharpness dependent on the degree 
of crystallinity; d) spectral feature common in HAP; e) oxygen oscillation. 
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Figure 2.11 Linear combination fit results for spent BOFS samples C2-S10 and C3-S1.  
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Figure 2.12 Saturation indices for calcium phosphate and other related phases calculated using 
PHREEQCI versus distance from influent to final effluent in year 3. Saturation index of 
hydroxyapatite (indicated by *) was plotted using a modified log Ksp value (Baker et al., 1998).   
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Figure 2.13 a) Concentrations of V and Al versus distance along the treatment flow path for 
three successive years of the trial. Five representative sampling events were selected for each 
year. b) Concentrations of V and Al in the BOFS effluent for all three years and for ZVI in year 
3. C1, C2, C3, and CO2 at the top represent Columns 1 to 3 and the neutralization tank, 
respectively. The dashed lines represent the relevant water quality guidelines for Ontario. 
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Figure 2.14 Optical microscopy images for a sample of reactive media collected 15 cm below 
the top surface of Column 1. The magnified images (40X) on the right hand side correspond to 
the boxed areas from the left hand side. 
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Table 2.1 Components of the reactive media and mass distribution during the study period. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   Year 1  Year 2 Year 3 
  Slag Source Levy, Detroit Stelco, Hamilton Stelco, Hamilton 
C
o
lu
m
n
 1
 Total Vol. (m
3) 0.695 0.695 0.695 
Media components BOFS Gravel BOFS Gravel BOFS Gravel 
Vol. ratio  0.5 0.5 0.5 0.5 0.5 0.5 
Mass* (kg) 677 534 752 534 724 534 
C
o
lu
m
n
 2
 Total Vol. (m
3) 0.695 0.695 0.695 
Media components BOFS Gravel BOFS Gravel BOFS Gravel 
Vol. ratio  0.5 0.5 0.5 0.5 0.5 0.5 
Mass* (kg) 677 534 752 534 724 534 
C
o
lu
m
n
 3
 
Total Vol. (m3) 0.695 0.695 0.347 (Lower 
part) 
0.347 (Upper 
part) 
Media components BOFS Gravel BOFS Gravel BOFS Gravel ZVI  Sand 
Vol. ratio  0.5 0.5 0.5 0.5 0.5 0.5 0.02 0.98 
Mass* (kg) 677 534 752 534 362 267 12 298 
* Media component masses were calculated using particle densities (Table 2.2) and measured 
porosity values (0.41, 0.42, 0.50, and 0.34 for the BOFS, gravel, ZVI, and sand, respectively). 
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Table 2.2 Physical and chemical properties of the BOFS materials used in the experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BOFS type BOFS-A BOFS-B BOFS-C 
BOFS source Levy, Detroit Stelco, Hamilton Stelco, Hamilton 
 Particle size (mm) Surface area (m2 g-1) 
P
h
ys
ic
al
 p
ro
p
er
ti
es
 
4-2 2.66 4.62 3.22 
2-1 4.29 5.05 4.67 
1-0.5 6.11 7.33 6.82 
<0.5 7.33 9.00 9.60 
Particle size (mm) Mass weighted surface area (m2 g-1) 
4-2 73.0 121 82.8 
2-1 76.7 94.5 71.2 
1-0.5 70.3 87.9 77.9 
<0.5 317 388 442 
Density (g cm-3) 3.30 3.67 3.53 
C
h
em
ic
al
 p
ro
p
er
ti
es
 
C
h
em
ic
al
 c
o
m
p
o
si
ti
o
n
 (
 w
t.
 %
) 
CaO 36.3 33.1 40.0 
Fe2O3 24.7 33.8 18.1 
SiO2 9.21 11.8 15.3 
MgO 9.41 7.95 9.08 
MnO 3.39 5.43 4.04 
Al2O3 5.84 3.96 5.05 
P2O5 0.66 - - 
TiO2 0.45 0.38 1.13 
K2O <0.01 0.02 0.03 
Na2O <0.10 0.10 0.09 
Cr2O3 0.11 - - 
Loss on ignition 5.78 3.49 7.12 
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Table 2.3 Mean values and range of pH, alkalinity, and PO4-P of the input and BOFS column effluent in years 1, 2, and 3. 
  Year 1 Year 2 Year 3 
  Input BOFS 
Column Eff. 
Final Eff. Input BOFS Column 
Eff. 
Final Eff. Input BOFS Column 
Eff. 
Final Eff. 
pH Mean 7.40 8.49 8.47 7.30 10.94 8.84 7.73 11.95 8.13 
 Range 7.20-7.85 8.09-9.12 7.72-9.64 7.18-7.58 9.36-11.63 8.07-9.64 7.15-10.94 11.78-12.17 6.18-12.17 
Alk (mg L
-1 
CaCO3) Mean 169 183 157 155 111 111 225 493 344 
 Range 118-280 78-362 70-240 124-262 60-176 78-134 160-360 130-1146 96-1020 
PO4-P (mg L
-1
) Mean 0.37 0.07 0.03 0.32 0.03 0.02 0.34 <0.005 0.005 
 Range 0.29- 0.55 0.02-0.12 0.01-0.06 0.02- 0.49 0.01-0.15 <0.005-0.06 0.31-0.38  <0.005-0.008 <0.005-0.012 
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Table 2.4 P mass loading in the treatment system during years 1, 2, and 3. 
Year Total P 
mass in (g) 
Total P mass 
out (g) 
Total P mass 
removed (g) 
Total mass 
retained 
1 42 6 36 86% 
2 51 1 50 98% 
3 56 1 55 98% 
 
 
Table 2.5 EDX data showing the composition of the selected samples. 
  
wt. % of important elements 
Media Sample C O Mg Si P Ca 
Fresh BOFS 1 10.8 24.3 2.47 2.15 0.08 14.0 
Spent 
media from 
Column 1 
2 5.87 8.86 0.25 0.78 0.65 67.2 
3 17.7 31.4 2.38 2.07 0.66 31.7 
4a 14.0 29.5 1.56 1.45 0.96 37.5 
5a 5.95 11.8 1.74 4.16 1.04 36.0 
5b 45.5 25.0 2.30 1.60 0.70 8.90 
5c 14.2 40.9 13.4 7.31 0.35 10.1 
Spent 
media from 
Column 2 
6 23.5 30.5 8.08 9.93 1.28 7.53 
7 15.2 26.1 1.17 1.01 1.29 37.1 
8 11.8 24.0 1.56 3.84 1.17 25.1 
9 21.4 36.3 5.93 7.63 1.00 14.0 
Spent 
media from 
Column 3 
10 18.2 36.3 1.80 4.29 0.69 19.8 
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Table 2.6 Vibrational bands of calcium carbonate minerals. 
Reference 
materials 
Carbonate vibrational bands Reference 
 v1 v2 v3 v4  
Calcite - 874  713 Ni and Ratner (2008) 
  875 1440 713 Vongsavat et al. (2006) 
  877 1420 713 Andersen and Brecevic 
(1991) 
  872   Amarie et al. (2012) 
Aragonite  858  713, 700 Ni and Ratner (2008) 
 1083 854 1488, 
1440 
713, 700 Andersen and Brecevic 
(1991) 
      
 1083 857 1498 713 Vongsavat et al. (2006) 
Vaterite  874  744 Ni and Ratner (2008) 
 1089 877, 
873 
1487, 
1445 
746,738 Andersen and Brecevic 
(1991) 
Amorphous 
CaCO3 
1067 864 1490, 
1425 
725, 690 Andersen and Brecevic 
(1991) 
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Table 2.7 Vibrational bands of phosphate in the reference materials. 
Reference 
materials 
Phosphate vibrational bands 
v3 v1 v4 v2 
HAP-S 1092 962 568 475 
 
1045 
 
603 
 
   
633 
 HAP-WM 1090 962 571 474 
 
1042 
 
602 
 
   
633 
 β-TCP 1098 962 564 471 
 
1033 
 
603 
 
   
634 
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Table 2.8 Vibrational bands of calcium phosphate minerals. 
Reference 
materials 
Phosphate vibrational bands OH 
stretc
h 
Comments Reference 
 v1 v2 v3 v4    
HAP   1046 569 3443  Kim et al. (2006) 
966  1037  3576  Balan et al. (2011) 
962 472 1090, 1042 632, 602, 
566 
3570 Merck Rehman and Bonfield 
(1997) 
       
961 471 1096, 1031 604, 566 3744, 
3440 
nano 
particle 
Panda et al. (2003) 
963 477 1094, 1024 606, 574 3574  Matković et al. (2012) 
962  1087, 1040 601, 571   Pena and Vallet-Regi 
(2003) 
960 475 1092, 1044, 
1036 
573   De Oliveira Ugarte  et 
al. (2005) 
  1020-1025   Non-
stoichiome
tric 
Petra et al. (2005) 
962 477, 
437 
1089-1053 603, 569 3571  Sargin et al. (1997) 
963  1090, 1052 602, 573 3571  Rapacz-Kmita et al. 
(2005) 
  1092, 1060, 
1029 
  Sigma Antonakos et al. (2007) 
970  1026 598, 555 3571  Jalota et al. (2005) 
962  1030  3570  Nishikawa (2001) 
963 473  602, 571 3452  Ribeiro et al. (2006) 
Dicalcium 
phosphate 
962  1090, 1020 632, 601, 
570 
3571  Fernandez et al. (2012) 
-Tricalcium 
phosphate 
967  1126, 1024 614, 549   Matković et al. (2012) 
972, 
945 
 1120,1042, 
1025 
606, 594, 
552 
  Pena and Vallet-Regi 
(2003) 
971, 
948 
 1120, 1042 604   De Oliveira Ugarte  et 
al. (2005) 
-Tricalcium 
phosphate  
948, 
954 
 1055, 1025 613, 597, 
585, 563, 
551 
  Pena and Vallet-Regi 
(2003) 
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Table 2.9 Ca/C, Ca/P and O/Ca ratios of the samples analyzed. 
Sample 
ID 
Ca P3/2 Ca P1/2 Carbonate  P 2p3/2 P 2p1/2 Ca/C O/Ca Ca/P 
C1-S2 346.88 350.43 289.38 132.57 133.41 0.32 5.3 24 
C1-S3 347.07 350.62 289.54 132.77 133.61 0.29 4.8 33 
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Table 2.10 Linear combination fitting results of spent BOFS samples. 
Linear combination fits to C2-S10 as norm(E) 
Combination R-factor 2 
-TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 5.71E-3 2.30 0.581 0.236 0.184 
-TCP, CPDD 6.27E-3 2.52 0.64 0 0.36 
-TCP, -TCP 6.30E-3 2.53 0.67 0.33 0 
-TCP, CPDD 9.80E-3 3.94 0 0.413 0.587 
Linear combination fits to C1-S2 as norm(E) 
Combinations R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 8.47E-03 3.29 0.495 0.441 0.064 
-TCP, -TCP 8.52E-03 3.31 0.523 0.477 0 
-TCP, CPDD 1.09E-02 4.24 0.639 0 0.361 
-TCP, CPDD 1.11E-02 4.30 0 0.561 0.439 
Linear combination fits to C2-S4 as norm(E) 
Combinations R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 1.48E-02 5.48 0.494 0.401 0.104 
-TCP, -TCP 1.53E-02 5.67 0.552 0.448 0 
-TCP, CPDD 1.69E-02 6.27 0.618 0 0.382 
-TCP, CPDD 1.74E-02 6.46 0 0.518 0.482 
Linear combination fits to C2-S9 as norm(E) 
Combinations R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 8.97E-03 3.21 0.676 0.255 0.069 
-TCP, -TCP 9.27E-03 3.32 0.725 0.275 0 
-TCP, CPDD 9.97E-03 3.57 0.812 0 0.188 
-TCP, CPDD 1.47E-02 5.28 0 0.471 0.529 
Linear combination fits to C2-S11 as norm(E) 
Combinations R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 1.16E-02 4.42 0.607 0.366 0.027 
-TCP, -TCP 1.18E-02 4.47 0.621 0.379 0 
-TCP, CPDD 1.38E-02 5.24 0.875 0 0.125 
-TCP, CPDD 1.68E-02 6.38 0 0.635 0.365 
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Table 2.10 Continued Linear combination fitting results of spent BOFS samples. 
Linear combination fits to C3-S1 as norm(E)  
Combinations R-factor 2 
-TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 5.25E-03 2.13 0.641 0.233 0.126 
-TCP, -TCP 5.57E-03 2.26 0.703 0.297 0 
-TCP, CPDD 5.78E-03 2.34 0.694 0 0.306 
-TCP, CPDD 1.01E-02 4.10 0 0.415 0.585 
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Chapter 3 
Removal of Nutrients and Pathogens in an Advanced 
Pilot-scale Engineered Wetland Wastewater Treatment 
System 
3.1 Executive Summary  
A pilot-scale, multi-step Engineered Wetland (EW) wastewater treatment system with a 
phosphorus removal component was evaluated to assess the potential for removal of phosphorus 
(P), ammonia, cBOD5, COD, E. coli, total coliform, and trace metals.  Septic system effluent 
passed through the treatment system, composed of four cells including a mixing cell, a vertical 
subsurface flow (VSSF) aerobic cell based on Forced Bed Aeration™, a VSSF phosphorus 
treatment cell based on  the use of basic oxygen furnace (BOF) slag as a treatment material, and 
a horizontal subsurface flow (HSSF) anaerobic cell. The system was operated for 9 months with 
an average flow rate of 0.068 m
3
 d
-1
. The mean influent concentrations of P, ammonia, cBOD5, 
and COD were 7, 25, 27, and 60 mg L
-1
, respectively, and the mean influent levels of E. coli and 
total coliform were 2.2x10
4
 and 8.9x10
4
 CFU 100 mL
-1
.  Effluent from the system had 97-99% 
lower concentrations of P, NH3, cBOD5, E. coli, and total coliform, and a 72% lower 
concentration of COD, compared to influent values. The pH of the BOF slag cell was elevated 
(pH, 11.66±0.70), and was neutralized by sparging CO2(g) prior to discharge to the subsequent 
anaerobic cell. Vanadium and Al were leached from the BOF slag at levels that exceeded 
guideline values.  There was no significant decline in hydraulic performance observed during the 
study. Backscatter scanning electron (BSE) images and energy dispersion X-ray (EDX) spectra 
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and X-ray intensity element maps along with Fourier transform infrared (FTIR) spectra confirm 
the presence of phosphorus on the outer layer of the spent reactive material. The FTIR spectra 
also indicate the occurrence of calcium carbonate and phosphate minerals. The X-ray absorption 
near edge structure (XANES) spectra provides information on the speciation of solid-phase 
calcium phosphates accumulated on the spent reactive media. 
3.2 Introduction   
Phosphorus (P) in the discharge of wastewater treatment facilities is an important environmental 
concern. The release of an excessive amount of this nutrient can cause eutrophication and 
deterioration of water bodies (Sedlak, 1991; Parry, 1998). Thus, increasingly more conservative 
discharge criteria have been imposed. During the last decade, constructed wetland (CW) designs 
have been developed to achieve better overall treatment performance, and to provide compound-
speciﬁc treatment (Vymazal, 2011). Recent studies have focused on the use of treatment media 
with a high efficiency for phosphorus removal, identifying bacteria which promote treatment 
processes, and development of models to optimize pollution removal (Vymazal, 2011). 
Conventional CWs effectively treat a broad range of wastewater effluents. However, these 
CWs are relatively ineffective at removing phosphorus (Kadlec and Knight, 1996; Kadlec et al., 
2000).  Although high initial rates of P removal have been observed in CWs, up to 42% (Kadlec 
and Knight, 1996; Knight et al., 2000) and 45.7% (Vymazal, 2004), P removal has been 
observed to decline over time. Development of multistep systems and integration of more 
complete phosphorus removal with a conventional CW could provide superior P treatment 
efficiency.   
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A number of studies have focused on the role of substrate materials used in CWs to improve 
the P treatment capacity (Johansson, 1999; Drizo et al., 1999; Drizo et al., 2002; Jenssen and 
Krogstad, 2003). Materials with high sorption capacity and/or the ability to precipitate phosphate 
phases are considered as candidate substrates for CWs to remove P from wastewater. The most 
promising substrates are industrial by-products including blast furnace (BF) slag (Grüneberg and 
Kern, 2001; Cameron et al., 2003; Korkusuz et al., 2005; Gustafsson et al., 2008), basic oxygen 
furnace (BOF) slag (Mann and Bavor, 1993; Drizo et al., 1999; Cha et al., 2006),electric arc 
furnace (EAF) slag (Drizo et al., 2002; Drizo et al., 2006), shale (Drizo et al., 1999),and 
lightweight aggregates (Jenssen and Krogstad, 2003). BOF slag is among the treatment materials 
that can be used to remove phosphorus from the effluent of the CWs. BOFS is a waste by-
product generated during the steelmaking process (Mikhail et al., 1994; Shi, 2004; Bowden et al., 
2009). The major phases (>10 wt. %) of BOFS are di-calcium silicate (Ca2SiO4), tri-calcium 
silicate (Ca3SiO5), ferrous oxide (FeO), and Ca-Mg-Mn-Zn-ferrite ((Ca,Mg,Mn,Zn)Fe2O4) 
(Mikhail et al., 1994). Calcium oxides, Fe2O3, and SiO2 are the main chemical components that 
comprise approximately 70-85 wt. % of BOFS, and MgO, MnO, Al2O3, P2O5, TiO2, K2O, Na2O, 
and Cr2O3 comprise the remaining portion of the material (Table 3.1; Cha et al., 2006; Xue et al., 
2009; Mahieux et al., 2009; Yildirim and Prezzi, 2011; Belhadj et al., 2012).  The average 
percentage of the major constituents of BOFS are Ca (28.01%), Fe (18.43%), Si (5.97%), Mg 
(5.53%), Mn (3.29%), and Al (2.38%); minor constituents are P (0.32%), C (0.26%), Cr-total 
(0.13%), S (0.11%), and V (0.10%) (Proctor et al., 2000).  
BOFS has been recognized as a potential material for removing phosphorus, arsenic, and 
waterborne pathogens from groundwater and wastewater (Blowes et al., 1996; Bowden et al., 
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2009; Xue et al., 2009).  Laboratory and field applications have demonstrated very high levels of 
removal (often >99%) of arsenic, phosphate, and pathogen indicators (e.g. E-coli) in simulated 
wastewater and wastewater (Baker et al., 1997, 1998; McRae et al., 1999; Blowes et al., 2000; 
Smyth et al., 2002b; Stimson et al., 2010). The extent of removal depends on the contact time 
between the BOFS and wastewater, with contact times of up to 24 hours required to ensure 
maximum removal of phosphorus (Baker et al., 1998).  Exceedingly alkaline effluent and the 
potential for metal leaching from BOFS are two of the potential drawbacks that need to be 
reasonably eliminated prior to widespread application of BOFS as a wastewater treatment 
material.   
Aerated sand filters are effective in removing cBOD5 (>90%) from wastewater (Johnson and 
Mara, 2005). Enzymes related to processes in the E. coli bacterium are often pH-sensitive. Faecal 
coliform die-off quickly at pH > 9 and nutrient-poor conditions (Pearson et al., 1987), and the 
bacterial indicators are also removed through aeration stages (Johnson and Mara, 2005). Highly 
aerobic conditions induced by aeration enhance die-off of E. coli (Seaman et al., 2009). 
This paper describes the incorporation of a BOFS cell into an engineered wetland (EW) system 
in a pilot-scale indoor facility with an average flow rate of 68 liters per day. The study 
investigated the capacity of the treatment systemto remove P, NH3, pathogens, dissolved metals, 
and the leaching behaviour of BOFS. A carbon dioxide injection system was used for the 
neutralization of the high pH effluent from the BOFS cell. Changes in the hydraulic conductivity 
of the BOFS cell were evaluated by monitoring the flow rate in this cell. Solid-phase analyses on 
outer layer material of the spent BOFS were used to determine the PO4 removal mechanism.  
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3.3 Materials and Methods 
3.3.1 System configuration  
A pilot-scale indoor wastewater treatment system (Figure 3.1) with a capacity of 50 -100 L day
-1, 
was constructed in the Center for Alternative Wastewater Treatment, Fleming College, Lindsay, 
Ontario, in the spring of 2009. The system consisted of a feed tank, a mixing cell to provide 
more uniform input chemistry (120 cm long, 100 cm wide, and 116 cm deep), a saturated top-
dosed aerated engineered vegetated wetland (EW) cell (Cell 3), a sealed and unvegetated BOFS 
cell (Cell 4), a pH adjustment cell (Cell 4*), and a vertical subsurface flow (VSSF) EW cell, 
which was anerobic at the base and vegetated at the top (Cell 5). A distribution manifold and 
collection manifold, both comprised of three parallel perforated polyvinyl chloride (PVC) pipes, 
were installed within each cell to evenly distribute the influent and to capture the effluent from 
all portions of the cell. 
Wastewater (sewage feed collected from the septic tank of the college) was stored in the feed 
tank (Cell 1, 1.0 m
3
) and introduced to the mixing cell (Cell 2) as required, and then transmitted 
through the treatment cells by gravity. The mixing cell had a 5 cm layer of sand placed at its base 
to cushion a water collection manifold. The collection manifold was covered with a 10 cm layer 
of washed gravel (Figure 3.2). The HRT of this cell was about 14 days. The mixing cell 
contained a heavy duty drum/barrel mixer, which was driven by a   ⁄   horse power, single-phase, 
60 Hz motor (Cole Parmer Leeson).  
Cell 3 was a saturated top-dosed aerated engineered wetland (EW) cell, constructed according 
to the Forced Bed Aeration™ technology. A 5 cm thick sand layer was placed at the bottom of 
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the cell to hold the distribution manifold.  The distribution manifold was then covered with 10 
cm thick layer of washed gravel layer and a specially-constructed aerator was installed on top of 
it. The aerator consisted of a 1.9 cm (  ⁄  in) PVC pipe connected to three 0.95 cm (  ⁄  in) plastic 
tubes, which were perforated with 0.32 cm (  ⁄  in) holes at regular intervals. A small air blower 
(HAILEA Model: ACO-009D), driven by a 135W, 110V/60 Hz motor, was used to provide 125 
L min
-1
 of air at a pressure of >0.004 Mpa. The aerator was overlain by a 98 cm thick layer of 
washed limestone gravel with a porosity of about0.35 (Figure 3.3). The nominal hydraulic 
retention time of wastewater passing through the Aerated Cell was 7 days, at an influent flow 
rate of 68 L day
-1
. A distribution manifold (with perforations on the top) was placed on the 
surface of the upper gravel layer. Finally, this cell was vegetated with cattails, Typha spp.   
Cell 4 contained a substrate of 50 vol. % screened BOFS and 50 vol. % washed limestone 
gravel with a median grain size of 1.9 cm (   ⁄ inch).  The cell was designed to be sealed and 
airtight.  The vertical distribution of reactive materials within Cell 4 included a 10 cm basal layer 
of sand, which supported the outlet collection grid, a 57 cm thick layer of the BOFS-gravel 
mixture in the central portion of the cell, and a 10 cm layer of 1.9 cm diameter (
3
/4 inch) crushed 
limestone was placed on top. The top gravel layer supported the distribution manifold at the top 
of the cell (Figure 3.4). The BOFS was screened and washed prior to use in the cell. The mean 
hydraulic retention time was 6.3 days with an average influent wastewater flow rate of 68 L day
-
1
. Cell 4* was an open-topped vessel into which effluent from Cell 4 flowed. Carbon dioxide gas 
was bubbled from the bottom of the vessel using large gas spargers. This CO2 addition cell was 
introduced between Cell 4 and Cell 5 after 15 weeks of operation.  
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The design of Cell 5 was similar to Cell 3 but without aeration.  The base of the cell was filled 
with a 5 cm thick sand layer. A collection manifold was placed on top of the sand layer and the 
manifold was covered with a 10 cm gravel layer. The gravel layer was overlain by a 50 cm thick 
layer of substrate (a mixture of 7 parts pulp and paper biosolids to provide a source of organic 
carbon, 5 parts gravel, and 2 parts sand). This layer was overlain by another 25 cm thick layer of 
substrate (a mixture of 7 parts pulp and paper biosolids, 12 parts gravel, and 2 parts sand). 
Finally, there was a 25 cm thick unwashed gravel layer placed at the top. The perforated 
distribution manifold was placed on top of the final gravel layer and leveled (Figure 3.5). This 
cell was also vegetated with transplanted cattails, Typha spp.  The mean hydraulic retention time 
was 6.5 days. The treatment cells were placed in series and connected with a piping network. 
Sample collection ports (plastic valves) were located between cells.  
3.3.2 Reactive material characterization  
This study used BOFS from the US Steel Stelco Hilton Works facility (Hamilton, ON, Canada). 
The particle density of the BOFS was determined using a pycnometer (Air Comparison 
Beckman Model 930). Surface area was determined with a surface area analyzer 
(Micromeritics Gemini
®
 VII 2390 Series). The composition of BOFS was determined by X-ray 
fluorescence (XRF, MiniPal4, PANanalytical). The constituent phases of BOFS were obtained 
using a Rigaku D/MAX 2500 rotating anode powder diffractometer using monochromatic CuKα 
radiation at 50 kV and 260 mA. The measurements were conducted with 2 angular range from 
5-70
0
, where the step size and scan speed were 0.02
0
 and 1
0
/min. The phase identification was 
performed by using JADE version 9.3 coupled with the ICSD and ICDD diffraction databases.  
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3.3.3 Water sample collection and analysis 
The treatment system was monitored over an 8 month period at indoor temperatures (~23 
o
C) 
from July 2009 to February 2010. Influent, effluent from each cell, and overall system effluent 
samples were collected weekly. Sampling valves were purged at least three times before sample 
collection. The pH and Eh were measured on unfiltered samples immediately after collection 
using combination electrodes (Thermo Scientific Orion ROSS pH electrode and Thermo 
Scientific Orion Eh electrode). Alkalinity was measured on filtered (0.45 μm filter size) samples 
using a Hach™ digital titrator and standardized sulfuric acid and with phenolpthalein and 
bromocresol green-methyl red pH indicators. Samples were ﬁltered through 0.45 µm dedicated 
syringe filters and collected into polyethylene bottles for analysis of anions (not acidified), 
cations and trace metals (acidified to pH 2 with concentrated HNO3), PO4 and ammonia 
(acidified to pH 2 with 18 N H2SO4). Field blanks consisted of MilliQ water collected using the 
same collection and preservation methods like other samples in the field to evaluate whether 
contamination occurred during the filtering process or transport. The trip blanks were unfiltered 
MilliQ water (brought to the field) samples collected directly from a plastic container in the field 
and preserved in the same manner as the other samples to determine whether any contamination 
occurred in from the bottles and during the transport. All samples and blanks were stored on ice 
packs in a cooler at ~4°C during transport to the laboratory and refrigerated until analysis.   
Samples were analyzed for ortho-phosphate and total phosphate using a UV-
spectrophotometer (HACH, DR-2800) within 7 days of collection. The ascorbic acid method 
(HACH Method 8048 based on SM 4500 P E) was used for ortho-phosphate analysis and an 
ascorbic acid with acid persulfate digestion method (HACH method 8190 based on S M 4500 P 
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E) for total phosphate analysis (APHA, 1998). Samples were analyzed for major cations using 
inductively coupled plasma optical emission spectroscopy (ICP-OES; Thermo Instruments iCAP 
6500 Duo), for trace elements using inductively coupled plasma mass spectrometry (ICP-MS; 
Thermo Instruments XSeries 2), and for anions using ion chromatography (Dionex Ion 
Chromatograph model DX120, anion AS50 analytical column). The CBOD5 was measured using 
a HACH BOD meter (HQ40D) and probe (LBOD101) following standard method “SM 5210 B” 
(APHA, 1998).  Samples were analyzed for COD using a UV-spectrophotometer (HACH, DR-
2800) following standard method “SM 8000” (APHA, 1998). Dissolved oxygen was measured 
using an YSI 5100 Dissolved Oxygen Meter following the method described in the 
manufacturer’s operations manual. Conductivity of the samples was measured using a YSI 3100 
Conductivity meter (equipped with a temperature sensor and a platinum electrode) based on the 
method SM 2510 B (APHA, 1998).  Samples were analyzed for NH3-N using a UV-
spectrophotometer (HACH, DR-2800) following Salicylate (colorimetric) Method (HACH 
Method 10031). Coliform and Escherichia coli (E.coli) most probable number counts were 
determined using a 96 well titer plate method (Coliplate
TM
). All samples were analyzed in 
CAWT Laboratory, Fleming College and the Environmental Geochemistry Laboratory, 
University of Waterloo.  A subset of samples was analyzed for cations and trace metals at SGS 
Lakefield Research Limited, Lakefield, Ontario for QA/QC purposes.    
3.3.4 Solid-phase sample collection and analysis 
At the conclusion of the experiment, the formation of a white precipitate on the reactive media in 
Cell 4 was noted; therefore, the cell was excavated to collect samples for mineralogical analysis.  
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Samples were collected in 10-15 cm intervals from the top down to the base, in five vertical 
profiles (Figure 3.6). These samples were analyzed to determine the composition of the 
precipitate. Solid-phase samples were examined using scanning electron microscopy (Leo 1530 
field emission scanning electron microscopy (FE-SEM)) with energy dispersive X-ray (EDX) 
analysis.  
These samples also were studied by Fourier transform infrared spectroscopy (FTIR) (Tensor 
27, Bruker). Samples of the scale accumulated on the particle surfaces (adsorbed or precipitated 
material) were mixed with KBr with a ratio of approximately 1:100, ground in a mortar, and 
pressed into 1 cm diameter transparent disks/pellets (with 5 to 6 tonnes pressure for 1 min).  
Additional FTIR analyzes were performed with a second infrared spectrometer (IFS 55, Bruker) 
using a diamond compression cell in combination with a microscope equipped with micro-ATR 
(attenuated total reflectance). FTIR spectra were collected over a range of 4000-400 wave 
numbers (cm
-1
). A total of 16 scans were collection at a scan resolution of 4 cm
-1
. Background 
noise was minimized by subtracting a blank KBr data from each spectrum.  In addition to the 
KBr pellets, mounted sections of selected samples were prepared and polished. These samples 
were examined by optical microscopy. Reference materials including iron (III) phosphate (FeP), 
-tricalcium phosphate (-TCP), -tricalcium phosphate (-TCP), hydroxyapatite (HAP-S), 
calcium phosphate dibasic (CPD), and calcium phosphate dibasic dehydrate (CPDD) were 
obtained from Sigma Aldrich, Canada. Additional reference material, hydroxyapatite (HAP-
WM), was synthesized in the laboratory following a liquid mix technique described in Pena and 
Vallet-Regi (2003). These reference materials were also used in X-ray absorption near edge 
structure (XANES) analysis. The polished sections were also examined by scanning electron 
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microscopy coupled with energy dispersive X-ray spectroscopy (SEM/EDX) using a 
backscattered electron detector and EDX X-ray intensity elemental mapping.  The phosphorus-
rich areas were chosen for FTIR analysis using the micro ATR crystal (germanium) through the 
EDX X-ray intensity elemental maps constructed from analyzes 80-100 µm in diameter to a 
depth of 1-2 µm. 
X-ray photoelectron spectroscopic (XPS) analyzes were performed using a Kratos Axis Ultra 
spectrometer. A monochromatic Al K (alpha) source (15mA, 14kV) was used in this 
spectrometer. XPS can investigate the surface (penetration depth 5-7 ηm) and detect all elements 
except hydrogen and helium. Depending on the element, the detection limits varied from 0.1 to 
0.5 atomic percent. The work function of the instrument was calibrated with respect to Au 4f7/2 
line for metallic gold to a binding energy (BE) of 83.96 eV. The dispersion of the spectrometer 
was adjusted with respect to the Cu 2p3/2 line of metallic copper to a BE of 932.62 eV. For all 
specimens, the Kratos charge neutralizer system was used. The analysis area and pass energy of 
the survey scan analyzes were 300 x 700 microns and 160 eV, while the analysis area and the 
pass energy of high resolution analyzes were 300 x 700 µm and 20 eV. The spectra obtained 
were corrected for charge to the main line of the carbon 1s spectrum (adventitious carbon) set to 
284.8 eV. The CasaXPS software (version 2.3.14) was used to analyze the spectra. 
XANES experiments were conducted at the Canadian Light Source, Saskatoon, Canada using 
the 2.9 GeV storage ring. Phosphorus K absorption edge data was recorded using Soft X-ray 
Micro-characterization Beam line (SXRMB; 06B1-1) covering the region of 1700-10000 eV 
with photon resolution of 0.2eV and a beam spot size of 300 μm x 300 μm. XANES spectra were 
acquired in Total Electron Yield (TEY) and Fluorescent Yield (FY) modes. Experimental and 
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standard data were collected using a monochromator with Si (111) crystals and a flux of >1X10
11
 
photons s
-1
. Spectral data were averaged over 2–3 scans to improve signal-to-noise ratios. The 
XANES spectra of the unknown samples (spent BOFS) were compared with reference materials 
through linear combination fitting using data processing software, Athena, version 0.8.56 (Ravel 
and Newville, 2005). 
3.3.5 Geochemical modeling 
The saturation indices (SI) for calcium phosphate phases including hydroxyapatite and other 
mineral phases relevant to the treatment system were calculated using the geochemical modeling 
code PHREEQC Interactive (Parkhurst and Appelo, 1999). The WATEQ4F database was used 
for these calculations and solubility product values for brushite, monetite, octacalciumphosphate, 
β-tricalciumphosphate, and variscite were added to this database using published data (Baker et 
al., 1998; Stumm and Morgan, 1981).  
3.4 Results and Discussion 
3.4.1 Characteristics of the reactive materials 
The coarsest fraction of the BOFS had the highest mass weighted surface area (Table 3.2) as the 
material was screened and washed before use. The particle density of the BOFS was 3.49 g cm
-3
. 
The BOFS sample contained 39 wt.% CaO, 24 wt.%  Fe2O3, 12 wt.%  SiO2, 11 wt.%  MgO, 3.8 
wt.%  MnO, and 3.4 wt.%  Al2O3 (Table 3.1). The XRD patterns indicated the presence of 
Wuestite (FeO), Lime (CaO), Larnite (Ca(SiO4)),  Srebrodolskite (Ca2Fe2O5), Anhydrite 
(CaSO4) and possibly Portlandite (Ca(OH)2) in BOFS (Table 3.2). 
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3.4.2 Influent chemistry 
There were distinct differences in influent chemistry observed during the study period, reflecting 
changes in the student population at the college. During the first 157 days of the experiment 
influent concentrations of alkalinity, phosphate, ammonia, cBOD5, and COD were much lower 
than during the following 91 days. A low student population in the college during the first 157 
days of the experiment is one of the reasons for lower concentrations of these dissolved 
constituents. The mixing process was discontinued during the last 91 days, which largely 
reduced the influence of Cell 2 in this period and contributed to changes in the influent water 
composition.   Based on the differences in the influent concentrations, the results are discussed in 
two phases (Phase 1 includes the first 157 days and Phase 2 includes the final 91 days).  
3.4.3 pH and alkalinity 
The pH of Cell 1 effluent (treatment system influent) was 7.44±0.53. Small pH increases were 
observed in the effluent of Cell 2 (7.98±0.56) and Cell 3 (8.12±0.54) due to the presence of 
carbonate minerals in the gravel and the influence of atmospheric CO2 which was introduced to 
the cells during mixing and aeration (Figure 3.7). In the Cell 4 effluent, pH abruptly increased 
and remained very high (between 10.96 and 12.36) throughout the trial. A sudden drop in pH 
from 11.20±0.98 to 7.36±0.56 was observed in the Cell 5 effluent following the pH-adjustment 
unit (Figure 3.7). Mean alkalinity in Cells 1, 2, 3, and 4 effluents during Phase 1 were 298, 249, 
233, and 634 mg L
-1
 as CaCO3 ; during Phase 2 these values were 575, 523, 198, and 243 mg L
-1
 
as CaCO3 (Figure 3.7). Mean alkalinity values in the Cell 5 effluent were 433 and 239 mg L
-1
 as 
CaCO3 before and after CO2 sparging as the dissolved Ca in Cell 4 effluent reacted with CO2 to 
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form particulate calcium carbonate and precipitate in the sparging cell (Figure 3.7). Cell 4 
effluent initially released very high alkalinity water (total alkalinity >1500 mg L
-1
 as CaCO3) and 
pH (>12), probably due to the dissolution of free lime and portlandite from the BOFS (Figure 
3.7). However, the alkalinity gradually decreased to below 200 mg L
-1
 as CaCO3, and the pH 
gradually decreased to 10.96 at the end of the trial. Precipitates of CaCO3 were observed in the 
pH adjustment unit (Cell 4a) as CO2 was introduced to lower the pH. Based on the difference 
between the initial OH
-
 concentration measured in Cell 4 effluent and the final OH
-
 
concentration, typically 10
-2
 moles of CO2 were required to reduce the pH from 12 to 7.5 per liter 
of effluent.  
3.4.4 Major ion chemistry  
The mean Ca concentration in the system influent was 108 mg L
-1
, and decreased slightly in Cell 
2 effluent (104 mg L
-1
) and Cell 3 effluent (98 mg L
-1
). The substrate (washed limestone gravel) 
used in Cell 3 did not contribute any additional Ca.  At the beginning of the trial, the Ca 
concentrations increased sharply (~294 mg L
-1
) in the Cell 4 effluent, probably due to the 
dissolution of CaO and Ca(OH)2 in the BOFS. Over time the concentration gradually decreased 
to 123 mg L
-1
 as the cell was continuously flushed (Figure 3.8). Calcium concentrations 
decreased significantly in Cell 4* as Ca reacted with CO2 resulting in the formation of CaCO3 
(Figure 3.8). This CaCO3 accumulated at the bottom of the standing water in the cell. Higher Ca 
concentrations in the Cell 5 effluent compared to the Cell 4* effluent suggest that Ca may be 
derived from the pulp & paper mill bio-solids (a substrate used in Cell 5), which contained 
leachable amounts of Ca (Vance, 2000a).  The mean Na concentrations in Cells 1, 2, 3, 4, and 5 
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effluents were 112 mg L
-1
, 110 mg L
-1
, 109 mg L
-1
, 106 mg L
-1
 and 108 mg L
-1
 (Figure 3.8). The 
Na concentrations were more or less steady among the cells, although the influent concentrations 
gradually increased throughout the trial. Mean Mg concentrations in Cells 1, 2, 3, 4, and 5 
effluents were 12.22, 12.13, 12.05, 0.09, and 0.35 mg L
-1
. There were small variations in Mg 
concentrations observed in the effluent of Cells 1, 2, and 3. However, Mg concentrations 
decreased sharply to less than 0.01 mg L
-1
 in the Cell 4 effluent, probably due to the 
incorporation of Mg in CaCO3 precipitates. A slight increase of the Mg concentrations (0.35 mg 
L
-1
) was observed in Cell 5 effluent (Figure 3.8).       
The mean SO4
2- 
concentrations in the effluent of Cells 1, 2, 3, 4, and 5 were 43.39, 43.02, 
45.09, 33.10, and 40.45 mg L
-1
. About 16-66% less SO4
2- 
was observed in the Cell 5 effluent 
compared to Cell 3 effluent (Figure 3.8). Dissolved S
2- 
concentrations in Cell 1 effluents were 
lower than the detection limit (0.005 mg L
-1
), and increased in Cell 3 effluents (0.007 mg L
-1
).  
Both SO4
2-
 and S
2-
 concentrations decreased in the Cell 4 effluent; the dissolved S
2- 
concentration 
decreased to below detection, compared to the upstream treatment cells. However, the dissolved 
S
2-
 concentration increased significantly in Cell 5 (average 0.311 mg L
-1
) to concentrations that 
were higher than the SO4
2-
 concentrations. Eh measurements also suggest that reducing 
conditions prevailed in both Cells 4 and 5 (Figure 3.7).  
3.4.5 Phosphorus   
Mean PO4-P concentrations in Cells 1, 2, 3, 4, and 5 effluents were 6.97, 4.69, 3.01, 0.02, and 
0.35 mg L
-1 
(Figure 3.7).  Between 40% and 60% of the PO4-P entering Cell 2 was removed 
during the initial stage of the experiment. However, the extent of PO4-P removal decreased 
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substantially after ~73 days of operation and remained between 3 and 33% with few exceptions 
(Figure 3.7). The removal efficiency of PO4 -P in Cell 3 was 32±31% (average 36%), which is 
close to the values (40-60%) found in previous studies of constructed wetland cells (Kadlec and 
Knight, 1996; Knight et al., 2000, and Vymazal, 2004). The removal efficiency of PO4 in Cell 4 
with respect to the concentration in Cell 3 effluent was 97.4-99.9%. Higher PO4 concentrations 
were observed in Cell 5 effluent compared to Cell 4 effluent, which indicates that the biosolids 
added to Cell 5 released a small amount of PO4. The total P-masses in, masses out and masses 
retained in the BOFS Cell were 47.7, 0.30, and 47.4 g. Thus about 99.4% P-masses were retained 
by the BOFS Cell (Figure 3.9).    
Inorganic PO4 can be adsorbed on hydrous oxides of Fe and Al under acidic conditions, and 
can combine with Ca to form calcium phosphate in alkaline environments (Qualls and 
Richardson, 1995). Inadequate concentrations of Ca, Fe, and Al (the most common metals 
present in P-bearing phases; Vymazal, 2004) in the filtration medium of Cell 3 (crushed stone) 
explains the limited P removal capacity. The BOFS, used in the reactive mixture of Cell 4, 
contains significant amounts of Ca, Fe, Al, and Mg oxides (Table 3.1), thus favored greater 
removal of P. Precipitation of calcium phosphate phases (dependent on the Ca concentration) 
including hydroxyapatite (HAP) is another potentially important PO4 removal mechanism in 
BOFS based treatment systems (Baker et al., 1998; Bowden et al., 2009). However, the 
formation of crystalline hydroxyapatite can be inhibited by the substitution of Mg into the Ca 
position in the hydroxyapatite structure (Kim et al., 2006). Moreover, Fe, Al, and Mg-phosphate 
phases may also form under certain pH conditions in BOFS-based treatment systems.  When 
wastewater was introduced to Cell 4, the reactive media, which contained a high percentage of 
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CaO, developed a highly alkaline condition (pH>9). Adsorption is less favoured under the 
conditions prevalent in Cell 4 because HPO4
2-
 and PO4
3-
 become the dominant phosphate species 
at pH >9. These species are attracted to positively charged surfaces, which tend to be less 
prevalent under high pH conditions (Stumm and Morgan, 1981). However, BOFS does contain 
metal oxides with elevated pH of zero point of charge (pHZPC) values, including MgO (with 
pHZPC of 12.4; Parks, 1965), Al2O3 (with pHZPC of 9.1; Parks, 1965), and Fe2O3 (with pHZPC of 
8.5; Davis and Kent, 1990), therefore limited PO4 adsorption in the BOFS cell is possible. 
Significant quantities of Fe2O3 (24.3%), MgO (11.2 %), and Al2O3 (3.4 %) were present in the 
BOFS materials used in this study (Table 3.1) suggesting that adsorption may be a possible PO4 
removal mechanism. There was no substantial decrease in the rate of PO4 removal during the 
study. 
Although precipitation of Al-phosphate and Fe-phosphate is favoured under near neutral to 
acidic conditions (Stumm and Morgan, 1981), the Cell 4 effluent remained strongly basic, 
suggesting that formation of Al- and Fe-phosphate minerals is unlikely to result in significant 
PO4 retention.  The substrate, pulp and paper mill biosolids, present in Cell 5 contained a 
significant amount of PO4 (Vance, 2000a, Vance, 2000b).  As a result, an elevated PO4 
concentration was observed in Cell 5 effluent. However, the PO4 concentration in Cell 5 effluent 
were much lower (~70%) than the untreated wastewater (Figure 3.7).  
FES-EM images and EDX data were collected from samples of the fresh BOFS material and 
from the spent media to investigate changes in composition near the surfaces of these materials. 
The phosphorus content of the fresh BOFS was ~0.38 wt. %. Samples of the spent media from 
Cell 4 were collected in 10-15 cm intervals in five vertical profiles (Figure 3.6, Table 3.3). The 
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mass of P on the spent media was greatest (up to 8.55 wt. %) in the samples obtained from 
within close proximity to the distribution manifold and gradually decreased with depth at all 
locations sampled in Cell 4.  
The solid-phase phosphorus contents in Profiles 1 and 2 were lower than Profiles 3, 4, and 5. 
Profile 5, located in the effluent side of Cell 4 opposite to the inlet piping, showed the highest P 
contents at depths 40 cm, 55 cm, and 70 cm from the surface of the Cell (Figure 3.10). The high 
P content in Profile 5 and the accumulation of precipitates on the distribution matrix in close 
proximity of this profile (coordinate: 0, 80, 0), and cementation along the profile suggest that this 
part of Cell 4 received the majority of the input, possibly due to uneven distribution or 
preferential flow paths. At all depth levels, a gradual decrease in P content from Profiles 5 to 3 
was observed (Figure 3.10). The bottom-most part of Profile 3, close to the outlet port, had a P 
content of 0.41 wt. %, which is similar to the fresh BOFS (0.38 wt. %). This low P content in the 
reactive media in close proximity of the outlet port and very low mean PO4 concentration (0.02 
mg L
-1
) in the Cell 4 effluent indicates that the aqueous PO4 in the Cell 4 influent (3.01 mg L
-1
) 
was attenuated in the upper part of Cell 4 and the bottom part of Profile 3 was beyond the P-
removal front (Figure 3.7, 3.10).  
The influent water was undersaturated with respect to brushite, monetite, vivianite, and 
variscite (Figure 3.11) in both sampling events, undersaturated with respect to strengite and 
gibbsite in the first sampling event, and supersaturated with respect to strengite and gibbsite in 
the second sampling event. The influent water was also supersaturated with respect to 
octacalciumphosphate, β-tricalciumphosphate, strengite, MnHPO4, calcite, aragonite, goethite, 
ferrihydrite, hydroxyapatite, and an inferred hydroxyapatite phase (Baker et al., 1998). The pore 
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water was supersaturated with respect to calcium phosphate phases including hydroxyapatite, a 
commom phosphate bearing phase in calcium and phosphorus rich environments (Yamada et al., 
1986; Bowden et al., 2009; Stumm and Morgan, 1981). Very low phosphate concentrations in 
Cell 4 effluent suggest that precipitation of hydroxyapatite or another calcium phosphate phase is 
a possible mechanism for P retention in the BOFS media. 
3.4.5.1 FTIR 
Elemental maps of polished cross-sections of samples S-20 and S-21 collected from Cell 4 
(Figure 3.6) indicate accumulation of phosphorus on the boundary of the grains. The EDX 
spectra collected from two locations observed in the elemental maps suggested the occurrence of 
phosphorus at the boundary of the grains (Figure 3.12). FTIR-ATR spectra from phosphorus rich 
boundaries showed vibrational frequencies of carbonate and phosphate bands (Figure 3.13). The 
vibrational frequencies at 712 cm
-1
 (carbonate v4), 872 cm
-1
 (carbonate v2), and 1408 cm
-1
 
(carbonate v3) indicate the occurrence of calcite, whereas the vibrational frequencies at 1027 cm
-1
 
(phosphate v3), a very weak shoulder at 960 cm
-1
 (phosphate v3), and at 602 cm
-1
 (phosphate v4) 
along with the OH
-
 stretch at 3277 cm
-1
 indicated the occurrence of hydroxyapatite (Rehman and 
Bonfield, 1997; Panda et al., 2003; Pena and Vallet, 2003; and De Oliveira Ugarte et al., 2005; 
Ribeiro et al., 2006; Kim et al., 2006; Singh and Purohit, 2011, Matković et al., 2012).      
The FTIR spectra of the samples were compared with the major vibrational bands of phosphate 
and carbonate phases. An example of these comparisons is shown in Figure 3.14. The spectra of 
the solid-phase samples collected from Cell 4 showed a sharp carbonate v4 band at 712 and 713 
cm
-1
, well-defined and broad carbonate v3 band at 1424-1428  cm
-1
, sharp carbonate v2 band at 
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873-875 cm
-1
, and carbonate overtones or combination of the carbonate bands at 1796-1799 cm
-1
 
(v1+ v4; Gillet et al., 1996; Vongsavat et al., 2006; Tatzber et al., 2007; Gunasekaran and 
Anbalagan, 2008), at 2513-2514 cm
-1
  (v1+ v3; Vongsavat et al., 2006; 2v2+ v4; Gunasekaran and 
Anbalagan, 2008). Weak carbonate overtones or a combination of the carbonate bands at 2872-
2876 cm
-1
 and 2980-2984 cm
-1
 were also observed (2v3; Gunasekaran and Anbalagan, 2008). 
The vibrational frequencies 712-713 cm
-1
 (carbonate v4) and 873-875 cm
-1
 (carbonate v2), along 
with other vibrational frequencies of different carbonate bands and overtones indicated that 
calcite was the main carbonate mineral accumulated on the spent reactive materials (Vagenas et 
al., 2003; Vongsavat et al., 2006; Ni and Ratner, 2008; Kurap et al., 2010).   
The vibrational bands of phosphate for reference materials are provided in Table 3.4. 
Phosphate v3, v4, and v2 bands were obtained in most of the samples collected from Cell 4. 
However, comparatively sharp peaks of v3 and v4 bands were observed in the spectrum of sample 
S-20 at 1045 cm
-1
 (phosphate v3) and a doublet at 604 and 572 cm
-1
 (phosphate v4). A very weak 
shoulder of phosphate v1 at 963 cm
-1
 and weak peaks of phosphate v2 at 446 and 454 cm
-1
 were 
also observed in the spectrum of sample 20. Phosphate v3 at 1048 cm
-1
, phosphate v4 doublet at 
604 and 571 cm-1, phosphate v2 at 456 and 468 cm
-1
, and very weak phosphate v1 peak at 959 
cm
-1
 were also observed in the spectrum of sample S-21, however, phosphate v3, v4, and v2 peaks 
were not as prominent as observed in the spectrum for sample S-20. The vibrational frequencies 
1048 cm
-1
 (phosphate v3), 604 and 572 cm
-1
 (phosphate v4), 446 and 454 cm
-1
 (phosphate v2), and 
a very weak shoulder at 963 cm
-1
 (phosphate v1) were observed, which were similar to the 
reference HAP-S, HAP-WM, and β-TCP,  and also consistent with previous studies (Rehman 
and Bonfield, 1997; Ribeiro et al., 2006; Panda et al., 2003; Singh and Purohit, 2011, Matkovic 
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et al., 2012; Kim et al., 2006; Pena and Vallet, 2003; and De Oliveira Ugarte et al., 2005). These 
similarities in vibrational bands indicated the possible occurrence of hydroxyapatite or β-TCP in 
samples S-20 and S-21.  
3.4.5.2 XPS      
The XPS survey spectra and high resolution spectra of sample S-20, S-21, S-16, S-11, and S-1 
powder were studied. Oxygen, Ca, Mg, C, P, Si and Al peaks were observed in the survey XPS 
spectra of most samples. The surface atomic ratio of Ca/P and O/Ca were two to three times 
higher than the typical hydroxyapatite (Table 3.5; Lu et al., 2000). Calcium 2p3/2 binding 
energies for all samples range from 346.8 and 347.3 eV.  Phosphorus 2p3/2 binding energies 
range from 132.6 to 133.1 eV. The Ca 2p3/2 peak from a reference sample of calcium carbonate 
has a binding energy of 346.7 to 347.0 eV. The Ca 2p3/2 binding energy for a calcium phosphate 
reference sample was at 347.3 eV with the P 2p3/2 peak at 133.0 eV. The binding energies of Ca 
2p3/2 and P2p3/2 obtained in the samples were within the same range of the binding energies of 
calcium phosphate and calcium carbonate, which is consistent with the presence of both calcium 
phosphate and calcium carbonate. An example high resolution spectra is given in Figure 3.15. 
3.4.5.3 XANES 
XANES refers to the portion of the X-ray absorption spectra near an absorption edge, extending 
approximately from -50 to +200 eV with respect to the edge energy (Kelly et al., 2008). The 
primary fluorescence peak positions of the phosphate-bearing (PO4 tetrahedra with oxidation 
state +5) phases are very similar. However, the characteristics of the secondary spectral features, 
including size, shape, and position, are diagnostic for different compounds and minerals 
 83 
(Brandes et al., 2007).  The primary peak positions for phosphate species are around 2151 eV, 
which represent strong peaks or absorption edges or white lines in XANES spectra (Brandes et 
al., 2007). The white line of P represents the energy required to eject electrons from the K shell 
of P atoms (Güngör et al., 2007). The white line for phosphate may vary between ± 0.5 eV 
depending on the charge, electronegativity, and interatomic distance of the coordinating cation 
(Franke and Hormes, 1995). P K-edge XANES also has been reported at 2150 eV (Shober et al., 
2006). Spectral characteristics of phosphorus K-edge XANES spectra for Ca-, Al-, and Fe-
phosphates are reviewed comprehensively in previous studies (Hesterberg et al., 1999; Ajiboye 
et. al., 2008; Shober et al., 2006; Sato et al., 2005; Eveborn et al., 2009; Beauchemin et al., 
2003).   
In this study, the XANES spectra of the reference materials displayed a number of pre- and 
post-edge spectral features (Figure 3.16). The white lines of reference materials ranged between 
2151.5 and 2151.7 eV except for FeP (2152.2 eV). Iron (III) phosphate showed a unique pre-
edge feature at 2148.5 eV (-3.7 eV with respect to the white line), which is consistent (between -
2 and -5 eV) with previous studies (Hesterberg et al., 1999; Khare et al., 2007; Ajiboye et. al., 
2008; Shober et al., 2006; Sato et al., 2005; Eveborn et al., 2009; and Beauchemin et al., 2003). 
The presence of a shoulder at ~2154.7 eV was one of the important spectral features observed in 
all calcium phosphate reference materials (Figure 3.16 c). However, the sharpness of this feature 
increased with an increase in crystallinity. Similar spectral features are reported by Peak et al. 
(2002). Two other dominant spectral features were observed at ~2162.5 eV and ~2169 eV in all 
calcium phosphate samples and reference materials (Figure 3.16 d, e). The relative positions of 
these features with respect to P K-edge were similar to the features observed at around ~2170 eV 
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and ~2175 eV (Peak et al., 2002) and ~2159 eV and 2166 eV (Sato et al., 2005), and were 
identified as a signature of calcium phosphate species and oxygen oscillation.  
XANES spectra of the spent BOFS samples displayed a number of post edge spectral features 
similar to the reference materials, however, no pre-edge spectral features were observed in these 
samples (Figure 3.16). The white lines of the samples ranged between 2151.4 and 2151.6 eV, 
which was similar to the range obtained for the reference materials. Although the locations of the 
post-edge features of the samples and the reference materials appeared in the similar energy 
range, the sharpness of the features varied substantially from one spectrum to another. After 
careful visual inspection it was evident that the spectra from sample S-20 resembled the 
crystalline calcium phosphate reference materials more closely than that of samples S-21, S-16, 
and S-11.  This observation is not unexpected because S-20 contained a higher mass of PO4 than 
the other samples.  A PO4 sorbed on CaCO3 standard was also included as the reference 
materials. This spectrum exhibited similar post-edge spectral features to sample S-20 (Figure 
3.16, 3.17). The spectral similarities of PO4 sorbed on CaCO3 with sample S-20 suggest that 
sorbed PO4 could be present in the reacted BOFS. The FTIR spectra of each spent BOFS 
samples indicated the presence of calcite.  
Linear combination fitting was conducted to determine the similarity between the spectra for 
the spent BOFs samples and the spectra for the reference materials. XANES spectra of FeP was 
excluded from the LC fitting analysis because the distinctive pre-edge feature at around 2148.5 
eV (a, Figure 3.16), which is characteristic of Fe-PO4 phases, was not observed in the spectra of 
spent BOFS samples. A series of binary and ternary combination fittings of the reference 
materials were conducted for the spent BOFS samples. The proportion of the contributing 
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phosphate species were predicted with 2 goodness of fit criteria. All of the best-fit combinations 
included -TCP as a significant component. Beta-tricalcium phosphate, HAP-S, and CPD 
provided the best combination (2 =1.03) for sample S-20, whereas -TCP and CPD were the 
best combination for sample S-21 (2 =0.79), and -TCP, -TCP, and CPDD provided the 
optimum LC fitting for samples S-16 (2=1.26) and S-11 (2=2.91). Although the 2 value was 
slightly lower with respect to -TCP, CPD, and HAP-S combination fit for sample S-21, the total 
weight of the contributing reference materials was overestimated (1.006) and contribution from 
HAP-S was zero. Thus this combination was not considered. Sample S-11 showed poor fitting 
with high 2 values for different combinations, which is probably due to the lower phosphate 
accumulation on the BOFS in this sample location. FTIR and EDX analyzes also showed strong 
indications of the presence of a more soluble phosphate phase in this sampling location (Figure 
3.12, 3.13, 3.14). Among the calcium phosphate reference materials considered in this study, -
TCP was identified as the most abundant component (contributing between 50 and 100% to the 
LC fitting) in all of the spent BOFS samples (Figure 3.18, Table 3.6). A significant contribution 
from HAP-S (~22 %) was observed in sample S-20, however HAP-S provided little to no 
contribution in the S-21 LC fit and no contribution in the other samples. These results were 
consistent with the FTIR results (Figure 3.16). A small contribution from CPD (~9%) was also 
indicated in LC fits for samples S-20 and S-21, however no contribution was observed in the 
other samples (Figure 3.18, Table 3.6). There were significant contributions from -TCP 
(between 36 and 40%) observed in samples S-16 and S-11. The predicted contributions of CPDD 
in samples S-16 and S-11 were between 4 and 9%.    
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3.4.6 Ammonia and nitrate 
The concentration ranges, mean concentrations, and removal efficiencies of NH3-N and NO3-N 
along the flow path in Phases 1 and 2 are summarized in Table 3.7.  There was a sharp difference 
in influent NH3-N concentrations between Phase 1 (7.70±7.60 mg L
-1
) and 2 (51.0±26.1 mg L
-1
, 
Figure 3.19). The overall removal efficiency of NH3-N in Cells 2, 3, and 4 was 97%. However, 
the average NH3-N concentrations increased in Cell 4 effluents by >5 times compared to the Cell 
3 effluent.  Cell 5 played a negative role on the overall NH3 removal (51% removal) to the 
system. Small increases in NH3-N concentrations were observed in Cell 5 effluents with respect 
to the Cell 4 effluent. There was an increasing trend observed in NO3-N concentrations from 
Cells 1 to 3 in both phases (Figure 3.19). These trends were attributed to oxidation of ammonia 
to nitrate in Cells 2 and 3. Ammonia oxidation was enhanced by the mixing and aeration 
systems, which resulted in high DO concentrations in Cells 1 and 2 (Figure 3.15, 3.19; Table 
3.8). The NO3-N concentrations decreased slightly in Cell 3 effluent (~4%) in Phase 1 from the 
preceding cell (Cell 2), probably due to mixing and oxidation in Cell 2. However, a sharp 
increase in NO3-N concentration was observed in Phase 2, when the mixing was eventually 
suspended. In both phases NO3-N concentrations gradually decreased in Cell 4, and the Cell 5 
effluent was similar to the Cell 3 effluent (Figure 3.19). There was a negative correlation 
observed between NH3-N and NO3-N concentrations (Figure 3.19). Thus, in both phases NH3 
oxidized to NO3 in the presence of O2(g), which is consistent with results observed in previous 
studies (Davies and Hart, 1990). Relatively more reducing conditions, which prevailed in Cell 5, 
resulted in lower NO3 concentrations, and increased concentrations of NH3 in both phases of the 
study.   
 87 
3.4.7 Carbonaceous biochemical oxygen demand (cBOD5) and 
chemical oxygen demand (COD) 
The concentration ranges, mean concentrations, and removal efficiencies of cBOD5 and COD 
along the flow path in Phases 1 and 2 are summarized in Figure 3.20 and Table 3.8.  The removal 
efficiencies of cBOD5 in Cells 2, 3, 4, 4*, 5, and 6 were calculated with respect to the Cell 1 
effluent in both phases. Although a decrease in the removal efficiency of cBOD5 was observed in 
both phases, this was not as significant in Phase 2. The concentrations of cBOD5 decreased 
gradually in Cells 2, 3, and 4. However, concentrations increased by approximately 7 times (in 
Phase 1) and 10 times (in Phase 2) in the Cell 5 effluent compared to the Cell 4 effluent. The 
removal of cBOD5 in aerated EW cell (Cell 3) was 87% with respect to  Cell 1 effluent, which 
was similar to previously reported values (90%; Johnson and Mara, 2005). The removal of 
cBOD5 in the treatment cells in both phases indicate that both aeration cells (Cells 2 and 3) and 
highly alkaline conditions (in Cell 4) played an important role in degrading labile organic 
carbon. Low cBOD5 concentrations (below the detection limit of 1 mg L
-1
) in the Cell 4 effluent 
throughout the experiment suggest that 
 
the BOFS present in Cell 4 has the potential to remove 
cBOD5 (Figure 3.20). The mechanism contributing to cBOD5 removal, however, is unclear.    
Although the cBOD5 concentration increased in the Cell 5 effluent, the cumulative removal 
efficiencies of cBOD5 in phases 1 and 2 were 79 and 90%. The elevated cBOD5 in Cell 5 
effluent probably was derived from the breakdown of the biosolids included in the substrate. 
 Although the COD concentration did not change significantly in Cells 2 and 3 during Phase 1, 
much lower concentrations were observed in the Cell 4 effluent during Phase 1 (Table 3.8, 
Figure 3.20). In Cell 5 effluent, COD concentrations increased by ~4 times from Cell 4 effluent. 
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A negative removal efficiency of COD in Cell 5 (-40%) with respect to Cell 1 effluents suggests 
that the substrate (boisolids) in Cell 5 added to the excess concentration. The concentrations of 
COD gradually decreased in Cells 2-4 with maximum 87% removal in the Cell 4 effluent 
compared to the Cell 1 effluent. However, COD concentrations increased again in Cell 5 
effluents by ~25%.  Due to high removal efficiencies of cBOD5 and COD in Cells 2-4, the 
concentrations of these two parameters decreased to low levels (Figure 3.20).  
 
3.4.8 Geochemical modeling 
The influent water was undersaturated with respect to brushite, monetite, vivianite, and variscite 
(Figure 3.11) in both sampling events, undersaturated with respect to strengite and gibbsite in the 
first sampling event, and supersaturated with respect to strengite and gibbsite in the second 
sampling event.   The influent water was also supersaturated with respect to 
octacalciumphosphate, β-tricalciumphosphate, strengite, MnHPO4, calcite, aragonite, goethite, 
ferrihydrite, hydroxyapatite, and an inferred hydroxyapatite phase (Baker et al., 1998). 
Supersaturation of the pore water with respect to calcium phosphate phases including 
hydroxyapatite, one of the common P-bearing phases in Ca- and P-rich environments (Yamada et 
al., 1986; Bowden et al., 2009; Stumm and Morgan, 1981), and the very low phosphate 
concentrations in Cell 4 effluent suggest that precipitation of hydroxyapatite or another calcium 
phosphate phase are possible mechanisms for P retention in the BOFS media.  
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3.4.9 Trace metals 
The concentrations of dissolved trace metals, including Zn, Fe, Mn, Cr, Ni, and Pb, in the 
treatment system effluent remained below the Provincial Water Quality Objectives (PWQO) for 
Ontario (Figure 3.21, MOEE, 1994). Mean Al concentrations in Cells 1, 2, 3, 4, and 5 were 6.16, 
5.71, 7.44, 683, and 401 µg L
-1
. Initially (for 108 days), Cell 5 received high pH water from Cell 
4 effluent until the pH adjustment cell was introduced. Mean Al concentrations in Cell 5 effluent 
before and after installing the pH adjustment cell were 1290 µg L
-1
, and 20 µg L
-1
, which is 
consistent with the predicted pH dependent solubility of Al (Figure 3.22; Stumm & Morgan, 
1981). A sharp increase in Al concentrations was observed in Cell 4 effluent, which initially 
increased from 670 µg L
-1
 to a maximum concentration of 1185 µg L
-1
, then gradually decreased 
to 186 µg L
-1 
(Figure 3.21, 3.22). Mean V concentrations in Cells 1, 2, 3, 4, and effluent were 
0.42, 0.64, 1.33, 27, and 12 µg L
-1
 (Figure 3.21). The BOFS in Cell 4 released V (>PWQO value 
of 6 µg L
-1
) after continuous flushing of wastewater for 72 days. This was the initiation of the 
rising limb of the V concentration curve (Figure 3.22).  The concentrations of V increased to as 
high as 48.6 µg L
-1
. The influent Cu concentrations exceeded the PWQO value of 1 µg L
-1 
and 
were mostly higher than the treatment cell effluents, which suggest that the BOFS did not release 
Cu, but rather removed Cu to some extent (Figure 3.21).   
3.4.10 Removal of bacterial indicators (E. coli and total coliforms) 
Mean influent concentrations of E. coli and total Coliform were 2.2x10
4
 and 8.9x10
4
 CFU per 
100 mL, which sharply decreased (>99%) while passing through Cell 3 by aeration and the 
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bacterial indicators were completely (~100%) attenuated in Cell 4 due to its highly alkaline 
condition (Figure 3.23). Thus no additional disinfection was required downstream of Cell 4.  
3.4.11 Hydraulic performance 
Mean flow rate was 68 L day
-1
. The extent of carbonate-mineral precipitation and cementation in 
the spent media was investigated to evaluate the longevity of the treatment system in terms of 
hydraulic performance. Cell 4 was uncovered and excavated after completion of the study. 
Growth of green algae was noted on the top part of the cell; development of white precipitates on 
the outlet side of the distribution manifold and coatings of yellowish brown precipitates on 
reactive materials were observed. While excavating the cell, cemented media was encountered 
along the outlet side of the cell. These precipitates including scale, coatings, and cements reacted 
vigorously with HCl and produced effervescence. The FE-SEM images and EDX data of the 
precipitates or adsorbents scraped from the outer layer of the spent reactive material collected 
from the top of the cell at the effluent end indicated a composition consistent with a carbonate 
phase rich in calcium and phosphorus and from the bottom part of the effluent side indicated a 
composition predominantly calcium carbonate (Figure 3.24). Despite sealing the Cell 4 container 
to restrict air ingress, the dissolved CO2 was sufficient to result in precipitation of carbonate 
minerals.  It is likely that the effluent from Cell 3 (influent for Cell 4) contained an elevated 
HCO3
-
 concentration, which reacted with Ca on the outer layer of the BOFS grains, and released 
from the BOFS, to form calcium carbonate. Approximately 15% (by volume) of the media had 
been cemented by carbonate precipitates. However, although the pore spaces were partially 
clogged, the media was not impermeable. Moreover, the degree of cementation observed around 
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the outlet piping network was not sufficient to impede the expected flow. Thus, a similar system 
configuration can be anticipated to operate without a significant decline in hydraulic 
performance. However, provisions for removing precipitates from the piping network could be 
incorporated in future designs.  
3.5 Conclusions 
A multi-step wastewater treatment system, was installed and operated in an indoor facility. 
Removal efficiencies for cBOD5, COD, PO4, NH3, E. coli, and total in Cells 3 and 4 were often 
>99% with respect to the system influent. High pH and elevated concentrations of V and Al 
derived from the BOFS materials used in the system were of potential concern. The pH of the 
system was neutralized by sparging with CO2(g) prior to discharge to the environment. Aluminum 
concentrations declined following pH neutralization. There was no significant change in 
hydraulic performance of the treatment system. Sealing of Cell 4 (BOFS cell) limited the ingress 
of CO2(g). Phosphorus on the outer layer of the spent reactive material was characterized using 
combination techniques including BSE imaging and EDX spectra analysis, and examination of 
X-ray intensity element maps, and FTIR spectra. Some samples showed the probable occurrence 
of carbonated hydroxyapatite or β-TCP. XANES analysis and LC fit results confirmed the 
probable occurrence of β-TCP. In addition to phosphate removal, the system disinfected the 
wastewater and, with the exception of V, resulted in declines in trace metal(loid) concentrations. 
The final horizontal subsurface flow anaerobic constructed wetland cell did not enhance the 
treatment efficiency of the system. Thus this system enhancement is not likely required in future 
studies. The results of these experiments suggest that this integrated treatment system can be 
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used to provide removal of multiple contaminants from wastewater including P using a relatively 
passive design.  
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Figure 3.1 Schematic diagram of the cells in the pilot-scale treatment system. Wastewater continuously flows through the system by 
combination of gravity feed and pumping.    
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Figure 3.2 Cross-section of the Mixing cell (Cell 2) showing the thickness and vertical 
distribution of different components of the cell.   
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Figure 3.3 Cross-section of the Aerated EW
 
cell (Cell 3) showing the thickness and vertical 
distribution of different components of the cell.   
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Figure 3.4 Cross-section of the BOFS cell (Cell 4) showing the thickness and vertical 
distribution of different components of the cell.   
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Figure 3.5 Cross-section of the Anaerobic polishing cell (Cell 5) showing the thickness and 
vertical distribution of different components of the cell.   
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Figure 3.6 Locations of solid phase spent media collected from the BOFS cell, where P 
represents locations of profile samples and S represents locations of samples within individual 
profiles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 99 
E
h
 (
m
V
)
0
100
200
300
400
500
Cell
P
O
4
-P
 (
m
g
 L
-1
)
0
5
10
15
20
p
H
6
8
10
12
14
A
lk
 (
m
g
 L
-1
 C
a
C
O
3
)
0
600
1200
1800
Cell
P
O
4
-P
 (
m
g
 L
-1
)
-5
0
5
10
15
20
Cell
P
O
4
-P
 (
m
g
 L
-1
)
0
2
4
6
8
10
12
p
H
6
8
10
12
14
p
H
6
8
10
12
14
Before pH adjustment After pH adjustment
A
lk
 (
m
g
 L
-1
 C
a
C
O
3
)
0
600
1200
1800
A
lk
 (
m
g
 L
-1
 C
a
C
O
3
)
0
600
1200
1800
Before pH adjustment After pH adjustment
Phase 1 Phase 2
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5
 
Figure 3.7 Box plots of pH, alkalinity, Eh and PO4-P versus distance (Cells 1-5) along the 
treatment flow path. Dotted lines represent the Ontario Provincial Water Quality Objective 
(PWQO). pH and alkalinity of the total study period, before and after pH adjustment are  
presented in rows 1 and 2,  Eh of the total study period , alkalinity before and after pH 
adjustment are presented in row 3, and PO4-P of the total study period, phases 1 and 2 are 
presented in row 4. Horizontal solid lines and broken lines on the boxes represent median and 
mean concentrations. Top and bottom most dots represent maximum observation above upper 
fence and minimum observation below lower fence.   
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Figure 3.8 Concentrations of Ca, Na, Mg and SO4 versus distance (Cells 1-5) along the 
treatment flow path. The 4 and 4* represent BOFS cell and pH adjustment cell. 
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Figure 3.9  Flow rate, PO4-P concentrations in the influent and effluent, and P load in the 
treatment system.    
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Figure 3.10  Solid phase P versus depth from the surface of Cell 4.  
Phosphorus content in fresh BOFS is plotted at a depth of 0 cm.   
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Figure 3.11 Saturation indices for calcium phosphate and other related phases calculated using 
PHREEQCI versus distance (Cells 2-5) along the reaction flow path. Saturation indices of HAP 
were plotted twice using an inferred Ksp value from Baker et al. (1998) (indicated by * in the 
plot) and a Ksp value for HAP obtained from the WATEQ4F database. 
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Figure 3.12 High magnification BSE image, X-ray intensity element maps, and EDX spectra for 
a phosphorus-rich area and an area with no phosphorus accumulation.     
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Carbonate  
Phosphate 
Figure 3.13 FTIR-ATR spectrum from the phosphorus rich zone on particle surface 
indicated by a white square.   
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Figure 3.14 FTIR spectrum of sample S-20 (with highest mass) and major phosphate vibrational 
bands of a) HAP-S, and b) -TCP; and major carbonate bands of c) calcite, and d) aragonite are 
compared. Vertical dotted lines in subplots a) and b) represent phosphate vibrational bands while 
vertical dotted lines in c) and d) represent carbonate vibrational bands. 
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Figure 3.15 High-resolution XPS spectra showing O (1s), Ca (2p), C (1s), and P (2p) peaks. 
 
 
 
 
S-20 O 1s/8
Binding Energy (eV)
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Name                                                   Pos.    FWHM     L. Sh.       Area    %Area 
O 1s Si Oxide, Organic O, Water       533.03    1.71       GL(30)    1331.6      12.7 
O 1s CaCO3, Al Oxide, Phosphate    531.45    1.71       GL(30)    9138.4      87.3       
x10
2
S-20 Ca 2p/8
Binding Energy (eV)
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20
30
40
Name                            Pos.    FWHM     L. Sh.       Area     %Area 
Ca 2p 1/2 CaCO3        350.76    1.52       GL(30)     2277.5       0.0 
Ca 2p 3/2 CaCO33       347.21    1.52       GL(30)     4555.0    100.0       
x10
2
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P
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Name                Pos.    FWHM     L. Sh.       Area     %Area 
Carbonate        289.54    1.40       GL(30)      789.1     2 2.0 
C=O                287.81    1.40       GL(30)      263.5        7.3
C-OH, C-O-C   286.31   1.40       GL(30)      535.1       14.9 
C-C, C-H         284.81    1.40       GL(30)    1994.6       55.7       
x10
2 S-20 P 2p/11
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P 2p 1/2 Phosphate        133.96    1.49       GL(30)      166.1      0.0 
P 2p 3/2 Phosphate        133.12    1.49       GL(30)      332.2   100.0         
x10
1
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Figure 3.16 XANES spectra for reference materials and sample S 20. Vertical lines represent 
various spectral features: (a) pre edge feature for FeP, (b) absorption edge (white line) for CaP 
species, (c) shoulder (sharpness dependent on the degree of crystallinity, (d) spectral feature 
common in HAP, and (e) oxygen oscillation.    
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Figure 3.17 XANES spectra for PO4 sorbed on CaCO3 (PSC), LC fit for sample S 20 with the 
combination of -TCP, HAP-S, and CPD; and samples S 20, S 21, S 16, and S 11. Vertical 
dotted lines represent (a) absorption edge (white line); (b) shoulder (sharpness dependent on the 
degree of crystallinity; (c) spectral feature common in HAP; and (d) oxygen oscillation.    
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Figure 3.18 Linear combination fit of XANES spectra for spent BOFS samples S 20, S 21, S 16 
and S 11.   
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Figure 3.19 Box plots of NH4-N and NO3-N concentrations versus distance (Cells 1-5) along the 
flow path. Columns 1, 2, and 3 of this figure represent total treatment period, Phase 1, and Phase 
2. Horizontal solid lines and broken lines on the boxes represent median and mean 
concentrations. Top and bottom most dots represent maximum observation above upper fence 
and minimum observation below lower fence.   
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Figure 3.20 Box plots of DO, cBOD5, and COD concentrations versus distance (Cells 1-5) along 
the treatment flow path. Columns 1, 2, and 3 of this figure represent total treatment period, Phase 
1, and Phase 2, respectively. Horizontal solid lines and broken lines on the boxes represent 
median and mean concentrations. Top and bottom most dots represent maximum observation 
above upper fence and minimum observation below lower fence.   
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Figure 3.21 Box plots of V, Al, Cu, Zn, Fe, Ni, Mn, Cr, and Pb concentrations versus distance 
(Cells 1-5) along the treatment flow path. Dotted lines represent the Ontario Provincial Water 
Quality Objective (PWQO). 
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Figure 3.22 Concentrations of V and Al in the treatment cells effluent versus time. 
Concentrations of Al decreased abruptly in the anaerobic cell effluent as the pH was adjusted to 
near neutral, reflecting the amphoteric nature of this element. 
 
 
 
 
 
 115 
CellCell
C
F
U
/1
0
0
m
L
log E.coli log Coliform 
1 2 3 4 5 1 2 3 4 5
6
5
4
3
2
1
0
7
 
Figure 3.23 Box plots of E.coli and total coliform concentrations versus distance (Cells 1-5) 
along the treatment flow path. Horizontal solid lines and broken lines on the boxes represent 
median and mean concentrations. Top and bottom most dots represent maximum observation 
above upper fence and minimum observation below lower fence.   
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Figure 3.24 SEM images of precipitates that formed on the spent reactive media collected 
from location 1, 18, 20, and 21 (Figure 3.6) indicated by a, b, c, and d. Unless indicated with 
circles, the EDX data were obtained from the entire image area. The phosphorus contents 
obtained from the EDX data are shown on the images. Well-defined crystal faces were 
observed in “b” (sample S-18). Formation of crystal faces were also noted in “d” (sample S-
21). 
 
 
117 
 
 
 
Table 3.1 Chemical composition of BOFS used in this study analyzed by XRF and analysis from previous studies. 
wt. % CaO SiO2 Al2O3 MgO FeO Fe2O3 Fe 
total 
SO3 MnO TiO2 P2O5 Free 
CaO 
K2O Na2O Cr2O3 Cl Loss 
on 
igniti
on 
This study 38.8 11.5 3.40 11.2  24.3   3.81 0.30 -  <0.0
1 
<0.1
0 
-  6.75 
A 45.0 10.8 1.90 4.50  32  0.40 2.60 0.50 1.40    1.10 
B 39.4 12.0 2.16 9.69 30.2   0.12 2.74 0.40 1.00  0.05 0.25 0.20 0.01 1.80 
C 47.7 13.3 3.00 6.40 - 24.4 - - 2.60 0.70 1.50 9.20      
D 45.4 13.7 6.80 7.30 - - 17.8 - - - - - - - - -  
E 47.5 11.8 2.00 6.30 - 22.6 - - 1.90 0.50 2.70 -      
F 39.3 7.80 0.98 8.56 - 38.1 - - 4.20 0.90 - -      
G 52.2 10.8 1.30 5.04 17.2 10.1 - - 2.50 0.60 1.30 10.2      
H 32.1 19.6 3.16 2.53 - 17.9 - - 2.02 0.46 0.73 - 0.06 0.25 - - 0.80 
I 30.0
-
55.0 
8.00
-
20.0 
1.00  
-  
6.00 
5.00 
- 
15.0 
10.0 
- 
35.0 
  0.05
-
0.15 
2.00 
- 
8.00 
0.40 
- 
2.00 
0.20 
- 
2.00 
   0.10 
- 
0.50 
  
aBelhadj et al., 2012; b Yildirim and Prezzi, 2011; c Waligora et al., 2010; d Xue et al., 2009; e Mahieux et al., 2009; f Shen et al., 2009, g Poh et al., 
2006; hCha et al., 2006; i Shi, 2004. 
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Table 3.2 Physical properties and mineralogical composition of the 
BOFS material used in the experiments 
Slag type: BOFS 
BOFS source: Stelco, Hamilton 
P
h
ys
ic
al
 p
ro
p
er
ti
es
 
Particle size (mm) Surface area (m2g-1) 
4-2   7.14   
2-1   9.35   
1-0.5   14.65   
 <0.5   15.31   
Particle size (mm) Mass weighted surface area (m2g-1) 
4-2   515.04   
2-1   124.1   
1-0.5    88.58   
<0.5    130.83   
Density (g cm-3) 3.49   
 M
in
er
al
o
gi
ca
l c
o
m
p
o
si
ti
o
n
 o
f 
B
O
FS
 
This study Yildrim and Prezzi (2011) 
Wuestite (FeO) 
Lime (CaO) 
Larnite (Ca(SiO4)) 
Srebrodolskite (Ca2Fe2O5) 
Anhydrite (CaSO4) and  
 
Probable 
Portlandite (Ca(OH)2) 
Portlandite (Ca(OH)2)  
Srebrodolskite (Ca2Fe2O5)  
Merwinite (Ca3Mg(SiO4)2) 
Larnite (Ca2SiO4)  
Calcite (manganoan) ((Ca,    Mn)CO3) 
Lime (CaO) 
Dolomite (CaMg(CO3)2)  
 
Probable 
Wollastonite (CaSiO3)  
Periclase (MgO)  
Pentahydrite (MgSO4·5H2O) 
Monticellite (CaMgSiO4) 
Hematite (Fe2O3) 
Magnesite (MgCO3) 
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Table 3.3 Semiquantitative EDX measurements showing the composition of the 
selected samples 
ID Elements (wt. %)   
  C  O Mg Si P Ca 
S1 51.6 30.91 0.5 0.65 4.91 10.63 
S2 12.13 38.23 1.32 13.51 0.72 23.55 
S3 19.77 22.64 0.49 1.13 0.7 52.42 
S4 18.09 45.73 1.07 1.31 0.31 31.72 
S5 12.4 35.07 4.22 8.69 0.2 21.96 
  
S6 25.05 36.48 11.59 8.03 1.1 4.24 
S7 22.4 40.37 1.73 1.23 0.97 31.15 
S8 18.1 38.79 7.49 7.21 0.65 20.37 
S9 7.93 33.86 11.32 8.83 0.22 18.89 
S10 15.14 34.01 2.3 1.81 0.2 21.24 
  
S11 52.19 30.8 0.73 0.47 4.07 11.73 
S12 20.9 36.07 8.03 4.73 2.19 16.44 
S13 26.97 39.57 3.75 3.31 0.63 16 
S14 19.11 34.92 1.07 0.77 0.45 38.51 
S15 19.34 32.37 1.13 5.86 0.32 26.7 
 
S16 44.93 27.52 1.21 1.45 6.34 18.54 
S17 18.93 37.78 0.95 1.1 3.39 29.16 
S18 20.38 48.18 0.43 0.38 1.07 29.56 
S19 7.64 26.22 0.73 7.59 0.51 45.92 
 
S20 30.99 40.07 0.76 0.81 8.55 18.7 
S21 25.63 27.1 4.74 2 5.95 18.71 
S22 29.67 37.31 4.62 2.73 1.7 19.96 
 
Mineral phase C  O Mg Si P Ca 
Calcite, CaCO3 12 47.96       40.04 
Aragonite, CaCO3 12 47.96       40.04 
Hydroxyapatite, 
Ca5(PO4)3(OH) 
- 41.41     18.5 39.89 
rbonate 
Hydroxyapatite, 
Ca5(PO4,CO3)3(OH) 
1.24 41.25     15.97 41.33 
References: http://webmineral.com/ 
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Table 3.4 Vibrational bands of phosphate in the reference materials. 
Reference 
materials 
Phosphate vibrational bands 
v3 v1 v4 v2 
HAP-S 1092 962 568 475 
  1045   603   
  
 
  633   
HAP-WM 1090 962 571 474 
  1042   602   
      633   
 β-TCP 1098 962 564 471 
  1033   603   
      634   
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Table 3.5 Ca/P and O/Ca ratios of the samples analyzed. 
  S-20 S-21 S-16 S-11 S-1 powder 
Ca/P 4.34 3.02 3.68 3.61 3.24 
O/Ca 3.59 3.13 3.58 4.01 4.38 
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Table 3.6 Linear combination fitting results of spent BOFS samples. 
Sample 
ID 
Combination R-factor 2 -TCP 
(weight) 
HAP-S 
(weight) 
CPD 
(weight) 
S 20 
norm(E) 
-TCP, HAP-S, CPD 1.79E-03 1.03 0.697 0.215 0.087 
-TCP, HAP-S 1.89E-03 1.09 0.772 0.228 0 
-TCP, CPD 1.94E-03 1.12 0.911 0 0.089 
HAP-S, CPD 3.02E-03 1.74 0 0.753 0.247 
Sample 
ID 
Combination R-factor 2 -TCP 
(weight) 
CPD 
(weight) 
HAP-S 
(weight) 
S 21 
norm(E) 
 
 
-TCP, CPD, HAP-S 1.82E-03 0.79 0.908 0.098 0 
-TCP, CPD 1.86E-03 0.80 0.908 0.092 0 
-TCP, HAP-S 2.15E-03 0.93 1 0 0 
CPD, HAP-S 5.54E-03 2.39 0 0.356 0.644 
Sample 
ID 
Combination R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
S 16 
norm(E) 
-TCP, -TCP, CPDD 3.13E-03 1.26 0.599 0.363 0.038 
-TCP, -TCP 3.36E-03 1.36 0.625 0.375 0 
-TCP, CPDD 4.60E-03 1.85 0.719 0 0.281 
-TCP, CPDD 7.74E-03 3.11 0 0.581 0.419 
Sample 
ID 
Combination R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
S 11 
norm(E) 
-TCP, -TCP, CPDD 7.27E-03 2.91 0.515 0.392 0.093 
-TCP, -TCP 7.40E-03 2.96 0.566 0.434 0 
-TCP, CPDD 8.85E-03 3.54 0.62 0 0.38 
-TCP, CPDD 1.06E-02 4.22 0 0.557 0.443 
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Table 3.7 Values of pH, alkalinity and concentration ranges of other target parameters including PO4-P, NH3-N, NO3-N, Al, V in the 
effluents of Cell 1, 2, 3, 4, 4*, and 5. 
   
Unit Cell 1 Cell 2 Cell 3 Cell 4 Cell 4* Cell 5 Cell 6 
p
H
  
Total treat. period 
 
6.91-7.97 7.42-8.54 7.58-8.66 10.96-12.36 5.20-10.68 
  
 
Before CO2 addition 
     
- 10.22-12.17 
 
 
After CO2 addition 
     
5.20-10.68 6.80-7.92 
 
A
lk
 
 
Total treat. period 
mg L-1 
214-688 212-626 168-270 200-1560 42-338 122-952 
 
 
Phase 1 214-352 212-284 175-271 340-1560 
   
 
Phase 2 432-688 397-625 168-226 200-286 
   
 
Before CO2 addition 
     
146-952 
 
 
After CO2 addition 
    
42-338 122-472 
 
P
O
4-
P
 
 
Total treat. period 
mg L-1 
2.68-11.2 2.23-9.27 1.74-7.38 
0.005—
0.081 
0.007-0.093 0.02-2.46 0.007-1.74 
 
Phase 1 2.68-10.6 2.23-6.39 1.74-3.26 0.005-0.065 0.005-0.013 0.01-2.47 0.007-1.74 
 
Phase 2 3.26-11.2 5.30-9.27 3.82-7.37 0.005-0.08 0.003-0.09 0.02-1.08 0.08-0.98 
N
H
3-
N
 
P
h
as
e 
1
 
Conc. range 
mg L-1 
0.10-15.3 0.05-4.3 0.02-0.13 0.07-0.60 0.10-0.40 1.80-6.50 0.10-6.30 
Mean Conc. 8.18 1.13 0.04 0.21 0.25 3.97 2.01 
Removal efficiency* % - 86 100 97 97 51 75 
P
h
as
e 
2
 
Conc. range 
mg L-1 
24.9-77.0 10.8-57.6 0.03-6.10 0.06-3.60 0.02-5.60 0.60-3.70 0.26-2.80 
Mean Concentration 52.01 32.61 0.83 0.53 0.97 1.54 0.65 
Removal efficiency* % - 37 98 99 98 97 99 
N
O
3-
N
 
P
h
as
e 
1
 
Conc. range 
mg L-1 
0.05-5.84 1.66-11.2 2.99-9.97 1.40-9.17 3.28-3.47 0.05-2.86 0.05-3.70 
Mean Conc. 1.41 6.74 6.47 5.2 3.37 0.57 0.67 
Removal efficiency* % 
 
-378 -359 -269 -139 60 52 
P
h
as
e 
2
 
Conc. range 
mg L-1 
0.05-0.73 0.05-5.57 11.4-92.5 7.79-78.3 4.76-51.6 0.84-41.3 1.02-38.1 
Mean Conc. 0.16 1.5 41.3 31.6 21.6 14.6 13.6 
Removal efficiency* % 
 
-839 -25753 -19691 -13446 -9019 -8432 
Al µg L-1 0.28-15.3 0.08-20.0 0.08-21.3 186-1183 5.98-1516 
  
V µg L-1 0.06-0.91 0.47-1.14 0.72-2.31 1.46-48.6 1.47-26.37 
  
* calculated with respect to Cell 1 effluent 
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Table 3.8 Concentration ranges of DO, cBOD5, COD, E. coli, and total coliform in the effluents of Cell 1, 2, 3, 4, 4*, and 5. 
 
  
 
Unit Cell 1 Cell 2 Cell 3 Cell 4 Cell 4* Cell 5 Cell 6 
D
O
 
 
Total treat. period 
mg L-1 
0.12-10 1.0-11 3.7-11 1.2-22 7.2-15 1.6-8.3 1.0-16 
Phase 1 0.40-10 1.0-11 5.7-9.9 1.2-21 7.2-14 1.6-8.1 1.0-16 
Phase 2 0.12-1.8 1.5-5.7 3.7-11 3.0-6.2 7.7-15 3.5-8.3 7.8-11 
cB
O
D
5 
P
h
as
e 
1
 
Conc. range 
 
6.0-40 4.0-48 0.50-42 0.50-0.50 0.50-0.50 0.50-18 0.16-30 
Mean Conc. 16 13 11 0.5 0.5 3.4 5.7 
Removal efficiency* % - 22 32 97 97 79 65 
P
h
as
e 
2
 
Conc. range 
mg L-1 
13-168 9.7-58 1.7-9.9 0.50-0.50 0.50-6.3 0.50-6.7 3.9-12 
Mean Concentration 49 25 6.1 0.5 1.2 5.0 6.1 
Removal efficiency* % - 49 87 99 97 90 88 
C
O
D
 
P
h
as
e 
1
 
Conc. range 
mg L-1 
20-76 5.1-81 9.3-115 3.7-48 9.6-15 15-183 21-157 
Mean Conc. 38 31 36 13 13 54 51 
Removal efficiency* % - 20 7 67 67 -40 -32 
P
h
as
e 
2
 
Conc. range 
mg L-1 
25-231 37-127 21-44 5.0-27 5.3-27 5.0-31 12-32 
Mean Conc. 102 78 31 13 14 17 20 
Removal efficiency* % - 24 70 87 86 84 81 
E. coli CFU 100 
mL-1 
2.2x104 1.1x104 7.5x101 5.3x100 3.0x100 9.1x100 5.1x100 
Total Coliform 8.9x104 2.2x104 6.9x102 6.1x100 3.0x100 1.4x101 7.7x102 
* calculated with respect to Cell 1 effluent       
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Chapter 4 
Advanced Phosphorus Removal in a Demonstration-
scale Engineered Wetland Wastewater Treatment 
System 
4.1 Executive Summary  
Integration of a phosphorus removal component in an engineered wetland (EW) wastewater 
treatment system provided enhanced treatment efficiencies of phosphorus, ammonia, cBOD5, 
COD, E. coli, total coliform, and trace metals from septic system effluent. The phosphate 
removal component utilized basic oxygen furnace slag (BOFS) as a treatment medium. The 
effluent from a conventional septic system circulated through the treatment cells with an average 
flow rate of 1.1 m
3 
day
-1
, which was approximately 25% of the capacity of the treatment system 
(4-5 m
3
 day
-1
).   The average influent concentrations of P, ammonia, cBOD5, and COD were 7, 
48, 63, and 143 mg L
-1
, respectively. Removal efficiencies for P, ammonia, cBOD5, and COD in 
the treatment system were > 99, >82, >98, and >76%, respectively. Removal efficiencies for E. 
coli and total coliform in the treatment system were >99%. The effluent of the phosphate 
treatment cell was elevated (pH, 10.88±1.47), and was neutralized by sparging with CO2(g) prior 
to discharge to the local sewage system. A thin layer of ZVI imbedded at the bottom part of the 
BOFS cell was utilized to maintain low concentrations of dissolved metals and metalloids, 
including V, leached from basic oxygen furnace slag (BOFS). The pH neutralization process 
enhanced removal of Al.   Fourier Transform Infrared (FTIR) spectra indicated the presence of 
calcium carbonate and calcium phosphate minerals on the spent BOFS.  X-ray absorption near 
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edge structure (XANES) spectra also indicated the accumulation of calcium phosphate species 
on the spent BOFS. The results show the benefits of integrating complementary treatment 
technologies for the removal of nutrients and other constituents from domestic wastewater.  
4.2 Introduction   
Domestic and municipal wastewater often contains elevated concentrations of dissolved 
nutrients, including phosphorus (P) and nitrogen (N) species. Although N species may be 
removed in wastewater treatment systems, elevated concentrations of P are commonly 
discharged from wastewater treatment facilities and introduced to proximal water bodies, which 
may lead to eutrophication (U. S. EPA, 2007; Vymazal, 1997). Subsurface horizontal and 
vertical flow constructed wetland systems are effective for the removal of a wide range of 
wastewater pollutants (Vymazal, 2007; Vymazal, 2011). Although initial removal of ~46% P 
from wastewater was observed by Vymazal (2004) subsequent declines in P removal indicate 
that constructed wetlands are not suitable for treating P for extended periods (Kadlec and Knight, 
1996; Knight et al., 2000; Vymazal, 2004).   In recent years, research has explored compound 
speciﬁc treatment strategies and suitable P treatment media for engineered wetlands (EWs) 
(Vymazal et al., 2011). 
Several studies concentrated on identifying potential substrates that can be used in EWs to 
improve the P removal efficiency (Johansson, 1999; Drizo et al., 1999; Drizo et al., 2002; 
Jenssen and Krogstad, 2003). Materials selected as substrates in EWs are based on high P 
sorption capacities and on the potential to precipitate phosphate-bearing phases. Potential 
substrate materials include industrial byproducts such as electric arc furnace (EAF) slag (Drizo et 
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al., 2002; Drizo et al., 2006), shale (Drizo et al., 1999), lightweight aggregates (Jenssen and 
Krogstad, 2003), and blast furnace steel slags (Vohla et al., 2011). 
Basic oxygen furnace slag (BOFS), a waste by-product generated during steelmaking 
processes (Mikhail et al., 1994; Shi, 2004; Bowden et al., 2009), has been used as a reactive 
material for phosphate removal (Baker et al., 1998). The chemical composition of BOFS differs 
depending on the raw materials used at various steel production sites. Basic oxygen furnace slag 
is comprised of four dominant phases (>10 wt%) including Ca2SiO4, Ca3SiO5, FeO, and 
(Ca,Mg,Mn,Zn)Fe2O4; with major phases (5-10 wt%) including Ca(OH)2, Ca2Fe2O4, and 
MgFe2O4; and minor phases (<5 wt%) including SiO2, 3Al2O3SiO2, CaO∙Al2O3∙2SiO2, MgO, 
CaO, 2CaO∙ Al2O3∙ SiO2, CaFeO2, (Mg, Mn)Fe2O4, MnFeO, and Fe (Mikhail et al., 1994). The 
major constituents (~70-80 wt. %) of BOFS are CaO, Fe2O3, and SiO2; and the minor 
constituents (20-30 wt. %) of the material are MgO, MnO, Al2O3, P2O5, TiO2, K2O, Na2O, and 
Cr2O3 (Cha et al., 2006; Kim et al., 2006; Bowden et al., 2009; Xue et al., 2009; Navarro et al., 
2010; Stimson et al., 2010). Analysis of 17 BOFS samples indicate a mean composition of Ca 
(28.01%), Fe (18.43%), Si (5.97%), Mg (5.53%), Mn (3.29%), and Al (2.38%); with significant 
minor constituents of P (0.32%), C (0.26%), Cr-total (0.13%), S (0.11%), and V (0.10%) 
(Proctor et al., 2000). Blowes et al. (1996) identified BOFS as a low cost reactive material that 
has potential to remove phosphorus, arsenic and waterborne pathogens, from groundwater and 
wastewater. The treatment efficiencies of arsenic, phosphate and pathogen indicators (e.g., E-
coli) are often over 99% in BOFS based on laboratory and field applications treating wastewater 
(Baker et al., 1997, 1998; McRae et al., 1999; Blowes et al., 2000; Smyth et al., 2002b, Stimson 
et al., 2010). 
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Based on a laboratory experiment, Baker et al. (1998) suggests hydraulic retention times of at 
least 24 hours in BOFS media may be required to ensure maximum phosphorus removal 
efficiency. Exceedingly alkaline effluent and the potential for metal leaching from BOFS are 
concerns that need to be considered when implementing a BOFS treatment system.   
This paper describes the integration of a BOFS-based phosphate treatment system with a EW 
System in a demonstration-scale outdoor facility with a capacity of 4-5 m
3
 per day. The study 
investigated the removal of nutrients (PO4 and NH3), cBOD5, COD, and pathogens (E,coli and 
Total coliform)  in the treatment cells, and examined the release of V (potentially derived from 
BOFS) and subsequent removal using a zero valent iron (ZVI) layer. The pH of the effluent was 
neutralized by sparging CO2 in a large volume of high pH effluent from the BOFS component of 
the treatment system. The hydraulic performance of the treatment system was monitored 
throughout the period of operation. The occurrence of calcium carbonate and calcium phosphate 
(CaP) minerals on the outer layer of the spent BOFS as well as the possible CaP speciation were 
also investigated through FTIR and XANES.  
4.3 Materials and Methods 
4.3.1 System configuration  
The demonstration scale Engineered Wetland (EW)-phosphate treatment system was installed 
during the fall 2009 at the outdoor experimental facility at the Center for Alternative Wastewater 
Treatment, Fleming College, Lindsay, Ontario. Regular flow and monitoring of the system 
commenced in late January 2010.  The feed wastewater for the system is derived from the 
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effluent from a pre-treatment septic tank (Cell 1). The septic tank effluent passed through a series 
of treatment components including a vegetated horizontal subsurface flow cell (Cell 2), a 
vegetated vertical subsurface flow aerated engineered wetland  cell (Cell 3), a BOFS phosphate 
treatment cell (Cell 4), and a pH adjustment cell (Cell 5) before release into the City of Kawartha 
Lakes sewer system (Figure 4.1). The volume of Cell 2 was 24 m
3 (dimensions: 6 m ˣ 4 m ˣ 1 m). 
Cell 2 was filled with a 0.81 m thick gravel layer which contained the inlet and outlet piping 
network, where inlet and out flow pipes were surrounded by coarse gravel. The gravel used in 
Cell 2 contained a small amount of organic carbon derived from the wetland plants and may 
contain biomass from previous loading (because this cell was previously used for another study). 
The pore volume of the media in Cell 2 (6.80 m
3
) was calculated from the media volume (19.44 
m
3
, based on the thickness of the media) and porosity (~35%).  Cell 3 was 24.2 m
3
 (dimensions: 
2.7 m ˣ 4 m ˣ 2.24 m) and was filled with a 0.28 m thick layer of granitic gravel at the bottom 
that covered the collection pipe. An aeration grid was placed directly on the granite layer and 
covered by a second 1.51 m granitic gravel layer. The pore volume of the cell (6.77 m
3
) was 
calculated from the volume (19.33 m
3
, based on the thickness of the media) and porosity (~35%) 
of the media. A sewage distribution manifold was placed on top of the upper granitic gravel 
layer. Reeds (Phragmites australis) were planted at the level of the distribution manifold. A 0.45 
m layer of insulating straw was placed on top of the distribution manifold (Figure 4.2). Cell 4 
was a 27.4 m
3
 (dimensions: 4.1 m ˣ 4 m ˣ 1.67 m) tank operated in a downflow direction. A 
distribution manifold was placed in a 0.29 m layer at the top of the tank, which was underlain by 
a 0.55 m thick layer of BOFS. A thin layer of granitic gravel mixed with zero valent iron (ZVI) 
filings (Connelly GPM Inc., Chicago, Illinois, USA) was placed beneath the BOFS layer to 
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remove V from effluent derived from the overlying BOFS. A collection manifold was placed at 
the base of the tank within a 0.26 m thick layer of granitic gravel layer (Figure 4.3). The pore 
volume of Cell 4 (5.31 m
3
) was calculated from the media volume (13.28 m
3
, based on the 
thickness of the media below the distribution network) and porosity (~40%) of the media. A 
small sacrificial container (~1/2 m
3
) was places before the BOFS cell. Cell 5 consisted of two 
connected plastic tanks (1000 L each), used to adjust the high pH effluent derived from the 
BOFS in Cell 4. An automatic flow monitor was employed to monitor the flow continuously 
excluding the period when the monitor was malfunctioning due to clogging. Flow volume was 
calculated from the automatically monitored data during the period when the flow monitor was 
functioning.  Flow volume was calculated assuming constant flow during the periods when the 
monitor was malfunctioning.  
4.3.2 Characterization of the reactive material and reaction products 
Basic oxygen furnace slag (BOFS) was collected from the US Steel Stelco Hilton Works facility, 
Hamilton, ON, Canada.  Zero valent iron was obtained from the Connelly-GPM, Chicago, 
Illinois, USA. The particle density of BOFS and ZVI were determined using a pycnometer (Air 
Comparison Beckman Model 930). Surface area was determined with a surface area analyzer 
(Micromeritics Gemini
®
 VII 2390 Series).  
The chemical and mineralogical composition of the BOFS were determined by X-ray 
fluorescence (XRF; MiniPal4, PANanalytical), and X-ray diffraction (XRD, Rigaku D/MAX 
2500 rotating anode powder diffractometer). Samples of precipitates from Cell 4 effluent 
(accumulated at the bottom of the Cell 4 collection chamber) and from Cell 5 (accumulated at the 
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bottom of a plastic tank) were examined using a Leo 1530 field emission scanning electron 
microscopy (FE-SEM) with energy dispersive X-ray (EDX) analysis. 
The samples of the spent media were collected from nine sampling locations in Cell 4 for 
solid-phase analyzes. At each location, samples were collected in 8-10 cm vertical intervals from 
the surface of the reactive material (Profiles 1-9, Figure 4.4). Materials accumulated (adsorbed or 
precipitated) on the spent BOFS were analyzed using FTIR and XANES. The FTIR spectra were 
collected for the top-most samples from all nine sampling profiles using a Bruker Tensor 27 
infrared spectrometer.   
Phosphorus K absorption edge data was recorded using the Soft X-Ray Micro-characterization 
Beam line (SXRMB; 06B1-1) on two samples collected from the influent zone (Profile 1, 
samples 1 and 2) and a sample from the effluent zone of Cell 4 (Profile 8, sample 1) at the 
Canadian Light Source, Saskatoon, Canada using the 2.9 GeV storage ring. XANES spectra were 
processed and analyzed using the Athena (version 0.8.56) data processing package (Ravel and 
Newville, 2005).  Linear combination fitting was used to compare the spectra from spent BOFS 
and the reference materials based on the goodness of fit criteria. Detailed methods for collection 
and interpretation of FTIR and XANES are described in Chapter 3. Reference materials, 
including hydroxylapatite (HAP-S), tricalcium phosphate (-TCP & -TCP), calcium phosphate 
dihydrite (CPD), calcium phosphate dihydrite dibasic (CPDD), and iron phosphate (FeP) used 
for FTIR and XANES analysis were obtained from Sigma Aldrich, Canada. In addition, 
hydroxyapatite (HAP-WM) was synthesized in the laboratory following a liquid mix technique 
described in Pena and Vallet-Regi (2003) and used as reference material.   
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4.3.3 Sample collection and analysis 
The demonstration-scale treatment system was monitored regularly over two years from January 
2010 to December 2011. A flow meter was installed between Cell 4 and Cell 5 to measure flow 
rate of the system.   Influent and effluent samples from the overall system, and effluent samples 
from each cell were collected more frequently in year 1(weekly) than in year 2 (monthly). 
Samples were collected with polyethylene containers after purging at least three times to avoid 
cross contamination and ensure representative samples. The values of pH, Eh and alkalinity were 
measured in the field using the same instruments and following the procedures described in 
Chapter 3. Samples for cations, anions, phosphate, ammonia, COD, CBOD5, total Coliform and 
Escherichia coli (E.coli) were collected, preserved, and analyzed using the methods described in 
Chapter 3.   
4.3.4 Geochemical modeling 
The geochemical modeling code PHREEQC Interactive was used to calculate the saturation 
indices (SI) for CaP phases (e.g., hydroxylapatite) and other mineral phases relevant to the 
treatment system (Parkhurst and Appelo, 1999). The WATEQ4F database was used for these 
calculations. Solubility product values for brushite, monetite, octacalciumphosphate, β-
tricalciumphosphate, and variscite (Table 4.1) were added to the database using published 
solubility constants (Baker et al., 1998). Saturation indices were calculated for four sampling 
events at the effluent of Cells 1, 2, 3, and 4. 
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4.4 Results and Discussion 
4.4.1 Characteristics of the reactive materials 
The BOFS particle size ranged from <0.5 to 8 mm. The finest fraction of the BOFS had the 
highest mass-weighted surface area (Table 4.2). The particle density of the BOFS was 3.43 g cm
-
3
. XRF analysis results indicate the composition of BOFS material,  expressed as oxides, was  
33.8 wt. % CaO, 24.3% Fe2O3, 11.3% SiO2, 9.6% MgO, 4.1% MnO, and 7.4% Al2O3 (Table 
4.2). XRD measurements of two BOFS samples collected from the source material indicated that 
BOFS material contained wuestite (FeO), lime (CaO), larnite (Ca(SiO4)),  srebrodolskite 
(Ca2Fe2O5), anhydrite (CaSO4) and possibly portlandite (Ca(OH)2). However, only one of the 
samples analyzed contained both lime and anhydrite. The XRD analysis also indicated the 
presence of corundum (Al2O3), which was probably derived from the mortar and pestle used to 
prepare the samples (Table 4.2). The particle size, surface area and density of ZVI were 8 to 50 
mesh (0.297- 2.38 mm), 4.4 m
2
g
-1
, and 6.7 g cm
-3
.   
4.4.2 Flow characteristics 
The flow rate was highly variable throughout the study period due to variations in the size of 
student population at the college. The average flow rate was 0.89 m
3
 day
-1 
and the flow rate 
varied between 0.02 and 4.3 m
3
 day
-1
 (σ=625, Figure 4.5). Mean hydraulic retention time was 7.6 
(minimum HRT of 1.59 days), 7.6 (minimum HRT of 1.59 days), and 6.0 (minimum HRT of 
1.24 days) days in Cells 2, 3, and 4. Due to the formation of particulate CaCO3 in Cell 4 effluent, 
the flow meter between Cells 4 and 5 clogged several times. High electrical conductivity and 
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high concentrations of TSS in the Cell 4 effluent (Figure 4.6) confirmed the presence of 
suspended and dissolved solids. Although no significant change in flow rate was observed during 
the experiment, a decrease in flow rate can be anticipated in cases of long-term operation without 
any maintainance.  
4.4.3 pH and alkalinity 
Mean pH values of effluent from Cells 1, 2, 3, and 4 were 7.61, 7.81, 7.84, and 11.4 respectively 
(Table 4.3).  A gradual increase in pH was observed in Cells 2 and 3 effluents, which is probably 
due to respiration of CO2 through plant roots in Cell 2 and through aeration in Cell 3 (Figure 
4.6). The pH of the Cell 4 effluent was consistently over 9.4 (pH range, 10.9±1.47) throughout 
the experiment. The mean alkalinity in Cells 1, 2, 3, and 4 effluents were 534, 483, 222, and 802 
mg L
-1 
as CaCO3, respectively (Table 4.3). The alkalinity values in Cell 4 effluent were very high 
(up to 2360 mg L
-1 
as CaCO3) during the initial stage of the experiment, which was probably due 
to the dissolution of CaO and Ca(OH)2 on the outer layers of the BOFS. The alkalinity values 
gradually decreased over time as the labile calcium oxide and hydroxide phases were depleted by 
continuous flushing by the Cell 3 effluent.  However, pH values did not change significantly 
over time as the hydraulic retention time (~5 days) probably was sufficient to dissolve the 
calcium species (CaO and Ca(OH)2) from the BOFS. The high pH effluent from Cell 4 was 
neutralized in Cell 5 (pH adjustment tank) by sparging with CO2 based on results from an indoor 
pilot-scale (~1 m
3
 capacity) treatment system (Chapter 3).  A large volume of white precipitate 
accumulated in the bottom of the Cell 4 effluent collection chamber. The accumulation of these 
precipitates was anticipated due to very high average electrical conductivity (4050 µS cm
-1
) and 
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total suspended solid (TSS) concentrations (245 mg L
-1
) in the Cell 4 effluent relative to the 
effluent from the other cells effluents (Figure 4.6). The FTIR analysis suggests that these 
precipitates were mainly calcium carbonate and calcium phosphate (Table 4.4). The formation of 
these carbonate minerals was minimized when the pH was maintained between 6.5 and 7 (by 
sparging CO2). The rate of CO2 addition required to neutralize the effluent pH was determined 
on the basis of the difference between the OH
-
 concentration measured in Cell 4 effluent and the 
desired OH
-
 concentration. Typically 10
-2
 moles of CO2 were required to reduce the pH from 12 
to 7.5 per liter of effluent.   
4.4.4 Phosphorus removal  
Mean PO4-P concentrations in the effluent from Cells 1, 2, 3, and 4 were 5.49, 5.89, 3.49, and 
0.07 mg L
-1 
respectively (Figure 4.6).  The removal efficiency of PO4 in Cells 2, 3, and 4 was -
7%, 44%, and 62%, respectively (Figure 4.6). Thus the overall PO4 removal efficiency in the 
treatment system was ~99%.  The removal efficiency of PO4 in Cell 3 (aerated EW cell) was 
44%. Similar efficiencies (40-60%) have been reported for other aerated EW systems (Kadlec 
and Knight, 1996; Knight et al., 2000, and Vymazal, 2004). The extent of PO4 removal was 
greatest (62%) in Cell 4. Furthermore, PO4 removal efficiency in Cell 4 was about 98% with 
respect to the Cell 3 effluent. The concentrations of PO4 in Cell 5 effluent were greater than in 
the Cell 4 effluent (Figure 4.7). Phosphorus mass retention was higher in Cell 4 (~94%), 
compared to Cell 2 (1.3%) and Cell 3 (27%) during the experiment (Figure 4.5, Table C 32 in 
Appendix C). 
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Adsorption of inorganic PO4 on hydrous oxides of Fe and Al is favored in acidic 
environments; however, alkaline conditions are suitable for precipitation of calcium phosphate 
phases (Qualls and Richardson, 1995). Low removal efficiency of PO4 in Cell 3 was probably 
due to the low abundances of Ca, Fe, and Al, in the granitic gravel, because these metals are 
commonly involved in formation of P-bearing phases (Vymazal, 2004). On the other hand, 
presence of significant quantities of Ca, Fe, Al, and Mg oxides (Table 4.2) in the BOFS probably 
enhanced removal of PO4 in Cell 4. 
Precipitation of Al-phosphate and Fe-phosphate phases is favoured in near neutral to acidic 
conditions (Stumm and Morgan, 1981). Whereas, Ca-rich alkaline conditions (pH>9) favor the 
formation of calcium phosphate phases (e.g., hydroxyapatite) (Baker et al., 1998; Bowden et al., 
2009).  In BOFS based treatment systems, precipitation of calcium phosphate phases (i.e. 
hydroxyapatite) is found to be the most important PO4 removal mechanism (Baker et al., 1998; 
Bowden et al., 2009). However, the formation of hydroxyapatite can be inhibited by high 
concentrations of dissolved Mg (Kim et al., 2006). In addition to calcium phosphate phases, iron, 
aluminum, and magnesium phosphate phases may also form in BOFS based treatment system.   
Although adsorption of PO4
3-
 is anticipated to be less significant at high pH, predominance of 
the negatively charged HPO4
2-
 and PO4
3-
 species at pH >9 is reported (Stumm and Morgan, 
1981). The scarcity of positively charged surfaces is more predominant at lower pH. However, 
the BOFS reactive media in Cell 4, contains an abundance of metal oxides, some of which have 
high pH greater than zero point of charge (pHZPC) values, including 11.2 % MgO (with pHZPC of 
12.4; Parks, 1965) and 3.4 % Al2O3 (with pHZPC of 9.1; Parks, 1965).  The removal efficiency for 
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PO4 in Cell 4 did not decrease significantly because the reactive material consistently released 
effluent with high pH and high Ca during the investigation (Table C 6 in Appendix C).  
The influent water was undersaturated with respect to brushite, monetite, and vivianite in all 
sampling events (Figure 4.8); undersaturated with respect to variscite in all sampling events 
except Jun 03, 2010; and supersaturated with respect to octacalciumphosphate, β-
tricalciumphosphate, MnHPO4, calcite, aragonite, gibbsite, goethite, ferrihydrite, hydroxyapatite 
and strengite in all sampling events except Jun 03, 2010. Very low phosphate concentrations in 
Cell 4 effluent and the supersaturation of the pore water with respect to calcium phosphate 
phases including hydroxyapatite, one of the major P-bearing phases in Ca- and P-rich 
environments (Yamada et al., 1986; Bowden et al., 2009; Stumm and Morgan, 1981), suggest 
that precipitation of calcium phosphate phases is likely mechanisms for P retention in the BOFS 
media.  
4.4.4.1 FTIR 
The FTIR spectra were collected for the outer layer materials of the spent media from top the 5 
cm of the nine sampling locations in Cell 4. All of the spectra showed pronounced carbonate and 
phosphate bands.  Sharp carbonate bands, including the v4 band at  712-713 cm
-1
, the v2 band at 
872-874 cm
-1
, and a broad distinct carbonate v3 band at 1422-1426 cm
-1
, carbonate overtones 
including the combination bands of v1 and v4  at 1797-1800 cm
-1
 (v1+ v4; Gillet et al., 1996; 
Vongsavat et al., 2006; Tatzber et al., 2007; Gunasekaran and Anbalagan, 2008), and the 
combination bands of v1 and v3 or 2v2 and v4 at 2514-2515 cm
-1
 were observed (v1+ v3; 
Vongsavat et al., 2006; 2v2+ v4; Gunasekaran and Anbalagan, 2008). Relatively weaker 
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carbonate overtones were also observed at 2874-2876 cm
-1
, and 2980-2982 cm
-1
 (2v3; 
Gunasekaran and Anbalagan, 2008). The carbonate vibrational frequencies v4, v2, and v3 along 
with the overtones suggested that calcite was one of the predominant minerals in the outer layer 
materials accumulated on the spent reactive materials (Vagenas et al., 2003; Vongsavat et al., 
2006; Ni and Ratner, 2008; Kurap et al., 2010). An example spectrum plotted with labelled 
carbonate vibrational bands for calcite and aragonite is shown in Figure 4.9. A broad phosphate 
v3 band at 1030-1039 cm
-1
, several phosphate v4 bands at 632-635, 602-608, 595-597, 583-588, 
and 567-575 cm
-1
, and a phosphate v2 band between 450-461 cm
-1
 and 475 cm
-1
 were also 
observed. However, none of these spectra showed any signature of phosphate v1 band (Table 4.4). 
Although phosphate v3 and v2 bands were well-defined, most of the phosphate v4 bands were 
weak to very weak. The FTIR spectra were compared with the reference materials including 
HAP-S and β-TCP (Figure 4.9). The wavenumbers of the phosphate vibrational bands obtained 
from the reference materials were similar to the HAP and β-TCP reported in the previous studies 
(Rehman and Bonfield, 1997; Ribeiro et al., 2006; Panda et al., 2003; Singh and Purohit, 2011, 
Matkovic et al., 2012; Kim et al., 2006; Pena and Vallet, 2003; and De Oliveira et al., 2005).   
The phosphate vibrational bands of β-TCP showed better match with the samples compare to 
HAP-S. However, due to inadequate concentration of P compared to the Ca concentration in the 
samples and the absence of appropriate conditions (e.g. high temperature, ~1000 
0
C for 
crystallization of HAP and β-TCP) during the formation of CaPO4, wavenumbers may not be the 
same as the crystalline reference materials.  
 139 
4.4.4.2 XANES 
XANES spectra were collected for samples P2-S1, P2-S2, and P8-S1 from the upper influent and 
effluent part of Cell 4 (Figure 4.10). The XANES spectra can show the presence of phosphate 
(oxidation state +5) bearing phases, by comparing primary fluorescence peak positions.  The 
primary peak positions reported for the reference phosphate species are around 2149 eV 
(Hesterberg et al., 1999; Sato et al., 2005 ), 2150 eV (Shober et al., 2006, Güngör et al., 2007), 
2151 eV (Brandes et al., 2007), and 2158.5 eV (Peak et al., 2002). This primary peak is also 
designated as absorption edges or white lines in XANES spectra (Brandes et al., 2007; Güngör et 
al., 2007) and is based on the charge, electronegativity, and interatomic distance of the 
coordinating cation; the white line may vary between ± 0.5 eV (Franke and Hormes, 1995). The 
pre- and post-edge spectral features characteristic of various phosphate phases including Ca-, Al-
, and Al-phosphates are described in previous studies (Hesterberg et al., 1999; Ajiboye et. al., 
2008; Shober et al., 2006; Sato et al., 2005; Eveborn et al., 2009; Beauchemin et al., 2003). 
The energy range of P K-edge of the CaP reference materials analysed in this study were 
between 2151.5 and 2151.7 eV. A well-defined post-edge shoulder at ~2154.7 eV and two other 
features at ~2162.5 eV, and ~2169.0 eV were observed in the spectra.   The iron phosphate 
reference material, iron (III) phosphate, showed the white line at a higher energy (2152.2 eV) 
and also displayed a unique pre-edge feature at 2148.5 eV. The position of this pre-edge feature 
is consistent with previous studies (Hesterberg et al., 1999; Khare et al., 2007; Ajiboye et. al., 
2008; Shober et al., 2006, Sato et al., 2005, Eveborn et al., 2009; and Beauchemin et al., 2003).  
 
 140 
The calcium phosphate phases all exhibited a shoulder at ~2154.7 eV (Figure 4.10 c) and a 
distinct feature at ~2162.5 eV (Figure 4.10 d). Although other studies reported different energies 
for these features, the relative positions of these features with respect to the white lines were 
within the same range (Peak et al., 2002; Sato et al., 2005). Another feature at ~2169 eV was 
observed at a similar position, relative to the white line, as a feature attributed to the oxygen 
oscillation by Peak et al. (2002) and Sato et al. (2005).     
XANES spectra of the calcium phosphate reference materials and the spent BOFS samples are 
compared in a single plot (Figure 4.10). Phosphate sorbed on calcite  (PSC) was synthesized in 
the laboratoty and included as a reference material in this study. The XANES spectrum of this 
PSC sample closely resembled the PSC spectrum presented in Peak et al. (2002). The absorption 
edges of all of the spectra collected for the samples from Cell 4 were between 2151.5 and 2151.7 
eV. This edge position is similar to that observed for the Ca-PO4 reference materials. The 
samples obtained from Cell 4 also showed post-edge features including a shoulder at 2154.7 eV, 
a Ca-PO4 peak at 2162.5 eV, and an oxygen oscillation peak at 2169.0 eV. Although the relative 
positions were similar to those observed in the reference materials, these features were not as 
distinct as observed in the reference materials.  The sharpness of the spectral features is 
proportional to the degree of crystallinity (Peak et al., 2002; Sato et al 2005).  The XANES 
spectra showed small differences between the samples, suggesting minor differences in 
composition or structure. There was no pre-edge feature observed in the XANES spectra of the 
samples, indicating an absence of iron phosphate phases. 
The linear combination (LC) fitting tool of Athena was used to compare the XANES spectra of 
the samples and the reference materials. Binary and ternary combinations of Ca-PO4 reference 
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materials were compared to the spectra for each sample. The Fe-PO4 was considered in the LC 
fitting because it showed an unique pre-edge feature, which is not observed in the samples 
(Figure 4.11). Sample P2-S1 showed the best LC fit (2 =1.01) with the combination of -TCP, 
-TCP, and CPDD. The contributions from -TCP were greatest in the linear combination fit 
(70%), followed by -TCP (~20%) and CPDD (~10%) (Figure 4.11, Table 4.5). Sample P8-S1 
showed a similar LC fit with contributions from -TCP, -TCP, and CPDD of ~72%, ~16% and 
~12%. The best LC fit (2 =2.71) for sample P2-S2 was observed for the combination of -TCP 
(~57%), -TCP (~41%), and CPDD (~2%), suggesting that the greatest contribution was from -
TCP, rather from -TCP, as found in the other samples. Comparatively higher 2 values were 
observed in different combinations of Ca-PO4 reference materials for sample P2-S2 than for the 
other samples. However, similar high values are not uncommon in the literature (Güngör et al., 
2007).    
4.4.5 Ammonia and nitrate 
Mean concentrations of NH3-N in Cells 1, 2, 3, and 4 effluents were 47.9, 38.8, 4.31 and 8.38  
mg L
-1
, respectively; and mean concentrations of NO3-N in Cells 1, 2, 3, and 4 effluents were 
3.55, 3.47, 38.0 and 32.6  mg L
-1
, respectively. There were sharp differences observed in NH3-N 
and NO3-N concentrations between Cells 2 and 3 effluent during the experiment (Table 4.3).   
Removal efficiencies of NH3-N in Cells 2, 3, and 4 were 19, 72, and -9.0%, respectively. 
Although Cell 4 contributed ~ 9.0% NH3-N, the overall removal efficiency of the treatment 
system was ~82%.  
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Mean NO3-N concentrations decreased in Cell 2 by 2.3% and then increased sharply in Cell 3 
(~ 11 times higher than the concentrations in the Cell 2 effluent). Finally, the NO3-N 
concentration decreased 14% in the Cell 4 with respect to the Cell 3 effluent (Figure 4.5).  The 
33.8 mg L
-1
 loss in NH3-N in Cell 2 corresponds closely to the 34.5 mg L
-1
 gain in NO3-N. These 
sharp changes in NH3-N and NO3-N concentrations from Cell 2 to Cell 3 can be attributed to 
microbially mediated oxidation of NH3 to NO3
-
. Nitrification is enhanced by the continuous 
supply of O2 through the forced aeration system as was evident by the high DO (dissolved 
oxygen) concentrations in these cells (Figure 4.6, Table 4.6).  Similar degrees of nitrification 
have been observed in other studies of EW systems (Green et al., 1998; Ye and Li, 2009). 
The ZVI layer at the bottom of Cell 4 may play an important role in the increasing ammonia 
concentrations in Cell 4 effluent. Reduction of nitrate and nitrite by ZVI and release of NH3 are 
reported in previous studies (Rahman and Agrawal, 1997; Cheo et al., 2004). A very low positive 
change in mass (2% N mass loss) was observed in this treatment system (Table C 36 in Appendix 
C). 
4.4.6 Carbonaceous biochemical oxygen demand (cBOD5) and 
chemical oxygen demand (COD) 
Mean concentrations and the concentration ranges of cBOD5 and COD of in Cells 1, 2, 3 and 4 
are summarized in Table 4.6. The removal efficiencies of cBOD5 in Cells 2, 3, and 4 were 58, 
30, and 10%, respectively. Thus the overall removal efficiency of cBOD5 in the treatment system 
was > 98%. However, the removal efficiency of cBOD5 in Cell 3 was 71% compared to the Cell 
2 effluent, which is about 20% less than values reported previously (Johnson and Mara, 2005). 
Although Cell 4 contributed only 10% of the total cBOD5 removal (>98%) in the treatment 
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system, this cell has potential for removing a higher percentage of the cBOD5 (86% removal 
compared to Cell 3 effluent) of cBOD5. Thus all three treatment cells played important roles in 
degrading labile organic carbon compounds.            
Mean concentrations of COD in Cells 1, 2, 3, and 4 were 143, 72.1, 28.4, and 34.0, 
respectively. Removal efficiencies of COD in Cells 2, 3, and 4 were 50, 31 and -4.0%, relative to 
the Cell 1 effluent.  However, the COD removal efficiency in Cell 2 was 50% with respect to 
Cell 1 effluent; in Cell 3 removal was 61% with respect to Cell 2 effluent; and in Cell 4 was -
20% with respect to Cell 3 effluent. Thus both Cells 2 and 3 were effective in removing COD 
from wastewater, whereas Cell 4 contributed COD to the effluent. Both cBOD5 and COD 
loading fluctuate with the flow variation depending on the student population (Table C37, C38).    
4.4.7 Major ion chemistry  
Mean Ca concentrations in Cells 1, 2, 3, and 4 effluents were 100.8, 101.2, 105.1, and 193.2 mg 
L
-1
, respectively. There were no significant changes in Ca concentrations between the Cell 1 and 
Cell 2 effluent. Calcium concentrations increased by 5% and 61% in the Cells 3 and 4. A sharp 
increase in Ca concentrations (as high as 568.2 mg L
-1
) was observed in Cell 4 effluent at the 
initial stage of the trial. This sharp increase in Ca concentration was probably due to the 
dissolution of CaO and Ca(OH)2. Over time, as the cell continuously flushed, the Ca 
concentrations gradually decreased (Figure 4.12). In Cell 5, where CO2 is introduced to the 
system by sparging, Ca concentrations decreased and precipitates accumulated (Figure 4.7). 
Mean Na concentrations in the Cell 1, 2, 3, and 4 effluents were 131.0, 126.3, 120.6, and 118.7 
mg L
-1
, respectively.  Although Na concentrations gradually decreased from Cell 1 to Cell 4 
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(Figure 4.12), the small differences in concentrations (<5%) is consistent with the conservative 
nature of Na.  Mean Mg concentrations were in the Cell 1, 2, 3, and 4 effluent were 11.8, 11.2, 
14.1, and 4.3 mg L
-1
, respectively. Although the Mg concentration decreased slightly in Cell 2 
(5%), Mg concentrations in Cell 3 effluent increased by 25%. The Mg concentration decreased 
(70%) in Cell 4 effluent relative to the Cell 3 effluent (Figure 4.12). This decrease in Mg, may 
result from substitution of Mg for Ca in calcite or hydroxyapatite (Kim et al., 2006). Mean SO4
2- 
concentrations in Cells 1, 2, 3, and 4 effluents were 42.3, 33.9, 45.6, and 30.5 mg L
-1
, 
respectively (Figure 4.12).  Mean SO4
2-
 concentrations decreased by 20% in Cell 2 with respect 
to Cell 1 effluent, and increased by 35% in Cell 3 with respect to Cell 2 effluent, then decreased 
by 33% in Cell 4 with respect to Cell 3 effluent. Reducing conditions in Cell 4 (indicated by low 
Eh values; Figure 4.6) favour reduction of SO4 and precipitation of metal sulfides. Chloride 
concentrations in Cells 1, 2, 3, and 4 did not significantly change (5% variation was observed) 
throughout the treatment system (Figure 4.12, Table 4.3), which indicate Cl is conservative is 
this system.    
4.4.8 Trace metals 
With few exceptions in the initial stage of the experiment, the concentrations of the dissolved 
trace metals (Zn, Fe, Mn, Cr, Ni, and Pb) remained at low concentrations below water quality 
guidelines for Ontario (Figure 4.13, MOEE, 1994).  
Mean Al concentrations in Cells 1, 2, 3, and 4 were 17.1, 24.0, 28.4, and 32.3 µg L
-1
,
 
respectively. The concentrations of Al gradually increased along the flow path. The  increase in 
Al concentrations observed in Cells 2, 3, and 4 probably were due to the progressive release  
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from the treatment materials, with the greatest concentrations derived from the BOFS media, 
where the pH increases to pH>11. However, Al concentrations decreased in Cell 5 as pH of the 
cell was adjusted to near neutral by sparging with CO2 (Figure 4.7, Stumm & Morgan, 1981). 
Mean V concentrations in Cells 1, 2, 3, and 4 effluents were 0.63, 0.72, 5.15, and 2.77 µg L
-1
, 
respectively (Figure 4.13).  
The release of V from BOFS has been observed previously (Chaurand et al., 2007) and the 
observed increase in V, was probably derived from the BOFS. The V concentrations in Cell 3 
effluent were abnormally high (as high as 13.76 µg L
-1
) in the initial stage of the experiment. 
This elevated V concentration probably was derived from a small sacrificial container filled with 
BOFS installed immediately below the effluent pipe of Cell 3. However, the release of V from 
this chamber declined at later stages of the experiment. Although V concentrations increased to 
10.45 µg L
-1
 in the effluent from Cell 4, this increase was less than that observed in previous 
reports (Proctor et al. 2000; Chapter 2). The ZVI layer, placed at the base of Cell 4 probably 
reduced vanadate (VO4
3-
) resulting in precipitation or adsorption of vanadium, yielding lower 
concentrations. Addition of this thin ZVI layer is not expected to have significant effect on flow.     
Average Cu concentrations in the effluent from Cell 1, 2 3 and 4 were 26.9, 14.4, 17.6, and 
24.8 µg L
-1
. The Cu concentrations in the Cell 1 effluent (system influent) were up to 59.9 µg L
-1
 
and exceeded water quality guidelines for Ontario (1 µg L
-1
;
 
MOEE, 1994).  The average Cu 
concentration in the Cell 4 effluent reached a maximum of 27.5 µg L
-1
, but remained lower than 
in Cell 1 effluent suggesting the EW system removed Cu from the effluent water (Figure 4.13). 
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4.4.9 Removal of bacterial indicators (total coliforms and E. coli) 
Concentrations of E. coli of 2.2 ˣ 103 to 2.4 ˣ 106 CFU 100 mL-1 in Cell 1, decreased to 0.3 ˣ 102 
to 4.8 ˣ 105 CFU 100 mL-1 in Cell 2, 0.03 ˣ 102 to 2.4 ˣ 104 CFU 100 mL-1 in Cell 3, and 0.03 ˣ 102 
to 2.4 ˣ 103 CFU 100 mL-1 in Cell 4 showing progressive removal of E. coli in the treatment 
system (Table 4.6). In addition, concentrations of total coliform of 3.8 ˣ 103 to 1.2 ˣ 107 CFU 100 
mL
-1
 in Cell 1 decreased to 0.5 ˣ 102 to 1.2 ˣ 106 CFU 100 mL-1 in Cell 2, 0.03 ˣ 102 to 2.4 ˣ 104 
CFU 100 mL
-1
 in Cell 3, and 0.03 ˣ 102 to 2.4 ˣ 103 CFU 100 mL-1 in Cell 4 (Table 4.6). Both 
E.coli and total coliform sharply decreased while passing through Cell 3 by aeration and the 
bacterial indicators and were further removed in Cell 4 due to highly alkaline condition of the 
cell (Figure 4.14). Thus, Cell 4 may also be considered a disinfection component within the 
treatment system. 
4.5 Conclusions 
The removal efficiencies of cBOD5, COD, PO4, NH3, E. coli, and total coliform in the 
demonstration-scale wastewater-treatment system were often >99%. Elevated pH and dissolved 
Al and V concentrations in the effluent from Cell 4, derived from the BOFS materials, were 
potential concerns associated with the treatment system. The high pH was neutralized by 
sparging with CO2(g) prior to discharge to the sewer system. Dissolved Al concentrations 
decreased as the pH was neutralized. The ZVI layer placed at the bottom of Cell 4 maintained the 
V concentration below the PWQO value. There was no significant effect of sesonal temperature 
variation on the overall performance of the treatment system. The precipitates derived from Cell 
4 effluent were separated from the effluent in a settling chamber prior to sparging with CO2, 
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maintaining low total PO4 concentrations in the final effluent. Removal of E. coli and total 
coliform in the treatment system is attributed to the high pH concentrations prevalent in Cell 4. 
The trace metal concentrations were mostly within the guideline ranges in Cell 4 effluent. FTIR 
data indicated the occurrence of Ca-PO4 minerals on the outer layers of samples of the spent 
BOFS. XANES spectra and LC fit results showed the probable occurrence of -TCP on the outer 
layers of samples of the spent BOFS.     
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Figure 4.1 Schematic diagram of the EW-BOFS demonstration-scale treatment system. The 
treatment system comprises 4 outdoor cells (Cells 1-4) and an indoor cell (Cell 5). Wastewater 
continuously flushes through the system by a combination of gravity feed and pumping. In this 
diagram HSSF EW represents horizontal subsurface flow engineered wetland, VSSF aerated EW 
represents vertical subsurface flow aerated engineered wetland, BOFS represents basic oxygen 
furnace slag, and CLK represents City of lake Kawartha.   
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Figure 4.2 Cross-section of the Aerated EW
 
cell (Cell 3) showing the thickness and vertical 
distribution of different components of the cell.   
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Figure 4.3 Cross-section of the BOFS
 
cell (Cell 4) showing the thickness and vertical 
distribution of different components of the cell.   
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Figure 4.4 Locations of solid phase spent media collected from the BOFS cell. 
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Figure 4.5 Flow rate, PO4-P concentrations in the influent and effluent, and P load in BOFS 
Cell.   
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Figure 4.6 Box plots of pH values, Eh, conductivity, alkalinity, PO4-P, DO, cBOD5, 
COD, Cl, SO4, NH3-N, NO3-N, NO2-N, NH3-N/NT, NO3-N/NT versus distance (Cells 1-4) 
along the treatment flow path. Dotted lines represent the Ontario Provincial Water Quality 
Objective (PWQO). Horizontal solid lines and broken lines on the boxes represent median 
and mean concentrations. Top and bottom most dots represent maximum observation 
above upper fence and minimum observation below lower fence.   
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Figure 4.7 pH values, Ca, Al, and PO4-P concentrations versus distance 
(Cells 1-5) along the flow path.  
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Figure 4.8 Saturation indices for calcium phosphate and other related phases (calculated using 
PHREEQCI) along the treatment cells during 3 sampling events. Saturation index of 
hydroxyapatite (indicated by *) was plotted using a modified log Ksp value (Baker et al., 1998).   
 
 156 
 
 
 
 
 
 
 
Figure 4.9 FTIR spectrum of sample with highest mass and reference materials and sample P2-
S1, with phosphate vibrational bands for a) HAP-S, b) -TCP, c) calcite, d) aragonite. Vertical 
dotted lines in “a” and “b” represent phosphate vibrational bands, while vertical dotted lines in 
“c” and “d” represent carbonate vibrational bands. 
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Figure 4.10 XANES spectra for reference materials, PO4 sorbed on CaCO3 (PSC; Peak et al., 
2002), and samples P2-S1, P2-S2, P8-S1.  Vertical lines represent various spectral features: a) 
pre edge feature for FeP; b) absorption edge (white line) for CaP species; c) shoulder (sharpness 
dependent on the degree of crystallinity; d) spectral feature common in HAP; e) oxygen 
oscillation.   
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Figure 4.11 Linear combination fit results for spent BOFS samples P2-S1, P2-S2, and P8-S1.   
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Figure 4.12 Box plots of Ca, Na, Mg, K, SO4, and Cl concentrations versus distance (Cells 1-4) 
along the flow path. Horizontal solid lines and broken lines on the boxes represent median and 
mean concentrations. Top and bottom most dots represent maximum observation above upper 
fence and minimum observation below lower fence.   
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Figure 4.13 Box plots of V, Al, Cu, Zn, Fe, Ni, Mn, Cr, and Pb concentrations versus distance 
(Cells 1-4) along the flow path. Dotted lines represent the Ontario Provincial Water Quality 
Objective (PWQO). Horizontal solid lines and broken lines on the boxes represent median and 
mean concentrations. Top and bottom most dots represent maximum observation above upper 
fence and minimum observation below lower fence. 
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Figure 4.14 Concentrations of E. coli, total coliform (in the left Y-axis), DO, pH (in the right Y-
axis) versus cells (1-4) along the flow path. 
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Table 4.1 Ksp values of the calcium phosphate minerals added to the PHREQCI database.   
 
 
Mineral Phases Reactions log Ksp References 
Hydroxyapatite* Ca5(PO4)3OH + H
+ = 5Ca+2 + 3PO4
-3 + H2O -36.31 Baker et al., 1998 
Brushite CaHPO4:2H2O = Ca
+2 + PO4
-3 + 2H2O + H
+ -18.91 Baker et al., 1998 
Monetite CaHPO4 = Ca
+2 + PO4
-3 + H+ -19.24 Baker et al., 1998 
Octacalciumphosphate Ca8H2(PO4)6:5H2O = 8Ca
+2 +5H2O + 6PO4
-3 + 2H+ -93.95 Baker et al., 1998 
β-tricalciumphosphate Ca3(PO4)2 = 3Ca
+2 + 2PO4
-3 -28.94 Baker et al., 1998 
Variscite AlPO4:2H2O = Al
+3 + PO4
-3 + 2H2O -21 Stumm and Morgan, 1981 
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Table 4.2 Physical and chemical properties of the BOFS materials used in the experiments. 
 
 
Slag type:   BOFS 
Slag source:  Stelco Hamilton 
Physical properties 
Particle size (mm) Surface area (m
2g-1) 
4-2 6.05 
2-1 8.98 
1-0.5 11.5 
<0.5 13.9 
Particle size (mm) Mass weighted surface area (m2g-1) 
4-2 154 
2-1 196 
1-0.5 250 
<0.5 429 
Density (g cm-3): 3.49 
Chemical properties 
Chemical composition wt. % 
CaO 33.8 
Fe2O3 24.3 
SiO2 11.3 
MgO 9.62 
MnO 4.08 
Al2O3 7.43 
P2O5 - 
TiO2 0.38 
K2O 0.03 
Na2O 0.07 
Cr2O3 - 
Loss on ignition 8.96 
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Table 4.3 Mean concentrations and concentration ranges (expressed as average of maximum and minimum values) of pH, alkalinity, 
conductivity, and other target parameters including PO4, NH3-N, NO3-N, NO2-N, Cl, and SO4 in the effluents of Cells 1, 2, 3, and 4. 
 
 
  
Unit   
Effluents 
Cell 1  Cell 2 Cell 3 Cell 4 
pH  Average 7.61 7.81 7.94 11.4 
Range 7.89±1.06 8.42±1.20 7.65±0.94 10.88±1.47 
Alk mg L-1 as 
CaCO3 
Average 534 483 222 802 
Range 661±389 494±246 284±256 1225±1135 
Conductivity μS cm-1 Average 1636 1546 1333 4052 
Range 1669±665 1412±610 1268±449 4661±3500 
o-PO4 mg L
-1 Average 7.00 6.74 3.86 0.33 
  Range 12.9±9.32 8.40±6.21 5.12±3.29 1.03±1.03 
o-PO4_UW mg L-1 Average 5.22 5.15 3.46 0.05 
  Range 5.14±2.41 4.87±2.68 3.25±1.80 0.13±0.12 
PO4-P mg L
-1 Average 7.00 6.74 3.86 0.33 
  Range 12.9±9.32 8.40±6.21 5.12±3.29 1.03±1.03 
PO4-P dissolved 
comb. 
mg L
-1
 
 
Average 5.22 5.15 3.46 0.05 
Range 7.20±4.71 7.68±6.02 4.69±3.88 0.24±0.24 
TP mg L-1 Average 8.41 7.23 3.64 1.13 
Range 13.5±9.83 10.2±8.16 4.98±3.01 3.67±3.64 
NH3-N mg L
-1 Average 47.9 38.8 4.79 8.38 
Range 62.2±47.2 54.7±46.9 15.0±15.0 29.4±29.2 
NO3-N mg L
-1 Average 3.59 3.47 37.3 32.1 
Range 22.6±22.6 31.2±31.2 51.3±41.6 41.6±38.8 
NO2-N mg L
-1 Average 0.83 4.53 2.07 2.62 
Range 8.59±8.58 36.73±36.72 12.04±12.04 3.48±3.24 
Cl mg L-1 Average 169.2 169.7 161.1 151.9 
Range 152±104 144±99 141±84.3 144±76.0 
SO4 mg L
-1 Average 42.25 33.9 45.6 30.5 
Range 42.8±36.3 42.6±42.0 58.5±42.6 42.3±35.8 
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Table 4.4 Vibrational bands of carbonate and phosphate and the corresponding wavenumbers in 
the FTIR spectra of the surface materials. 
Carbonate  P1-S1 P2-S1 P 3-S1 P4-S1 P5-S1 P6-S1 P7-S1 P8-S1 P9-S1 
v4 712 712 712 712 712 712 712 713 712 
v2 873 874 873 873 873 872 873 874 873 
v3 1426 1426 1425 1423 1426 1422 1425 1425 1426 
v1+v4 1798 1797 1800 1799 1798 1799 1798 1798 1799 
v1+v3 or 2v2+v4 2514 2514 2515 2514 2515 2514 2514 2515 2515 
2v3 2874 2874 2875 2875 2874 2876 2875 2874 2875 
2v3 2980 2980 2980 2982 2981 2982 2978 2982 2980, 
2924 
Phosphate           
v3 1035 1037 1035 1037 1035 1037 1039 1034 1030 
v1  -        
v4 602, 
583, 
567 
632, 
608,  
574 
604, 
584, 
572 
604, 
576, 
568 
635, 
605, 
588, 
573 
604, 
578, 
569 
606, 
580, 
568 
605, 
597, 
587, 
579, 
569 
 
632, 
604, 
595, 
587, 
568 
v2 450 475, 
453 
451 450 451 450 461 454 459 
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Table 4.5 Linear combination fitting results of spent BOFS samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Linear combination fits to P2-S1 
Combination R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 2.36E-03 1.01 0.703 0.202 0.095 
-TCP, -TCP 2.45E-03 1.05 0.749 0.251 0 
-TCP, CPDD 2.76E-03 1.18 0.759 0 0.241 
-TCP, CPDD 7.96E-03 3.40 0 0.412 0.588 
Linear combination fits to P2-S2 
Combination R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 7.10E-03 2.71 0.571 0.407 0.021 
-TCP, -TCP 7.28E-03 2.78 0.568 0.432 0 
-TCP, CPDD 9.93E-03 3.79 0.956 0 0.044 
-TCP, CPDD 1.31E-02 4.99 0 0.984 0.016 
Linear combination fits to P8-S1 
Combination R-factor 2 -TCP 
(weight) 
-TCP 
(weight) 
CPDD 
(weight) 
-TCP, -TCP, CPDD 3.13E-03 1.34 0.726 0.156 0.118 
-TCP, -TCP 3.24E-03 1.38 0.778 0.222 0 
-TCP, CPDD 3.36E-03 1.43 0.765 0 0.235 
-TCP, CPDD 9.10E-03 3.88 0 0.365 0.635 
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Table 4.6 Mean concentrations and concentration ranges (expressed as average of maximum and minimum values) of DO, cBOD5, 
COD, total coliform, and E. coli in the effluents of Cells 1, 2, 3, and 4. 
 
 
 
 
 
 
  Unit   
Effluents 
Cell 1  Cell 2 Cell 3 Cell 4 
       
DO mg L-1 Average 1.49 2.21 9.05 4.57 
Range 3.61±3.48 2.41±2.23 8.59±3.91 5.74±3.54 
cBOD5 mg L
-1 Average 62.71 26.4 7.61 1.05 
Range 103±98.5 48.1±46.2 18.9±18.2 1.59±0.59 
COD mg L-1 Average 143 72.1 28.4 34.0 
Range 194±154 154±119 39.2±26.0 64.2±47.8 
Total coliform CFU 100 mL-1 Average 1.76 x106 9.04 x104 2.42 x103 2.61 x102 
Range 6.06x106±6.06x106 5.87x105±5.87x105 1.21x104±1.21x104 1.21x103±1.21x103 
E. coli CFU 100 mL-1 Average 3.31 x105 3.00 x104 1.26 x103 1.02 x102 
Range 1.24x106±1.24x106 2.42x105±2.42x105 1.21x104±1.21x104 1.21x103±1.21x103 
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Chapter 5 
Transport and Attenuation of Pharmaceutical 
Compounds and Acesulfame-K in a Demonstration-
scale Wastewater Treatment System 
 
5.1 Executive Summary  
The occurrence of pharmaceutically active compounds (PhACs), an artificial sweetener, and 
other wastewater constituents derived from a septic system, and subsequent removal in an 
engineered wetland with an integrated phosphate-removal system were investigated. Water 
samples from four locations in the treatment system and effluent from three subsequent treatment 
cells were collected and analyzed to evaluate rates of removal. The PhACs evaluated in this 
study covered a range of octanol-water partition coefficients and acid dissociation constants, and 
included carbamazepine, caffeine, sulfamethoxazole, ibuprofen, and naproxen. The study also 
evaluated the occurrence and treatment of acesulfame-K, a commonly used artificial sweetener. 
The concentrations of caffeine, carbamazepine, sulfamethoxazole, ibuprofen, naproxen and 
acesulfame in the septic system effluent were between 5.2 and 61 µg L
-1
, 0.15 and 9.3 µg L
-1
, 
0.003 and 0.1 µg L
-1
, 19-70 µg L
-1
, 2.3 and 13 µg L
-1
, and 35 and 94 µg L
-1
, respectively. Based 
on the removal efficiencies, the PhACs were classified into four different groups, including those 
that were a) efficiently removed with >75% removal (e.g. caffeine), b) moderately removed with 
50-75% removal (e.g. ibuprofen), c) poorly removed with 25-50% removal (e.g. 
sulfamethoxazole and naproxen), and d) very poorly removed or recalcitrant with <25% removal 
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(e.g. carbamazepine). Acesulfame-K was classified as category “d”. Removal efficiencies of P, 
ammonia and cBOD5 in the treatment system were 62 and >99%. The mean flow rate in the 
system was 0.89 m
3
 day
-1
 (0.02 to 4.27 m
3
 day
-1
) representing a hydraulic retention time of 5 
days. Variability in concentrations and treatment efficiencies were observed in different 
sampling events, which may be due to variations in input concentrations or changes in flow rate.  
5.2 Introduction 
Pharmaceutically active compounds (PhACs) consumed by humans and animals for therapeutic 
purposes, and excreted as metabolized or non-metabolized forms, may be released from sewage 
treatment plants (STPs), and other wastewater treatment systems, and subsequently introduced to 
the aquatic environment (Daughton and Ternes, 1999). A wide variety of PhACs and/or their 
metabolites have been detected in wastewater (Ternes, 1998; Heberer, 2002; Lishman et al., 
2006; Castiglioni et al., 2006; Carrara et al., 2008; Spongberg and Witter, 2008; Jelic et al., 
2011), surface water (Ternes, 1998; Halling-Sørensen et al., 1998; Daughton and Ternes, 1999; 
Kolpin et al., 2002; Tixier et al., 2003; Sanderson, 2011), groundwater (Sacher et al., 2001; 
Ternes et al., 2007; Carrara et al., 2008; Fram and Belitz 2011), and drinking water (Ternes et al., 
2002; Webb et al., 2003; Benotti et al., 2009; Bruce et al., 2010; Sanderson, 2011; Fram and 
Belitz 2011). The metabolized forms of some PhACs (derived from oxidation, reduction or 
hydrolysis reaction) often become more reactive and more toxic than the parent compounds 
(Halling-Sorensen et al., 1998). However, in the aquatic environment the metabolites may revert 
to the parent compounds or be modified further (Bendz et al., 2005). This chapter is focused on 
the occurrence, transport, and removal of PhACs including carbamazepine, sulfamethoxazole, 
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caffeine, ibuprofen, and naproxen as these are frequently observed in the environment.  An 
artificial sweetener acesulfame-K is also included in the analysis for the same reason.  
Caffeine, ibuprofen, and naproxen are typically removed in conventional wastewater treatment 
plants with high efficiencies (>99, 90, 69, and 66%); but carbamazepine (-25 to 96%) and 
sulfamethoxazole (-25%) are often highly persistent (Ternes, 1998; Heberer, 2002b; Metcalfe et 
al., 2003; Bendz et al., 2005; Dordio et al., 2010). There was no significant effect of hydraulic 
retention time on the removal efficiency of neutral drugs including carbamazepine in sewage 
treatment plants. Metcalfe et al. (2003) reported poor or negative removal of carbamazepine with 
increasing hydraulic retention time. The interpretation of concentration data for influent and 
effluent samples requires caution for these because of the potential for changes in influent 
concentrations within the hydraulic retention over a particular sampling event (Metcalfe et al., 
2003). Although changes in influent concentration may occur for any component, these changes 
may be particularly significant for the PhACs because of the very low concentrations of these 
compounds.  
Studies focused on removal of the selected PhACs in alternative wastewater treatment systems 
indicate variable results. For example, removal of PhACs in a series of mesocosm-scale 
constructed wetlands with different configurations was evaluated by Hijosa-Valsero et al. (2010). 
Results show that the concentrations of carbamazepine decreased by 24-36% in winter and 48% 
in summer, ibuprofen decreased by 51- 54% in winter and 85-96% in summer during flow 
through a floating-macrophyte surface-flow constructed wetland; concentrations of caffeine 
decreased by 58- 65% in winter and 99% in summer during flow through a horizontal subsurface 
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flow constructed wetland; and concentrations of naproxen decreased by 66% in winter and 83% 
in summer during flow through a planted horizontal subsurface flow constructed wetland.  
Although a very high percentage of removal of individual PhACs was observed for each 
constructed wetland evaluated, no single constructed wetland is able to remove all compounds.  
However,  a wastewater treatment plant with a  combination of a series of aerated lagoons, 
constructed wetlands, a UV disinfection unit, and a natural forested wetland removed 51% of 
carbamazepine, >90% of sulfamethoxazole and gemfibrozil,  and ≥99% of caffeine,  ibuprofen, 
and  naproxen from wastewater (Conkle et al., 2008). Additional studies (Matamoros and 
Bayona, 2006; Matamoros et al., 2007, 2008; Hijosa-Valsero et al., 2010; Zhang et al., 2011) 
reported that wetlands constructed for PhAC removal are more efficient than conventional 
wastewater treatment plants not designed for PhAC removal.  
Studies on the occurrence and fate of artificial sweeteners in the environment indicate relative 
persistence of these compounds in the environment.  Acesulfame-K is one of the artificial 
sweeteners commonly used in food, beverages, and other products. Acesulfame-K is detected in 
a wide variety of water samples including untreated and treated wastewater (12-46 μg/L; Buerge 
et al., 2009; Van Stempvoort et al., 2011a), surface waters (Buerge et al., 2009), groundwater 
(Buerge et al., 2009; Scheurer et al., 2009; Van Stempvoort et al., 2011a), septic system plumes 
(Van Stempvoort et al., 2011b) and tap water (up to 2.6 μg/L; Buerge et al., 2009). Remediation 
of artificial sweeteners including Acesulfame-K was observed after natural organic matter and 
hydroxyl radical scavengers are removed from the water (Toth et al., 2012).   Steel slag has been 
used in previous laboratory and field investigations to treat phosphorus-rich water (Baker et al., 
1998; Smyth et al., 2002a; Kim et al., 2006; Bowden et al., 2009). This material was not 
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evaluated previously for treating wastewater containing PhACs and artificial sweeteners. In 
particular the removal of PhACs and artificial sweetener using BOFS and ZVI has not been 
considered. 
In this study, the removal of selected PhACs (including carbamazepine, caffeine, 
sulfamethoxazole, ibuprofen, and naproxen) and acesulfame-K were evaluated in a 
demonstration-scale treatment system. The demonstration system consisted of four treatment 
cells. The first treatment cell is a horizontal subsurface flow cell filled with granitic gravel and 
vegetated with cattails, Typha spp (Figure 5.1). The second treatment cell is a down flowing, 
vertical surface flow force bed aerated cell filled with granitic gravel and vegetated with cattails, 
Typha spp. The third treatment cell is a down-flow vertical surface-flow cell filled with basic 
oxygen furnace slag (BOFS) and zero valent iron (ZVI). The fourth treatment cell is a pH 
adjustment cell equipped with a CO2 sparger. Wastewater was sampled at different stages along 
the treatment system over six sampling events to evaluate the treatment effectiveness under a 
range of operational conditions.   
5.3 Materials and Methods 
5.3.1 Chemicals/ chemical standards  
Carbamazepine, naproxen, sulfamethoxazole, ibuprofen and caffeine were obtained from Sigma 
Aldrich Canada Ltd., Oakville, Ontario, Canada.  Isotope-labelled internal standards (IS) were 
used to quantify each analyte. The type of IS and the properties of each analyte and IS(s) are 
provided in Table 5.1. Sulfamethoxazole d4 was obtained from Toronto Research Chemicals 
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(Toronto, ON, Canada) and all other IS(s) were obtained from CDN Isotopes (Quebec, Canada). 
Nanopure water (Milli-Q, Billerica, MA) was provided through the use of a 0.45 μm Millipore 
Q-Gard1 unit.  High performance liquid chromatography (HPLC) grade methanol (MeOH) 
(99.9%), ammonium acetate, formic acid, acetic acid and acetonitrile were obtained from 
Caledon Laboratories Ltd. (Georgetown, ON, Canada).   
5.3.2 Field methods 
5.3.2.1 System configuration 
Samples were collected from a multi-stage Engineered Wetland (EW)-Phosphate treatment 
system which was installed in Autumn 2009 at the Center for Alternative Wastewater Treatment, 
Fleming College, Lindsay, Ontario. A detailed description of these cells including dimensions of 
the cells, pore volume of each cell, and  physical and chemical characteristics of the reactive 
materials including basic oxygen furnace slag (BOFS) and zero valent iron (ZVI) are provided in 
Chapter 4. Briefly, the influent of the treatment system, wastewater, was received from a pre-
treatment septic tank (Cell 1). The treatment system consisted of four treatment stages including 
a vegetated horizontal subsurface flow engineered wetland (Cell 2), a vegetated vertical 
subsurface-flow aerated engineered wetland (Cell 3), a phosphate-treatment cell (Cell 4), and a 
pH-adjustment unit (Cell 5). The effluent from Cell 1 passed through Cells 2 through 5 in 
sequence prior to being released into the City of Kawartha Lakes sewer system (Figure 5.1).  
Flow was monitored continuously with an automatic flow meter with interruptions when the 
meter was clogged. Flow volume was calculated based on the periods when flow was 
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automatically monitored. During other times, flow rates were assumed to be consistent with the 
periods when monitoring data was available.  
5.3.2.2 Sampling Procedure 
Water samples were collected throughout the treatment system for analysis of PhaCs, 
acesulfame-K, and other water quality parameters. All samples were ﬁltered with 0.45 µm 
cellulose acetate ﬁlters prior to preservation  Samples for PhAC and acesulfame-K analyzes were 
collected in 500 ml amber glass bottles using a sampling pump with dedicated tubing and filters 
and acidiﬁed to pH < 2 with 18 N H2SO4. The samples for PhACs and acesulfame-K were 
collected from each cell effluent except Cell 5 (pH adjustment cell), because this unit was not 
regulated systematically during the sampling events.  Analyzes were performed within 3 days of 
sample collection. Duplicates of each sample were collected in the field and archived in a 
freezer.  Field blanks for PhACs consisted of MilliQ water collected using the same collection 
and preservation methods like other samples in the field to evaluate whether contamination 
occurred during the filtering process or transport. The trip blanks for PhACs were unfiltered 
MilliQ water (brought to the field) samples collected directly from a plastic container in the field 
without using a pump and preserved in the same manner as the other samples to determine 
whether any contamination occurred in from the bottles and during the transport. All samples 
were maintained at 4
0
C until analysis. The results for six sampling events (SE), conducted 
between Feb 2010 and Jan 2011, are reported here.  
The values of pH, Eh, and alkalinity were measured onsite immediately after the samples were 
collected following the same procedure as described in Chapter 3. Samples, field and trip blanks 
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were collected for analysis of cations, anions, PO4-P, and NH4-N following the same collection 
and preservation methods as describe in Chapter 3.  
The samples were collected during winter and pre-spring period. The average minimum and 
maximum air temperatures were -4.0 and 17.6
o 
C and the influent sample temperatures were 
between 4.3 and 14.2
o
C. There was a sampling event during the summer months as well. 
However, data obtained from this sampling event was not included in this discussion because of 
poor data quality. The samples were stored at 4
o 
C (instead of freezing) for more than six months 
before analysis, jeopardizing data quality.      
5.3.3 Analytical methods 
Samples were analyzed to determine dissolved concentrations of major cations, trace metals, and  
Cl, NO2, NO3, SO4, PO4, and NH3 using the methods described in Chapter 3.  The concentrations 
of the PhACs including carbamazepine, caffeine, sulfamethoxazole, ibuprofen, and naproxen, 
were determined using high performance liquid chromatography electrospray tandem mass 
spectrometry (HPLC-ESI-MS/MS).  The analytical procedure utilized was modified from 
procedures described by Vanderford et al. (2006) and Stafiej et al. (2007).  Unique isotopically 
labelled compounds were added to each sample prior to analysis for use as IS(s).  
Solid-phase extraction (SPE) was performed on samples (180 ml) spiked with a mixture of the 
six IS(s). Oasis HLB 5 mL glass cartridges were used for SPE and the pressure maintained below 
10psi for the vacuum to facilitate percolation of the samples through the cartridges. Prior to 
loading the samples, the cartridges were prepared by loading 5 ml HPLC grade MeOH (5%, v/v) 
and 5 ml MilliQ water. After loading the samples the cartridges were washed with 5 ml HPLC 
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grade MeOH (5%, v/v). Finally, 6 ml of MeOH (2 ml at a time) was loaded to the cartridges and 
extracts were collected in amber glass bottles and preserved at 4°C until analysis. The samples 
were spiked to achieve a final concentration of 1 μg L-1 of each IS after the extraction process. 
Internal standards were employed to account for potential loss of analyte during the SPE steps 
and to account for matrix effects during analysis (Gros et al., 2007).   
The nebulizer gas at the ionization source and the collision gas used to fragment the parent ion 
was N2.  A multiple reaction monitoring scan (MRM) was utilized for quantification, using a 
ratio between the analyte peaks to that of the corresponding internal standard.  
Analyzes of caffeine, carbamazepine and sulfamethoxazole were conducted in positive ESI 
mode.  A Symmetry RP18 column (Waters Corporation, Mississauga, ON, Canada) with a length 
of 50 mm, an internal diameter of 4.6 mm, and a particle size of 3 μm was used for separation.  
The rate of solvent flow through the column was 1.25 mL min
-1
, with an injection volume of 15 
μL. Mobile phase “A” consisted of 5 mM ammonium acetate and 0.1 % formic acid in nanopure 
water.  Mobile phase “B” was 100 % MeOH with 0.1 % formic acid.  The gradient started at 15 
% for mobile phase “B”, and after 0.76 min increased to 100 %, then at 2.5 min decreased back 
to 15 % until 4 min was reached.   
Naproxen, gemfibrozil, ibuprofen, and acesulfame were analyzed in negative ESI mode.  An 
XDB-C18 column (Agilent Technologies, Mississauga, ON, Canada) with a length of 150 mm, 
an internal diameter of 4.6 mm and a particle size of 5 μm was used.  The flow rate through the 
column was 1 mL min
-1, with a total injection volume of 10 μL.  Mobile phase “A”, at pH 4, was 
30 % acetonitrile diluted with nanopure water with 6.9 mM acetic acid.  Mobile phase “B” was 
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100 % acetonitrile.  The gradient started at 0 % of mobile phase “B”, at 18 min increased to 3 %, 
at 22 min to 12%, 40 min to 40 %, and ended at 45 min at 0 %.  
5.3.3.1 Quality Control and Quality Assurance 
In addition to the use of internal standards, additional calibration blanks (CB) and calibration 
verification (CV) samples were analyzed on a continuous basis to ensure that cross 
contamination between injections was minimal and to assess recovery of the analytes. The CCB 
samples were MeOH/H2O, 50/50 v/v.  The CCV solutions were prepared from an independent 
stock solution than the calibration standards. A CCV sample (MeOH/H2O, 50/50 v/v spiked with 
IS and analytes) was analyzed directly after each CCB to ensure ongoing acceptable calibration 
performance during analysis of each batch of samples. This calibration pair (CCB and CCV) was 
analyzed after initial calibration, after every ten samples, and at the end of the analysis. The CCV 
values were within ±15% of expected values (Table 5.2).  
Standards prepared in water, including aqueous blanks which consisted of MilliQ water spiked 
with IS were analyzed for each batch of SPE. Quality control samples (QCS) were prepared from 
MilliQ water spiked with analytes of different concentrations and the mixture of ISs. An aqueous 
blank and a QCS were processed through the SPE with each set of 10 samples. The aqueous 
blanksamples were used to check any cross contamination and the recovery of the IS. The QCSs 
were used to check whether there was any loss of IS or analytes during storage, SPE, and 
analysis.  
The calibration range was 0.1-40 μg L-1 with 9 calibrators and calibration curve was linear (R2 
> 0.9999).  The LOD and LOQ for caffeine, carbamazepine, and sulfamethoxazol were 10 ng L
-1
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and 20-100 ng L
-1
. The LOD and LOQ for ibuprofen, and naproxen were 5-200 ng L
-1
 and 10-
500 ng L
-1
, after correcting for dilution prior to reporting the concentration of the respective 
compounds. Recoveries of the internal standards in the CCV samples, QC samples, and samples 
from the treatment system were between 90 and 125% (Table 5.2). Recoveries of the IS in the 
QC samples for the selected PhACs were between 72 and 127% (Table 5.2). Recoveries of IS for 
caffeine and carbamazepine, with few exceptions, were between 82 and 121% in all of the 
samples collected during the sampling events except the fourth (between 52 and 68%). For 
sulfamethoxazole, IS recoveries were, with few exceptions, between 92 and 121% in SE 1, 2, 
and 3. However, recoveries for sulfamethoxazole were between 15 and 58% in SE 4, between 
121 and 160% in SE 5, and between 55 and 75% in SE 6 (Table 5.3).  Recoveries of IS  for 
ibuprofen were between 75 and 86% in SE 1, 2, and 5, between 58 and 72 in SE 3 and 4, and 
between 32 and 45% in SE 4 (Table 5.3). Recoveries of IS for naproxen were between 86 and 
96% in SE 1, between 62 and 74% in SE 5 and 6 and between 6 and 35% in SE 2, 3, and 4 
(Table 5.3). The reported concentrations were corrected for the observed recoveries of IS for 
each event.  
5.4 Results and Discussion  
The physical and chemical characteristics of BOFS and ZVI used in this system are provided in 
Chapter 4. The flow rate was dependent on the availability of septic tank effluent, which was 
proportional to the on campus student population in different times of the year. The observed 
flow rate was highly variable (σ=625) during the study period. The mean flow rate was 
calculated to be 0.89 m
3
 day
-1
 during the study period. Hydraulic retention time (HRT) is one of 
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the major factors for the removal efficiency of PhACs (Conkle et al., 2008). The average HRT in 
Cells 2, 3, and 4 were 7.6, 7.6, and 6.0 days.  
5.4.1 Characteristics of wastewater  
The chemical composition of the effluent of the treatment cells reflected the pH conditions in 
each of the cells (Table 5.4). The pH in Cells 1, 2, and 3 was slightly alkaline (8.17±0.79 in cell 
1, 8.66±0.96 in cell 2, and 7.76±0.35 in cell 3). In Cell 4, the pH increased substantially up to 
10.87±1.46 and a corresponding elevated total alkalinity was observed at the onset of the 
experiment (maximum 1620 mg L
-1
 as CaCO3; Figure 5.2). The total alkalinity in Cell 4 effluent 
decreased with time as the cell was flushed with the near neutral effluent from Cell 3, likely due 
to leaching of free lime (CaO) and portlandite (Ca(OH)2) from the outer layer of the BOFS 
during the course of the study. The high pH effluent from Cell 4 was neutralized in Cell 5 
(indoor pH adjustment tanks; Figure 5.3). The highest mean Eh was observed in Cell 3 effluent 
and the lowest mean Eh was observed in Cell 1 effluent (Figure 5.2).  Low mean dissolved 
oxygen (DO) concentrations were observed in the effluents of Cell 1 (1.61 mg L
-1
) and Cell 2 
(2.26 mg L
-1
), indicating relatively anoxic conditions in these cells. High average DO 
concentrations, up to 8.93 mg L
-1
, were observed in Cell 3 effluent. However, the DO 
concentrations decreased significantly (mean concentration, 4.70 mg L
-1
) in Cell 4 effluent. 
Mean concentrations of NH3-N were 50, 53, 21, and 19 mg L
-1 
in effluent collected from Cells 1, 
2, 3, and 4, indicating a decrease along the flow path (Figure 5.2). In contrast, concentrations of 
NO3-N were 9, 2, 49, and 43 mg L
-1
,
 
showing an increase along the flow path. The calculated 
ratios of NH3-N/ NO3-N decreased from 5.56 to 0.44, showing the influence of oxidation 
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reactions. The presence of the fresh ZVI layer added to Cell 4 may have initially led to the 
reduction of NO3 to NH3. Reduction of NO3 to NH3 by ZVI is reported in previous studies 
(Rahman and Agrawal, 1997). Thus, the changes in Eh values were directly proportional to the 
changes in DO and NO3-N concentrations and inversely proportional to the changes in NH3-N 
concentration along the flow path. 
5.4.2 Carbonaceous biochemical oxygen demand (cBOD5) 
High concentrations of cBOD5 were observed in Cell 1 effluent (mean, 99.12 mg L
-1
). Mean 
cBOD5 concentrations in Cells 2, 3, and, 4 were 49.5, 16.1, and 0.83 mg L
-1
.  The cBOD5 
removal efficiencies in Cells 2, 3, and 4 were 50, 34, and 15%. Thus the overall cBOD5 removal 
efficiency in the treatment system was >99%. The removal of cBOD5 in Cell 2 can be explained 
by the influence of plants, which introduced atmospheric O2 in the system through the roots. The 
residual amount of cBOD5 in the wastewater after treatment in Cell 3 was removed in Cell 4, 
which suggests that highly alkaline conditions in Cell 4 can successfully lead to degradation of 
the remaining labile organic compounds. Both cBOD5 and NH3 removal efficiencies in Cell 3 
were considerably higher (33.7% and 63.9%; Figure 5.2) than in other cells.  The high oxidation-
reduction potential measurements in the Cell 3 effluent resulted from the aeration of the cell. The 
cBOD5 removal efficiency in Cell 3 indicates that the aerobic degradation was the dominant 
mechanisms removing organic matter. These results are consistent with previous studies (Brix 
and Arias, 2005; Matamoros et al., 2007). A sharp increase in NO3 and a decrease in NH3 in Cell 
3 suggest that higher NO3 concentrations were derived from the oxidation of NH3 (Figure 5.2).   
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5.4.3 Pharmaceutical compounds (PhACs) 
The results of the analyses of effluent samples collected along the treatment system indicate a 
general decrease in concentrations of the majority of the PhACs analyzed (Figure 5.4, 5.5; Table 
5.4), with the notable exception of carbamazepine which showed little change along the 
treatment system. The influent concentrations fluctuated, likely in response to changes in the 
student population in the college. For example, the presence of relatively high concentrations of  
pharmaceutical compounds including ibuprofen, naproxen and carbamazepine in the Cell 2 
effluent compared to the Cell 1 effluent (system influent) in some of the sampling events 
suggests carryover from earlier loading events.  The presence of trace concentrations of all of the 
PhACs in the last cell for most sampling events indicates some degree of persistence even for the 
more reactive compounds.  
Mean initial concentrations of ibuprofen, naproxen, caffeine, carbamazepine, sulfamethoxazole, 
and acesulfame-K were 47, 8.8, 23, 3.6, 0.06, and 66 µg L
-1 
(Figure 5.5, Table 5.4). The removal 
efficiencies of these PhACs and artificial sweetener are shown in Table 5.4.  
The P-values from the t-tests (two-sample assuming unequal varience) for the pooled sample 
sets (concentrations of each chemical in 6 sampling events) were obtained from EXCEL. The p-
values from the t-tests for the compounds (concentrations of caffeine between Cells 1 and 4, 
Cells 2 and 4; ibuprofen between Cells 1 and 3, Cells 1 and 4, Cells 2 and 3, and Cells 2 and 4; 
naproxen between Cells 2 and 4) were less than 0.05. Thus the null hypothesis would be rejected 
and there were statistically significant differences observed (Table 5.5). In contrast, the p-values 
from the t-tests for the the rest of the compounds (caffeine, ibuprofen, and naproxen with other 
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cell combinations and carbamazepine, sulfamethoxazole, and acesulfame-K with all cell 
combinations) were greater than 0.05. Thus the null hypothesis would not be rejected, indicating 
no significant differences were observed. However, for selected sampling dates (e.g. Feb, 09, 
2010: caffeine, carbamazepine, ibuprofen and acesulfame-K; Apr 06, 2010: caffeine, ibuprofen, 
acesulfame-K; Apr 13, 2010: ibuprofen, naproxen, and acesulfame-K; Dec 10, 2010: ibuprofen, 
and naproxen; and Jan 28, 2011: ibuprofen and acesulfame-K) obvious decreases in 
concentrations were observed, suggesting removals on these dates.       
5.4.3.1 Analgesic anti-inflammatory drugs 
Ibuprofen is a non-steroidal anti-inflammatory drug. Ibuprofen is considered as one of the most 
biodegradable PhACs (Dordio et al., 2010). There were no significant changes in concentrations 
observed in Cell 2 effluent and the mean concentration increased slightly to 48.0 µg L
-1
 relative 
to the system influent. The concentration increase in Cell 2 can be explained by the carryover 
from the previous loads and the variation of input concentrations. A sharp decrease in 
concentrations with a mean concentration of 23.7 µg L
-1
 was observed in Cell 3 effluent. An 
additional decrease in concentrations with a mean concentration of 19.0 µg L
-1
 was observed in 
Cell 4 effluent. The concentration profile showed decreasing trend along the flow path from Cell 
2 effluent. The removal efficiency for ibuprofen in Cell 3 (52%) was consistent with other 
studies (Matamoros and Bayona, 2006; Hijosa-Valsero et al., 2010). For example, Matamoros 
and Bayona (2006) observed similar to slightly greater removal of ibuprofen under more 
oxidizing conditions in a shallow bed subsurface flow constructed wetland (50-80% removal 
efficiency). In this study, all samples were collected in winter and early spring. The removal 
 183 
efficiencies for ibuprofen observed in this study (range: 38-75%, mean: 60%) were slightly 
higher than the removal efficiencies observed by Hijosa-Valsero et al. (2010) (range: 27-74%) 
and by Castiglioni et al. (2006) (range: 25-72%, mean: 38%) in winter months. However, about 
82% removal of ibuprofen in winter is reported by Dordio et al. (2010). The aeration process 
increased the amount of oxygen in Cell 3, which favoured the aerobic biodegradation of 
ibuprofen. A positive linear correlation between redox potential and the removal efficiency for 
ibuprofen was observed in this study, which is consistent with observations by Hijosa-Valsero et 
al. (2010).  
Naproxen is also a non-steroidal anti-inflammatory drug. The concentration profile of 
naproxen was similar to that of ibuprofen along the flow path. The concentrations of naproxen 
increased in Cell 2 effluent relative to the system influent, with a mean concentration of 11.04 µg 
L
-1
 then gradually decreased in Cells 3 and 4 effluents with mean concentrations of 7.82 and 5.44 
µg L
-1
.   In this treatment system, naproxen showed much lower removal efficiency (39%) than 
ibuprofen (60%). However, this removal rate was consistent with values reported by Matamoros 
and Bayona (2006) and Hijosa-Valsero et al. (2010).  
5.4.3.2 Stimulant 
Caffeine is a stimulant drug ingested in food, beverages and medicinal products. A decreasing 
trend was observed along the flow path, where the mean concentrations in Cells 2, 3, and 4 
effluents were 18.85, 6.64, and 4.14 µg L
-1
. The sharp drop in concentrations in Cell 3 effluent 
compared to Cell 2 effluent was similar to the change observed for ibuprofen.  
 184 
The total removal efficiency for caffeine was 82%, which was the highest removal observed 
for the drugs investigated in this study. The removal efficiencies for caffeine observed in this 
study (sampled in winter and early spring time) were higher than removal efficiencies reported 
for winter months in a previous study (Hijosa-Valsero et al., 2010), and approached the higher 
rates reported for summer months.  Hijosa-Valsero et al. (2010) showed removal efficiency in 
summer (average temperature 19.9 
0
C) was approximately three times greater than the rates 
observed in winter (average temperature 7 
0
C).  
5.4.3.3 Anti-epileptic drug 
Carbamazepine is an anticonvulsant and antidepressant drug. Mean concentrations of 
carbamazepine in the effluent from Cells 2, 3, and 4 were 4.07, 3.77, and 3.89 µg L
-1
. An 
increase in concentrations was observed in the Cell 2 effluent compared to the Cell 2 influent. A 
small decrease in concentrations was observed in the Cell 3 effluent with respect to the Cell 2 
effluent.  In the first two cells, carbamazepine concentrations showed a trend that was similar to 
the trends observed for caffeine, ibuprofen, and naproxen. However, this drug did not show 
similar decreasing trend in Cell 4 effluent. Although the mean removal efficiency for 
carbamazepine was about 8% in Cell 3 with respect to Cell 2 effluent, the overall mean removal 
efficiency for this compound in the treatment system was negative 9% (Figure 5.6). This was the 
most recalcitrant pharmaceutical compound analyzed in this study. The recalcitrant nature of 
carbamazepine is widely reported in the available literature (Matamoros et al., 2007; Conkle et 
al., 2008; Matamoros et al., 2008, Zhang et al., 2011). However, about 96% removal in summer 
and 88% removal in winter are reported by Dordio et al. (2010).    
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5.4.3.4 Sulfonamide 
Sulfamethoxazole is an antibiotic drug. A decrease in concentrations of 32% was observed in 
Cell 2 effluent (0.003-0.08 µg L
-1
). This removal may be explained by oxidation reactions in this 
aerated cell. However, the actual cause of this attenuation was unclear. The mean concentrations 
remain the same in Cells 3 and 4 effluent. Neither Cell 3 (6% removal) nor Cell 4 (4% removal) 
provided significant removal of sulfamethoxazole. Sulfamethoxazole has been reported to be 
relatively recalcitrant, closely resembling carbamazepine, in terms of biodegradation (Benotti 
and Brownawell, 2009; Suarez et al., 2010). Removal efficiencies for sulfamethoxazole were 
24% in a conventional sewage treatment plant (Ternes et al., 2007). Higher removals have been 
observed in other studies (as high as 78%) especially in systems with long hydraulic retention 
times of 30 days (Conkle et al., 2008). In this study, removal efficiencies of sulfamethoxazole 
were about 32% in Cell 2 at a mean HRT of 7.6 days, about 5.6% in Cell 3 at a mean HRT of 7.6 
days, and about 4.4% in Cell 4 at a mean HRT of 6.0 days. 
The removal efficiencies of sulfamethoxazole in Cells 3 and 4 were similar to the extent of 
removal (38%) reported in a laboratory experiment at a low biomass concentration (Alexy et al., 
2004). However, Al-Ahmad et al. (1999) reported no biodegradation of sulfamethoxazole in a 
closed bottle test and also noted that only a small group of bacteria present in the inoculum are 
affected by sulfamethoxazole. High biomass conditions usually favor biodegradation of 
sulfamethoxazole (Batt et al., 2007). Thus, >30% removal efficiency for sulfamethoxazole in 
Cell 2 (32%) is attributed to the higher biomass in this cell because it was well vegetated and 
existed long before the other cells were reconstructed.  
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Among the treatment cells, the removal of caffeine, carbamazepine, and naproxen was greater 
in Cell 3 compared to other cells, likely due to the oxidizing conditions in this cell, which 
favoured aerobic degradation. Based on the removal efficiency observed during this study, the 
selected PhACs can be classified in to four different groups a) efficiently removed with >75% 
removal (e.g. caffeine), b) moderately removed with 50-75% removal (e.g. ibuprofen), c) poorly 
removed with 25-50% removal (e.g. sulfamethoxazole and naproxen), and d) very poorly 
removed or recalcitrant with <25% removal (carbamazepine).  
5.4.4 Artificial sweetener  
Acesulfame-K is a commonly used artificial sweetener. The concentrations of this sweetener 
were gradually decreased along the flow path, where the mean concentrations of Cells 2, 3, and 4 
were 58.5, 54.2, and 48.7 µg L
-1
. The removal efficiencies of acesulfame-K in Cells 2, 3, and 4 
were 12.0, 6.4 and 8.4%. Thus the treatment system removed ~27% acesulfame-K from 
wastewater. The presence of hydroxyl radicals (due to dissociation of CaO and Ca(OH)2) and 
low natural organic matter (very low cBOD5 concentrations) in Cell 4 was expected to favor 
Acesulfame-K removal (Toth et al., 2012). However, the removal was not very extensive. The 
mechanism of Acesulfame-K removal in Cell 2 was not clear.  
5.4.5 Removal mechanisms 
5.4.5.1 Acid dissociation constant (pKa) and ionic forms 
Although the target PhACs have similar molecular weights, the octanol-water partitioning 
coefficients and hydrophobicity of these compounds are different. The compounds analyzed in 
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this study covered a range of octanol-water partition coefficients and acid dissociation constants. 
Ibuprofen, naproxen, and sulfamethoxazole are expected to dissociate predominantly into their 
anionic forms in the treatment system, as the pH values of each treatment cell effluent including 
the septic tank effluent (system influent) were greater than the pKa values of these compounds 
(Table 5.1, Figure 5.7). The pH values in the first 3 cells (Cells 1, 2, and 3) were less than the 
pKa value of caffeine, whereas the pH in Cell 4 was greater than the pKa value of caffeine 
(Figure 5.7). These conditions indicated that this compound was predominantly in a neutral form 
in the first 3 cells and in its anionic form in the 4
th
 cell.  The pH values of each cell effluent were 
substantially less than the pKa value of carbamazepine, thus, the compound was predominantly 
in its neutral form in all of the cells (Figure 5.7).  Adsorption of negatively charged compounds 
onto aquifer materials (including calcium carbonate and calcium phosphate) is generally not 
expected under high pH conditions. However, due to the presence of metal oxides with a high pH 
of zero point charge (pHzpc) including 33% CaO (pHzpc=8.1; Hanawa et al., 1998), 24% Fe2O3 
(pHzpc=6.9; Parks, 1965), 8-9% MgO (pHzpc=12.4; Parks, 1965), and 4-6% Al2O3 (pHzpc=9.1; 
Parks, 1965) in BOFS media, adsorption of the negatively charged compounds in Cell 4 may still 
be possible. Moreover, upon continuous flushing with wastewater, labile CaO and Ca(OH)2 
would be removed from the outer layer of the BOFS, and would lead to a decrease in generation 
of alkalinity. Adsorption and/or precipitation of other inorganic compounds may coat the outer 
layer of the BOFS grains and restrict the CaO and Ca(OH)2  from dissolving to create alkaline 
condition. Precipitation of calcite (CaCO3, pHzpc= 9.5; Parks, 1965), and hydroxyapatite 
(Ca5OH(PO4)3, pHzpc=7.6; Davis and Kent, 1990) on the outer layer of BOFS, was indicated by 
FTIR spectra, may also favor adsorption of negatively charged compounds.  Based on the 
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decreasing trend of pH it can be predicted that over time with continuous flushing the pH of Cell 
4 is expected to decrease potentially leading to improved removal of PhACs.  
5.4.5.2 Hydrophobicity 
Compounds can be classified on the basis of log Kow values as hydrophillic (log Kow<1; 
Verliefde et al., 2008; Ney, 1990), intermediate or transphilic (1>log Kow<3; Verliefde et al., 
2008), and hydrophobic (log Kow >3; Verliefde et al., 2008).  Amiard-Triquet et al. (2011) 
further classified the hydrophobic compounds as moderately hydrophobic (3<log Kow <7) and 
very hydrophobic (log Kow >7).  Due to acid-base transformation of the insoluble organic 
compounds, pH-dependent octanol-water distribution coefficients (log Dow values) can be 
calculated and are usually distinctly different than the intrinsic hydrophobicity when partial or 
complete dissociation takes place (log Kow, Nghiem and Hawkes, 2009). The log Dow expresses 
the relationship between Kow, pH and pKa and can be calculated using the following equation 
(Stuer-Lauridsen et al., 2000).  
(5.1)                                              
   
          
 
The log Dow values vary substantially from the log Kow for acidic drugs that dissociate under the 
pH conditions at the site.  This difference has important implications on the fate and transport of 
the PhACs. It is anticipated that caffeine, sulfamethoxazole, and naproxen would display a 
hydrophilic nature in the treatment cells (with pH between 7.38 and 12.32) based on the log Dow 
values (<1) (Figure 5.8). Carbamazepine showed intermediate hydrophobicity and did not show 
any significant change (log Dow from 2.45 to 2.44) under the range of pH values observed in the 
treatment system (Figure 5.8). Ibuprofen showed very low to low hydrophobicity (log Dow>1) 
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below pH 7.82 (Figure 5.8). However, carbamazepine was transported through the system, 
despite its low to moderate hydrophobicity.  
5.4.5.3 Aeration 
Aeration, which creates oxidizing conditions, is an important factor affecting the attenuation of 
several PhACs. Removal of caffeine, acetaminophen, and naproxen often exceeds 99% from the 
influent concentrations (Conkle et al., 2008). Aeration also facilitates volatilization, a function of 
Henry’s coefficient (KH) and the air flow contacting the wastewater, which is one of the removal 
mechanisms of pharmaceutical compounds in STPs (Carballa et al., 2007). The compounds 
studied are not expected to be volatile, nor was the aeration agressive.  Therefore, attenuation of 
these compounds, particularly in Cell 3, is attributed to the presence of oxidizing conditions.  
Moreover, based on the decreasing trend of pH it can be predicted that over time with continuous 
flushing the pH of Cell 4 is expected to decrease potentially leading to improved removal of 
PhACs.        
5.4.5.4 Reduction through ZVI  
Constructed wetland treatment systems designed for the removal of pharmaceutical compounds 
commonly use gravel and/ or sand as a substrate (Matamoros and Bayona, 2006; Matamoros et 
al., 2007; Hijosa-Valsero et al., 2010; Zhang et al., 2011). ZVI has been used as reactive media 
for the removal of metals from groundwater (Blowes et al., 2000; Morrison et al., 2002) and 
occasionally for the removal of antibiotics from aqueous solution (Ghauch et al., 2009) and for 
the degradation of the pharmaceutical diazepam (Bautitz et al., 2012).   In Cell 4, a reactive zone 
containing ZVI was placed at the bottom of Cell 4 and the DO concentration in the effluent of 
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Cell 4 was much lower than Cell 3 effluent. Zero valent iron promotes the reduction of water 
through the reaction 
(5.2)               
         
  
ZVI is oxidized to      in the presence of     (predominant electron receptor), leading to an 
increase in pH and a decrease in redox potential (Zhang, 2003; Reardon, 2005; Wei et al., 2010).  
Although an increase in the pH does not favor adsorption of the pharmaceutical compounds on 
the surfaces of the substrates, reducing conditions created due to the presence of ZVI may have 
contributed to additional treatment in Cell 4.   
5.4.5.5  Other potential removal mechanisms  
In addition to the above removal mechanisms, there is potential for removal of pharmaceuticals 
compounds through degradation reactions. Hydrolytic degradation is one of the most common 
degradation pathways for organic contaminants in the environment. The hydrolysis of organic 
compounds involves substitution of an atom or group of atoms by water or hydroxide ions. 
Hydrolysis reactions, however, are not expected to be an important degradation process in the 
environment for caffeine, carbamazepine, and naproxen due to the lack of hydrolysable 
functional groups in these chemicals (Lyman et al., 1990). Ibuprofen is not expected to undergo 
hydrolysis as carboxylic acid functional groups are generally resistant to hydrolysis (Lyman et 
al., 1990). Under field conditions, hydrolysis also is not a likely degradation process for 
sulfamethoxazole (Lam et al., 2004) or acesulfame-K (Buerge et al. 2009). While there is 
potential for additional removal mechanisms, this study did not focus on delineation of those 
mechanisms.    
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5.5 Conclusions 
The overall treatment efficiencies observed in the multi-cell system evaluated in this study were 
similar to those observed in large scale wastewater treatment systems and comparable to 
mesocosm-scale constructed wetlands. The removal of the PhACs was strongly correlated to the 
measured pH and Eh values. The highly alkaline condition of Cell 4 likely promoted dissociation 
of some compounds, enhancing the mobility (i.e. sulfamethoxazole and ibuprofen). Aeration is 
an important factor affecting the attenuation of caffeine, carbamazepine, ibuprofen, and 
naproxen. Incorporation of BOFS and ZVI may have provided this additional removal. Although 
the system was operated during the winter and early spring, the treatment performance observed 
for caffine and ibuprofen were higher than that observed in similar wastewater treatment systems 
during winter periods.     
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Figure 5.1 Schematic diagram of the outdoor cells of the EW-BOFS pilot-scale treatment system. 
Cell 2 represents a horizontal subsurface flow constructed wetland, Cell 3 represents a vertical 
subsurface flow aerated engineered wetland, and Cell 4 contains a mixture of BOFS and ZVI. 
Wastewater was continuously flushed through the system by a combination of gravity feed and 
pumping (from Chapter 4). In this diagram HSSF EW represents horizontal subsurface flow 
engineered wetland, VSSF aerated EW represents vertical subsurface flow aerated engineered 
wetland, BOFS represents basic oxygen furnace slag, and CLK represents City of lake Kawartha.   
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Figure 5.2  Box plots of pH, alkalinity, Eh,  cBOD5, DO, Cl, NH3-N, NO3-N, NH3-N/NO3-N, Fe, 
Mn, and SO4 versus distance (Cells 1-4) along the treatment flow path. Horizontal solid lines and 
broken lines on the boxes represent median and mean concentrations.   
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Figure 5.3 pH versus distance (Cells 1-5) along the treatment flow path. 
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Figure 5.4 Selected pharmaceutical compounds, caffeine (CAF), carbamazepine (CBZ), 
sulfamethoxazole (SMX), ibuprofen (IBU), naproxen (NAP), and an artificial sweetener, 
acesulfame-K (ACE), along the treatment flow path. 
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Figure 5.5 Box plots of selected pharmaceutical compounds, caffeine (CAF), 
carbamazepine (CBZ), sulfamethoxazole (SMX), ibuprofen (IBU), naproxen (NAP), 
and an artificial sweetener, acesulfame-K (ACE), along the treatment flow path. 
Horizontal solid lines and broken lines on the boxes represent median and mean 
concentrations. 
 
  
 197 
 
 
 
 
Figure 5.6 Selected pharmaceutical compounds, caffeine (CAF), carbamazepine (CBZ), 
sulfamethoxazole (SMX), ibuprofen (IBU), naproxen (NAP), and an artificial sweetener, 
acesulfame-K (ACE), along the treatment flow path. a) Contribution of each cell to the total 
removal efficiency, b) total removal efficiency. 
 
 
a b 
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Figure 5.7 pKa of each pharmaceutical of interest plotted on the pH scale with dotted lines and 
the pH range of the treatment cells (Cells 1-4) shown with vertical bars. 
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Figure 5.8 Calculated values of log Dow versus pH in the influent (Cell 1 effluent) and three 
other treatment cells (Cells 2, 3, and 4).     
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Table 5.1 Chemical properties and structures of pharmaceutically active compounds (Trenholm 
et al., 2006) and artificial sweetener, along with their molecular weights. Molecular weights of 
the internal standards are also provided. 
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Table 5.2 Quality control samples and preparation blanks, continuing calibration verification and 
continuing calibration blanks. 
  ACE CBZ CAF SMX IBU GEM NAP 
LOD (ng L-1) Limit of detection  
       
 50 0.1 3 3 10 3 30 
LOQ (ng L-1) Limit of quantification 70 9 30 10 80 10 250 
         Internal Standard Recovery %   ACE CBZ CAF SMX IBU GEM NAP 
Samples 
 
33 119 101 104 113 119 81 
Trip Blank 
 
59 97 104 84 88 90 80 
Field Blank 
 
50 96 73 108 95 78 93 
Preparation Blank (PRB) 
 
12 90 98 102 122 113 74 
Quality control samples (QCS) 
 
20 95 98 98 118 94 72 
Continuing calibration verification (CCV)    20 113 97 116 120 125 90 
         Analyte Recovery %   ACE CBZ CAF SMX IBU GEM NAP 
Quality control samples (QCS) 
 
105 106 127 118 105 105 72 
Continuing calibration verification (CCV)  
 
85 97 102 103 98 91 87 
Continuing calibration blank (CCB) 
 
<LOD <LOD <LOD <LOD <LOD <LOD <LOD 
Recovery sample different dilutions % 115 117 110 200 127 111 105 
         
Standards Range (ng L-1)   
1000-
100000 
20-
2000 
50-
2000 
50-
2000 
100-
40000 
10-
40000 
50-
40000 
Correlation coefficient %   0.9998 0.9999 0.9993 0.9998 0.9997 0.9993 0.9991 
 
Quality control samples and preparation blank samples were prepared with every set of samples. Continuing calibration 
verification and continuing calibration blank samples were analyzed every 5 or 10 samples.  SPE factor (30) and the dilution 
factor (10) were considered on the calculation of LOD and LOQ. 
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Table 5.3  Internal standard recoveries of laboratory blanks, trip blanks, field blanks, 
continuous calibration blnk (CCB), and continuous calibration verification (CCV) of each 
analysis during the study period. 
 
Sampling event  1(SE 1): 19-Feb-10 
Standard 
Recovery 
Lab Blank Trip Blank Field Blank CCB  CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Com-
ments 
Conc. 
(µg/L) 
Accuracy 
(%) 
  
CAF 
  
0.125 117 <0 128 0.027 90 
3.1 
<LOD 
2 101 
1.8 20 102 
5.3 0.02 92 
  
CBZ 
  
0.063 110 0.0096 97 0.011 96 
- 
<LOD 
2 N/A 
- 20 100 
- 0.02 90 
  
SMX 
  
0.007 N/A No Peak N/A 
No 
Peak 
N/A 
No 
Peak 
<LOD 
2 105 
0.88 20 101 
0.60 0.02 87 
  
IBU 
  
<0 84 0.004 88 0.021 95 
- 
<LOD 
0.05 N/A 
- 0.5 101 
- 10 102 
NAP 0.023 45 0.83 86 0.041 99 
- 
<LOD 
0.05 188 
- 0.5 95 
- 10 87 
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Table 5.3 continued 
SE 2: 6-Apr-10 
Standard 
Recovery 
Preparation 
Blank 
Trip Blank Field Blank CCB  CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Com-
ments 
Conc. 
(µg/L) 
Accuracy 
(%) 
  
<0 106 <0 120 <0 105 
17 
- 
- - 
CAF 101 10 113 
  12 1 107 
  
0.06 105 0.036 109 0.048 122 
- 
-  
- - 
CBZ - 10 77 
  - 1 102 
  
0.022 131 No Peak 123 
No 
Peak 
144 
- 
-  
- - 
SMX 4.0 10 82 
  - 1 79 
  
No 
Peak 
28 No Peak 45 
No 
Peak 
54 
- 
-  
- - 
IBU - 5 96 
  - 10 112 
  
0.607 8 No Peak 29 0.26 16 
- 
-  
- - 
NAP - 5 94 
  - 10 71 
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Table 5.3 continued 
SE 3: 13-Apr-10 
Standard 
Recovery 
Lab Blank Trip Blank Field Blank CCB  CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Comm
ents 
Conc. 
(µg/L) 
Accuracy 
(%) 
  
CAF 
  
<0 106 <0 133 <0 95 
17 
-  
- - 
101 10 113 
12 1 107 
  
CBZ 
  
0.0597 105 No Peak 118 0.009 95 
- 
-  
- - 
- 10 77 
- 1 102 
  
SMX 
  
0.0217 131 No Peak 169 
No 
Peak 
107 
-  
-  
- - 
 - - - 
-  - - 
  
IBU 
  
No 
Peak 
28 No Peak 47 
No 
Peak 
26 
 - 
-  
 - - 
 - - - 
-  - - 
  
NAP 
  
0.607 8 No Peak 16 
No 
Peak 
8 
-  
-  
-  - 
-   -  - 
-   -  - 
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Table 5.3 continued 
SE 4: 30-Apr-10 
Standard 
Recovery 
Lab Blank Trip Blank Field Blank CCB  CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Comm
ents 
Conc. 
(µg/L) 
Accuracy 
(%) 
  
CAF 
  
- - - - - - 
74 
-  
- - 
No 
Peak 
2 83 
80 10 99 
  
CBZ 
  
- - - - - - 
- 
 - 
- - 
2.5 2 96 
- 0.2 95 
  
SMX 
  
- - - - - - 
1.3 
 - 
- - 
5.2 2 99 
2.1 0.1 99 
  
IBU 
  
No 
Peak 
40 - - - - 
- 
 - 
- - 
- 5 108 
- 10 107 
  
NAP 
  
No 
peak 
7 - - - - 
- 
- 
- - 
- 5 99 
- 10 89 
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Table 5.3 continued 
SE 5: 10-Dec-10 
Standard 
Recovery 
Lab Blank Trip Blank Field Blank CCB (b conc. 
in µg/L) 
CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Comm
ents 
Conc. 
(µg/L) 
Accuracy 
(%) 
CAF -  -  -  -  <10 85 
- 
-  
- - 
- 0.5 114 
- 2 109 
CBZ  -  -  -  - <10 128 
- 
 - 
- - 
- 0.5 84 
- 2 107 
SMX  -  -  -  - <10 147 
- 
 - 
- - 
- 0.5 106 
- 2 103 
IBU 
No 
Peak 
66 - - - - 
- 
 - 
- - 
- 0.5 207 
- 1 211 
NAP - - - - - - 
- 
- 
- - 
- - - 
- - - 
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Table 5.3 continued 
SE 6: 28-Jan-11 
Standard 
Recovery 
Lab Blank Trip Blank Field Blank CCB (b conc. 
in µg/L) 
CCV 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
Conc. 
(µg/L) 
IS 
Rec. 
(%) 
b 
Conc. 
(µg/L) 
Comm
ents 
Conc. 
(µg/L) 
Accuracy 
(%) 
CAF -  -  -  -  <10 84 
-  
-  
-  -  
-  -  -  
-  -  -  
CBZ  -  -  -  - <10 117 
-  
 - 
-  -  
-  -  -  
-  -  -  
SMX  -  -  -  - <10 114 
-  
 - 
-  -  
-  -  -  
-  -  -  
IBU 
No 
Peak 
70  -  -  -  - 
-  
 - 
-  -  
-  -  -  
-  -  -  
NAP - - - - - - 
-  
- 
-  -  
-  -  -  
-  -  -  
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Table 5.4 Values of pH, Eh, alkalinity and the concentration range of the pharmaceuticals and acesulfame-K 
in the influent and the treatment cells. 
 Unit Cell 1 
effluent 
(System 
influent) 
Cell 2 
(HSSF-EW 
cell) 
effluent 
Cell 3 
(VSSF-AEW 
cell) 
effluent 
Cell 4 
(BOFS cell) 
effluent 
Removal efficiency 
contributed by 
each cell with 
respect to mean 
initial 
concentration (%) 
Overall 
Removal 
efficiency 
Cell 
2 
Cell 
3 
Cell 
4 
 
pH  7.38-8.96 7.70-9.65 7.41-8.11 12.32-
10.40 
    
Eh mV -69 to 112 -4 to 152 250 to 520 30 to 180     
Alkalinity mg L
-1
 as 
CaCO3 
425-729 340-740 175-540 200-1620     
Caffeine 
µ
g 
L-
1
 
range 5.2-61 9.6-53 1.5-11 0.32-10     
 mean 23 19 6.6 4.1 17 54 11 82 
Carbamazepine range 0.15-9.3 0.17-8.4 0.16-8.1 0.12-6.8     
 mean 3.6 4.1 3.8 3.9 -14 8.4 -3.3 -8.9 
Sulfamethoxazole 
range 
0.003-0.1 0.003-0.08 0.003-0.09 0.003-0.07     
 mean 0.06 0.04 0.4 0.04 32 5.6 4.4 42 
Ibuprofen 
range 
19-70 23-69 6.2-43 4.6-37     
 mean 47 48 24 19 -1.9 52 9.8 60 
Naproxen range 2.3-13 4.0-13 1.2-16 0.29-9.7     
 mean 8.8 11 7.8 5.4 -25 37 27 39 
Acesulfame-K 
range 
35-94 39-79 42-69 34-66     
 mean 66 59 54 49 12 6.4 8.4 27 
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Table 5.5 P-values obtained from t-Test, two-sample assuming unequal variances, for Cells 1-2, 
2-3, 3-4, 1-3, 1-4, and 2-4 for the selected chemicals 
 
P(T<=t) two-
tail Cell 1-2 Cell 1-3 Cell 1-4 Cell 2-3 Cell 2-4 Cell 3-4 
CAF 0.73 0.11 0.08 0.13 0.09 0.29 
CBZ 0.93 0.82 0.86 0.88 0.92 0.95 
SMX 0.46 0.40 0.32 0.87 0.75 0.89 
IBU 0.59 0.05 0.03 0.03 0.01 0.50 
NAP 0.45 0.75 0.19 0.33 0.05 0.40 
ACE 0.47 0.25 0.12 0.56 0.25 0.45 
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Chapter 6 
Conclusions 
6.1 Summary of Findings 
Removal of phosphorus (P) from hypolimnetic water and from wastewater is dependent on the 
pore water chemistry and the composition of the reactive media. Basic Oxygen Furnace Slag 
(BOFS) based treatment materials removed 83 to >99 % of the initial P from the influent surface 
water and wastewater. In addition to BOFS cells, the upstream aerated cells in the constructed 
wetland systems contributed to removal of P from wastewater.  
Geochemical modelling (using PHREEQCI) calculations based on the representative water 
chemistry data from the treatment systems (described in Chapters 2, 3, and 4) indicated 
supersaturation of the pore water with respect to hydroxyapatite, β-tricalciumphosphate, brucite, 
calcite, and aragonite. The presence of calcium phosphate mineral(s) on the outer layers of the 
spent reactive media was confirmed through multiple analytical techniques including FE-SEM-
EDX, XPS, FTIR, and XANES analysis, which was consistent with the geochemical modelling 
results.  FE-SEM-EDX techniques were used to estimate the elemental composition of the fresh 
BOFS and the precipitates collected from the outer layer of the spent media. The solid-phase P 
contents (in wt. %) were proportional to the aqueous P concentrations in the influent water for 
the treatment systems described in Chapters 2 and 3.  X-ray photoelectron spectroscopic analysis 
showed limited indications of the formation of CaP minerals on the spent media (described in 
Chapters 2 and 3) possibly due to the low penetration depth of this technique and interference of 
calcium carbonate. Fourier transform infrared (FTIR) spectroscopy was used to identify 
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phosphate and carbonate functional groups on the outer layer samples of the spent media. FTIR 
spectra reported for phosphate and carbonate minerals in previous studies and those obtained 
from the standard materials analyzed in this study were used to infer the mineralogical 
composition of the precipitates.  The presence of calcite in the samples was confirmed by FTIR 
spectroscopy (Chapters 2, 3, and 4). Although some samples showed well defined phosphate 
peaks (Chapter 3), it was not possible to confirm the presence of any specific CaP mineral. Very 
weak peaks of phosphate in the FTIR spectra for samples collected from the hypolimnetic 
treatment system (Chapter 2) reflect the low P concentration of the influent lake water.   
Accumulation of P at the interfaces between spent BOFS grains was confirmed through 
elemental maps of polished cut-sections which indicated an abundance of P at the edges of the 
grains and low concentrations of P in the inner parts of the grains. ATR-FTIR spectra indicated 
the occurrence of P-bearing minerals at corresponding locations. However, samples with low P 
contents did not show distinct differences between the outer layers of the spent BOFS grains and 
the interior of the grains. X-ray absorption near edge structure (XANES) spectra indicated the 
occurrence of CaP minerals on the outer layers of the spent reactive media. Linear combination 
fitting allowed a comparison of spectra from the treatment system samples with the CaP and FeP 
standards, and calculation of the proportions of the contributing phosphate species. The predicted 
CaP minerals included hydroxyapatite, -TCP, CPD, CPDD, and -TCP depending on the 
locations and concentrations of solid phase P of the samples. 
In addition to phosphate removal, the removal of other wastewater components was observed 
in the constructed wetland systems. Aeration processes in the force bed aerated cells enhanced 
the oxidation of ammonia and sharp decreases in NH4-N concentrations were observed. 
Although a significant positive mass change of total nitrogen (N mass loss, ~72%) was observed 
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in the indoor treatment system as discussed in chapter 3, a very low positive mass change (only 
2%) was observed in the outdoor treatment system as described in chapter 4. Extensive decreases 
in (>99% removal) in concentrations of pathogens (E.coli and total coliform) were observed in 
the aerated cells of the constructed wetland sytsems. High pH conditions generated in BOFS-
containing P-treatment cells (Cell 4 in Chapter 3 and Cell 4 in Chapter 4) provided further 
disinfection.   
Concerns associated with the use of BOFS include the release of high pH effluent and 
dissolved Al and V following contact with the BOFS media. Effluent pH values varied between 
8.08 and 12.35 depending upon the source and age of the slag. The elevated pH (often >12) was 
adjusted to near neutral conditions through sparging with CO2. Neutral pH conditions favoured a 
decrease in the concentration of Al (leached from BOFSs) due to its amphoteric nature.  A ZVI 
layer at the end of the BOFS layer removed excess V leached from BOFS effluent.  
The PhACs, including caffeine, ibuprofen, naproxen, carbamazepine, sulfamethoxazole, and 
an artificial sweetener acesulfame-K were detected in the influents of the demonstration-scale 
wastewater treatment system. An aerated cell (Cell 3 in Chapter 5) was more effective at 
removing caffeine, carbamazepine, ibuprofen, and naproxen than the other treatment cells. 
However, concentrations of caffeine, sulfamethoxazole, and acesulfame-K were observed to 
increase in Cell 2 (in Chapter 5); whereas concentrations of caffeine, sulfamethoxazole, 
ibuprofen and naproxen desreased in the BOFS cell (Cell 4).  
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6.2 Scientific Contributions  
This thesis presented research related to surface water and wastewater treatment and provided 
information regarding geochemical changes in aqueous- and solid-phases during the treatment 
processes. The principal scientific contributions from this thesis include:  
•  Demonstrating that BOFS is very effective for removing P from surface water and wastewater 
in pilot-scale systems.  
•  Demonstrating that the performance of BOFS can be enhanced by restricting atmospheric CO2 
into the reaction columns and cells.  
•  Identifying reaction products on the outer layers of the spent reactive media (described in 
Chapters 2, 3, and 4) through the application of surface analytical techniques including FE-
SEM-EDX, XPS, FTIR, ATR-FTIR, and synchrotron radiation based XANES methods. 
•  Evaluating the application of ZVI for the removal of V (leached from the BOFS) from the 
BOFS column and cell effluents.   
•  Demonstrating that pH adjustment can be effectively performed by sparging CO2 (g) and that 
this neutralization process also removed Al from BOFS column abd cell effluents.  
•  Demonstrating that attenuation of certain PhACs (caffeine, ibuprofen, naproxen, 
sulfamethoxazole) and an artificial sweetener (acesulfame-K) was achieved through a 
combination of an anaerobic EW cell, an aerated EW cell and a BOFS based cell. The 
persistence of carbamazepine also was observed in these treatment cells.  
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6.3 Recommendations and Future Work 
The BOFS treatment columns and cells were effective in removing P from lake water and 
wastewater. However, there are some important factors that should be considered in future 
research, which include potential clogging and subsequent decrease in hydraulic performance in 
long-term applications. Tight sealing of the BOFS columns/cells restricted the entry of 
atmospheric CO2. Thus, no significant decrease in hydraulic performance was noted after sealing 
the BOFS columns/ cells. However, low to moderate cementation observed in the BOFS 
columns and cells when these were uncovered to collect spent BOFS for solid-phase analyzes. 
Despite tight sealing, this cementation may have been taken place when dissolved CO2 from the 
previous cells or the ingress of atmospheric CO2(g) through leakage interacted with Ca-rich pore 
water and/or with the BOFS grains containing lime and portlandite. Although the degree of 
cementation in the BOFS columns and cells was not critical for the limited flow volumes during 
the study periods, continuous cementation and subsequent clogging may decrease the hydraulic 
performance in long-term treatment. This cementation was observed at the inlet part of the BOFS 
columns and cells in this study. Introducing sacrificial and removable BOFS blocks at the inlet of 
the system would allow replacement of lower permeability BOFS and ensure the long-term use 
of this material. Incorporation of a sacrificial chamber of BOFS before the main BOFS 
column/cell is recommended for future research.  
Although BOFS materials are inexpensive, transportation of these materials may be costly. In 
addition, reuse of the BOFS material would reduce the dumping cost of the spent media. Future 
research should be directed at evaluating the potential benefits of crushing the spent BOFS 
materials to smaller sizes, which would increase the surface area and provide fresh reactive 
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surfaces. The total cost of the BOFS-based treatment system would decrease significantly if the 
reuse of BOFS can be demonstrated through field-scale experiments.  
The addition of ZVI layers used in this study after the BOFS columns/cells was effective in 
removing V and PhACs (to some extent). Although 5 wt. % ZVI, used in this study led to 
removal of V for a limited time only, future research should focus on the benefits of increasing 
the thickness of the ZVI layer and the percentage of ZVI to between 10 and 20%. 
The basic oxygen furnace oxide (BOFO) may also be considered in future experiments as 
BOFO is locally available in some areas where BOFS is not available. Application of BOFO 
from local sources would also offer lower transport costs. This material potentially could be used 
with gravel and also with 10-20% BOFS to enhance the efficiency of P removal and ensure 
adequate hydraulic performance.           
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Table A 1: pH values along the treatment flow path in year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 26-Aug 02-Sep 16-Sep 23-Sep 29-Sep 06-Oct 11-Nov 
C1-Inf 0 7.20 7.36 7.85 7.31 7.35 7.31 7.24 7.33 7.65 
C1-P1 36 7.63 7.56 - - - - - - - 
C1-P2 68 8.00 7.83 - 7.41 7.53 7.71 7.89 8.95 8.31 
C1-P3 99 8.20 8.11 - 7.67 7.94 7.82 8.04 8.90 8.20 
C1-P4 130 8.34 8.39 - 7.79 7.83 7.98 8.23 8.81 8.27 
C2-Inf 151 8.39 8.42 7.80 7.72 8.16 8.12 8.30 8.54 8.06 
C2-P1 238 8.55 8.53 8.14 8.13 8.10 8.46 8.56 8.84 8.60 
C2-P2 299 8.74 8.57 8.19 8.01 8.48 8.42 8.61 8.51 8.61 
C3-Inf 320 8.90 8.53 8.14 8.34 8.15 8.47 8.51 8.51 8.39 
C3-P1 406 9.01 8.50 8.00 8.16 8.42 8.48 8.54 8.59 8.46 
C3-P2 468 9.12 8.50 8.09 8.26 8.11 8.53 8.59 8.67 8.56 
C3-Eff 509 - - - - - - - - - 
Final Eff 610 9.64 8.74 7.72 8.31 8.38 8.43 8.44 8.15 8.38 
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Table A 2: pH values along the treatment flow path in year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 26-Jul 03-Aug 10-Aug 17-Aug 25-Aug 02-Sep 09-Sep 30-Sep 10-Oct 17-Oct 27-Oct 
C1-Inf 0 7.38 7.34 7.34 7.37 7.32 7.18 7.19 7.26 7.25 7.20 7.22 7.58 
C1-P1 36 7.59 7.58 7.62 7.51 7.38 7.40 7.38 7.48 8.77 7.29 7.32 7.78 
C1-P2 68 8.41 8.50 8.58 8.53 8.14 7.60 7.73 8.02 9.09 7.63 7.83 8.61 
C1-P3 99 9.26 9.00 8.96 8.94 8.55 8.45 8.44 8.58 9.45 7.91 8.35 8.98 
C1-P4 130 10.10 9.85 9.83 9.30 8.71 8.75 8.71 8.80 9.57 8.27 8.79 9.22 
C2-Inf 151 10.83 10.75 10.83 10.80 9.31 9.12 8.91 8.86 - - - - 
C2-P1 238 11.41 11.58 11.34 11.45 10.48 9.82 9.51 9.36 9.95 8.62 8.95 9.34 
C2-P2 299 11.56 11.59 11.50 11.62 11.22 11.27 10.78 10.37 11.20 9.40 9.36 9.83 
C3-Inf 320 11.41 11.47 11.41 11.41 10.97 11.07 10.86 10.58 - - - - 
C3-P1 406 11.50 11.53 11.44 11.51 11.17 11.18 11.04 10.82 - - - - 
C3-P2 468 11.53 11.62 11.48 11.63 11.37 11.40 11.31 11.20 11.20 9.40 9.36 9.83 
C3-Eff 509 8.44 8.79 10.01 10.41 8.36 8.36 8.54 9.31 6.13 8.99 8.89 8.95 
Final Eff 610 8.07 8.58 9.17 9.64 8.51 8.54 8.68 9.22 8.44 9.09 9.06 9.03 
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Table A 3: pH values along the treatment flow path in year 3 (2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 09-Aug 15-Aug 22-Aug 28-Aug 13-Sep 21-Sep 26-Sep 01-Oct 06-Oct 11-Oct 17-Oct 22-Oct 
C1-Inf 0 7.33 7.69 7.36 9.11 10.94 7.25 7.30 7.28 7.15 7.23 7.28 7.22 7.34 
C1-P1 36 8.70 7.70 7.51 11.76 11.96 7.31 - 7.42 7.55 7.57 7.61 7.52 7.76 
C1-P2 68 8.75 8.22 7.78 12.03 12.07 7.41 7.34 7.56 7.57 7.81 7.77 7.68 8.05 
C1-P3 99 9.55 8.92 8.88 11.83 11.96 7.74 - 7.92 8.07 8.24 8.47 8.32 8.49 
C1-P4 130 11.72 11.59 11.33 11.80 11.88 9.68 11.00 9.84 9.97 10.04 10.35 10.23 10.02 
C2-Inf 151 11.64 11.64 11.55 12.46 12.40 10.60 10.96 10.55 9.67 9.60 9.60 9.58 9.40 
C2-P1 238 12.13 11.85 11.78 12.32 12.34 11.57 - 11.48 11.38 11.32 11.32 11.24 11.09 
C2-P2 299 12.19 11.92 11.89 12.29 - 11.68 11.60 11.57 11.52 11.52 11.65 11.66 11.51 
C3-Inf 320 12.10 12.07 12.02 12.45 12.41 11.82 11.67 11.76 11.69 11.64 11.82 11.78 11.56 
C3-P1 406 12.16 12.12 12.10 12.42 - 11.93 - 11.81 11.77 11.71 11.87 11.88 11.71 
C3-P2 468 12.11 12.11 12.13 12.19 - 12.00 11.84 11.80 11.84 11.79 11.98 11.96 11.79 
C3-Eff 509 12.15 12.17 12.15 - - 12.02 11.78 11.80 11.85 11.80 11.96 11.98 11.80 
Final Eff 610 8.78 12.17 11.58 6.18 - 6.67 - 7.82 7.70 7.38 7.18 7.02 6.99 
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Table A 4: Alkalinity (mg L
-1
 CaCO3) concentrations along the treatment flow path in year 1(2005) of the hypolimnetic  
withdrawal P treatment experiment.  
Sample ID Distance 
(cm) 
20-Jul 18-Aug 26-Aug 02-Sep 16-Sep 23-Sep 29-Sep 06-Oct 11-Nov 
C1-Inf 0 118 140 150 280 240 172 130 156 140 
C1-P1 36 157 158 - - - - - - - 
C1-P2 68 162 151 - 200 220 142 164 154 160 
C1-P3 99 158 152 - 140 240 180 166 138 180 
C1-P4 130 170 166 - 220 260 136 176 158 160 
C2-Inf 151 146 174 - 200 220 174 190 170 180 
C2-P1 238 156 178 246 200 220 180 196 174 180 
C2-P2 299 154 178 170 160 200 216 198 184 180 
C3-Inf 320 98 180 208 180 200 188 166 180 220 
C3-P1 406 94 182 170 180 240 234 181 156 240 
C3-P2 468 78 152 362 180 200 144 172 136 220 
C3-Eff 509 - - - - - - - - - 
Final Eff 610 70 108 - 170 230 150 162 128 240 
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Table A 5: Alkalinity (mg L
-1
 CaCO3) concentrations along the treatment flow path in year 2 (2006) of the hypolimnetic withdrawal P treatment 
experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 20-Jul 03-Aug 10-Aug 17-Aug 25-Aug 02-Sep 09-Sep 30-Sep 10-Oct 17-Oct 27-Oct 
C1-Inf 0 142 154 126 124 136 142 262 150 178 154 170 126 
C1-P1 36 154 146 138 146 148 154 162 160 129 164 164 102 
C1-P2 68 156 170 166 150 154 153 157 178 128 166 150 104 
C1-P3 99 110 116 120 132 177 156 174 160 133 168 184 110 
C1-P4 130 74 76 78 92 162 166 186 166 125 180 194 104 
C2-Inf 151 92 94 112 82 118 128 140 144 171 110 - - 
C2-P1 238 176 218 170 172 112 86 96 116 78 178 184 92 
C2-P2 299 240 218 262 196 144 134 118 118 87 132 138 82 
C3-Inf 320 190 178 216 152 107 96 91 94 51 98 - - 
C3-P1 406 194 192 237 166 122 88 86 79 84 70 - - 
C3-P2 468 258 252 254 212 150 128 122 108 134 144 - - 
C3-Eff 509 - - - - - - - - - - - - 
Final Eff 610 116 106 84 108 134 122 132 94 122 110 120 78 
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Table A 6: Alkalinity (mg L
-1
 CaCO3) concentrations along the treatment flow path in year 3 (2007) of the hypolimnetic withdrawal P  
treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 09-Aug 15-Aug 13-Sep 21-Sep 26-Sep 01-Oct 06-Oct 11-Oct 17-Oct 22-Oct 
C1-Inf 0 160 200 280 360 200 200 160 180 210 250 170 
C1-P1 36 156 200 180 280 - 230 230 220 160 200 190 
C1-P2 68 140 200 200 190 230 240 190 180 160 170 160 
C1-P3 99 134 180 180 200  220 220 200 260 220 180 
C1-P4 130 376 340 280 190 180 330 170 160 170 140 130 
C2-Inf 151 348 420 280 190 180 240 220 130 170 170 150 
C2-P1 238 1100 500 420 220 - 280 220 170 155 130 130 
C2-P2 299 1210 580 440 290 240 320 320 190 230 190 210 
C3-Inf 320 1030 800 520 340 280 330 210 220 220 200 200 
C3-P1 406 1150 900 760 420 - 420 280 250 200 230 220 
C3-P2 468 1050 920 680 518 370 360 440 280 300 250 230 
C3-Eff 509 1150 1000 780 620 130 440 370 330 330 260 250 
Final Eff 610 96 1020 420 360 - 330 270 200 220 260 250 
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Table A 7: Concentrations of PO4-P (mg L
-1
) along the treatment flow path in year 1 (2005) of the hypolimnetic  
withdrawal P treatment experiment. 
Sample ID Distance 
(cm) 
20-Jul 18-Aug 26-Aug 02-Sep 16-Sep 23-Sep 29-Sep 06-Oct 11-Nov 
C1-Inf 0 0.36 0.29 0.31 0.30 0.32 0.35 0.36 0.51 0.55 
C1-P1 36 0.46 0.29 - - - - - - - 
C1-P2 68 0.49 0.25 - 0.30 0.33 0.34 0.35 0.26 0.55 
C1-P3 99 0.27 0.22 - 0.30 0.32 0.33 0.34 0.26 0.54 
C1-P4 130 0.20 0.17 - 0.23 0.25 0.30 0.32 0.25 0.53 
C2-Inf 151 0.21 0.19 - 0.24 0.26 0.29 0.31 0.27 0.33 
C2-P1 238 0.14 0.13 0.15 0.18 0.22 0.24 0.27 0.21 0.41 
C2-P2 299 0.17 0.077 0.12 0.17 0.19 0.24 0.24 0.17 0.33 
C3-Inf 320 0.040 0.038 0.035 0.13 0.15 0.18 0.18 0.24 0.20 
C3-P1 406 0.046 0.023 0.085 0.074 0.11 0.14 0.16 0.13 0.13 
C3-P2 468 0.035 0.020 0.020 0.039 0.085 0.11 0.12 0.075 0.080 
C3-Eff 509 0.039 - - - - - - - - 
Final Eff 610 <DL <DL <DL <DL 0.038 0.060 0.058 0.059 0.040 
DL: 0.02 mg L-1 
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Table A 8: Concentrations of PO4-P (mg L
-1
) along the treatment flow path in year 2 (2006) of the hypolimnetic withdrawal P treatment 
experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 26-Jul 03-Aug 10-Aug 17-Aug 25-Aug 02-Sep 09-Sep 30-Sep 10-Oct 17-Oct 27-Oct 
C1-Inf 0 0.31 0.30 0.26 0.28 0.30 0.32 0.36 0.37 0.49 0.49 0.35 0.02 
C1-P1 36 0.30 0.29 0.26 0.29 0.31 0.33 0.37 0.39 0.49 0.49 0.28 0.03 
C1-P2 68 0.25 0.22 0.21 0.25 0.29 0.32 0.36 0.38 0.48 0.47 0.37 0.14 
C1-P3 99 0.11 0.077 0.087 0.15 0.25 0.28 0.32 0.34 0.32 0.45 0.47 0.20 
C1-P4 130 0.046 0.035 0.032 0.048 0.20 0.23 0.27 0.29 0.25 0.44 0.44 0.24 
C2-Inf 151 0.033 <DL <DL <DL 0.083 0.11 0.12 0.14 - - - - 
C2-P1 238 0.021 <DL <DL <DL 0.034 0.046 0.052 0.061 0.063 0.33 0.30 0.21 
C2-P2 299 <DL <DL <DL <DL <DL 0.023 0.023 0.024 <DL 0.12 0.15 0.11 
C3-Inf 320 <DL <DL <DL <DL <DL 0.021 <DL 0.020 - - - - 
C3-P1 406 <DL <DL <DL <DL <DL <DL <DL <DL - - - - 
C3-P2 468 <DL <DL <DL <DL <DL <DL <DL <DL <DL 0.12 0.15 - 
C3-Eff 509 0.025 <DL <DL <DL <DL <DL <DL <DL <DL <DL 0.064 0.060 
Final Eff 610 <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL 0.064 0.063 
DL: 0.02 mg L-1            
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Table A 9: Concentrations of PO4-P (mg L
-1
) along the treatment flow path in year 3 (2007) of the hypolimnetic withdrawal P treatment 
experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 09-Aug 15-Aug 13-Sep 21-Sep 26-Sep 01-Oct 06-Oct 11-Oct 17-Oct 22-Oct 
C1-Inf 0 0.33 0.32 0.36 0.33 0.34 0.32 0.32 0.37 0.31 0.36 0.36 
C1-P1 36 0.30 0.29 0.35 0.32 - 0.30 0.31 0.35 0.28 0.32 0.32 
C1-P2 68 0.23 0.25 0.28 0.30 0.31 0.30 0.30 0.32 0.28 0.31 0.31 
C1-P3 99 0.11 0.18 0.22 0.29 - 0.28 0.29 0.31 0.28 0.30 0.31 
C1-P4 130 <DL <DL <DL 0.12 0.087 0.12 0.15 0.11 0.085 0.084 0.10 
C2-Inf 151 <DL <DL <DL 0.084 0.025 0.060 0.098 0.16 0.14 0.20 0.17 
C2-P1 238 <DL <DL <DL <DL - <DL <DL <DL <DL <DL <DL 
C2-P2 299 <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL 
C3-Inf 320 <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL 
C3-P1 406 <DL <DL <DL <DL - <DL <DL <DL <DL <DL <DL 
C3-P2 468 <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL 
C3-Eff 509 <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL <DL 
Final Eff 610 <DL <DL <DL <DL - <DL <DL <DL <DL <DL <DL 
DL: 0.02 mg L-1 
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Table A 10: Concentrations of Ca (mg L-1) along the treatment flow path in  
year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 54.6 53.5 54.2 55.6 58.1 
C1-P1 36 59.1 58.3 - - - 
C1-P2 68 59.9 60.0 58.9 59.3 50.4 
C1-P3 99 53.0 63.7 60.4 61.2 - 
C1-P4 130 58.8 61.8 61.3 61.2 54.2 
C2-Inf 171 58.0 61.1 63.1 61.6 60.2 
C2-P1 238 55.2 60.1 61.1 66.6 53.9 
C2-P2 299 52.6 55.8 61.1 65.2 56.2 
C3-Inf 340 32.1 47.5 62.4 63.0 54.3 
C3-P1 406 24.3 44.3 59.7 60.7 50.6 
C3-P2 468 22.7 39.0 56.0 57.9 47.0 
C3-Eff 509 20.7 - - - - 
Final Eff 610 20.2 26.6 47.6 54.2 42.6 
DL: 0.21 mg L-1 
 
 
    
Table A 11: Concentrations of Ca (mg L-1) along the treatment flow path in  
year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 71.4 50.3 49.0 48.9 54.3 
C1-P1 36 67.0 52.0 53.6 50.4 40.4 
C1-P2 68 60.9 55.7 52.2 53.2 42.4 
C1-P3 99 65.8 38.9 51.9 55.7 38.9 
C1-P4 130 62.2 27.1 53.2 54.9 34.9 
C2-Inf 171 56.0 40.5 34.1 41.1 44.0 
C2-P1 238 85.0 71.0 30.8 27.4 21.4 
C2-P2 299 60.4 102.7 55.6 41.8 27.2 
C3-Inf 340 83.2 79.4 46.0 27.6 8.2 
C3-P1 406 97.1 50.7 52.1 27.1 29.4 
C3-P2 468 - - - 44.3 45.1 
C3-Eff 509 - - - 43.2 52.9 
Final Eff 610 64.4 30.3 61.3 39.5 40.7 
DL: 0.21 mg L-1      
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Table A 12: Concentrations of Ca (mg L-1) along the treatment flow path in  
year 3 (2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 51.7 49.9 52 51.4 55.4 
C1-P1 36 53.9 55.0 52.4 53.1 57.0 
C1-P2 68 51.1 56.1 52.6 53.4 58.0 
C1-P3 99 43.3 50.1 54.6 55.9 60.2 
C1-P4 130 155 104 48.5 47.5 45.6 
C2-Inf 151 136 102 49.9 46.4 47.0 
C2-P1 238 427 152 70.4 53.7 42.3 
C2-P2 299 489 174 89.7 71.6 65.7 
C3-Inf 320 410 246 113 83.8 68.4 
C3-P1 406 472 294 131 96.8 83.0 
C3-P2 468 426 297 147 108 92.7 
C3-Eff 509 476 318 158 113 94.7 
Final Eff 610 30.1 162 117 84.2 98.8 
DL: 0.21 mg L-1      
 
 
 
Table A 13: Concentrations of Na (mg L-1) along the treatment flow path in  
year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 51.0 48.6 48.9 49.9 48.0 
C1-P1 36 52.5 50.1 - - - 
C1-P2 68 53.1 49.8 49.3 48.4 48.0 
C1-P3 99 45.1 51.5 49.6 48.9 54.8 
C1-P4 130 51.8 50.3 49.7 48.3 48.2 
C2-Inf 171 50.4 49.8 50.6 48.3 51.5 
C2-P1 238 50.7 50.3 49.0 51.2 48.6 
C2-P2 299 52.8 49.2 48.5 50.4 49.6 
C3-Inf 340 51.5 48.9 50.6 49.6 48.4 
C3-P1 406 50.6 49.2 49.8 48.4 48.4 
C3-P2 468 51.4 50.2 49.3 48.0 49.8 
C3-Eff 509 51.2 - - - - 
Final Eff 610 50.0 49.9 49.9 48.7 48.1 
DL: 0.62 mg L-1      
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Table A 14: Concentrations of Na (mg L-1) along the treatment flow path in  
year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 58.8 43.9 42.6 41.7 41.3 
C1-P1 36 55.8 44.1 44.8 41.1 36.7 
C1-P2 68 48.3 45.2 42.2 41.7 37.4 
C1-P3 99 56.8 42.9 41.5 42.6 37.7 
C1-P4 130 63.4 42.2 44.2 42.4 37.2 
C2-Inf 171 57.1 45.2 44.3 41.4 38.7 
C2-P1 238 47.3 43.9 41.8 41.0 38.2 
C2-P2 299 48.0 46.2 41.2 41.4 36.5 
C3-Inf 340 45.3 41.7 42.0 42.0 38.2 
C3-P1 406 49.8 43.2 43.9 41.0 39.4 
C3-P2 468 - - - 41.6 37.2 
C3-Eff 509 - - - 40.3 37.7 
Final Eff 610 57.8 43.3 41.4 39.8 37.9 
DL: 0.21 mg L-1      
 
 
Table A 15: Concentrations of Na (mg L-1) along the treatment flow path in  
year 3 (2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample ID Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 76.5 41.5 59.5 38.6 39.4 
C1-P1 36 76.2 43.4 58.8 38.6 39.4 
C1-P2 68 76.3 42.9 58.5 38.4 40.5 
C1-P3 99 75.9 42.0 58.9 38.3 40.6 
C1-P4 130 78.1 44.2 59.4 39.0 39.5 
C2-Inf 151 76.9 42.8 59.9 38.9 39.1 
C2-P1 238 80.1 44.3 60.5 38.7 40.2 
C2-P2 299 80.6 42.2 61.1 39.3 40.7 
C3-Inf 320 79.5 43.8 61.2 39.7 41.9 
C3-P1 406 80.9 42.9 61.2 40.0 41.5 
C3-P2 468 80.0 44.4 61.4 40.0 41.2 
C3-Eff 509 79.7 43.6 62.3 40.3 41.1 
Final Eff 610 76.6 41.8 56.6 38.7 39.0 
DL: 0.21 mg L-1      
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Table A 16: Concentrations of Mg (mg L-1) along the treatment flow path in  
year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 7.40 7.11 7.17 7.39 7.51 
C1-P1 36 8.27 7.70 - - - 
C1-P2 68 8.83 8.11 7.56 7.65 6.34 
C1-P3 99 7.73 8.72 7.83 7.88 6.81 
C1-P4 130 9.44 9.13 8.17 7.96 6.68 
C2-Inf 171 8.96 8.79 8.41 7.99 8.05 
C2-P1 238 9.39 9.29 8.55 9.07 7.66 
C2-P2 299 10.2 9.57 8.53 8.93 8.10 
C3-Inf 340 9.78 10.1 9.18 8.86 8.55 
C3-P1 406 8.95 10.8 9.35 8.88 8.04 
C3-P2 468 9.19 11.9 9.71 8.95 8.29 
C3-Eff 509 6.35 - - - - 
Final Eff 610 5.91 12.7 10.8 9.49 9.42 
DL: 0.22 mg L-1 
     
 
Table A 17: Concentrations of Mg (mg L-1) along the treatment flow path in  
year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 6.87 6.46 6.28 6.11 6.59 
C1-P1 36 6.91 6.82 6.71 6.21 4.86 
C1-P2 68 7.30 8.05 6.77 6.90 5.71 
C1-P3 99 5.90 6.76 7.62 8.08 5.88 
C1-P4 130 5.24 4.49 8.40 8.49 5.77 
C2-Inf 171 2.60 1.46 7.44 8.72 8.93 
C2-P1 238 - <DL 4.21 8.44 4.96 
C2-P2 299 - <DL 1.70 3.74 - 
C3-Inf 340 - <DL 1.35 3.98 4.80 
C3-P1 406 0.94 <DL 0.35 1.29 0.49 
C3-P2 468 - - - <DL <DL 
C3-Eff 509 - - - <DL 0.45 
Final Eff 610 <DL <DL <DL <DL 0.94 
DL: 0.22 mg L-1 
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Table A 18: Concentrations of Mg (mg L-1) along the treatment flow path in  
year 3 (2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 6.89 6.82 6.71 6.80 7.06 
C1-P1 36 6.96 6.97 6.60 6.72 6.77 
C1-P2 68 6.70 6.51 6.53 6.83 6.74 
C1-P3 99 5.59 7.57 7.19 7.46 7.77 
C1-P4 130 0.41 0.77 6.00 5.29 6.12 
C2-Inf 171 < DL 0.26 3.21 4.35 4.89 
C2-P1 238 < DL < DL < DL 0.40 1.50 
C2-P2 299 < DL < DL < DL < DL 0.30 
C3-Inf 340 < DL < DL < DL < DL 0.26 
C3-P1 406 < DL < DL < DL < DL < DL 
C3-P2 468 < DL < DL < DL < DL < DL 
C3-Eff 509 < DL < DL < DL < DL < DL 
Final Eff 610 < DL < DL < DL < DL < DL 
DL: 0.22 mg L-1 
     
 
 
Table A 19: Concentrations of Mn (mg L-1) along the treatment flow path in  
year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 0.73 0.86 0.92 1.0 0.94 
C1-P1 36 0.83 0.91 - - - 
C1-P2 68 0.71 0.97 0.97 1.1 0.29 
C1-P3 99 0.52 0.89 1.0 1.1 0.28 
C1-P4 130 0.45 0.72 1.0 1.1 0.34 
C2-Inf 171 0.45 0.67 0.80 1.1 0.46 
C2-P1 238 0.33 0.45 0.78 0.99 0.33 
C2-P2 299 0.17 0.21 0.66 0.78 0.36 
C3-Inf 340 0.058 0.11 0.48 0.56 0.35 
C3-P1 406 0.043 0.14 0.25 0.31 0.21 
C3-P2 468 0.054 0.11 0.15 0.21 0.13 
C3-Eff 509 - - - - - 
Final Eff 610 <DL 0.066 0.12 0.15 0.10 
DL: 0.027 mg L-1      
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Table A 20: Concentrations of Mn (mg L-1) along the treatment flow path in  
year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 0.63 0.71 0.76 0.82 0.89 
C1-P1 36 0.67 0.76 0.79 0.87 0.26 
C1-P2 68 0.77 0.70 0.98 0.96 0.33 
C1-P3 99 0.21 0.19 1.1 0.99 0.35 
C1-P4 130 0.20 0.06 0.83 0.79 0.32 
C2-Inf 171 <DL <DL 0.24 0.32 0.44 
C2-P1 238 <DL <DL <DL 0.091 0.020 
C2-P2 299 <DL <DL <DL <DL <DL 
C3-Inf 340 <DL <DL <DL <DL <DL 
C3-P1 406 0.058 <DL <DL <DL <DL 
C3-P2 468 - - - <DL <DL 
C3-Eff 509 - - - - - 
Final Eff 610 <DL <DL <DL <DL 0.035 
DL: 0.027 mg L-1       
 
 
Table A 21: Concentrations of Mn (mg L-1) along the treatment flow path in  
year 3 (2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 0.99 0.94 0.92 0.83 0.89 
C1-P1 36 0.94 0.95 0.86 0.82 0.81 
C1-P2 68 0.72 0.80 0.92 0.84 0.81 
C1-P3 99 0.27 0.58 0.94 0.83 0.80 
C1-P4 130 <DL <DL 0.34 0.23 0.19 
C2-Inf 171 <DL <DL 0.22 0.37 0.42 
C2-P1 238 <DL <DL <DL <DL <DL 
C2-P2 299 <DL <DL <DL <DL <DL 
C3-Inf 340 <DL <DL <DL <DL <DL 
C3-P1 406 <DL <DL <DL <DL <DL 
C3-P2 468 <DL <DL <DL <DL <DL 
C3-Eff 509 <DL <DL <DL <DL <DL 
Final Eff 610 <DL <DL <DL <DL 0.036 
DL: 0.027 mg L-1  
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Table A 22: Concentrations of SO4 (mg L
-1) along the treatment flow path in  
year 1 (2005) of the hypolimnetic withdrawal P treatment experiment. 
Sample ID Distance 
(cm) 
20-Jul 18-Aug 23-Sep 
C1-Inf 0 12.3 11.1 9.47 
C1-P1 36 10.8 9.14 - 
C1-P2 68 10.2 7.18 6.19 
C1-P3 99 9.63 6.63 5.11 
C1-P4 130 9.83 6.11 5.64 
C2-Inf 171 9.57 5.31 - 
C2-P1 238 9.57 5.42 3.19 
C2-P2 299 - 5.31 4.11 
C3-Inf 340 8.69 5.16 3.30 
C3-P1 406 9.16 5.85 3.18 
C3-P2 468 9.43 5.50 3.57 
C3-Eff 509 - - - 
Final Eff 610 10.0 5.74 3.05 
DL: 0.01 mg L-1    
 
 
Table A 23: Concentrations of SO4 (mg L
-1) along the treatment flow path in  
year 2 (2006) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 17-Aug 09-Sep 10-Oct 
C1-Inf 0 12.6 11.0 10.8 11.3 
C1-P1 36 11.8 11.4 9.42 9.91 
C1-P2 68 8.08 8.87 6.16 6.82 
C1-P3 99 8.61 6.07 3.53 3.71 
C1-P4 130 10.2 6.29 2.28 3.46 
C2-Inf 171 9.72 6.81 2.77 1.76 
C2-P1 238 10.7 6.67 1.82 2.25 
C2-P2 299 9.62 7.04 2.98 2.33 
C3-Inf 340 8.80 7.03 2.56 2.76 
C3-P1 406 9.93 7.52 3.68 2.68 
C3-P2 468 9.95 6.30 3.79 2.92 
C3-Eff 509 - - - - 
Final Eff 610 10.2 7.49 2.83 3.09 
DL: 0.01 mg L-1     
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Table A 24: Concentrations of SO4 (mg L
-1) along the treatment flow path in  
year 3(2007) of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 10.1 11.9 13.3 10.9 13.6 
C1-P1 36 10.1 11.4 12.7 10.4 12.7 
C1-P2 68 5.44 9.14 12.8 9.99 12.1 
C1-P3 99 5.98 5.62 10.3 6.44 8.68 
C1-P4 130 5.42 5.17 4.75 5.58 2.41 
C2-Inf 171 5.94 3.94 3.48 8.48 9.57 
C2-P1 238 3.80 3.95 10.1 6.49 7.67 
C2-P2 299 3.23 3.75 4.51 5.32 8.15 
C3-Inf 340 2.81 4.42 7.00 8.06 7.89 
C3-P1 406 2.52 3.58 3.80 7.69 8.04 
C3-P2 468 3.39 2.62 5.28 8.12 8.00 
C3-Eff 509 1.97 3.48 5.02 3.72 8.14 
Final Eff 610 2.77 3.48 4.36 6.60 7.25 
DL: 0.01 mg L-1       
 
 
Table A 25: Concentrations of V (µg L-1) along the treatment flow path in year 1 (2005)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 0.109 0.109 <DL <DL <DL 
C1-P1 36 1.92 1.67 - - - 
C1-P2 68 3.31 3.06 1.79 1.88 - 
C1-P3 99 3.42 3.10 3.03 2.32 2.64 
C1-P4 130 5.33 3.29 3.14 2.37 1.93 
C2-Inf 171 4.21 2.18 3.96 1.96 5.86 
C2-P1 238 7.05 2.53 2.75 2.87 - 
C2-P2 299 8.14 2.22 2.64 2.50 1.02 
C3-Inf 340 13.1 2.03 2.99 2.40 2.51 
C3-P1 406 10.9 0.900 3.50 3.00 - 
C3-P2 468 9.30 1.45 1.75 1.93 2.21 
C3-Eff 509 19.9 - - - - 
Final Eff 610 20.7 3.91 4.77 2.06 8.22 
DL: 0.025 µg L-1 
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Table A 26: Concentrations of V (µg L-1) along the treatment flow path in year 2 (2006)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 26.8 <DL <DL <DL <DL 
C1-P1 36 25.0 1.15 0.441 0.271 2.48 
C1-P2 68 14.2 3.37 4.01 1.49 2.85 
C1-P3 99 48.5 13.1 2.39 1.75 2.48 
C1-P4 130 60.4 35.1 4.07 2.15 3.11 
C2-Inf 171 92.1 78.3 26.3 5.71 7.32 
C2-P1 238 118 120 32.2 9.37 19.8 
C2-P2 299 - - - - - 
C3-Inf 340 113 102 95.5 50.8 35.2 
C3-P1 406 112 92.3 108 71.5 91.4 
C3-P2 468 - - - - - 
C3-Eff 509 - - - - - 
Final Eff 610 112 84.5 127 91.8 73.0 
DL: 0.025 µg L-1 
       
  
Table A 26: Concentrations of V (µg L-1) along the treatment flow path in year 3 (2007)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 0.30 0.30 0.41 0.24 0.30 
C1-P1 36 3.20 1.40 1.11 2.35 3.86 
C1-P2 68 7.30 3.90 2.38 3.16 4.28 
C1-P3 99 27.4 9.20 2.30 2.22 2.38 
C1-P4 130 30.1 44.0 39.3 49.4 30.8 
C2-Inf 171 40.3 53.1 41.0 27.8 22.0 
C2-P1 238 5.00 34.7 72.7 87.3 69.8 
C2-P2 299 - - - - - 
C3-Inf 340 2.70 6.10 21.3 87.1 90.0 
C3-P1 406 2.00 3.70 11.1 83.2 101 
C3-P2 468 - - - - - 
C3-Eff 509 - - - - - 
Final Eff 610 0.20 0.100 2.15 46.2 85.7 
DL: 0.025 µg L-1 
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Table A 26: Concentrations of Al (µg L-1) along the treatment flow path in year 1 (2005)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
20-Jul 18-Aug 02-Sep 23-Sep 06-Oct 
C1-Inf 0 <DL 1.1 8.4 0.64 5.8 
C1-P1 36 19 12 14 - - 
C1-P2 68 44 35 18 8.4 53 
C1-P3 99 52 27 28 14 66 
C1-P4 130 63 27 32 18 46 
C2-Inf 171 62 26 21 28 33 
C2-P1 238 81 45 12 32 50 
C2-P2 299 47 35 23 21 31 
C3-Inf 340 11 18 14 12 8.4 
C3-P1 406 28 21 - 23 28 
C3-P2 468 30 22 14 14 24 
C3-Eff 509 23 - - - - 
Final Eff 610 25 19 <DL 14 22 
DL: 0.64 µg L-1 
     
 
Table A 27: Concentrations of Al (µg L-1) along the treatment flow path in year 2 (2006)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
19-Jul 03-Aug 17-Aug 09-Sep 30-Sep 
C1-Inf 0 5 2 2 <DL 1 
C1-P1 36 15 16 6 5 66 
C1-P2 68 46 46 16 11 63 
C1-P3 99 54 60 18 10 12 
C1-P4 130 55 53 22 15 17 
C2-Inf 171 108 158 14 28 8 
C2-P1 238 400 436 21 33 52 
C2-P2 299 525 849 266 128 71 
C3-Inf 340 400 599 109 49 19 
C3-P1 406 466 526 107 15 21 
C3-P2 468 616 - - 118 137 
C3-Eff 509 616 - - 159 108 
Final Eff 610 622 843 265 150 122 
DL: 0.606 µg L-1 
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Table A 28: Concentrations of Al (µg L-1) along the treatment flow path in year 3 (2007)  
of the hypolimnetic withdrawal P treatment experiment. 
Sample 
ID 
Distance 
(cm) 
01-Aug 15-Aug 13-Sep 01-Oct 22-Oct 
C1-Inf 0 10 <DL <DL <DL <DL 
C1-P1 36 30 10 <DL 10 20 
C1-P2 68 50 50 20 9.9 20 
C1-P3 99 70 40 20 30 20 
C1-P4 130 370 40 70 60 60 
C2-Inf 171 290 230 80 40 50 
C2-P1 238 300 400 190 70 30 
C2-P2 299 310 670 350 170 110 
C3-Inf 340 390 690 510 260 140 
C3-P1 406 340 660 600 350 180 
C3-P2 468 350 650 660 460 260 
C3-Eff 509 370 590 660 530 290 
Final Eff 610 350 570 140 100 140 
DL: 10 µg L-1 
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Appendix B 
Summary of Data Presented in Chapter 3 
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Table B 1: pH values along the treatment flow path of the EW-BOFS pilot-scale treatment system 
experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 7.37 8.54 8.54 12.19 11.67 
17-Jun-09 7.53 8.30 8.62 12.35 11.90 
22-Jun-09 7.38 8.09 8.62 12.34 12.07 
24-Jun-09 7.43 8.15 8.62 12.32 12.01 
26-Jun-09 7.11 7.96 8.61 12.28 12.01 
29-Jun-09 7.25 7.98 8.66 12.36 12.14 
2-Jul-09 7.47 8.02 8.57 12.35 12.17 
2-Jul-09 7.96 8.17 8.46 12.30 12.00 
8-Jul-09 7.42 8.09 8.60 12.35 12.07 
9-Jul-09 7.48 8.38 8.62 12.19 12.05 
15-Jul-09 - 8.17 8.53 12.30 11.85 
15-Jul-09 - 7.94 8.31 11.80 11.49 
22-Jul-09 7.19 7.70 8.24 11.70 11.48 
30-Jul-09 6.91 7.92 8.48 11.95 11.76 
5-Aug-09 7.19 7.68 8.41 11.78 11.45 
12-Aug-09 7.36 7.49 8.49 11.65 10.22 
19-Aug-09 7.38 7.52 8.45 11.72 11.11 
26-Aug-09 7.54 7.53 8.29 11.87 11.40 
9-Sep-09 7.51 7.68 8.41 11.64 - 
16-Sep-09 7.87 7.82 8.33 11.69 6.80 
23-Sep-09 7.69 8.00 8.58 11.88 7.25 
24-Sep-09 - - - 11.50 - 
25-Sep-09 - - - 11.37 7.07 
28-Sep-09 - - - 11.71 7.26 
29-Sep-09 - - - 11.44 6.84 
30-Sep-09 7.28 7.49 8.09 11.03 6.95 
1-Oct-09 - - - 11.35 7.14 
2-Oct-09 - - - 11.25 7.14 
5-Oct-09 - - - 11.65 7.11 
6-Oct-09 - - - 11.86 7.28 
7-Oct-09 7.71 7.74 8.40 11.59 7.18 
8-Oct-09 - - - 11.92 7.34 
9-Oct-09 - - - 11.80 7.04 
13-Oct-09 - - - 11.32 7.29 
14-Oct-09 7.59 7.86 8.50 11.80 7.28 
15-Oct-09 - - - 11.77 7.33 
15-Oct-09 - 8.01 8.62 11.98 7.51 
16-Oct-09 - - - 11.42 7.38 
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Table B 1 continued: pH values along the treatment flow path of the EW-BOFS pilot-scale treatment 
system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
19-Oct-09 - - - 11.78 7.41 
20-Oct-09 - - - 11.89 7.44 
21-Oct-09 - - - 11.58 7.44 
22-Oct-09 7.39 7.71 8.41 11.50 7.00 
23-Oct-09 7.38 7.65 8.41 11.60 7.34 
26-Oct-09 - - - 11.61 7.27 
27-Oct-09 - - - 11.63 7.24 
28-Oct-09 - - - 11.29 7.33 
29-Oct-09 - - - 11.64 7.45 
2-Nov-09 - - - 11.64 7.33 
3-Nov-09 - - - 11.21 7.31 
6-Nov-09 - - - 11.17 7.18 
9-Nov-09 - - - 11.14 7.07 
10-Nov-09 - - - 11.52 7.43 
13-Nov-09 - - - 11.54 7.30 
16-Nov-09 - - - 11.55 7.42 
17-Nov-09 - 7.73 8.39 11.74 7.53 
19-Nov-09 - - - 11.46 6.87 
20-Nov-09 - - - 11.40 6.94 
23-Nov-09 - - - 11.23 6.82 
24-Nov-09 - - - 11.66 7.13 
26-Nov-09 - - - 11.50 6.91 
27-Nov-09 - - - 11.27 6.88 
30-Nov-09 - - - 11.62 7.16 
2-Dec-09 7.44 7.42 7.85 11.15 7.24 
3-Dec-09 - - - 11.36 7.39 
7-Dec-09 - - - 11.31 7.50 
9-Dec-09 7.60 7.91 8.11 11.41 7.90 
14-Dec-09 - - - 11.52 7.72 
15-Dec-09 - - - 11.44 7.55 
16-Dec-09 7.49 7.63 7.99 11.35 7.46 
17-Dec-09 - - - 11.47 - 
14-Jan-10 7.74 7.72 7.59 11.60 7.91 
20-Jan-10 7.75 7.94 7.75 11.11 7.34 
27-Jan-10 7.89 7.66 7.58 10.96 6.97 
3-Feb-10 7.90 7.82 7.70 11.12 7.14 
9-Feb-10 - 7.99 7.57 11.46 7.47 
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Table B 2: Measurements of alkalinity (mg L
-1
 CaCO3) along the treatment flow path of the EW-BOFS 
pilot-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 305 243 175 1560 342 
17-Jun-09 308 248 220 1290 952 
24-Jun-09 333 256 220 1030 582 
2-Jul-09 316 252 224 1050 556 
2-Jul-09 347 254 241 995 621 
8-Jul-09 324 236 232 964 528 
9-Jul-09 - 221 250 920 659 
15-Jul-09 284 224 220 880 324 
22-Jul-09 240 212 228 744 356 
30-Jul-09 312 224 220 680 400 
5-Aug-09 340 232 212 592 352 
12-Aug-09 316 276 236 524 292 
19-Aug-09 352 284 236 480 216 
26-Aug-09 302 256 222 478 164 
2-Sep-09 285 268 226 422 146 
9-Sep-09 214 222 224 420 - 
16-Sep-09 248 240 240 340 688 
23-Sep-09 264 256 248 424 472 
30-Sep-09 276 266 252 386 258 
1-Oct-09 - - - 374 227 
2-Oct-09 - - - 378 206 
5-Oct-09 - - - 426 200 
7-Oct-09 274 266 254 446 196 
13-Oct-09 - - - 456 194 
14-Oct-09 334 284 270 410 182 
15-Oct-09 - 230 330 520 230 
16-Oct-09 - - - 410 194 
19-Oct-09 - - - 442 208 
21-Oct-09 - - - 435 195 
22-Oct-09 284 268 268 426 198 
29-Oct-09 - - - 398 174 
2-Nov-09 - - - 354 152 
13-Nov-09 - - - 278 230 
30-Nov-09 - - - 280 348 
2-Dec-09 433 398 225 265 335 
3-Dec-09 - - - 264 252 
7-Dec-09 - - - 286 292 
9-Dec-09 500 450 225 228 238 
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Table B 2 continued: Measurements of alkalinity (mg L
-1
 CaCO3) along the treatment flow path of the EW-
BOFS pilot-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
14-Dec-09 - - - 244 200 
15-Dec-09 - - - 254 184 
16-Dec-09 528 488 205 280 200 
20-Jan-10 633 560 170 203 175 
27-Jan-10 688 620 168 210 122 
3-Feb-10 670 625 194 200 130 
 
 
 
Table B 3: Measurements of Eh (mV) along the treatment flow path of the EW-BOFS pilot-scale treatment 
system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 6 
1-Jul-09 120 287 305 126 136 
10-Aug-09 90 179 310 130 170 
1-Oct-09 118 205 305 124 141 
17-Nov-09 88 181 310 113 181 
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Table B 4: Concentrations of PO4-P (mg L
-1
) along the treatment flow path of the EW-
BOFS pilot-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
3-Jun-09 7.77 4.34 2.50 0.07 0.31 
10-Jun-09 8.75 5.16 2.19 0.007 0.27 
18-Jun-09 8.55 4.48 1.97 0.03 0.72 
19-Jun-09 10.6 5.22 2.33 0.01 0.26 
24-Jun-09 8.62 5.18 1.97 0.03 0.85 
2-Jul-09 8.94 4.99 2.32 0.03 0.03 
3-Jul-09 8.95 4.99 2.32 0.03 0.03 
2-Jul-09 8.55 4.97 2.49 0.03 0.03 
8-Jul-09 8.95 5.11 2.39 0.03 0.03 
9-Jul-09 7.93 3.60 0.22 0.005 0.02 
10-Jul-09 8.03 4.27 2.06 0.007 0.10 
15-Jul-09 7.40 3.27 2.13 0.03 0.03 
21-Jul-09 6.90 2.94 1.84 0.03 0.03 
22-Jul-09 6.52 3.10 2.16 0.03 0.03 
24-Jul-09 6.40 3.33 2.25 0.03 0.11 
30-Jul-09 6.29 2.85 1.84 0.03 0.03 
30-Jul-09 6.21 3.03 2.12 0.03 0.03 
5-Aug-09 5.63 2.82 1.74 0.03 0.03 
7-Aug-09 6.13 3.15 1.93 0.03 0.03 
10-Aug-09 6.11 2.99 1.79 0.009 0.04 
12-Aug-09 5.62 3.19 1.90 0.03 0.03 
14-Aug-09 7.96 6.40 2.89 0.03 0.30 
19-Aug-09 7.37 4.08 2.20 0.03 0.36 
21-Aug-09 7.18 4.01 2.24 0.03 0.35 
26-Aug-09 6.53 4.96 2.76 0.03 0.24 
31-Aug-09 5.26 3.90 2.08 0.03 0.03 
2-Sep-09 5.18 3.97 2.40 0.03 0.03 
3-Sep-09 3.92 4.18 2.35 0.03 0.30 
9-Sep-09 4.89 3.26 2.43 0.03 0.03 
10-Sep-09 2.78 2.85 2.23 0.03 0.03 
16-Sep-09 2.68 2.23 2.16 0.03 2.47 
15-Oct-09 4.44 2.83 2.33 0.005 1.62 
30-Oct-09 6.40 4.11 2.79 0.007 1.98 
4-Nov-09 6.46 4.67 3.26 0.007 1.27 
11-Nov-09 7.65 6.04 3.82 0.04 0.62 
17-Nov-09 8.81 6.37 3.63 0.01 0.38 
18-Nov-09 9.17 6.82 4.41 0.05 0.63 
25-Nov-09 9.40 9.20 6.33 0.08 1.08 
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Table B 4 continued: Concentrations of PO4-P (mg L
-1
) along the treatment flow path of the 
EW-BOFS pilot-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
2-Dec-09 11.2 9.27 6.85 0.06 0.18 
9-Dec-09 10.8 7.61 5.55 0.007 0.23 
16-Dec-09 3.26 5.25 4.49 0.005 0.005 
14-Jan-10 4.97 8.06 7.37 0.04 0.38 
20-Jan-10 7.11 7.62 5.34 0.01 0.15 
20-Jan-10 6.26 6.07 6.00 0.07 0.20 
27-Jan-10 6.00 5.45 4.50 0.07 0.17 
3-Feb-10 6.78 5.64 4.83 0.02 0.18 
19-Feb-10 - 5.41 3.99 0.007 0.10 
 
 
Table B 5: Concentrations of Ca (mg L-1) along the treatment flow path during the EW-BOFS pilot-scale 
wastewater treatment experiment.  
Date  Cell 1 Cell 2 Cell 3  Cell 4 Cell 4* Cell 5 Cell 6 DL 
09-Jul-09 96 82 79 294 - 228 89 0.20 
10-Aug-09 95 83 78 228 - 102 23 0.20 
15-Oct-09 91 85 82 164 30 54 - 0.13 
04-Nov-09 93 89 85 123 17 41 51 0.23 
17-Nov-09 99 103 92 128 93 88 75 0.08 
03-Feb-10 157 132 125 140 68 81 73 0.08 
 
 
Table B 6: Concentrations of Na (mg L-1) along the treatment flow path during the EW-BOFS pilot-scale 
wastewater treatment experiment.  
Date  Cell 1 Cell 2 Cell 3  Cell 4 Cell 4* Cell 5 Cell 6 DL 
09-Jul-09 63.2 68.3 72.6 78.3 - 86.3 86.6 0.10 
10-Aug-09 87.3 75.9 72.4 67.9 - 72.3 72.2 0.10 
15-Oct-09 114 114 117 111 108 105 - 0.03 
04-Nov-09 108 109 110 109 109 106 107 0.10 
17-Nov-09 124 134 130 130 130 134 137 0.10 
03-Feb-10 179 162 162 147 142 144 144 0.10 
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Table B 7: Concentrations of Mg (mg L-1) along the treatment flow path during the EW-BOFS pilot-
scale wastewater treatment experiment.  
Date  Cell 1 Cell 2 Cell 3  Cell 4 Cell 4* Cell 5 Cell 6 DL 
09-Jul-09 11 11 10 <DL - 0.14 0.10 0.10 
10-Aug-09 10 11 10 <DL - 0.18 0.07 0.02 
15-Oct-09 11 11 11 <DL 0.63 <DL - 0.02 
04-Nov-09 11 11 11 <DL 0.62 0.02 0.64 0.02 
17-Nov-09 13 13 13 <DL <DL 0.77 0.75 0.10 
03-Feb-10 16 14 16 0.41 0.52 0.65 0.51 0.10 
 
 
Table B 8: Concentrations of SO4 (mg L
-1) along the treatment flow path during the EW-BOFS pilot-
scale wastewater treatment experiment.  
Date  Cell 1 Cell 2 Cell 3  Cell 4 Cell 4* Cell 5 Cell 6 MDL 
09-Jul-09 28 25 25 9 10 17 6 0.018 
10-Aug-09 47 47 50 24 30 33 32 0.018 
15-Oct-09 61 64 67 51 51 45 46 0.018 
04-Nov-09 61 64 67 54 52 52 48 0.018 
17-Nov-09 52 57 59 50 50 54 53 0.018 
03-Feb-10 29 22 23 29 34 46 43 0.018 
 
 
Table B 9: Concentrations of V (µg L-1) along the treatment flow path during the EW-BOFS pilot-
scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 0.40 0.63 1.8 1.9 1.8 0.006 
10-Aug-09 0.53 0.15 2.2 5.0 5.2 0.035 
15-Oct-09 0.91 1.1 1.3 13 2.1 0.015 
4-Nov-09 0.40 0.61 1.0 16 7.0 0.015 
11-Nov-09 0.06 0.56 1.5 37 8.5 0.009 
17-Nov-09 0.29 0.70 1.3 32 9.9 0.007 
16-Dec-09 0.20 0.53 0.73 49 24 0.004 
27-Jan-10 0.66 0.53 1.0 44 26 0.004 
3-Feb-10 0.35 0.47 0.72 47 24 0.020 
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Table B 10: Concentrations of Al (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 6.14 4.41 21.0 821 1334 0.030 
10-Aug-09 5.70 <DL 21.3 1183 1516 0.449 
15-Oct-09 3.54 2.03 5.16 955 23.4 0.055 
4-Nov-09 0.93 10.6 3.31 818 27.8 0.453 
11-Nov-09 0.28 0.08 2.22 637 10.7 0.080 
17-Nov-09 15.2 0.08 0.13 708 5.98 0.082 
16-Dec-09 5.70 6.08 0.08 425 40.0 0.227 
27-Jan-10 15.3 7.77 0.82 186 22.2 0.227 
3-Feb-10 3.72 5.63 0.42 431 13.3 0.280 
 
 
Table B 11: Concentrations of Zn (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 3.79 2.91 3.40 6.64 4.66 0.057 
10-Aug-09 5.40 5.93 4.53 4.67 12.2 0.067 
15-Oct-09 12.8 16.4 5.56 2.07 6.47 0.083 
4-Nov-09 15.9 8.58 4.61 1.60 5.11 0.025 
11-Nov-09 19.9 12.1 8.32 23.7 10.9 0.072 
17-Nov-09 21.9 35.3 3.17 1.27 23.3 0.086 
16-Dec-09 9.32 22.4 4.44 3.47 14.2 1.559 
27-Jan-10 5.32 5.93 5.79 4.37 5.57 1.559 
3-Feb-10 3.39 4.39 3.67 1.39 7.22 0.920 
 
 
Table B 12: Concentrations of Mn (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 59 3.7 0.56 2.6 7.5 0.011 
10-Aug-09 43 0.04 0.33 1.9 5.9 0.035 
15-Oct-09 32 9.7 0.47 0.89 85 0.019 
4-Nov-09 4 16 0.39 0.77 68 0.008 
11-Nov-09 79 41 1.1 1.6 90 0.012 
17-Nov-09 96 47 1.0 1.3 101 0.012 
16-Dec-09 93 101 0.65 0.75 8.1 0.012 
27-Jan-10 55 84 1.0 0.32 54 0.012 
3-Feb-10 46 65 0.47 0.92 49 0.030 
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Table B 13: Concentrations of Cr (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 0.06 0.04 0.06 2.13 0.46 0.009 
10-Aug-09 0.03 0.03 0.03 3.85 0.03 0.031 
15-Oct-09 0.07 0.13 0.11 3.94 2.10 0.019 
4-Nov-09 0.02 0.39 0.05 3.59 0.13 0.001 
11-Nov-09 0.27 0.23 0.25 4.38 0.37 0.012 
17-Nov-09 1.16 0.18 0.26 4.71 0.57 0.011 
16-Dec-09 0.35 0.38 0.10 4.21 1.32 0.015 
27-Jan-10 0.23 0.31 0.22 4.03 1.06 0.015 
3-Feb-10 0.23 0.25 0.16 4.32 1.14 0.040 
 
Table B 14: Concentrations of Cu (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 3.2 21 20 6.7 6.4 0.021 
10-Aug-09 5.5 18 24 12 10 0.029 
15-Oct-09 12 25 15 6.4 4.0 0.043 
4-Nov-09 7.9 9.6 12 6.3 4.4 0.021 
11-Nov-09 8.2 15 18 15 11 0.020 
17-Nov-09 14 26 25 16 16 0.020 
16-Dec-09 17 8.2 22 25 17 0.027 
27-Jan-10 4.2 4.3 16 7.9 6.8 0.027 
3-Feb-10 2.6 4.3 11 8.3 7.7 0.050 
 
Table B 15: Concentrations of Fe (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 47 14 15 8.3 42 0.050 
10-Aug-09 47 14 8.6 5.0 37 0.062 
15-Oct-09 34 16 40 3.7 317 0.050 
4-Nov-09 57 39 10 8.6 117 0.089 
11-Nov-09 64 25 9.4 5.0 37 0.081 
17-Nov-09 156 43 11 4.2 50 0.100 
16-Dec-09 98 118 19 4.6 20 0.066 
27-Jan-10 140 68 14 9.3 17 0.066 
3-Feb-10 107 55 13 8.5 18 0.660 
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Table B 16: Concentrations of Ni (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 2.2 2.1 1.9 0.36 1.3 0.015 
10-Aug-09 2.2 1.9 1.9 0.43 1.3 0.042 
15-Oct-09 3.0 2.7 2.1 0.78 1.6 0.018 
4-Nov-09 2.3 3.8 1.9 0.71 1.2 0.008 
11-Nov-09 3.5 2.7 2.8 1.5 1.3 0.021 
17-Nov-09 5.7 2.5 2.5 1.7 1.7 0.016 
16-Dec-09 4.3 3.9 2.3 1.3 1.4 0.047 
27-Jan-10 3.3 3.3 2.6 1.8 1.4 0.047 
3-Feb-10 2.5 2.5 2.0 1.0 1.4 0.050 
 
 
Table B 17: Concentrations of Pb (µg L-1) along the treatment flow path during the EW-BOFS 
pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 DL (µg L-1) 
9-Jul-09 0.08 0.05 0.05 0.33 0.15 0.002 
10-Aug-09 0.04 0.01 0.14 0.14 0.10 0.005 
15-Oct-09 0.08 0.71 0.07 0.08 0.10 0.006 
4-Nov-09 0.03 0.03 0.02 0.05 0.06 0.002 
11-Nov-09 0.28 0.45 0.33 0.58 0.47 0.002 
17-Nov-09 1.5 6.3 0.23 0.15 0.50 0.002 
16-Dec-09 0.43 0.47 0.90 0.22 1.1 0.003 
27-Jan-10 0.22 2.3 0.20 0.17 0.14 0.003 
3-Feb-10 0.30 0.64 0.45 0.36 1.1 0.014 
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Table B 18: Concentrations of NH3-N (mg L
-1
) along the treatment flow path during the EW-
BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 4.5 0.06 0.05 0.6 5.9 
17-Jun-09 8.8 0.16 0.02 0.41 6.4 
24-Jun-09 12 0.4 0.02 0.29 6.5 
2-Jul-09 11 0.15 0.02 0.22 3.6 
2-Jul-09 13 0.5 0.1 0.2 3.7 
8-Jul-09 8.2 0.37 0.02 0.2 4.5 
15-Jul-09 7.3 0.37 0.02 0.25 3.6 
22-Jul-09 1.8 0.05 0.03 0.17 3.7 
30-Jul-09 11 0.77 0.06 0.19 4.5 
5-Aug-09 9.1 0.65 0.02 0.15 2.9 
12-Aug-09 8.7 1.2 0.02 0.07 2.6 
19-Aug-09 15 4.3 0.02 0.23 6.3 
2-Sep-09 9.2 4.2 0.08 0.12 2.8 
9-Sep-09 0.1 0.11 0.13 0.22 - 
16-Sep-09 0.2 0.4 0.02 0.08 2.6 
30-Oct-09 - - 0.02 0.14 2.1 
4-Nov-09 12 4.3 0.02 0.07 1.8 
11-Nov-09 25 11 0.04 0.11 1.5 
18-Nov-09 28 16 0.07 0.06 1.5 
25-Nov-09 32 18 0.25 0.09 2.1 
2-Dec-09 42 31 0.38 0.06 0.95 
9-Dec-09 77 40 0.03 0.07 1.5 
16-Dec-09 51 40 0.06 0.09 0.98 
14-Jan-10 68 46 0.4 3.6 3.7 
20-Jan-10 58 14 0.8 0.4 1.4 
27-Jan-10 63 53 6.1 0.57 0.6 
3-Feb-10 76 58 0.2 0.23 1.1 
DL: 0.02 mg L-1      
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Table B 19: Concentrations of NO3-N (mg L
-1
) along the treatment flow path during the EW-
BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 0.15 1.7 2.3 1.6 0.53 
17-Jun-09 0.05 5.4 3.4 1.4 0.05 
24-Jun-09 0.05 7.5 5.1 2.9 0.05 
2-Jul-09 0.05 11 7.8 4.6 0.05 
2-Jul-09 0.05 9.3 7.3 4.4 0.06 
8-Jul-09 0.05 11 8.6 4.8 0.05 
15-Jul-09 0.22 9.5 7.5 6.9 0.05 
22-Jul-09 3.2 8.0 6.9 6.5 0.08 
29-Jul-09 0.05 7.1 6.2 5.8 0.28 
30-Jul-09 0.05 7.3 6.6 5.9 0.18 
5-Aug-09 0.05 7.0 6.3 5.3 0.63 
7-Aug-09 0.30 7.9 7.1 6.4 0.71 
12-Aug-09 0.19 6.4 6.8 6.4 0.24 
19-Aug-09 0.05 3.8 5.1 5.0 1.7 
26-Aug-09 2.0 3.5 7.5 5.3 2.4 
2-Sep-09 4.9 5.3 10 7.5 2.9 
9-Sep-09 5.8 7.3 8.3 9.2 
 16-Sep-09 5.7 5.4 4.1 6.0 
 30-Oct-09 1.7 5.0 5.5 3.5 0.05 
4-Nov-09 3.4 5.2 6.9 4.7 0.28 
11-Nov-09 0.73 5.6 11 7.8 0.84 
18-Nov-09 0.29 4.0 14 11 2.2 
25-Nov-09 0.05 2.6 26 18 3.7 
2-Dec-09 0.23 1.3 33 26 12 
9-Dec-09 0.05 1.3 39 31 11 
16-Dec-09 0.05 0.08 
 
17 11 
14-Jan-10 0.05 0.05 43 28 11 
20-Jan-10 0.05 0.05 52 42 19 
27-Jan-10 0.05 0.05 92 78 41 
3-Feb-10 0.05 0.05 60 57 33 
DL: 0.05 mg L-1      
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Table B 20: Concentrations of DO (mg L
-1
) along the treatment flow path during the EW-BOFS pilot-
scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 1.9 11 8.1 2.0 3.5 
17-Jun-09 2.5 7.3 7.4 2.1 4.3 
24-Jun-09 1.2 5.4 5.7 1.4 1.6 
2-Jul-09 1.2 6.2 7.0 1.4 3.2 
2-Jul-09 5.2 5.3 7.0 6.6 4.4 
8-Jul-09 1.1 6.5 7.0 1.2 1.8 
15-Jul-09 1.3 6.7 6.9 1.6 2.1 
22-Jul-09 1.8 7.0 7.0 1.4 1.7 
30-Jul-09 0.8 6.6 7.0 1.7 2.2 
5-Aug-09 1.1 6.5 7.2 1.7 2.5 
12-Aug-09 0.92 3.0 6.9 1.8 3.4 
19-Aug-09 0.40 1.0 7.4 1.8 1.8 
26-Aug-09 1.5 1.1 7.2 2.2 2.2 
2-Sep-09 3.1 4.0 8.7 1.7 2.9 
9-Sep-09 4.6 5.5 7.7 2.2  
16-Sep-09 7.1 5.9 8.0 2.9 3.5 
23-Sep-09 2.8 5.1 7.7 2.1 3.5 
30-Sep-09 5.6 4.8 8.9 2.7 3.9 
1-Oct-09 - - - 6.8 3.6 
2-Oct-09 - - - 3.1 6.1 
5-Oct-09 - - - 4.4 3.8 
6-Oct-09 - - - 2.7  
7-Oct-09 4.4 4.9 8.7 2.0 3.7 
8-Oct-09 - - - 3.2 3.7 
9-Oct-09 - - - 2.5 4.2 
13-Oct-09 - - - 2.9 5.6 
14-Oct-09 3.4 5.7 8.7 2.1 4.1 
15-Oct-09 - - - 2.2 4.0 
16-Oct-09 - - - 2.7 5.2 
19-Oct-09 - - - 2.3 5.0 
20-Oct-09 - - - 2.7 4.6 
21-Oct-09 - - - 2.5 8.1 
22-Oct-09 4 6.7 9.7 2.9 3.9 
23-Oct-09 10 9.9 9.9 22 8.1 
26-Oct-09 - - - 3.5 5.4 
27-Oct-09 - - - 2.7 5.0 
28-Oct-09 - - - 3.0 4.2 
29-Oct-09 - - - 2.5 4.4 
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Table B 20 continued: Concentrations of DO (mg L
-1
) along the treatment flow path during the      
EW-BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
2-Nov-09 - - - 4.8 4.9 
3-Nov-09 - - - 3.0 4.7 
6-Nov-09 - - - 4.9 4.7 
9-Nov-09 - - - 6.2 7.7 
10-Nov-09 - - - 5.7 4.9 
13-Nov-09 - - - 4.2 5.8 
16-Nov-09 - - - 3.2 5.0 
19-Nov-09 - - - 3.9 5.9 
20-Nov-09 - - - 4.0 5.6 
23-Nov-09 - - - 4.9 4.8 
24-Nov-09 - - - 4.6 4.6 
26-Nov-09 - - - 4.3 4.7 
27-Nov-09 - - - 6.0 8.0 
30-Nov-09 - - - 4.3 7.9 
2-Dec-09 1.8 5.7 9.7 4.9 7.9 
3-Dec-09 - - - 4.9 7.3 
7-Dec-09 - - - 3.8 7.1 
9-Dec-09 0.57 3.1 11 5.6 7.1 
14-Dec-09 - - - 5.5 8.3 
15-Dec-09 - - - 5.5 7.2 
16-Dec-09 0.46 1.9 9.4 4.3 6.9 
14-Jan-10 0.84 3.4 3.7 3.0 6.4 
20-Jan-10 0.21 1.5 7.2 3.8 3.5 
27-Jan-10 0.76 3.6 6.9 4.8 4.4 
3-Feb-10 0.12 2.7 7.6 5.3 4.5 
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Table B 21: Concentrations of cBOD5 (mg L
-1
) along the treatment flow path during the EW-
BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 40 48 42 1.0 18 
17-Jun-09 15 37 39 1.0 7.6 
24-Jun-09 20 11 5.0 1.0 5.2 
2-Jul-09 15 12 8.2 1.0 1.9 
2-Jul-09 6.0 4.0 4.0 4.0 4.0 
8-Jul-09 14 8.3 4.1 1.0 1.0 
15-Jul-09 11 6.3 7.9 1.0 1.0 
22-Jul-09 8.9 4.7 6.6 1.0 1.0 
30-Jul-09 23 8.3 8.9 1.0 1.0 
5-Aug-09 16 6.0 11 1.0 1.0 
12-Aug-09 17 8.5 11 1.0 1.0 
19-Aug-09 20 17 8.3 1.0 1.0 
26-Aug-09 16 9.6 3.9 1.0 1.0 
2-Sep-09 12 9.5 6.9 1.0 3.1 
9-Sep-09 8.8 4.3 7.4 1.0 11 
4-Nov-09 15 7.6 1.0 1.0 - 
11-Nov-09 18 9.8 1.7 1.0 4.0 
18-Nov-09 15 12 3.9 1.0 5.9 
25-Nov-09 13 10 6.1 1.0 5.3 
2-Dec-09 21 11 7.1 1.0 6.7 
9-Dec-09 53 27 7.3 1.0 6.1 
16-Dec-09 21 24 2.8 1.0 5.4 
20-Jan-10 80 46 9.7 1.0 6.1 
3-Feb-10 168 57 9.9 1.0 1.0 
DL: 1 mg L-1      
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Table B 22: Concentrations of COD (mg L
-1
) along the treatment flow path during the EW-
BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 76 81 115 48 183 
17-Jun-09 57 32 25 16 111 
24-Jun-09 52 56 27 15 91 
2-Jul-09 40 33 27 9.1 50 
2-Jul-09 44 30 32 9.0 46 
8-Jul-09 38 29 27 15 51 
15-Jul-09 33 24 23 7.0 47 
22-Jul-09 25 27 29 8.1 42 
30-Jul-09 30 5.1 9.3 3.0 27 
5-Aug-09 23 11 12 3.0 15 
12-Aug-09 37 29 22 8.6 32 
19-Aug-09 58 32 31 3.7 63 
26-Aug-09 40 27 27 11 40 
2-Sep-09 37 32 42 12 34 
9-Sep-09 20 25 36 14 - 
16-Sep-09 29 23 80 13 55 
23-Sep-09 27 26 36 13 36 
30-Sep-09 29 25 58 10 43 
30-Oct-09 37 31 26 12 23 
4-Nov-09 35 34 32 14 31 
11-Nov-09 48 38 32 15 19 
18-Nov-09 50 37 30 14 20 
25-Nov-09 70 42 30 9.3 18 
2-Dec-09 53 51 30 10 7.5 
9-Dec-09 127 78 27 16 14 
16-Dec-09 74 79 21 3.0 3.0 
14-Jan-10 152 113 32 8.7 31 
20-Jan-10 194 105 36 13 15 
27-Jan-10 231 127 44 27 22 
3-Feb-10 25 113 28 15 15 
DL: 3 mg L-1      
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Table B 23: Concentrations of E.coli  (CFU/100mL) along the treatment flow path during the EW-
BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 1.1E+04 1.5E+03 1.0E+02 6.0E+01 3.0E+01 
17-Jun-09 6.5E+02 3.0E+02 1.7E+02 1.0E+01 6.0E+00 
24-Jun-09 4.0E+02 1.4E+02 1.5E+01 3.0E+00 3.0E+00 
2-Jul-09 4.7E+03 3.0E+02 8.0E+00 3.0E+00 3.0E+00 
2-Jul-09 1.3E+03 1.9E+02 8.0E+00 2.0E+00 3.0E+00 
8-Jul-09 2.0E+02 1.5E+01 1.3E+01 3.0E+00 3.0E+00 
15-Jul-09 2.7E+04 5.9E+03 3.9E+02 3.0E+00 3.0E+00 
22-Jul-09 1.0E+02 1.6E+02 2.8E+01 3.0E+00 3.0E+00 
30-Jul-09 4.8E+04 1.4E+04 1.0E+03 3.0E+00 3.0E+00 
5-Aug-09 3.0E+02 6.0E+01 1.5E+01 3.0E+00 3.0E+00 
12-Aug-09 1.1E+04 1.6E+03 2.0E+01 3.0E+00 3.0E+00 
19-Aug-09 2.4E+04 2.1E+03 8.0E+00 3.0E+00 3.0E+00 
26-Aug-09 4.7E+03 3.8E+02 3.2E+01 3.0E+00 3.0E+00 
2-Sep-09 8.0E+02 2.2E+02 2.2E+01 3.0E+00 3.0E+00 
9-Sep-09 8.0E+02 2.6E+02 2.6E+01 3.0E+00 - 
16-Sep-09 2.5E+02 6.0E+01 1.0E+01 3.0E+00 3.0E+00 
30-Oct-09 6.5E+01 2.5E+01 3.0E+00 3.0E+00 3.0E+00 
4-Nov-09 8.0E+01 3.2E+01 3.0E+00 3.0E+00 9.0E+01 
11-Nov-09 1.5E+00 3.0E+00 3.0E+00 3.0E+00 3.0E+00 
18-Nov-09 1.6E+03 1.1E+02 3.0E+00 3.0E+00 3.0E+00 
25-Nov-09 4.6E+03 2.5E+02 3.0E+00 3.0E+00 3.9E+01 
2-Dec-09 2.5E+03 3.0E+01 3.0E+00 3.0E+00 3.0E+00 
9-Dec-09 2.4E+05 2.4E+04 3.0E+00 3.0E+00 3.0E+00 
16-Dec-09 7.9E+03 4.2E+03 3.0E+00 3.0E+00 3.0E+00 
14-Jan-10 1.5E+00 1.3E+02 5.0E+00 3.0E+00 - 
20-Jan-10 3.9E+03 9.8E+02 3.0E+01 3.0E+00 3.0E+00 
27-Jan-10 3.0E+04 1.7E+03 1.9E+01 3.0E+00 3.0E+00 
3-Feb-10 1.3E+05 1.2E+04 6.9E+01 3.0E+00 3.0E+00 
DL: 3CFU/100 ml     
 
 
 
 
 
 
 
 275 
 
Table B 24: Concentrations of Total coliform (CFU/100mL) along the treatment flow path during the 
EW-BOFS pilot-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 
1-Jun-09 7.7E+04 4.3E+03 1.0E+02 6.0E+01 3.0E+01 
17-Jun-09 4.2E+03 3.3E+02 3.5E+02 3.0E+01 6.0E+00 
24-Jun-09 9.7E+03 3.3E+03 2.2E+02 3.0E+00 3.0E+00 
2-Jul-09 4.7E+03 4.0E+03 2.8E+02 3.0E+00 3.0E+00 
8-Jul-09 1.1E+04 1.9E+03 1.1E+03 3.0E+00 3.0E+00 
15-Jul-09 4.8E+04 1.2E+04 2.9E+03 3.0E+00 3.0E+00 
22-Jul-09 2.1E+03 7.6E+02 6.1E+03 3.0E+00 3.0E+00 
30-Jul-09 4.8E+04 2.4E+04 4.8E+03 3.0E+00 3.0E+00 
5-Aug-09 1.3E+06 2.1E+03 1.9E+03 3.0E+00 3.0E+00 
12-Aug-09 2.6E+04 6.7E+03 5.5E+01 3.0E+00 3.0E+00 
19-Aug-09 2.3E+04 2.8E+03 7.5E+00 3.0E+00 3.0E+00 
26-Aug-09 5.9E+04 1.0E+03 2.0E+02 3.0E+00 3.0E+00 
2-Sep-09 4.4E+03 1.0E+03 1.2E+02 3.0E+00 3.0E+00 
9-Sep-09 2.5E+03 1.4E+03 2.6E+01 3.0E+00 - 
16-Sep-09 2.0E+03 4.4E+02 2.6E+01 3.0E+00 1.6E+01 
30-Oct-09 2.2E+03 1.7E+02 3.0E+00 3.0E+00 - 
4-Nov-09 5.3E+02 6.6E+01 3.0E+00 3.0E+00 1.1E+02 
11-Nov-09 4.7E+03 2.3E+02 3.0E+00 3.0E+00 3.0E+00 
18-Nov-09 5.1E+04 1.2E+03 5.0E+00 3.0E+00 4.6E+01 
25-Nov-09 1.7E+04 1.3E+03 1.9E+01 3.0E+00 4.6E+01 
2-Dec-09 8.7E+03 1.1E+03 5.0E+00 3.0E+00 2.2E+01 
9-Dec-09 2.4E+05 2.4E+05 5.0E+00 3.0E+00 5.0E+00 
16-Dec-09 1.6E+04 2.4E+05 5.0E+00 3.0E+00 3.0E+00 
14-Jan-10 1.3E+04 1.6E+03 9.0E+01 3.0E+00 - 
20-Jan-10 8.7E+03 1.8E+03 3.3E+01 3.0E+00 3.0E+00 
27-Jan-10 6.9E+04 3.4E+03 4.9E+01 3.0E+00 2.5E+01 
3-Feb-10 3.4E+05 1.9E+04 1.3E+02 3.0E+00 3.0E+00 
DL: 3CFU/100 ml     
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Table B 25: Mass change of P observed in different components of the treatment system. The +ve values 
indicate mass loses from the system component and the -ve values indicate mass gains within the system 
component. 
 
 
 
 
 
 
 
 
 
 
Table B 26: Mass change of NH3 observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
 
 
 
 
 
 
 
 
 
 
 
  
P mass 
in (mg) 
P mass 
out  
(mg) 
P mass 
change 
(mg) 
P mass 
change 
(Kg) 
P mass 
% 
change 
Overall 
treatment 
system 
100409 5944 94465 0.095 94.08 
Cell 2 100409 69828 30580 0.031 30.46 
Cell 3 69828 44940 24888 0.025 35.64 
Cell 4 44940 269 44671 0.045 99.40 
Cell 4* 269 155 114 0.0001 42.35 
Cell 5 155 8568 -8413 -0.008 -5430.9 
Cell 6 8568 5944 2624 0.003 30.63 
 NH3-N 
mass in 
(mg) 
NH3-N  
mass 
out  
(mg) 
NH3-N  
mass 
change 
(mg) 
NH3-N  
mass 
change 
(Kg) 
NH3-N  
mass % 
change 
Overall 
treatment 
system 
256661 20875 235786 0.236 91.87 
Cell 2 256661 132030 124631 0.125 48.56 
Cell 3 132030 3910 128120 0.128 97.04 
Cell 4 3910 3984 -74 -0.0001 -1.90 
Cell 4* 3984 3533 452 0.0005 11.33 
Cell 5 3533 44641 -41108 -0.041 -1163.6 
Cell 6 44641 20875 23766 0.024 53.24 
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Table B 27: Mass change of NO3 observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table B 28: Mass change of NT (NO3+ NH3) observed in different components of the treatment system. 
The +ve values indicate mass loses from the system component and the -ve values indicate mass gains 
within the system component.  
 
  
NT mass 
in (mg) 
NT mass 
out  
(mg) 
NT mass 
change 
(mg) 
NT mass 
change 
(Kg) 
NT mass 
% 
change 
Overall 
treatment 
system 275919 77112 198806 0.199 72.05 
Cell 2 275919 204667 71251 0.072 25.82 
Cell 3 204667 203279 1388 0.001 0.68 
Cell 4 203279 171098 32181 0.0319 15.83 
Cell 4* 171098 83904 87195 0.0875 50.96 
Cell 5 83904 101553 -17649 -0.017 -21.03 
Cell 6 101553 77112 24441 0.025 24.07 
 
 
 NO3-N 
mass in 
(mg) 
NO3-N 
mass 
out  
(mg) 
NO3-N  
mass  
change 
(mg) 
NO3-N  
mass  
change 
(Kg) 
NO3-N  
mass % 
change 
Overall 
treatment 
system 
19258 56237 -36980 -0.037 -192.03 
Cell 2 19258 72637 -53380 -0.053 -277.19 
Cell 3 72637 199369 -126732 -0.127 -174.47 
Cell 4 199369 167114 32255 0.032 16.18 
Cell 4* 167114 80371 86743 0.087 51.91 
Cell 5 80371 56912 23459 0.024 29.19 
Cell 6 56912 56237 675 0.001 1.19 
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Table B 29: Mass change of cBOD5 observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table B 30: Mass change of COD observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
 
 
 
 
 
 
 
 
 
 
 cBOD5 
mass in 
(mg) 
cBOD5 
mass 
out  
(mg) 
cBOD5 
mass  
change  
(mg) 
cBOD5 
mass  
change 
(Kg) 
cBOD5 
mass % 
change 
Overall 
treatment 
system 
285884 67420 218464 0.219 76.42 
Cell 2 285884 196336 89548 0.090 31.32 
Cell 3 196336 129195 67141 0.067 34.20 
Cell 4 129195 6630 122565 0.123 94.87 
Cell 4* 6630 3612 3018 0.003 45.52 
Cell 5 3612 59702 -56090 -0.056 -1552.8 
Cell 6 59702 67420 -7718 -0.008 -12.93 
 COD 
mass in 
(mg) 
COD 
mass 
out  
(mg) 
COD 
mass  
change 
(mg) 
COD 
mass  
change 
(Kg) 
COD 
mass % 
change 
Overall 
treatment 
system 
798257 615341 182916 0.183 22.91 
Cell 2 798257 604761 193496 0.194 24.24 
Cell 3 604761 494256 110505 0.111 18.27 
Cell 4 494256 182028 312228 0.312 63.17 
Cell 4* 182028 80100 101928 0.102 56.00 
Cell 5 80100 622831 -542731 -0.543 -677.57 
Cell 6 622831 615341 7490 0.008 1.20 
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Appendix C 
Summary of Data Presented in Chapter 4 
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Table C 1: pH values along the treatment flow path of the EW-BOFS demonstration-scale treatment 
system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 7.53 7.79 7.48 11.35 
3-Feb-10 7.98 8.11 8.10 11.83 
19-Feb-10 8.95 9.61 8.10 12.32 
6-Apr-10 8.68 8.30 7.40 11.97 
13-Apr-10 8.43 8.14 7.61 11.10 
30-Apr-10 7.38 7.70 7.58 10.40 
5-May-10 7.23 7.63 7.80 11.52 
12-May-10 7.19 7.63 8.06 11.29 
19-May-10 7.02 7.66 8.17 11.60 
27-May-10 7.22 7.69 8.13 11.53 
2-Jun-10 6.83 7.64 8.29 11.89 
8-Jun-10 7.04 7.55 8.26 11.29 
16-Jun-10 7.15 7.33 8.29 11.85 
23-Jun-10 6.98 7.33 7.76 11.52 
29-Jun-10 7.70 7.71 8.22 11.39 
6-Jul-10 7.01 7.22 8.14 11.56 
14-Jul-10 7.27 7.61 8.07 11.96 
20-Jul-10 7.50 7.55 8.45 11.86 
28-Jul-10 7.60 7.93 8.58 11.81 
4-Aug-10 7.62 7.95 8.25 11.84 
10-Aug-10 7.46 7.78 8.40 12.20 
18-Aug-10 7.68 7.84 8.21 11.88 
31-Aug-10 7.73 7.87 8.10 11.69 
8-Sep-10 8.04 7.80 7.95 11.37 
14-Sep-10 7.75 7.69 7.98 11.54 
19-Oct-10 7.67 7.65 7.35 9.81 
16-Nov-10 8.12 7.74 7.01 10.03 
10-Dec-10 8.12 8.13 7.82 9.41 
14-Dec-10 8.13 8.08 7.22 11.69 
20-Jan-11 8.11 7.94 7.92 11.15 
28-Jan-11 8.10 8.35 7.72 9.49 
16-Feb-11 8.56 8.43 6.71 9.56 
23-Mar-11 7.99 8.14 - 10.52 
13-Apr-11 7.52 7.96 7.59 11.07 
18-May-11 7.11 7.45 8.05 11.72 
22-Jun-11 7.56 7.25 8.16 12.10 
13-Jul-11 7.08 7.27 8.43 12.35 
16-Aug-11 6.97 7.46 8.33 11.68 
27-Oct-11 7.22 7.81 8.03 11.87 
29-Nov-11 7.20 7.56 7.81 12.10 
13-Dec-11 7.45 7.73 8.19 12.16 
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Table C 2: Measurements of alkalinity (mg L
-1
 CaCO3) along the treatment flow path of the            
EW-BOFS demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 636 455 195 2300 
3-Feb-10 763 538 225 2360 
19-Feb-10 635 489 230 1620 
6-Apr-10 460 520 200 640 
30-Apr-10 700 740 540 360 
5-May-10 728 248 250 403 
12-May-10 594 564 240 343 
19-May-10 650 450 275 768 
21-May-10 520 630 460 230 
27-May-10 536 638 320 682 
2-Jun-10 638 605 253 1530 
3-Jun-10 700 700 360 800 
8-Jun-10 613 688 295 443 
16-Jun-10 578 660 323 1670 
18-Jun-10 540 650 360 600 
23-Jun-10 533 550 288 713 
29-Jun-10 493 570 350 255 
6-Jul-10 470 605 300 1230 
14-Jul-10 368 470 275 825 
20-Jul-10 420 470 248 1530 
20-Jul-10 520 480 260 1540 
19-Aug-10 532 388 265 271 
31-Aug-10 310 340 241 823 
8-Sep-10 333 305 215 543 
14-Sep-10 448 344 208 678 
19-Oct-10 590 575 160 530 
16-Nov-10 605 605 65 90 
10-Dec-10 432 340 302 200 
14-Dec-10 425 438 100 470 
20-Jan-11 510 468 188 450 
28-Jan-11 425 460 175 200 
16-Feb-11 273 295 73 160 
23-Mar-11 340 388 - 258 
13-Apr-11 605 525 188 313 
18-May-11 506 646 176 442 
22-Jun-11 473 485 190 948 
13-Jul-11 1050 540 178 1440 
16-Aug-11 825 280 190 395 
27-Oct-11 480 463 28 500 
29-Nov-11 675 545 145 713 
13-Dec-11 725 530 155 845 
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Table C 3: Measurements of Eh (mV) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 -33 -4 279 31 
6-Apr-10 90 144 364 180 
13-Apr-10 83 128 311 130 
30-Apr-10 68 71 286 79 
19-May-10 -6 43 267 101 
2-Jun-10 -69 14 250 63 
3-Jun-10 -28 19 421 105 
16-Jun-10 -26 13 261 72 
20-Jul-10 112 152 520 92 
28-Jan-11 7 37 284 76 
13-Jul-11 82 229 228 59 
27-Oct-11 119 263 270 215 
29-Nov-11 265 419 407 232 
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Table C 4: Measurements of Conductivity (µS/cm) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 2118 1441 1349 8160 
3-Feb-10 2048 1504 1192 7500 
5-May-10 1818 1903 1706 2262 
12-May-10 1728 1706 1574 2258 
19-May-10 1947 1840 1699 4350 
27-May-10 1841 2000 1716 4720 
2-Jun-10 1830 1971 1686 7040 
8-Jun-10 1948 2021 1630 2489 
16-Jun-10 1705 1845 1540 7520 
23-Jun-10 1821 1852 1630 4020 
29-Jun-10 1579 1671 1510 1929 
6-Jul-10 1569 1774 1544 6280 
14-Jul-10 1360 1541 1440 7890 
20-Jul-10 1004 1468 1303 7480 
28-Jul-10 1256 1330 1231 4160 
4-Aug-10 1207 1337 1197 7360 
10-Aug-10 1222 1225 1128 6050 
18-Aug-10 1121 1187 1113 4500 
31-Aug-10 1101 1168 1093 2500 
8-Sep-10 1111 1030 999 1766 
14-Sep-10 1423 1171 1032 2930 
19-Oct-10 1777 1772 1424 1161 
16-Nov-10 1772 1865 1483 1347 
14-Dec-10 1580 1498 1297 2390 
20-Jan-11 1791 1584 1351 1582 
16-Feb-11 1754 1773 1694 1560 
23-Mar-11 1513 1536 - 1350 
13-Apr-11 1815 1589 1337 1431 
18-May-11 1448 1646 1256 2790 
22-Jun-11 1332 1307 1066 5030 
13-Jul-11 2334 1416 1058 6950 
16-Aug-11 1977 802 819 2202 
27-Oct-11 1587 1374 1095 2855 
29-Nov-11 1881 1514 1096 3511 
13-Dec-11 1953 1444 1044 4508 
DL:5 µS/cm  
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Table C 5: Concentrations of TSS (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
14-Sep-10 66 16 6 220 
14-Dec-10 27 11 5 283 
20-Jan-11 50 7 3 360 
16-Feb-11 25 5 3 140 
23-Mar-11 12 2 
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13-Apr-11 67 19 18 216 
18-May-11 43 31 3 79 
22-Jun-11 13 8 3 38 
27-Oct-11 32 3 3 65 
29-Nov-11 50 3 3 100 
13-Dec-11 52 3 3 10 
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Table C 6: Concentrations of PO4-P (mg L
-1
) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 6.47 4.26 2.42 <DL 
3-Feb-10 7.16 4.89 2.31 <DL 
19-Feb-10 4.50 2.19 1.45 <DL 
6-Apr-10 3.91 4.79 3.28 0.06 
13-Apr-10 4.36 5.05 4.08 0.01 
30-Apr-10 5.28 7.47 5.02 0.01 
5-May-10 3.35 5.04 4.41 0.12 
12-May-10 4.66 4.77 3.32 0.03 
19-May-10 6.33 6.24 2.69 0.03 
21-May-10 5.42 6.17 4.66 <DL 
27-May-10 5.16 5.41 2.58 0.03 
2-Jun-10 6.55 5.24 0.81 0.03 
8-Jun-10 8.52 6.83 2.88 0.03 
16-Jun-10 8.24 7.36 4.39 0.03 
18-Jun-10 7.54 6.44 2.34 <DL 
23-Jun-10 7.76 5.33 3.21 0.03 
29-Jun-10 7.50 8.82 4.79 0.03 
6-Jul-10 7.64 9.49 1.99 0.03 
14-Jul-10 5.48 8.86 3.23 0.03 
20-Jul-10 5.47 7.85 2.66 0.03 
20-Jul-10 5.22 7.55 2.75 0.01 
28-Jul-10 5.48 7.22 2.50 0.03 
4-Aug-10 4.62 5.09 3.43 0.03 
10-Aug-10 5.51 5.55 4.21 0.03 
18-Aug-10 4.82 7.50 3.37 0.03 
19-Aug-10 4.73 6.76 4.48 0.01 
31-Aug-10 3.59 4.34 4.63 0.01 
8-Sep-10 3.65 3.39 3.95 0.03 
9-Sep-10 2.73 2.65 3.68 0.06 
14-Sep-10 5.06 4.92 4.14 0.02 
24-Sep-10 7.30 6.96 5.06 <DL 
19-Oct-10 6.29 7.04 8.41 <DL 
16-Nov-10 7.11 5.97 7.89 0.09 
10-Dec-10 4.58 4.24 4.43 0.20 
14-Dec-10 3.95 3.03 3.98 0.02 
DL: 0.005 mg L-1    
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Table C 6 Continued: Concentrations of PO4-P (mg L
-1
) along the treatment flow path of the          
EW-BOFS demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
20-Jan-11 5.28 3.49 3.82 <DL 
28-Jan-11 3.80 2.68 2.46 0.25 
16-Feb-11 3.54 2.35 2.80 0.29 
23-Mar-11 4.40 3.07 - 0.04 
13-Apr-11 9.39 7.18 3.25 0.05 
22-Jun-11 6.72 10.6 3.64 <DL 
13-Jul-11 22.2 10.4 2.40 0.01 
27-Oct-11 8.22 9.26 3.75 0.01 
29-Nov-11 12.0 10.9 4.44 <DL 
13-Dec-11 12.9 9.31 4.82 <DL 
DL: 0.005 mg L-1 
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Table C 7: Concentrations of Ca (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (mg L-1) 
27-Jan-10 136 81 109 568 0.2 
3-Feb-10 134 92 - 116 0.2 
19-Feb-10 44 30 79 282 0.2 
6-Apr-10 77 83 101 315 0.2 
13-Apr-10 82 94 105 98 0.2 
30-Apr-10 131 139 126 96 0.2 
21-May-10 109 129 127 146 0.2 
3-Jun-10 123 134 120 316 0.2 
18-Jun-10 121 146 127 250 0.2 
20-Jul-10 85 98 91 456 0.2 
19-Aug-10 87 86 89 97 0.2 
9-Sep-10 62 71 74 88 0.2 
24-Sep-10 81 83 87 167 0.2 
19-Oct-10 97 106 100 56 0.2 
16-Nov-10 93 86 112 79 0.2 
10-Dec-10 103 106 99 85 0.2 
14-Dec-10 102 97 103 183 0.2 
20-Jan-11 124 148 128 121 0.2 
28-Jan-11 125 113 116 151 0.2 
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Table C 8: Concentrations of Na (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 159 123 100 118 0.2 
3-Feb-10 157 134 107 126 0.2 
19-Feb-10 119 114 136 131 0.2 
6-Apr-10 164 147 126 110 0.2 
13-Apr-10 147 148 149 135 0.2 
30-Apr-10 203 171 152 139 0.2 
21-May-10 184 179 179 172 0.2 
3-Jun-10 181 188 177 173 0.2 
18-Jun-10 168 165 171 157 0.2 
20-Jul-10 125 137 128 143 0.2 
19-Aug-10 96 102 109 110 0.2 
9-Sep-10 95 91 92 96 0.2 
24-Sep-10 102 103 102 95 0.2 
19-Oct-10 107 119 106 101 0.2 
16-Nov-10 93 98 100 99 0.2 
10-Dec-10 82 83 82 81 0.2 
14-Dec-10 90 82 82 81 0.2 
20-Jan-11 106 100 87 85 0.2 
28-Jan-11 112 113 108 104 0.2 
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Table C 9: Concentrations of K (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 27 24 16 29 0.5 
3-Feb-10 27 24 14 40 0.5 
19-Feb-10 46 36 36 36 0.5 
6-Apr-10 36 37 31 30 0.5 
13-Apr-10 32 36 39 57 0.5 
30-Apr-10 24 33 41 41 0.5 
21-May-10 22 23 26 32 0.5 
3-Jun-10 19 23 26 39 0.5 
18-Jun-10 24 20 25 26 0.5 
20-Jul-10 21 14 16 30 0.5 
19-Aug-10 12 9 11 14 0.5 
9-Sep-10 17 3 5 15 0.5 
24-Sep-10 26 17 15 16 0.5 
19-Oct-10 38 40 32 32 0.5 
16-Nov-10 40 43 40 34 0.5 
10-Dec-10 15 25 32 30 0.5 
14-Dec-10 22 16 27 25 0.5 
20-Jan-11 26 21 17 20 0.5 
28-Jan-11 31 38 31 24 0.5 
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Table C 10: Concentrations of Mg (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 13 7.4 33 <DL 0.2 
3-Feb-10 14 8.4 32 <DL 0.2 
19-Feb-10 7.9 4.2 12 <DL 0.2 
6-Apr-10 11 10 12 0.37 0.2 
13-Apr-10 11 11 13 7.7 0.2 
30-Apr-10 14 15 16 10 0.2 
21-May-10 13 13 15 6.0 0.2 
3-Jun-10 15 14 14 <DL 0.2 
18-Jun-10 14 15 15 <DL 0.2 
20-Jul-10 10 11 0.03 2.5 0.2 
19-Aug-10 8.1 8.6 10 0.34 0.2 
9-Sep-10 6.4 7.1 7.6 4.9 0.2 
24-Sep-10 9.5 8.4 8.8 0.23 0.2 
19-Oct-10 11 13 12 11 0.2 
16-Nov-10 11 10 12 13 0.2 
10-Dec-10 13 13 12 10 0.2 
14-Dec-10 13 12 13 <DL 0.2 
20-Jan-11 14 17 15 1.1 0.2 
28-Jan-11 14 14 14 13 0.2 
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Table C 11: Concentrations of Cl (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (mg L-1) 
27-Jan-10 215 151 120 81 0.0002 
3-Feb-10 49 147 121 82 0.0002 
19-Feb-10 189 182 185 154 0.0002 
6-Apr-10 220 204 170 144 0.0002 
13-Apr-10 189 198 193 186 0.0002 
30-Apr-10 218 226 206 195 0.0002 
5-May-10 256 232 204 185 0.0002 
12-May-10 222 215 194 167 0.0002 
19-May-10 227 220 217 175 0.0002 
27-May-10 126 138 139 133 0.0002 
2-Jun-10 200 204 198 157 0.0002 
8-Jun-10 237 242 215 164 0.0002 
16-Jun-10 208 212 205 187 0.0002 
23-Jun-10 207 206 196 182 0.0002 
29-Jun-10 197 194 191 182 0.0002 
6-Jul-10 196 207 191 182 0.0002 
14-Jul-10 185 182 180 184 0.0002 
20-Jul-10 170 183 173 182 0.0002 
28-Jul-10 151 157 163 165 0.0002 
4-Aug-10 136 158 157 178 0.0002 
10-Aug-10 133 137 142 166 0.0002 
18-Aug-10 112 137 139 148 0.0002 
31-Aug-10 118 126 125 132 0.0002 
8-Sep-10 110 130 125 138 0.0002 
14-Sep-10 127 121 117 122 0.0002 
19-Oct-10 141 137 134 131 0.0002 
16-Nov-10 154 173 158 150 0.0002 
10-Dec-10 140 148 140 135 0.0002 
14-Dec-10 153 147 140 134 0.0002 
20-Jan-11 186 164 152 152 0.0002 
28-Jan-11 205 209 192 184 0.0002 
16-Feb-11 214 219 225 220 0.0002 
23-Mar-11 169 167 - 155 0.0002 
13-Apr-11 176 165 153 146 0.0002 
18-May-11 134 136 138 128 0.0002 
22-Jun-11 127 115 120 114 0.0002 
13-Jul-11 136 120 110 145 0.0002 
16-Aug-11 96 45 57 76 0.0002 
29-Nov-11 152 142 116 68 0.0002 
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Table C 12: Concentrations of SO4 (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (mg L-1) 
27-Jan-10 24 30 101 25 0.018 
3-Feb-10 26 30 96 7.3 0.018 
19-Feb-10 49 46 41 24 0.018 
6-Apr-10 51 46 50 42 0.018 
13-Apr-10 46 43 50 44 0.018 
30-Apr-10 32 27 32 37 0.018 
5-May-10 54 29 40 33 0.018 
12-May-10 41 35 43 33 0.018 
19-May-10 39 30 49 35 0.018 
27-May-10 31 17 37 27 0.018 
2-Jun-10 23 12 36 9.2 0.018 
8-Jun-10 32 8.4 37 26 0.018 
16-Jun-10 37 27 30 7.7 0.018 
23-Jun-10 35 24 32 22 0.018 
29-Jun-10 35 13 28 26 0.018 
6-Jul-10 37 6.8 33 16 0.018 
14-Jul-10 36 18 29 6.8 0.018 
20-Jul-10 35 15 27 8 0.018 
28-Jul-10 39 10 29 19 0.018 
4-Aug-10 43 49 32 9 0.018 
10-Aug-10 41 39 39 15 0.018 
18-Aug-10 48 23 42 25 0.018 
31-Aug-10 47 48 38 28 0.018 
8-Sep-10 50 48 46 36 0.018 
14-Sep-10 53 42 50 37 0.018 
19-Oct-10 57 52 38 29 0.018 
16-Nov-10 39 44 35 31 0.018 
10-Dec-10 56 57 58 52 0.018 
14-Dec-10 71 66 63 47 0.018 
20-Jan-11 79 85 91 77 0.018 
28-Jan-11 74 77 85 78 0.018 
16-Feb-11 71 78 76 68 0.018 
23-Mar-11 56 61  - 57 0.018 
13-Apr-11 35 23 59 54 0.018 
18-May-11 25 1.9 16 17 0.018 
22-Jun-11 25 0.6 23 11 0.018 
13-Jul-11 6.6 0.8 24 6.5 0.018 
16-Aug-11 28 51 58 40 0.018 
29-Nov-11 40 6.1 40 21 0.018 
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Table C 13: Concentrations of V (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 0.03 13 10 0.42 0.022 
3-Feb-10 <DL 14  0.42 0.022 
6-Apr-10 0.48 7.1 5.5 0.74 0.026 
13-Apr-10 1.3 6.3 4.7 1.0 0.026 
30-Apr-10 1.1 7.4 7.2 0.11 0.026 
5-May-10 <DL 10 <DL <DL 5 
12-May-10 <DL 11 <DL <DL 5 
19-May-10 <DL 13 <DL <DL 5 
21-May-10 <DL 12 3.6 0.13 0.026 
27-May-10 <DL 12 <DL <DL 5 
2-Jun-10 <DL 14 <DL <DL 5 
8-Jun-10 <DL 12 <DL <DL 5 
16-Jun-10 <DL 11 <DL <DL 5 
18-Jun-10 0.16 10 3.8 0.32 0.026 
23-Jun-10 <DL 10 <DL <DL 5 
29-Jun-10 <DL 8.2 5.3 <DL 5 
6-Jul-10 <DL 11 5 <DL 5 
14-Jul-10 <DL 8.9 5 <DL 5 
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Table C 14: Concentrations of Al (µg L
-1
) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 4.6 - 24 <DL 0.149 
3-Feb-10 <DL 1.5 19 <DL 0.149 
6-Apr-10 <DL 1.3 <DL 1.4 0.155 
13-Apr-10 6.7 2.5 <DL 6.3 0.155 
30-Apr-10 <DL <DL <DL <DL 0.155 
5-May-10 44 14 <DL 12 10 
12-May-10 20 25 <DL <DL 10 
19-May-10 27 27 <DL <DL 10 
21-May-10 <DL 36 <DL <DL 0.155 
27-May-10 11 36 <DL <DL 10 
2-Jun-10 16 51 34 <DL 10 
8-Jun-10 42 60 10 <DL 10 
16-Jun-10 15 37 90 <DL 10 
18-Jun-10 <DL 24 <DL <DL 0.155 
23-Jun-10 <DL 21 <DL <DL 10 
29-Jun-10 <DL 31 <DL <DL 10 
6-Jul-10 <DL 39 12 <DL 10 
14-Jul-10 <DL 33 57 <DL 10 
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Table C 15: Concentrations of Zn (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 10 4.5 6.5 30 0.25 
3-Feb-10 3.5 2.0 2.8 0.29 0.25 
19-Feb-10 22 41 26 11 0.25 
6-Apr-10 9.2 5.3 6.8 20 0.25 
13-Apr-10 4.3 8.0 10 0.8 0.25 
30-Apr-10 3.6 1.0 2.3 1.1 0.25 
21-May-10 21 15 1.3 0.49 0.25 
3-Jun-10 5.9 6.4 0.29 0.29 0.25 
18-Jun-10 5.7 0.85 0.29 0.29 0.25 
20-Jul-10 9.4 19 5.0 37 0.29 
19-Aug-10 19 56 9.3 8.7 0.29 
9-Sep-10 21 7.7 9.1 8.9 0.29 
24-Sep-10 4.5 23 6.9 7.1 0.29 
19-Oct-10 70 39 22 18 0.29 
16-Nov-10 51 31 32 23 0.29 
10-Dec-10 2.4 20 10 6.6 0.29 
14-Dec-10 12 5.4 20 5.6 0.29 
20-Jan-11 88 9.3 9.2 29 0.29 
28-Jan-11 14 21 10 13 0.29 
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Table  C 16: Concentrations of Mn (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
 
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 44 12 44 11 0.04 
3-Feb-10 42 14 22 0.03 0.04 
19-Feb-10 89 11 4.9 0.15 0.04 
6-Apr-10 16 25 102 0.04 0.04 
13-Apr-10 17 39 140 2.1 0.04 
30-Apr-10 36 75 89 0.84 0.04 
21-May-10 31 63 8.2 0.73 0.04 
3-Jun-10 54 55 0.03 0.03 0.04 
18-Jun-10 54 78 0.04 0.03 0.04 
20-Jul-10 21 35 0.35 0.28 0.03 
19-Aug-10 16 56 0.41 0.03 0.03 
9-Sep-10 12 33 0.27 0.8 0.03 
24-Sep-10 24 27 4.0 0.04 0.03 
19-Oct-10 8.1 25 7.8 2.3 0.03 
16-Nov-10 13 31 3.9 0.91 0.03 
10-Dec-10 4.0 25 31 3.8 0.03 
14-Dec-10 5.1 21 1.8 0.24 0.03 
20-Jan-11 13 51 0.58 0.75 0.03 
28-Jan-11 24 15 30 23 0.03 
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Table C 17: Concentrations of Cr (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.   
 
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 0.05 0.05 0.89 13 0.05 
3-Feb-10 0.05 0.05 0.57 0.92 0.05 
19-Feb-10 0.05 0.05 1.4 4.0 0.05 
6-Apr-10 0.05 0.05 0.05 0.05 0.05 
13-Apr-10 0.05 0.26 0.05 0.05 0.05 
30-Apr-10 0.05 0.05 0.05 0.59 0.05 
21-May-10 0.05 0.05 0.05 1.6 0.05 
3-Jun-10 0.05 0.05 0.05 0.05 0.05 
18-Jun-10 0.05 0.05 0.05 0.05 0.05 
20-Jul-10 0.69 0.32 0.30 0.40 0.05 
19-Aug-10 0.28 - 0.31 0.34 0.05 
9-Sep-10 1.7 0.31 0.32 0.50 0.05 
24-Sep-10 0.48 0.03 0.77 0.62 0.05 
19-Oct-10 0.32 0.43 0.46 0.28 0.05 
16-Nov-10 0.33 0.24 0.66 0.55 0.05 
10-Dec-10 0.45 0.76 0.20 0.39 0.05 
14-Dec-10 0.09 0.26 0.15 0.30 0.05 
20-Jan-11 0.49 0.69 0.31 0.13 0.05 
28-Jan-11 0.05 1.8 0.20 0.54 0.05 
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Table C 18: Concentrations of Cu (µg L
-1
) along the treatment flow path during theEW-BOFS 
demonstration-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 4.9 4.5 29 27 0.04 
3-Feb-10 2.8 3.7 21 22 0.04 
19-Feb-10 60 44 24 14 0.04 
6-Apr-10 8.3 3.9 17 11 0.04 
13-Apr-10 9.1 3.9 15 12 0.04 
30-Apr-10 4.5 2.6 12 10 0.04 
21-May-10 10 9.1 14 2.0 0.04 
3-Jun-10 10 2.4 16 8.0 0.04 
18-Jun-10 6.5 2.0 15 7.8 0.04 
20-Jul-10 14 16 15 176 0.10 
19-Aug-10 13 56 18 19 0.10 
9-Sep-10 23 14 19 27 0.10 
24-Sep-10 11 12 18 16 0.10 
19-Oct-10 26 12 23 10 0.10 
16-Nov-10 23 8.5 18 7.1 0.10 
10-Dec-10 3.1 9.3 14 9.2 0.10 
14-Dec-10 11 20 15 11 0.10 
20-Jan-11 252 14 12 73 0.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 299 
Table C 19: Concentrations of Fe (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 28 78 41 55 0.07 
3-Feb-10 9.5 60 23 3.4 0.07 
19-Feb-10 76 97 22 3.4 0.07 
6-Apr-10 21 39 28 2.2 0.07 
13-Apr-10 29 64 51 21 0.07 
30-Apr-10 25 82 57 4.7 0.07 
21-May-10 37 75 11 0.81 0.07 
3-Jun-10 48 49 28 0.26 0.07 
18-Jun-10 61 78 1.4 0.26 0.07 
20-Jul-10 37 62 25 25 0.26 
19-Aug-10 39 56 28 20 0.26 
9-Sep-10 39 139 25 24 0.26 
24-Sep-10 32 60 27 8.1 0.26 
19-Oct-10 19 53 17 20 0.26 
16-Nov-10 57 58 14 3.9 0.26 
10-Dec-10 13 25 15 23 0.26 
14-Dec-10 9.3 17 15 5.1 0.26 
20-Jan-11 11 41 12 7.3 0.26 
28-Jan-11 11 21 16 4.7 0.26 
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Table C 20: Concentrations of Ni (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 2.6 4.4 4.6 42 0.04 
3-Feb-10 2.6 3.5 4.3 28 0.04 
19-Feb-10 7.4 11 40 30 0.04 
6-Apr-10 6.6 3.1 3.7 9.8 0.04 
13-Apr-10 6.5 3.5 4.3 9.0 0.04 
30-Apr-10 3.8 2.7 2.9 8.7 0.04 
21-May-10 3.6 3.0 2.4 0.17 0.04 
3-Jun-10 3.2 3.8 2.1 16 0.04 
18-Jun-10 3.7 2.9 2.0 17 0.04 
20-Jul-10 3.3 2.3 1.4 20 0.08 
19-Aug-10 3.1 - 1.9 4.4 0.08 
9-Sep-10 3.7 1.8 2.1 3.4 0.08 
24-Sep-10 2.7 2.3 3.2 3.7 0.08 
19-Oct-10 2.3 1.7 3.5 1.6 0.08 
16-Nov-10 2.1 2.2 2.8 1.5 0.08 
10-Dec-10 1.1 2.5 3.3 2.1 0.08 
14-Dec-10 3.3 3.0 3.3 2.1 0.08 
20-Jan-11 3.1 6.4 3.5 2.7 0.08 
28-Jan-11 3.8 2.2 3.6 0.72 0.08 
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Table C 21: Concentrations of Pb (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
27-Jan-10 0.03 0.03 3.8 14 0.01 
3-Feb-10 4.3 5.1 0.07 8.3 0.01 
19-Feb-10 0.74 0.98 14 3.8 0.01 
6-Apr-10 0.03 0.03 0.03 0.33 0.01 
13-Apr-10 0.03 0.03 0.03 0.03 0.01 
30-Apr-10 0.03 0.03 0.03 0.03 0.01 
21-May-10 0.03 0.15 0.03 0.87 0.01 
3-Jun-10 0.03 0.03 0.03 0.69 0.01 
18-Jun-10 0.03 0.03 0.03 0.14 0.01 
20-Jul-10 7.7 4.5 3.0 24 0.03 
19-Aug-10 4.1 5.6 3.8 4.2 0.03 
9-Sep-10 4.7 4.9 3.2 4.0 0.03 
24-Sep-10 4.0 3.2 4.4 2.6 0.03 
19-Oct-10 2.0 2.4 2.1 1.2 0.03 
16-Nov-10 4.1 1.1 2.6 0.83 0.03 
10-Dec-10 0.72 0.85 1.5 0.73 0.03 
14-Dec-10 1.1 3.5 1.3 1.7 0.03 
20-Jan-11 - 3.1 2.2 9.3 0.03 
28-Jan-11 2.9 5.4 2.5 1.1 0.03 
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Table C 22: Concentrations of NH3-N (mg L
-1
) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 85 64 10 59 
3-Feb-10 85 61 8.0 50 
19-Feb-10 61 35 13 47 
6-Apr-10 47 59 22 14 
13-Apr-10 57 68 30 20 
30-Apr-10 40 60 27 13 
5-May-10 27 55 0.80 4.6 
12-May-10 15 21 0.30 4.2 
19-May-10 32 25 0.40 5.5 
27-May-10 29 40 0.02 5.6 
2-Jun-10 45 40 0.06 8.0 
8-Jun-10 42 39 0.02 2.5 
16-Jun-10 46 34 0.02 4.7 
23-Jun-10 50 31 0.02 2.3 
29-Jun-10 39 18 0.02 5.3 
6-Jul-10 29 30 0.02 2.8 
14-Jul-10 28 27 0.02 3.4 
20-Jul-10 32 25 0.02 2.8 
28-Jul-10 20 21 0.02 1.6 
4-Aug-10 29 28 0.02 2.3 
10-Aug-10 26 22 0.02 1.8 
18-Aug-10 24 17 0.02 1.4 
31-Aug-10 16 16 0.02 1.3 
8-Sep-10 27 13 0.02 0.19 
14-Sep-10 20 22 0.02 1.1 
19-Oct-10 70 78 0.02  
16-Nov-10 83 102 0.02 2.4 
14-Dec-10 53 51 0.02 3.5 
20-Jan-11 57 33 0.02 2.3 
16-Feb-11 42 54 0.02 21 
23-Mar-11 21 27 0.02 0.68 
13-Apr-11 68 44 0.02 0.75 
18-May-11 37 53 0.02 1.8 
22-Jun-11 32 27 0.02 2.2 
13-Jul-11 108 27 0.02 3.3 
16-Aug-11 98 7.9 0.02 1.6 
27-Oct-11 55 36 0.02 5.1 
29-Nov-11 85 42 0.02 2.6 
13-Dec-11 109 41 0.02 5.2 
DL: 0.02 mg L-1 
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Table C 23: Concentrations of NO3-N (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 0.05 12 62 10 
3-Feb-10 0.05 0.05 63 3.0 
19-Feb-10 5.3 7.7 83 12 
6-Apr-10 10 1.0 48 56 
13-Apr-10 7.7 0.16 48 48 
30-Apr-10 8.9 0.00 43 58 
5-May-10 4.4 0.03 64 59 
12-May-10 0.05 0.05 46 41 
19-May-10 0.05 0.05 47 41 
27-May-10 0.10 0.05 23 28 
2-Jun-10 0.05 0.05 38 36 
8-Jun-10 0.12 0.05 40 31 
16-Jun-10 0.05 0.05 37 39 
23-Jun-10 0.29 0.04 36 35 
29-Jun-10 0.58 0.23 36 35 
6-Jul-10 0.05 0.05 39 33 
14-Jul-10 0.56 0.05 34 30 
20-Jul-10 0.09 0.05 29 28 
28-Jul-10 0.52 0.04 27 23 
4-Aug-10 0.67 0.03 25 26 
10-Aug-10 0.03 0.03 22 23 
18-Aug-10 0.03 0.03 21 21 
31-Aug-10 2.2 0.05 18 18 
8-Sep-10 1.5 2.7 15 16 
14-Sep-10 0.03 1.9 15 15 
19-Oct-10 1.4 0.03 59 50 
16-Nov-10 0.29 0.03 93 80 
14-Dec-10 - 0.82 - - 
20-Jan-11 9.1 0.74 39 40 
16-Feb-11 45 37 75 58 
23-Mar-11 23 15 - 51 
13-Apr-11 0.03 0.03 44 46 
18-May-11 0.03 0.03 55 46 
22-Jun-11 0.44 0.13 33 32 
13-Jul-11 0.12 0.09 36 42 
16-Aug-11 0.03 0.03 17 21 
29-Nov-11 0.03 0.05 44 20 
13-Dec-11 0.04 0.09 43 31 
DL: 0.05 mg L-1 
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Table C 24: Concentrations of NO2-N (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 <DL <DL 2.5 1.9 
3-Feb-10 <DL <DL 1.1 1.2 
19-Feb-10 1.1 60 0.76 1.2 
6-Apr-10 17 42 24 0.37 
13-Apr-10 <DL 73 24 0.60 
30-Apr-10 <DL <DL 18 0.77 
5-May-10 1.4 <DL 1.4 1.6 
12-May-10 <DL <DL <DL 2.3 
19-May-10 <DL <DL <DL 2.0 
27-May-10 0.14 <DL <DL 2.1 
2-Jun-10 3.2 <DL <DL 5.5 
8-Jun-10 <DL <DL <DL 5.7 
16-Jun-10 <DL <DL <DL 6.7 
23-Jun-10 <DL <DL 0.82 1.9 
29-Jun-10 <DL <DL <DL 1.6 
6-Jul-10 <DL <DL <DL 5.1 
14-Jul-10 <DL <DL <DL 6.6 
20-Jul-10 <DL <DL <DL 6.4 
28-Jul-10 0.43 <DL <DL 6.4 
4-Aug-10 0.75 <DL <DL 5.9 
10-Aug-10 <DL <DL <DL 4.6 
18-Aug-10 <DL <DL <DL 3.2 
31-Aug-10 0.82 0.08 <DL 1.8 
8-Sep-10 1.6 0.07 <DL 1.2 
14-Sep-10 <DL 0.29 0.54 2.0 
19-Oct-10 0.05 <DL 2.5 3.1 
16-Nov-10 <DL <DL 0.26 1.8 
10-Dec-10 0.32 0.53 0.11 0.47 
14-Dec-10 0.68 0.90 0.30 0.69 
20-Jan-11 1.0 0.20 <DL 0.41 
28-Jan-11 0.98 <DL <DL 0.25 
16-Feb-11 1.6 1.9 1.8 1.3 
23-Mar-11 1.2 0.59 - 0.42 
13-Apr-11 <DL 0.07 1.8 1.5 
18-May-11 <DL <DL <DL 0.84 
22-Jun-11 <DL <DL <DL 4.5 
13-Jul-11 <DL <DL <DL 4.8 
16-Aug-11 <DL <DL <DL 1.9 
29-Nov-11 0.06 <DL 0.11 1.9 
13-Dec-11 0.05 <DL <DL 2.5 
DL: 0.05 mg L-1   
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Table C 25: Concentration ratio of ammonia and total nitrogen (NH3-N/NT) along the treatment flow 
path during the EW-BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 1.0E+00 8.5E-01 1.4E-01 8.3E-01 
3-Feb-10 1.0E+00 1.0E+00 1.1E-01 9.2E-01 
19-Feb-10 9.6E-01 3.6E-01 4.1E-01 9.2E-01 
6-Apr-10 7.1E-01 5.8E-01 3.9E-01 5.1E-01 
13-Apr-10 9.7E-01 4.8E-01 4.6E-01 6.4E-01 
30-Apr-10 9.5E-01 1.0E+00 4.9E-01 4.9E-01 
5-May-10 8.2E-01 1.0E+00 1.2E-02 7.1E-02 
12-May-10 9.9E-01 1.0E+00 6.5E-03 8.9E-02 
19-May-10 1.0E+00 1.0E+00 8.4E-03 1.1E-01 
27-May-10 9.9E-01 1.0E+00 8.5E-04 1.6E-01 
2-Jun-10 9.3E-01 1.0E+00 1.6E-03 1.6E-01 
8-Jun-10 1.0E+00 1.0E+00 4.9E-04 6.5E-02 
16-Jun-10 1.0E+00 1.0E+00 5.4E-04 9.4E-02 
23-Jun-10 9.9E-01 1.0E+00 5.5E-04 5.9E-02 
29-Jun-10 9.8E-01 9.8E-01 5.5E-04 1.3E-01 
6-Jul-10 1.0E+00 1.0E+00 5.1E-04 6.8E-02 
14-Jul-10 9.8E-01 1.0E+00 5.8E-04 8.4E-02 
20-Jul-10 1.0E+00 1.0E+00 2.7E-03 7.4E-02 
28-Jul-10 9.6E-01 1.0E+00 7.5E-04 5.0E-02 
4-Aug-10 9.5E-01 1.0E+00 1.2E-03 6.8E-02 
10-Aug-10 1.0E+00 1.0E+00 9.0E-04 6.1E-02 
18-Aug-10 1.0E+00 1.0E+00 1.3E-02 5.7E-02 
31-Aug-10 8.4E-01 9.9E-01 1.1E-02 6.2E-02 
8-Sep-10 9.0E-01 8.2E-01 4.7E-03 1.1E-02 
14-Sep-10 1.0E+00 9.1E-01 1.8E-01 5.9E-02 
19-Oct-10 9.8E-01 1.0E+00 1.4E-01 0.0E+00 
16-Nov-10 1.0E+00 1.0E+00 2.1E-04 2.9E-02 
10-Dec-10 7.5E-01 9.3E-01 4.7E-01 2.8E-01 
14-Dec-10 9.9E-01 9.7E-01 9.1E-01 8.4E-01 
20-Jan-11 8.5E-01 9.7E-01 2.1E-03 5.4E-02 
28-Jan-11 6.6E-01 4.4E-01 6.7E-02 3.6E-02 
16-Feb-11 4.7E-01 5.8E-01 8.3E-02 2.6E-01 
23-Mar-11 4.6E-01 6.4E-01 - 1.3E-02 
13-Apr-11 1.0E+00 1.0E+00 4.0E-02 1.6E-02 
18-May-11 1.0E+00 1.0E+00 1.8E-04 3.6E-02 
22-Jun-11 9.9E-01 9.9E-01 6.0E-04 5.6E-02 
13-Jul-11 1.0E+00 1.0E+00 8.2E-04 6.5E-02 
16-Aug-11 1.0E+00 9.9E-01 1.2E-03 6.4E-02 
29-Nov-11 1.0E+00 1.0E+00 5.6E-03 1.0E-01 
13-Dec-11 1.0E+00 1.0E+00 4.7E-04 1.3E-01 
 
 306 
Table C 26: Concentration ratio of ammonia and total nitrogen (NO3-N/NT) along the treatment flow 
path during the EW-BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 5.8E-04 1.5E-01 8.3E-01 1.4E-01 
3-Feb-10 5.7E-04 8.0E-04 8.7E-01 5.5E-02 
19-Feb-10 1.9E-02 1.8E-02 5.7E-01 5.5E-02 
6-Apr-10 3.4E-02 2.3E-03 1.9E-01 4.7E-01 
13-Apr-10 2.9E-02 2.6E-04 1.7E-01 3.4E-01 
30-Apr-10 4.8E-02 0.0E+00 1.8E-01 4.8E-01 
5-May-10 1.4E-01 5.9E-04 9.7E-01 9.0E-01 
12-May-10 3.1E-03 2.4E-03 9.9E-01 8.6E-01 
19-May-10 1.5E-03 1.9E-03 9.9E-01 8.4E-01 
27-May-10 3.4E-03 1.2E-03 1.0E+00 7.8E-01 
2-Jun-10 1.0E-03 1.2E-03 1.0E+00 7.3E-01 
8-Jun-10 2.9E-03 1.3E-03 1.0E+00 7.9E-01 
16-Jun-10 1.1E-03 1.4E-03 1.0E+00 7.7E-01 
23-Jun-10 5.9E-03 1.2E-03 9.8E-01 8.9E-01 
29-Jun-10 1.5E-02 1.3E-02 1.0E+00 8.4E-01 
6-Jul-10 1.7E-03 1.6E-03 1.0E+00 8.1E-01 
14-Jul-10 2.0E-02 1.8E-03 1.0E+00 7.5E-01 
20-Jul-10 2.8E-03 2.0E-03 1.0E+00 7.6E-01 
28-Jul-10 2.4E-02 1.9E-03 1.0E+00 7.5E-01 
4-Aug-10 2.2E-02 1.1E-03 1.0E+00 7.6E-01 
10-Aug-10 1.2E-03 1.4E-03 1.0E+00 7.9E-01 
18-Aug-10 1.3E-03 1.8E-03 9.9E-01 8.2E-01 
31-Aug-10 1.2E-01 3.3E-03 9.9E-01 8.5E-01 
8-Sep-10 5.0E-02 1.8E-01 9.9E-01 9.2E-01 
14-Sep-10 1.5E-03 7.9E-02 8.0E-01 8.3E-01 
19-Oct-10 2.0E-02 4.1E-04 8.3E-01 9.4E-01 
16-Nov-10 3.5E-03 3.0E-04 1.0E+00 9.5E-01 
10-Dec-10 2.5E-01 5.9E-02 5.2E-01 7.1E-01 
14-Dec-10 - 1.6E-02 - - 
20-Jan-11 1.4E-01 2.2E-02 1.0E+00 9.4E-01 
28-Jan-11 3.2E-01 5.6E-01 9.3E-01 9.6E-01 
16-Feb-11 5.1E-01 4.0E-01 9.0E-01 7.3E-01 
23-Mar-11 5.2E-01 3.5E-01 - 9.8E-01 
13-Apr-11 4.4E-04 6.7E-04 9.2E-01 9.5E-01 
18-May-11 8.1E-04 5.7E-04 1.0E+00 9.5E-01 
22-Jun-11 1.4E-02 4.8E-03 1.0E+00 8.3E-01 
13-Jul-11 1.1E-03 3.3E-03 1.0E+00 8.4E-01 
16-Aug-11 3.1E-04 3.8E-03 1.0E+00 8.6E-01 
29-Nov-11 3.5E-04 1.3E-03 9.9E-01 8.2E-01 
13-Dec-11 3.6E-04 2.2E-03 1.0E+00 8.0E-01 
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Table C 27: Concentrations of DO (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 1.4 1.4 12 3.0 
3-Feb-10 0.26 0.20 11 3.8 
5-May-10 3.5 0.70 8.7 6.0 
12-May-10 0.85 2.4 11 3.4 
19-May-10 0.20 2.2 12 4.0 
27-May-10 1.8 1.6 9.0 2.6 
2-Jun-10 0.13 1.0 8.8 2.7 
8-Jun-10 0.22 2.4 9.2 6.8 
16-Jun-10 0.42 2.0 9.0 2.6 
23-Jun-10 0.14 1.4 7.2 4.6 
29-Jun-10 4.9 3.1 8.5 5.0 
6-Jul-10 0.35 2.3 8.4 4.3 
14-Jul-10 2.4 0.18 6.5 3.0 
20-Jul-10 0.19 0.26 8.4 2.4 
28-Jul-10 1.5 4.3 8.4 3.7 
4-Aug-10 2.5 4.5 8.2 3.8 
10-Aug-10 0.85 1.3 8.2 3.1 
18-Aug-10 0.51 2.3 8.9 3.2 
31-Aug-10 3.7 2.5 8.4 6.1 
8-Sep-10 1.2 2.6 8.8 6.7 
14-Sep-10 0.41 2.8 7.5 5.1 
19-Oct-10 0.49 1.4 4.6 2.7 
16-Nov-10 0.53 0.3 9.4 3.3 
14-Dec-10 2.9 3.7 10 7.8 
20-Jan-11 1.3 4.6 10 8.5 
16-Feb-11 6.4 3.7 7.7 4.2 
23-Mar-11 7.1 3.7 - 9.3 
13-Apr-11 0.43 2.9 9.5 8.5 
18-May-11 0.20 3.8 9.9 5.7 
22-Jun-11 1.9 1.6 8.1 3.6 
13-Jul-11 1.2 1.9 8.6 3.4 
16-Aug-11 0.18 1.4 8.0 3.9 
27-Oct-11 1.0 2.4 10 2.2 
29-Nov-11 0.84 2.2 10 6.6 
13-Dec-11 0.31 2.2 12 4.2 
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Table C 28: Concentrations of cBOD5 (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 169 52 37 1.0 
3-Feb-10 202 85 37 1.0 
5-May-10 59 63 10 1.0 
12-May-10 92 76 9.0 1.0 
19-May-10 79 94 32 1.0 
27-May-10 60 51 4.0 1.0 
2-Jun-10 124 85 13 1.0 
8-Jun-10 49 30 10 1.0 
16-Jun-10 91 32 11 1.0 
23-Jun-10 43 20 10 1.0 
29-Jun-10 30 17 8.0 1.0 
6-Jul-10 34 9.0 6.0 1.0 
14-Jul-10 18 18 3.0 1.0 
20-Jul-10 10 6.0 4.0 1.0 
28-Jul-10 5.0 2.0 1.0 <DL 
4-Aug-10 16 15 6.0 <DL 
10-Aug-10 25 15 10 <DL 
18-Aug-10 20 12 5.0 <DL 
31-Aug-10 9.0 9.0 5.0 <DL 
8-Sep-10 25 10 2.0 <DL 
14-Sep-10 55 9.0 4.0 <DL 
19-Oct-10 39 25 5.0 1.0 
16-Nov-10 52 24 2.0 <DL 
14-Dec-10 22 10 2.0 <DL 
20-Jan-11 52 11 1.0 <DL 
16-Feb-11 26 10 4.0 2.0 
23-Mar-11 18 5.0  1.0 
13-Apr-11 84 7.0 2.0 1.0 
18-May-11 105 84 2.0 1.0 
22-Jun-11 22 9.0 2.0 <DL 
13-Jul-11 185 8.0 2.0 <DL 
16-Aug-11 42 5.0 3.0 <DL 
27-Oct-11 142 9.0 3.0 <DL 
29-Nov-11 78 4.0 2.0 <DL 
13-Dec-11 114 6.0 3.0 <DL 
DL: 1 mg L-1 
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Table C 29: Concentrations of COD (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 332 273 65 112 
3-Feb-10 335 240 64 88 
5-May-10 109 128 38 36 
12-May-10 118 82 30 32 
19-May-10 167 85 50 24 
27-May-10 131 89 26 30 
2-Jun-10 174 76 19 36 
8-Jun-10 128 71 25 31 
16-Jun-10 123 59 24 33 
29-Jun-10 90 46 18 17 
6-Jul-10 118 49 23 27 
14-Jul-10 73 44 18 33 
20-Jul-10 104 74 52 61 
28-Jul-10 41 46 22 32 
4-Aug-10 60 38 20 33 
10-Aug-10 66 39 19 34 
18-Aug-10 73 45 20 27 
31-Aug-10 53 38 21 34 
8-Sep-10 75 35 21 21 
14-Sep-10 137 37 21 28 
19-Oct-10 122 90 37 35 
16-Nov-10 155 86 32 34 
14-Dec-10 86 49 24 30 
20-Jan-11 150 45 22 18 
16-Feb-11 94 61 43 50 
23-Mar-11 54 40 - 21 
13-Apr-11 210 50 24 22 
18-May-11 242 154 19 17 
22-Jun-11 56 49 30 28 
16-Aug-11 348 46 28 29 
27-Oct-11 244 38 25 35 
29-Nov-11 244 37 13 20 
13-Dec-11 210 41 16 16 
DL: 3 mg L-1 
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Table C 30: Concentrations of E.coli  (CFU/100mL) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 - 3.0E+02 3.0E+00 1.1E+01 
3-Feb-10 3.1E+05 5.0E+01 1.6E+01 <DL 
5-May-10 4.9E+04 2.5E+03 1.4E+02 <DL 
12-May-10 1.5E+05 3.0E+03 7.5E+02 <DL 
19-May-10 1.6E+05 2.2E+03 3.0E+01 <DL 
27-May-10 7.8E+04 5.9E+03 1.5E+01 <DL 
2-Jun-10 3.0E+04 6.0E+02 1.5E+01 <DL 
8-Jun-10 3.2E+04 3.0E+02 1.1E+01 <DL 
16-Jun-10 1.7E+05 9.5E+02 6.0E+01 <DL 
23-Jun-10 5.2E+04 3.0E+03 1.3E+01 <DL 
29-Jun-10 1.4E+05 2.9E+04 <DL <DL 
14-Jul-10 3.3E+04 1.5E+02 <DL <DL 
28-Jul-10 2.2E+03 1.3E+03 <DL <DL 
4-Aug-10 9.4E+04 1.3E+03 8.0E+00 <DL 
10-Aug-10 3.3E+03 2.2E+03 5.0E+00 <DL 
18-Aug-10 5.5E+04 1.0E+03 8.0E+00 <DL 
31-Aug-10 5.9E+04 8.6E+02 3.8E+02 <DL 
8-Sep-10 7.4E+05 5.1E+03 4.9E+02 <DL 
14-Sep-10 2.5E+05 1.2E+05 5.1E+03 <DL 
19-Oct-10 6.2E+05 1.0E+05 2.1E+03 7.9E+02 
16-Nov-10 2.4E+06 4.8E+05 6.0E+00 3.0E+00 
14-Dec-10 7.2E+04 7.9E+04 5.5E+03 6.0E+00 
20-Jan-11 2.5E+06 3.2E+04 2.5E+02 3.0E+00 
16-Feb-11 3.5E+05 1.4E+04 2.4E+04 2.4E+03 
23-Mar-11 5.2E+04 9.2E+04 - 3.0E+01 
13-Apr-11 1.4E+05 4.0E+03 6.0E+01 6.0E+00 
18-May-11 8.5E+05 6.0E+02 3.0E+01 3.0E+00 
22-Jun-11 2.2E+04 1.0E+03 3.0E+00 3.0E+00 
13-Jul-11 7.6E+04 1.2E+03 3.0E+01 3.0E+00 
16-Aug-11 8.1E+05 3.0E+01 3.0E+01 3.0E+00 
27-Oct-11 4.4E+04 1.5E+02 8.0E+01 3.0E+00 
29-Nov-11 2.5E+05 1.5E+02 3.0E+01 3.0E+00 
13-Dec-11 2.0E+04 5.0E+01 3.0E+01 3.0E+00 
DL: 3CFU/100 ml 
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Table C 31: Concentrations of Total coliform (CFU/100mL) along the treatment flow path during the 
EW-BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
27-Jan-10 9.7E+06 1.3E+03 1.4E+02 <DL 
3-Feb-10 6.9E+05 5.0E+01 7.6E+01 <DL 
5-May-10 1.6E+05 2.4E+04 2.4E+03 <DL 
12-May-10 1.2E+06 1.9E+04 1.5E+03 <DL 
19-May-10 1.2E+06 1.8E+04 5.0E+02 <DL 
27-May-10 4.8E+06 4.2E+04 2.2E+02 <DL 
2-Jun-10 4.3E+05 3.8E+03 3.6E+02 <DL 
8-Jun-10 1.5E+05 6.5E+03 2.1E+02 <DL 
16-Jun-10 1.7E+06 1.5E+04 1.3E+02 <DL 
23-Jun-10 3.4E+05 1.6E+04 2.0E+02 <DL 
29-Jun-10 4.7E+05 8.1E+04 3.3E+01 <DL 
14-Jul-10 1.9E+05 4.7E+03 5.2E+01 8.0E+00 
28-Jul-10 3.8E+03 3.8E+03 4.9E+01 <DL 
4-Aug-10 1.8E+05 7.0E+04 1.1E+02 <DL 
10-Aug-10 8.6E+04 4.7E+04 9.8E+01 <DL 
18-Aug-10 9.4E+05 9.8E+03 8.7E+01 <DL 
31-Aug-10 4.3E+05 3.3E+03 1.0E+03 <DL 
8-Sep-10 9.4E+05 1.0E+04 6.5E+02 <DL 
14-Sep-10 3.4E+06 2.4E+05 1.9E+04 <DL 
19-Oct-10 8.6E+05 1.3E+05 2.7E+03 - 
16-Nov-10 2.4E+06 4.8E+05 4.8E+03 - 
14-Dec-10 1.9E+06 1.2E+06 9.7E+03 <DL 
20-Jan-11 6.8E+06 2.5E+05 1.5E+03 <DL 
16-Feb-11 1.4E+06 5.4E+04 2.4E+03 - 
23-Mar-11 4.9E+05 1.6E+05 - 3.0E+01 
13-Apr-11 3.5E+05 6.7E+03 9.8E+02 6.0E+00 
18-May-11 9.7E+06 8.1E+04 1.6E+03 3.0E+00 
22-Jun-11 5.6E+05 1.5E+04 9.8E+01 3.0E+00 
13-Jul-11 1.6E+06 1.2E+03 1.9E+03 3.0E+00 
16-Aug-11 1.2E+07 2.1E+03 8.7E+02 2.4E+03 
27-Oct-11 2.2E+05 8.6E+03 5.9E+02 3.0E+00 
29-Nov-11 5.8E+05 8.0E+02 9.4E+02 3.0E+00 
13-Dec-11 1.7E+05 1.3E+02 3.0E+01 3.0E+00 
DL: 3CFU/100 ml 
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Table C 32: Mass change of PO4-P observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
  
PO4-P 
mass in 
(mg) 
PO4-P   
mass out  
(mg) 
PO4-P  
mass 
change 
(mg) 
PO4-P 
mass 
change 
(Kg) 
PO4-P 
mass % 
change 
Overall 
treatment 
system 
2003663 89904 1913759 1.91 95.51 
Cell 2 2003663 1978166 25497 0.03 1.27 
Cell 3 1978166 1450086 528080 0.53 26.70 
Cell 4 1450086 89904 1360182 1.36 93.80 
 
 
 
Table C 33: Mass change of NH3-N observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
  
NH3-N 
mass in 
(mg) 
NH3-N  
mass out  
(mg) 
NH3-N  
mass 
change 
(mg) 
NH3-N  
mass 
change 
(Kg) 
NH3-N  
mass % 
change 
Overall 
treatment 
system 
16487032 3516451 12970581 12.97 78.67 
Cell 2 16487032 16298910 188122 0.19 1.14 
Cell 3 16298910 937765 15361145 15.36 94.25 
Cell 4 937765 3516451 -2578686 -2.58 -274.98 
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Table C 34: Mass change of NO3-N observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
  NO3-N 
mass in 
(mg) 
NO3-N  
mass out  
(mg) 
NO3-N  
mass 
change 
(mg) 
NO3-N  
mass 
change 
(Kg) 
NO3-N  
mass % 
change 
Overall 
treatment 
system 
1257749 13219591 -11961842 -11.96 -951.05 
Cell 2 1257749 656414 601335 0.60 47.81 
Cell 3 656414 17408976 -16752562 -16.75 -2552.13 
Cell 4 17408976 13219591 4189385 4.19 24.06 
 
 
 
Table C 35: Mass change of NO2-N observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
  NO2-N 
mass in 
(mg) 
NO2-N  
mass out  
(mg) 
NO2-N  
mass 
change 
(mg) 
NO2-N  
mass 
change 
(Kg) 
NO2-N  
mass % 
change 
Overall 
treatment 
system 
176941 814301 -637360 -0.64 -360.21 
Cell 2 176941 66841 110100 0.11 62.22 
Cell 3 66841 244506 -177665 -0.18 -265.80 
Cell 4 244506 814301 -569795 -0.57 -233.04 
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Table C 36: Mass change of NT observed in different components of the treatment system. The +ve values 
indicate mass loses from the system component and the -ve values indicate mass gains within the system 
component. 
 
  
NT mass in 
(mg) 
NT mass 
out  (mg) 
NT  mass 
change 
(mg) 
NT  mass 
change 
(Kg) 
NT  mass % 
change 
Overall 
treatment 
system 
17921722 17550343 371379 0.37 2.07 
Cell 2 17921722 17022165 899557 0.90 5.02 
Cell 3 17022165 18591246 -1569081 -1.57 -9.22 
Cell 4 18591246 17550343 1040904 1.04 5.60 
 
 
Table C 37: Mass change of cBOD5 observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
  
cBOD5 
mass in 
(mg) 
cBOD5  
mass out  
(mg) 
cBOD5 
mass 
change 
(mg) 
cBOD5 
mass 
change 
(Kg) 
cBOD5 
mass % 
change 
Overall 
treatment 
system 
22388542 361100 22027443 22.03 98.39 
Cell 2 22388542 12029514 10359029 10.36 46.27 
Cell 3 12029514 3510693 8518820 8.52 70.82 
Cell 4 3510693 361100 3149594 3.15 89.71 
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Table C 38: Mass change of COD observed in different components of the treatment system. The +ve 
values indicate mass loses from the system component and the -ve values indicate mass gains within the 
system component. 
 
  
COD mass 
in (mg) 
COD  mass 
out  (mg) 
COD mass 
change 
(mg) 
COD mass 
change 
(Kg) 
COD mass 
% change 
Overall 
treatment 
system 
48819048 13549821 35269227 35.27 72.24 
Cell 2 48819048 32135788 16683260 16.68 34.17 
Cell 3 32135788 11550415 20585373 20.59 64.06 
Cell 4 11550415 13549821 -1999405 -2.00 -17.31 
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Appendix D 
Summary of Data Presented in Chapter 5 
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Table D 1: Concentrations of caffeine (µg L
-1
) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 61 53 11 10 
6-Apr-10 26 11 1.5 2.0 
13-Apr-10 15 13 7.6 2.9 
30-Apr-10 15 10 1.6 0.32 
10-Dec-10 5.1 12 6.8 3.9 
28-Jan-11 13 15 11 5.8 
 
 
 
Table D 2: Concentrations of carbamazepine (µg L
-1
) along the treatment flow path of the 
EW-BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 9.3 8.4 8.1 5.9 
6-Apr-10 5.4 4.7 2.1 6.3 
13-Apr-10 3.6 4.0 4.7 3.7 
30-Apr-10 2.7 6.8 7.2 6.8 
10-Dec-10 0.17 0.17 0.16 0.12 
28-Jan-11 - 0.42 0.38 0.55 
 
 
 
Table D 3: Concentrations of sulfamethoxazole (µg L
-1
) along the treatment flow path of 
the EW-BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 0.073 0.078 0.060 0.028 
6-Apr-10 - 0.044 0.092 - 
13-Apr-10 0.101 0.075 - 0.066 
30-Apr-10 0.080  0.028 0.063 
10-Dec-10 0.003 0.003 0.003 0.003 
28-Jan-11 - 0.019 0.018 0.027 
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Table D 4: Concentrations of ibuprofen (µg L
-1
) along the treatment flow path of the EW-
BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 59 44 16 16 
6-Apr-10 70 68 29 22 
13-Apr-10 70 69 43 37 
30-Apr-10 36 54 26 18 
10-Dec-10 29 31 22 18 
28-Jan-11 19 23 6.2 4.6 
 
 
 
 
Table D 5: Concentrations of naproxen (µg L
-1
) along the treatment flow path of the EW-
BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 8.5 12 16 9.7 
6-Apr-10 11 13 8.0 7.3 
13-Apr-10 13 12 11 7.0 
30-Apr-10 7 13 4.8 4.5 
10-Dec-10 11 12 6.6 3.9 
28-Jan-11 0.78 1.3 0.27 0.12 
 
 
 
 
Table D 6: Concentrations of acesulfame-K (µg L
-1
) along the treatment flow path of the 
EW-BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 54 51 42 36 
6-Apr-10 94 56 52 66 
13-Apr-10 77 68 61 34 
30-Apr-10 35 39 44 41 
10-Dec-10 58 58 56 54 
28-Jan-11 81 79 69 62 
 
 
 
 
 319 
Table D 7: pH values along the treatment flow path of the EW-BOFS demonstration-scale 
treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 8.95 9.61 8.10 12.32 
6-Apr-10 8.68 8.30 7.41 11.97 
13-Apr-10 8.43 8.14 7.61 11.10 
30-Apr-10 7.38 7.70 7.58 10.40 
10-Dec-10 8.12 8.13 7.82 9.41 
28-Jan-11 8.10 8.35 7.72 9.49 
 
 
 
Table D 8: Measurements of alkalinity (mg L
-1
 CaCO3) along the treatment flow path of the EW-
BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 630 490 230 1620 
6-Apr-10 729 520 260 760 
13-Apr-10 460 520 200 640 
30-Apr-10 700 740 540 360 
10-Dec-10 430 340 300 200 
28-Jan-11 425 460 175 200 
 
 
 
Table D 9: Measurements of Eh (mV) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 -33 -4 279 31 
6-Apr-10 90 144 364 180 
13-Apr-10 83 128 311 130 
30-Apr-10 68 71 286 79 
19-May-10 -6 43 267 101 
2-Jun-10 -69 14 250 63 
3-Jun-10 -28 19 421 105 
16-Jun-10 -26 13 261 72 
20-Jul-10 112 152 520 92 
28-Jan-11 7 37 284 76 
13-Jul-11 82 229 228 59 
27-Oct-11 119 263 270 215 
29-Nov-11 265 419 407 232 
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Table D 10: Concentrations of DO (mg L
-1
) along the treatment flow path of the EW-BOFS 
demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 1.4 1.4 12 3.0 
6-Apr-10 0.26 0.20 11 3.8 
13-Apr-10 3.5 0.70 8.7 6.0 
30-Apr-10 0.85 2.4 11 3.4 
10-Dec-10 2.9 3.7 10 7.8 
28-Jan-11 1.3 4.6 10 8.5 
 
 
 
 
Table D 11: Concentrations of cBOD5 (mg L
-1
) along the treatment flow path of the EW-
BOFS demonstration-scale treatment system experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 169 52 37 <DL 
6-Apr-10 202 85 37 <DL 
13-Apr-10 59 63 10 <DL 
30-Apr-10 92 76 9.2 <DL 
10-Dec-10 22 10 2.0 <DL 
28-Jan-11 52 11 1.0 <DL 
DL: 1 mg L-1    
 
 
 
Table D 12: Concentrations of NH3-N (mg L
-1
) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 61 35 13 47 
6-Apr-10 47 59 22 14 
13-Apr-10 57 68 30 20 
30-Apr-10 40 60 27 13 
10-Dec-10 41 49 30 18 
28-Jan-11 57 49 4.4 2.0 
DL: 0.02 mg L-1 
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Table D 13: Concentrations of NO3-N (mg L
-1
) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 5.3 7.7 83 12 
6-Apr-10 10 1.0 48 56 
13-Apr-10 7.7 0.16 48 48 
30-Apr-10 8.9 0.01 43 58 
10-Dec-10 14 3.1 33 46 
28-Jan-11 9.1 0.74 39 40 
DL: 0.05 mg L-1 
    
 
 
Table D 14: Concentrations of Cl (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 189 182 185 154 
6-Apr-10 220 204 170 144 
13-Apr-10 189 198 193 186 
30-Apr-10 218 226 206 195 
10-Dec-10 140 148 140 135 
28-Jan-11 205 209 192 184 
 
 
 
 
 
Table D 15: Concentrations of SO4 (mg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 
19-Feb-10 37 45 49 25 
6-Apr-10 51 46 50 42 
13-Apr-10 46 43 50 44 
30-Apr-10 32 27 32 37 
10-Dec-10 56 57 58 52 
28-Jan-11 74 77 85 78 
DL: 0.018 mg L-1 
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Table D 16: Concentrations of Fe (µg L
-1
) along the treatment flow path during the EW-
BOFS demonstration-scale wastewater treatment experiment. 
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
19-Feb-10 22 97 76 3.4 0.07 
6-Apr-10 21 39 28 2.2 0.07 
13-Apr-10 29 64 51 21 0.07 
30-Apr-10 25 82 57 4.7 0.07 
10-Dec-10 13 25 15 23 0.26 
28-Jan-11 11 21 16 4.7 0.26 
 
 
Table D 17: Concentrations of Mn (µg L
-1
) along the treatment flow path during the EW-BOFS 
demonstration-scale wastewater treatment experiment.  
Date Cell 1 Cell 2 Cell 3 Cell 4 DL (µg L-1) 
19-Feb-10 4.9 11 89 0.15 0.04 
6-Apr-10 16 25 102 0.04 0.04 
13-Apr-10 17 39 140 2.1 0.04 
30-Apr-10 36 75 89 0.84 0.04 
10-Dec-10 4.0 25 31 3.8 0.03 
28-Jan-11 24 15 30 23 0.03 
 
